cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
21493,Benzyl 4-hydroxyphenyl ketone,219-654-5,2491-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
21494,"3-[[4-[(5,6-dichloro-2-benzothiazolyl)azo]-3-methylphenyl]ethylamino]propiononitrile",248-824-1,28080-90-2,Not Classified,Notified C&L,10,Not classified:10
21500,N-(4-chlorobenzhydryl)piperazine,206-137-4,303-26-4,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Repr. 2,REACH registration C&L,56,H314:2;H317:2;H361:12;H318:2;H302:13;H315:52;H319:52;H400:2;H335:49
21502,"Potassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']ferrate(1-)",259-411-0,54959-35-2,Not Classified,REACH registration C&L,94,Not classified:94
21503,1-(furan-2-ylmethylsulfanyl)propan-2-one,611-617-5,58066-86-7,Not Classified,Notified C&L,93,Not classified:88;H335:5;H315:5;H319:5
21504,Dibutyl thioperoxydicarbonate,203-330-5,105-77-1,Acute Tox. 4,Notified C&L,38,H302:38
21505,Trineopentylaluminium,256-000-8,42916-36-9,Not Classified,Notified C&L,1,Not classified:1
21506,Zinc diundec-10-enoate,209-155-0,557-08-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,37,H412:33;H315:33;H319:33;Not classified:3;H410:1;H302:1
21509,"Disodium 7-[[4,6-bis[(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-2-sulphonate",269-246-6,68201-95-6,Not Classified,REACH registration C&L,131,Not classified:94;H314:37
21511,"Dihydro-3-(octenyl)furan-2,5-dione",247-899-8,26680-54-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,93,H317:85;H413:85;H315:92;H319:90;Not classified:1;H302:1;H312:1
21512,3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride,618-049-7,87691-88-1,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Repr. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H317:1;H302:1;H361:1;H410:1;H400:1
21513,"musk xylene;5-tert-butyl-2,4,6-trinitro-m-xylene",201-329-4,81-15-2,Expl. 1.1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H201:0;H351:0;H400:0
21518,2-hydroxytetrahydrofuran,236-569-9,13436-46-9,Flam. Liq. 2,Notified C&L,38,H225:38
21520,benzyl alcohol,202-859-9,100-51-6,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0
21521,"Imidazolium compounds, 4,5-dihydro-2-(hydrogenated nortallow alkyl)-1-[2-(hydrogenated tallow amido)ethyl]-3-methyl-, Me sulfates",297-467-8,93572-37-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,6,H315:6;H318:6
21523,Allyltributylstannane,246-494-3,24850-33-7,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H301:45;H372:43;H319:44;H315:44;H410:44;H312:44;H400:44;H331:1;H311:1;H330:1
21526,Saccharomyces cerevisiae (yeast),614-750-7,68876-77-7,Not Classified,Notified C&L,1,Not classified:1
21527,2-Chloro-5-fluoroanisole,610-224-6,450-89-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
21528,Sodium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),264-966-7,64611-73-0,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,150,H317:14;H319:97;H412:92;Not classified:46;H411:6
21529,"Extracts (petroleum), catalytic reformed light naphtha solvent;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",295-331-2,91995-68-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
21532,"Cobaltate(1-), bis[[]6-(amino-[?]N)-5-[[]2-[[]2-(hydroxy-[?]O)-4-nitrophenyl]diazenyl-[?]N1]-N-methyl-2-naphthalenesulfonamidato(2-)]-, sodium (1:1)",615-088-1,70236-59-8,Not Classified,Notified C&L,15,Not classified:15
21534,(N-phenylcarbamimidoyl)ammonium carbonate hydrate,485-350-6,,Skin Sens. 1;Eye Dam. 1,Notified C&L,2,H317:2;H318:2;H411:1
21536,"Disodium 3-hydroxy-4-[(2,4,5-trimethylphenyl)azo]naphthalene-2,7-disulphonate",222-638-0,3564-09-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,39,H351:39;H319:38;H335:38;H302:38;H315:38;H341:1
21539,3-(4-methoxybenzoyl)propionic acid,221-593-4,3153-44-4,Not Classified,REACH registration C&L,44,Not classified:1;H335:42;H315:43;H319:43
21541,Acetophenone oxime,210-360-2,613-91-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,43,H302:43;H318:38
21543,"(3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide",420-380-5,136465-81-1,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0
21544,4-hydroxyazobenzene,216-880-6,1689-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H351:1;H302:1
21546,Ciclonium bromide,249-687-0,29546-59-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 2,Notified C&L,39,H302:39;H330:38;H312:38
21548,"9,10-dioxoanthracene-2-carboxylic acid",204-207-9,117-78-2,Not Classified,REACH registration C&L,3,Not classified:1;H361:2;H351:2;H341:2
21553,2-(butylnitroamino)ethyl nitrate,279-976-7,82486-82-6,Expl. 1.3;Acute Tox. 4;Muta. 2,REACH registration C&L,4,H203:4;H302:2;H341:2
21556,Ethyl anisate,202-320-8,94-30-4,Not Classified,Notified C&L,137,Not classified:137
21557,4-pyridylmethanol N-oxide,244-926-5,22346-75-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
21558,Carmustine,205-838-2,154-93-8,Acute Tox. 2;Carc. 1B;Repr. 1B,Notified C&L,41,H300:41;H350:41;H360:41;H372:2;H370:2;H341:2
21559,α-oxocyclohexaneacetic acid,224-426-3,4354-49-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H302:2;H315:2;H319:2
21560,"2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol",419-740-4,137658-79-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
21561,"Tricyclo[3.3.1.13,7]decane-1,3-dicarboxylic acid",254-395-1,39269-10-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:1;H319:1;Not classified:1
21568,"Bidens tripartita, ext.",289-613-4,89957-92-6,Eye Irrit. 2;STOT SE 3,Notified C&L,25,H335:25;H319:25
21570,"Methyl [1R-[1α,2β(Z)]]-3-oxo-2-(pent-2-enyl)cyclopentaneacetate",214-918-6,1211-29-6,Not Classified,Notified C&L,88,Not classified:88
21572,1-(3-methoxypropyl)-4-piperidinamine,431-950-8,179474-79-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H314:0;H302:0;H412:0;H312:0
21573,Methyl nonadecan-1-oate,217-056-9,1731-94-8,Not Classified,Notified C&L,6,Not classified:6
21576,"Acide phosphorique, esters d'alkyles avec l'heptadécényl-2 dihydro-4,5 1H-imidazole éthanol-1",919-798-5,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
21578,Dibenzofuran-3-ol,243-671-7,20279-16-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
21580,"Ethyl 9,9-dioctyl-4,7,11-trioxo-3,8,10-trioxa-9-stannatetradeca-5,12-dien-14-oate",268-500-3,68109-88-6,Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 1,REACH registration C&L,24,H372:24;H361:24;H315:24;H319:3;H413:21
21584,"Polymethylenepolyphenylene polyisocyanate, oligomeric reaction products with 2,2-bis (bromomethyl)-propane-1,3-diol, polyethoxylated and polypropoxylated glycerol, α, α' ,α '' -1,2,3-propanetriyltris[ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)]], toluene diisocyanate and water",500-601-2,161278-12-2,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,2,H317:2;H334:2;H319:2
21588,cyclohexyl-hydroxy-phenyl-acetic acid prop-2-ynyl ester,922-954-5,,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H336:1;H319:1;H228:1;H332:1;H302:1;H312:1
21590,"Oils, Calendula officinalis",615-192-7,70892-20-5,Not Classified,Notified C&L,77,Not classified:77
21591,2-[(4-methoxy-2-nitrophenyl)azo]acetoacetanilide,229-354-6,6486-21-1,Not Classified,Notified C&L,17,Not classified:17
21594,"Disodium 3,6-bis[(o-arsonophenyl)azo]-4,5-dihydroxynaphthalene-2,7-disulphonate",263-516-7,62337-00-2,,Notified C&L,4,H410:4;H301:4;H373:4;H331:4
21600,"2,4-dichlorobenzyl alcohol",217-210-5,1777-82-8,Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,371,H332:86;H412:358;H318:96;H335:5;H315:5;Not classified:1;H319:2;H302:2;H312:1
21604,Butyl-2-thiourea,216-165-9,1516-32-1,Acute Tox. 3,Notified C&L,44,H301:38;H302:5;H335:1;H315:2;H319:2
21609,picoxystrobin (ISO); methyl (2E)-3-methoxy-2-[2-({[6-(trifluoromethyl)pyridin-2-yl]oxy}methyl)phenyl]acrylate,601-478-9,117428-22-5,Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,228,H332:228;H410:190;H319:228;H400:228
21611,4-[4-(Trifluoromethoxy)phenoxy]piperidine,608-252-9,287952-67-4,,Notified C&L,6,H335:5;H315:6;H319:6
21612,2-(2-pyridyl)benzimidazole,214-508-7,1137-68-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H335:60;H302:60;H315:61;H319:61;Not classified:1
21613,"Decahydro-1,1,7-trimethyl-3a,7-methano-3aH-cyclopentacyclooct-3-yl formate",261-118-8,58096-47-2,Aquatic Chronic 2,REACH registration C&L,98,H401:2;H411:12;Not classified:61;H317:25
21614,LIQUIWAX (TM) DIEFA,438-100-5,,Not Classified,Notified C&L,1,Not classified:1
21616,"reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate",402-660-9,,Aquatic Chronic 3;Repr. 1B,Harmonised C&L,0,H412:0;H360:0
21619,"Sulfuric acid magnesium salt (1:1), monohydrate",604-246-5,14168-73-1,Not Classified,Notified C&L,7,Not classified:7
21621,Undecylbenzene,229-806-2,6742-54-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
21622,"Pine, Pinus halepensis, ext.",306-894-1,97435-13-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H304:1;H226:1;H317:1;H315:1;H411:1
21625,"11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-hexanoate",273-898-7,69164-69-8,Repr. 1A;STOT RE 2,Notified C&L,26,H373:25;H360:24;H319:1;H335:1;H332:1;H302:1;H315:1;H312:1;H361:1
21626,Triethylindium,213-095-0,923-34-2,Pyr. Liq. 1;Skin Corr. 1B,Notified C&L,39,H250:39;H314:38;H252:1;H319:1;H260:1;H335:1;H315:1
21627,"3,5-dichloro-2-hydroxybenzenesulphonyl chloride",245-619-9,23378-88-3,Skin Corr. 1B,Notified C&L,43,H314:43;H318:1
21629,Chlorphentermine hydrochloride,205-782-9,151-06-4,Acute Tox. 3;Repr. 2,Notified C&L,1,H301:1;H361:1
21633,"Disodium [5-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzene-1,3-disulphonato(4-)]cuprate(2-)",276-541-3,72252-61-0,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,1316,H317:4;H302:4;H318:4;Not classified:1312
21635,"3,5-dimethylhex-1-yn-3-ol",203-500-9,107-54-0,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,233,H302:112;H315:104;H319:143;H226:194;Not classified:38;H301:51;H331:38;H311:38;H312:57;H332:21;H335:13
21636,"1,2-dichloro-3-(dichloromethyl)benzene",611-456-0,57058-14-7,Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H314:2;H318:1;H335:1;H332:1;H302:1;H312:1
21638,6-Methyl pyridine-3-carboxylic methyl ester,611-187-9,5470-70-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H335:47;H315:54;H319:54;H332:1;H302:1
21640,"Erythraea centaurium, ext.",284-285-9,84837-00-3,Not Classified,Notified C&L,2,Not classified:2
21641,2-methylhydroquinone,202-443-7,95-71-6,Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,471,H335:112;H317:97;H314:10;H410:42;H318:103;H400:267;H302:422;H351:119;H341:119;H315:151;H319:145;H312:22;Not classified:5;H332:1;H301:2
21647,"Disodium 4,5-dihydroxy-3-phenylazonaphthalene-2,7-disulphonate",224-085-0,4197-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:40;H315:41;H319:41;Not classified:1
21651,"1,2,4-Benzenetricarboxylic acid, ester with 1,2-propanediol phosphate",269-046-9,68186-81-2,Not Classified,Notified C&L,650,Not classified:650
21653,Tetrafluoro-p-benzoquinone,208-411-9,527-21-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
21655,"L-1,2-dihydroxy-4-((1-hydroxy-2-(isopropyl)amino)ethyl)benzene D-bitartrate",259-322-7,54750-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;Not classified:38;H315:38;H319:38
21656,Ketocaine,214-131-8,1092-46-2,Acute Tox. 4;STOT SE 3,REACH registration C&L,2,H302:2;H335:2
21660,2-octyldodecyl oleate,245-228-3,22801-45-2,Not Classified,Notified C&L,4,Not classified:4
21664,"1,5-anhydro-2-deoxy-D-arabino-hex-1-enitol",236-259-3,13265-84-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
21670,"2,2'-[methylenebis(o-phenyleneoxymethylene)]bisoxirane",259-026-8,54208-63-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,26,H317:24;H315:24;H319:24;Not classified:2;H411:2
21671,1-ethynylcyclohexyl acetate,226-040-0,5240-32-4,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,224,H412:1;H302:1;H315:1;Not classified:223
21672,3-methoxypropene,210-997-6,627-40-7,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2,Notified C&L,43,H302:38;H319:39;H225:43;H315:1
21676,"D-Phenylalanine, N-[(phenylmethoxy)carbonyl]-",607-387-0,2448-45-5,Not Classified,Notified C&L,2,Not classified:2
21678,p-(dimethoxymethyl)anisole,218-577-4,2186-92-7,Not Classified,Notified C&L,86,Not classified:85;H303:1;H335:1;H315:1;H319:1
21681,"4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol",410-610-2,111850-24-9,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H317:0;H373:0;H315:0;H410:0;H400:0
21684,"Propionic acid, 2,2',2''-[(methylsilylidyne)trioxy]tri-, triethyl ester",605-844-9,17898-75-8,Not Classified,Notified C&L,1,Not classified:1
21688,"3,5-Dibromotoluene",605-248-9,1611-92-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
21689,3-methyl-2-thenoic acid,245-894-5,23806-24-8,,Notified C&L,6,H335:5;H315:6;H319:6
21690,Isonicotinonitrile,202-856-2,100-48-1,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,216,H302:212;H319:16;H332:201;H312:201;H315:5;H335:1
21695,"D-Glucopyranose, oligomers, branched and linear C9-11-alkyl glycosides",500-394-9,157707-87-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,11,H315:8;H318:8;H319:2;Not classified:1
21696,"Acetamide,N-[9-[[2-(acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-",617-838-3,86357-14-4,Muta. 2;Carc. 2;Repr. 2;Lact.,REACH registration C&L,2,H362:1;H361:1;H351:2;H341:1;H360:1;H340:1
21699,"Formaldehyde, reaction products with epichlorohydrin and ethanolamine",291-302-3,90367-52-5,Not Classified,Notified C&L,1,Not classified:1
21704,"2,3-dihydro-4-quinolone hydrochloride",275-428-6,71412-22-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H335:2;H302:3;H315:2;H319:2
21710,"α,α,α,α',α',α'-hexafluoro-3,5-xylidine",206-335-0,328-74-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:40;H315:47;H319:47;H332:5;H373:5;H302:5;H312:5;H226:1;H301:1;H330:1;H311:1
21713,Myristic acid,208-875-2,544-63-8,Not Classified,Notified C&L,2681,Not classified:2105;H319:354;H315:183;H317:72;H411:73;H318:72;H413:76;H335:6;H351:1
21715,1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile,427-450-4,152630-47-2,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H411:0;H373:0
21717,Diallyl itaconate,220-448-2,2767-99-9,,Notified C&L,1,H335:1;H315:1;H319:1
21720,"7,17,28,38-tetraazatridecacyclo[24.16.2.2²,⁵.1⁸,¹².1²⁹,³³.0³,²².0⁴,¹⁹.0⁶,¹⁷.0²³,⁴³.0²⁷,³⁸.0⁴⁰,⁴⁴.0¹⁶,⁴⁶.0³⁷,⁴⁵]octatetraconta-1(42),2(48),3,5(47),6,8,10,12(46),13,15,19,21,23,25,27,29(45),30,32,34,36,40,43-docosaene-18,39-dione; 7,17,28,38-tetraazatridecacyclo[24.16.2.2²,⁵.1⁸,¹².1²⁹,³³.0³,²².0⁴,¹⁹.0⁶,¹⁷.0²³,⁴³.0²⁸,³⁹.0⁴⁰,⁴⁴.0¹⁶,⁴⁶.0³⁷,⁴⁵]octatetraconta-1(42),2(48),3,5(47),6,8,10,12(46),13,15,19,21,23,25,29,31,33,35,37(45),38,40,43-docosaene-18,27-dione",475-310-6,,Not Classified,REACH registration C&L,1,Not classified:1
21721,Diallyldiphenylsilane,234-061-1,10519-88-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
21723,"1,3-bis(methoxymethyl)imidazolidin-2-one",220-210-8,2669-72-9,,Notified C&L,1,Not classified:1
21728,4-[4-trans-(trans-Propen-1-yl)-cyclohexyl]-benzonitril,619-197-5,96184-40-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
21732,"Formaldehyde, reaction products with sulfonated 1,1'-oxybis[methylbenzene] and sulfonylbis[phenol], sodium salts",302-224-7,94095-19-9,Aquatic Chronic 3,Notified C&L,33,H412:33
21734,2-Amino-4'-chlorobiphenyl,601-706-7,1204-44-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1;H332:1;H302:1;H312:1
21736,"2,6,10-trimethylundec-9-enal",205-460-8,141-13-9,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1633,H410:1376;H317:1295;H411:6;H400:1376;Not classified:256;H361:1
21737,"Quaternary ammonium compounds, di-C8-18-alkyldimethyl, monoisooctyl phosphates (1:1)",277-958-3,74665-00-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,47,H315:47;H319:47
21740,"Stearic acid, lead salt",231-068-1,7428-48-0,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1,Notified C&L,2,H360:1;H332:2;H373:1;H302:1;H410:1;H400:1;H301:1;H319:1;H335:1;H315:1;H311:1
21742,3-[[]butoxy(methyl)phosphoryl]-1-cyanopropyl acetate,605-460-1,167004-78-6,Acute Tox. 3;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H301:1;H317:1;H411:1
21744,"diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate",401-770-4,148324-78-1,Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H314:0;H302:0
21746,"Sodium hydrogen -2-amino-5-methoxybenzene-1,4-disulphonate",280-718-0,83763-33-1,Eye Dam. 1,Notified C&L,1,H318:1
21748,"Benzenemethanesulfonamide, N-methyl-4-nitro-",617-784-0,85952-29-0,,Notified C&L,4,H335:4;H315:4;H319:4
21749,"p-mentha-1,4-diene",202-794-6,99-85-4,Flam. Liq. 3;Repr. 2;Aquatic Chronic 2,REACH registration C&L,1963,H361:55;H411:44;H226:1951;H304:1868;H315:97;H335:48;H319:49;H412:24;H317:25;H332:17;H302:28;Not classified:5;H410:1
21755,"5,5'-Bis-1H-tetrazol, Diammoniumsalz",619-489-2,3021-02-1,Self-react. C;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,15,H315:14;H319:14;H242:12;H335:2;H225:1;H228:2;H360:1
21756,2-methoxyaniline;o-anisidine,201-963-1,90-04-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B,Harmonised C&L,0,H301:0;H350:0;H331:0;H341:0;H311:0
21757,"Amines, N,N,N'-trimethyl-N'-tallow alkyltrimethylenedi-",272-192-6,68783-25-5,,Notified C&L,1,H315:1;H318:1;H400:1
21759,Naphthalenedisulfonic acid,607-579-4,25167-78-6,Skin Corr. 1B,REACH registration C&L,1,H314:1
21761,(R)-3-phenyllactic acid,230-803-3,7326-19-4,Not Classified,REACH registration C&L,1,Not classified:1
21766,"Fats and Glyceridic oils, vegetable, esters with polyglycerol",614-841-1,68953-55-9,Not Classified,Notified C&L,1,Not classified:1
21768,"2,5-dimethylthiophen-3-yl methyl ketone",219-779-5,2530-10-1,Not Classified,Notified C&L,94,Not classified:82;H315:12;H319:12;H335:6;H302:1
21769,"2-Oxepanone, polymer with 1,3-propanediol, block",617-811-6,861883-84-3,,Notified C&L,25,Not classified:25
21777,O-methylhydroxylamine,200-660-1,67-62-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,157,H332:157;H302:157;H314:157;H312:157;H318:157
21780,N-butylacetanilide,202-071-5,91-49-6,Skin Corr. 1C;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H314:1;H412:1;H319:1
21784,[3-(Ethoxycarbonyl)propyl]triphenylphosphonium bromide,610-534-1,50479-11-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
21789,"(4R)-4-phenyl-1,3-oxazolidin-2-one",618-527-5,90319-52-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H302:2;H312:2
21791,"D-Glucopyranose, oligomers, monocitrate, coco alkyl glycosides",500-535-4,161074-99-3,Not Classified,Notified C&L,1,Not classified:1
21800,Octanohydrazide,228-612-5,6304-39-8,Eye Irrit. 2;STOT SE 3,Notified C&L,92,H335:53;H319:54;H302:39;H315:1
21803,Trisodium orthophosphate,231-509-8,7601-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1271,H335:977;H315:1081;H319:1083;H314:107;Not classified:77;H318:11;H290:3;H331:3;H302:1
21804,Tripelennamine hydrochloride,205-833-5,154-69-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:38;H302:49;H315:38;H319:38;H331:11;H373:11;H361:11;H411:11;H318:11;Not classified:1
21805,"Anise, ext.",283-872-7,84775-42-8,Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,1485,H412:1420;H317:1457;H351:1405;H341:1405;Not classified:26;H411:14;H226:4;H332:2;H302:2;H312:2
21809,"(1R,3s,5S)-8-benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane",447-620-1,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,3,H412:3;H302:3;H318:3
21811,"Dodecane-1,2-diol",214-289-8,1119-87-5,Eye Irrit. 2,Notified C&L,108,H319:83;Not classified:25
21813,"Hydrocarbons, C",308-132-3,97862-82-3,Carc. 1B,Harmonised C&L,0,H350:0
21816,Butenyne,211-713-3,689-97-4,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,68,H280:68;H220:68
21822,4-nitrophenyl acetate,212-593-5,830-03-5,Ox. Sol. 3;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1,H317:1;H272:1;H318:1
21826,Cefalotin sodium,200-394-6,58-71-9,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,43,H317:43;H334:42;H335:1;H315:1
21829,"Nonanoic acid, mixed esters with heptanoic acid, pentaerythritol and valeric acid",274-765-6,70693-39-9,Not Classified,REACH registration C&L,3,Not classified:3
21832,6-dimethylaminohexan-1-ol,404-680-3,1862-07-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H314:0;H302:0;H412:0
21836,"Cyclohex-4-ene-1,2-dicarboxylic acid",201-872-7,88-98-2,Eye Dam. 1,Notified C&L,49,H318:47;Not classified:1;H315:1;H319:1
21844,Methysergide hydrogen maleate,204-950-9,129-49-7,Acute Tox. 3,Notified C&L,43,H301:43;H331:3;H311:1;H361:1;H341:1
21845,"2,2-bis(p-chlorophenyl)-1,1-dichloroethylene",200-784-6,72-55-9,,Notified C&L,17,H331:8;H400:14;H332:8;H302:16;H315:8;Not classified:9;H311:8;H410:6;H351:1
21846,Barium distearate,229-966-3,6865-35-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,332,H332:320;H302:326;Not classified:6
21848,"Hyacinth (plant), ext.",305-055-7,94333-75-2,Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,55,H351:55;H319:55;H317:55;H412:55;H341:55
21849,"2,3-dibromopropionamide",239-153-5,15102-42-8,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,46,H314:38;H302:38;H335:42;H315:5;H319:5;Not classified:3
21852,"2-({[[](4,6-dimethoxypyrimidin-2-yl)carbamoyl]amino}sulfonyl)-N,N-dimethylpyridine-3-carboxamide",601-148-4,111991-09-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,283,H410:276;H400:276;H315:45;H319:44;H411:1;H331:1;H412:1;H317:1;H351:1
21853,[No public or meaningful name is available],476-100-7,,Not Classified,Notified C&L,25,Not classified:25
21854,"Hydrocarbons, C",308-133-9,97862-83-4,Carc. 1B,Harmonised C&L,0,H350:0
21856,"1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinamide",249-433-9,29097-12-9,Not Classified,REACH registration C&L,13,Not classified:11;H317:1;H318:1;H315:1;H319:1
21859,2-furfurylthio-3-methylpyrazine,261-690-9,59303-07-0,Not Classified,Notified C&L,126,Not classified:88;H335:38;H315:38;H319:38
21861,"Residues (petroleum), catalytic cracking;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C",295-511-0,92061-97-7,Carc. 1B,Harmonised C&L,0,H350:0
21866,Dimethylaluminium chloride,214-668-8,1184-58-3,Flam. Liq. 2;Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,40,H250:40;H260:40;H225:38;H314:40
21869,(isodecanoato-O)(isononanoato-O)nickel,284-348-0,84852-36-8,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H372:0;H350:0;H334:0;H360:0;H317:0;H410:0;H341:0;H400:0
21877,4-chlorophenol,203-402-6,106-48-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H302:0;H411:0;H312:0
21879,2-chloro-4-hydroxybenzoic acid,260-132-1,56363-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H315:2;H319:2
21881,"Silane, butylchlorodimethyl-, hydrolysis products with silica",296-747-7,93028-55-8,Eye Irrit. 2,Notified C&L,38,H319:38
21885,Barium hydrogen 3-hydroxy-2-(phosphonatooxy)propionate,258-813-3,53823-72-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38
21888,"1-Propanesulfonic acid, 3-[ethyl(3-methylphenyl)amino]-2-hydroxy-, sodium salt (1:1)",617-377-8,82692-93-1,,Notified C&L,2,H332:1;H302:1;H312:1;Not classified:1
21890,2-propylthiazole,241-606-7,17626-75-4,,Notified C&L,1525,H302:1286;H226:1292;Not classified:233
21892,[No public or meaningful name is available],924-804-4,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H317:25;H319:25
21893,1-(allyloxy)butane,223-122-8,3739-64-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43;H225:39;H224:4
21896,Tris(tridecan-1-yl) phosphite,223-821-8,4089-53-6,Not Classified,Notified C&L,2,Not classified:1;H317:1
21898,"Cobaltate(3-), bis[5-chloro-2-hydroxy-3-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenesulfonato(3-)]-, diethanolamine sodium salts",284-052-1,84777-24-2,Eye Dam. 1,Notified C&L,84,H318:84
21903,"L-lysine, compound with 5-oxo-L-proline (1:1)",250-275-8,30657-38-6,Not Classified,Notified C&L,1,Not classified:1
21904,6-methyl-2-oxoperhydropyrimidin-4-ylurea,214-447-6,1129-42-6,Not Classified,REACH registration C&L,87,Not classified:87
21910,"2,2-dibromopropane",209-828-9,594-16-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
21914,"3-(3-formamidosalicylamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate",211-380-4,642-15-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,194,H331:194;H301:194;H311:194
21917,"S(-)-3-(4-phenylpiperazin-1-yl)-1,2-propanediol L(+)-tartrate",927-754-1,,Not Classified,Notified C&L,1,Not classified:1
21920,Methyl 5-(chloromethyl)-2-furoate,218-405-8,2144-37-8,Skin Corr. 1B,Notified C&L,40,H314:38;H335:2;H315:2;H319:2
21923,Tristrontium bis(orthophosphate),231-206-0,7446-28-8,Not Classified,Notified C&L,2,Not classified:2
21924,C.I. Disperse Red 343,619-390-4,99035-78-6,Not Classified,Notified C&L,2,Not classified:2
21929,(2-hydroxyethyl)ammonium toluene-p-sulphonate,264-785-3,64339-49-7,Not Classified,Notified C&L,11,Not classified:9;H319:2
21930,trans-1-butoxy-4-(4-propylcyclohexyl)benzene,279-238-4,79709-84-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
21931,"1,2,3,4,6,7,8,9-octahydrophenazine",223-659-8,4006-50-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
21932,4-[2-(4-tert-butyl-phenyl)-ethoxy]-quinazoline,601-746-5,120928-09-8,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H332:194;H301:194;H410:194;H400:194
21933,"Amides,from tallow fatty acids and tetraethylenepentamine",614-474-7,68425-45-6,Skin Corr. 1C;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H314:1;H317:2;H410:1;H335:1;H315:1;H319:1
21935,Allyl phenoxyacetate,231-335-2,7493-74-5,Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 1,REACH registration C&L,1576,H317:1500;H302:1576;H400:20;H315:1515;H312:1486;H332:39;H311:79;H319:35;H301:1;H335:1
21943,nickel dioxide,234-823-3,12035-36-8,Skin Sens. 1;STOT RE 1;Aquatic Chronic 4;Carc. 1A,Harmonised C&L,0,H317:0;H350:0;H413:0;H372:0
21946,"(S)-(-)-a,a-Diphenypyrrolidin-2-methanol",601-153-1,112068-01-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:45;H315:47;H319:47;Not classified:1
21947,Trimethyl(2-propynyloxy)silane,226-981-7,5582-62-7,Flam. Liq. 2,Notified C&L,43,H225:43;H302:5;H319:1;H335:1;H315:1
21951,"Trisodium 5-[[4-[(2-bromo-1-oxoallyl)amino]benzoyl]amino]-3-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4-hydroxynaphthalene-2,7-disulphonate",274-398-1,70210-00-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,19,H315:14;H319:14;H317:8;Not classified:3
21952,"1,3,3-trimethyl-2-[(methylphenylhydrazono)methyl]-3H-indolium chloride",259-858-1,55850-01-6,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H410:2;H301:2;H318:4;H400:2;H302:3;H319:1;Not classified:1
21955,Diammonium dihydrogenpyrophosphate,237-059-9,13597-86-9,Not Classified,Notified C&L,2,Not classified:2
21956,"Fatty acids, C8-10, calcium salts",292-908-0,91002-30-1,Not Classified,Notified C&L,3,Not classified:3
21960,"1,3-Propanediamine, N-[3-(tridecyloxy)propyl]-, branched",270-851-2,68479-04-9,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,961,H314:961;H410:496;H400:496;H317:441;H318:441;H302:50;H372:1;H370:1
21962,Tripiperazine dicitrate,205-622-8,144-29-6,Skin Corr. 1B;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,7,H314:2;H317:2;H319:4;H302:3;H318:3;H335:2;H315:2
21963,3-ethylhexahydro-3H-benzofuran-2-one,259-185-3,54491-17-7,Not Classified,Notified C&L,233,Not classified:233
21965,1-(3-phenoxyphenyl)ethan-1-one,251-259-3,32852-92-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
21967,"Phenol, 4-(trans-4-butylcyclohexyl)-",618-183-6,88581-00-4,Not Classified,Notified C&L,2,Not classified:1;H317:1;H413:1
21971,"Formaldehyde, reaction products with epichlorohydrin, 1H-imidazole and morpholine",291-303-9,90367-53-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1;H400:1
21974,1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one,208-912-2,546-80-5,Acute Tox. 4,Notified C&L,1769,H302:1603;H301:167;H319:2;H304:1;H317:1;H315:2;H410:1;H311:1;H226:1;H332:1
21978,"Sodium 5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetate",264-669-2,64092-48-4,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H331:38;H300:38;H311:38
21983,(2-hydroxypropyl)ammonium citrate,250-342-1,30798-32-4,Not Classified,REACH registration C&L,2,Not classified:2
21985,Phosphate,604-302-9,14265-44-2,Not Classified,Notified C&L,1,Not classified:1
21990,4-phenylbutan-1-ol,222-128-8,3360-41-6,Aquatic Chronic 3,REACH registration C&L,3,H412:1;Not classified:2
21995,Vinylcyclooctane,262-623-6,61142-41-4,Flam. Liq. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H302:38;H225:38;H400:38
21997,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-ol",205-099-6,133-21-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,50,H302:39;H319:39;Not classified:11
22001,"trichlorfon (ISO);dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate",200-149-3,52-68-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H302:0;H400:0
22003,3-amino-5-[(methylthio)methyl]oxazolidin-2-one,247-064-8,25517-72-0,Not Classified,REACH registration C&L,2,Not classified:2
22005,bis(4-tert-butylphenyl)iodonium hexafluorophosphate,620-341-4,61358-25-6,Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,56,H410:10;H317:10;H318:10;H400:10;H314:40;H335:5;H315:5;H319:5;Not classified:1;H332:1;H302:1
22007,"Poly(oxy-1,2-ethanediyl), a,a'-(iminodi-2,1-ethanediyl)bis[w-hydroxy-, N-[3-[(C13-rich C11-14-isoalkyl)oxy]propyl] derivs",606-978-0,223129-76-8,Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,23,H314:23;H410:23
22009,Mebhydrolin napadisilate,228-170-3,6153-33-9,Aquatic Chronic 2,Notified C&L,26,H411:24;H302:2
22012,"1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, oxime",612-371-1,61747-22-6,,REACH registration C&L,1,H335:1;H302:1;H315:1;H319:1
22014,"3,5-bis(trifluoromethyl)benzonitrile",248-240-7,27126-93-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,49,H319:47;H335:46;H332:46;H302:42;H315:47;H312:45;H301:7;H330:1;H311:3;H331:2;H227:1
22016,"Sodium 3,5-dichloro-2-hydroxybenzenesulphonate",259-416-8,54970-72-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:2;H315:4;H319:3;H332:1
22017,"[1R-(1α,4aβ,4bα,10aα)]-1,2,3,4,4a,4b,5,6,10,10a-decahydro-7-isopropyl-1,4a-dimethylphenanthren-1-methanol acetate",259-025-2,54200-50-9,Not Classified,Notified C&L,1374,Not classified:1374
22018,pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate,205-391-3,140-01-2,Acute Tox. 4;STOT RE 2,Harmonised C&L,0,H332:0;H373:0
22023,Hyaluronic acid,232-678-0,9004-61-9,Not Classified,Notified C&L,28,Not classified:28
22026,"Creosote;[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]",232-287-5,8001-58-9,Carc. 1B,Harmonised C&L,0,H350:0
22027,"Croton eluteria, ext.",284-284-3,84836-99-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1418,H304:1418;H226:1417;H317:1418;H315:1289;H411:1394;H412:24
22029,"Panicum miliaceum, ext.",290-125-9,90082-36-3,Not Classified,Notified C&L,1,Not classified:1
22032,"N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide",434-500-9,52583-35-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
22033,3-methyl-4-nitroanisole,226-356-9,5367-32-8,Acute Tox. 4,Notified C&L,44,H302:43;H301:1;H311:1
22036,Nifursol,240-963-6,16915-70-1,,Notified C&L,1,H302:1
22037,"Propylidynetrimethanol, propoxylated",500-041-9,25723-16-4,Not Classified,REACH registration C&L,233,Not classified:224;H312:9;H319:9
22039,4-vinylanisole,211-298-9,637-69-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
22040,2-(Trifluoromethyl)phenylhydrazine,609-255-8,365-34-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:45;H302:44;H315:45;H319:45;H332:6;H312:6;H301:1;H331:1;H311:1
22042,"α,4-dimethylcyclohex-3-ene-1-acetaldehyde",249-688-6,29548-14-9,Skin Sens. 1,Notified C&L,1374,H317:1374
22043,"Amides, from C16-18 fatty acids and diethylenetriamine",292-515-4,90623-09-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,34,H315:31;H318:28;Not classified:3;H319:3
22044,DL-cystine,213-094-5,923-32-0,Not Classified,Notified C&L,5,Not classified:4;H302:1
22055,(R)-6-(isopropyl)-3-methylcyclohex-2-en-1-one,224-957-0,4573-50-6,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1375,H317:1;H315:961;H319:1;Not classified:414
22064,Dibutylammonium dibutyldithiocarbamate,219-242-5,2391-80-2,Not Classified,Notified C&L,35,Not classified:35
22065,"Phenol,4-[[4-(1-methylethoxy)phenyl]sulphonyl]",619-116-3,95235-30-6,Aquatic Chronic 2,Notified C&L,9,H411:9
22068,Quinidine hydrogen sulphate,212-020-9,747-45-5,Acute Tox. 3;Skin Sens. 1,Notified C&L,4,H301:3;H317:4;H302:1
22072,"Amidase, penicillin",232-753-8,9014-06-6,Resp. Sens. 1,REACH registration C&L,17,H334:5;Not classified:12
22074,Glycollic acid,201-180-5,79-14-1,Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,3116,H314:3105;H332:766;H318:701;H302:2682;Not classified:12;H290:2;H315:1;H360:2;H319:1;H331:1
22078,"2,6-dichloro-4-trifluoromethylaniline",416-430-0,24279-39-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H332:0;H317:0;H302:0;H315:0;H410:0;H400:0
22079,"4-PYRIDINEETHANETHIOL, HYDROCHLORIDE",613-125-6,6298-11-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,2,H319:2;H334:1;H335:2;H317:1;H302:2;H315:2;H312:1
22080,"Ar-(allyloxy)xylene-α,α'-diol",249-128-0,28655-63-2,Not Classified,Notified C&L,59,Not classified:59
22083,"1,1'-[ethylidenebis(oxy)]bis(3-methylbutane)",235-839-3,13002-09-0,Not Classified,Notified C&L,89,Not classified:89
22084,"4'-(octyloxy)[1,1'-biphenyl]-4-carbonitrile",257-878-5,52364-73-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:39;H335:38;H332:39;H315:39;H312:39;H302:1;Not classified:1;H413:1
22093,"S,S-PP",453-060-9,,Acute Tox. 4;Skin Corr. 1A,Notified C&L,1,H314:1;H302:1
22095,"Molybdenum sulfide (MoS2), roasted",289-178-0,86089-09-0,Carc. 2,REACH registration C&L,104,H351:104
22097,"Boric acid (H3BO3), solid soln. with strontium oxide, europium-doped",310-028-8,102110-29-2,Not Classified,REACH registration C&L,8,Not classified:8
22098,Octyl 2-methylbutyrate,249-872-6,29811-50-5,Not Classified,Notified C&L,89,Not classified:89
22099,"Isooctadecanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",289-375-1,88120-12-1,Not Classified,Notified C&L,1,Not classified:1
22104,"1-aminopropan-2-ol, compound with orthoboric acid",247-422-3,26038-90-4,Not Classified,Notified C&L,104,Not classified:85;H302:17;H319:2
22108,"2-methyl-p-phenylenediamine;2,5-toluenediamine",202-442-1,95-70-5,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H332:0;H317:0;H312:0;H411:0
22109,Potassium (Z)-N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate,278-503-1,76622-74-7,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,452,H412:3;H332:4;H315:6;H410:3;H318:6;H400:6;Not classified:446
22112,2-hydroxyiminopropiophenone,204-329-2,119-51-7,Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,3,H317:2;H411:2;H400:2;Not classified:1
22115,"Sodium 2-anilino-5-(2,4-dinitroanilino)benzenesulphonate",228-921-5,6373-74-6,Not Classified,REACH registration C&L,296,Not classified:237;H318:39;H319:12;H412:9;H317:9;H335:1;H315:1
22120,"2-octadecyl-1H-thioxantheno[2,1,9-def]isoquinoline-1,3(2H)-dione",248-702-8,27870-92-4,Not Classified,REACH registration C&L,98,Not classified:96;H319:2
22123,"Oils, lard, sulfated, sodium salts",268-866-4,68153-10-6,Not Classified,Notified C&L,109,Not classified:79;H315:30;H319:28;H318:2
22127,"3-methoxyestra-2,5(10)-dien-17β-ol",214-130-2,1091-93-6,Repr. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H362:2;H361:2;H410:2;H400:2
22138,"Fatty acids, tallow, aluminum salts",269-169-8,68188-94-3,Not Classified,Notified C&L,5,Not classified:5
22139,"14H-anthra[2,1,9-mna]thioxanthen-14-one",240-385-4,16294-75-0,Skin Sens. 1,REACH registration C&L,2155,H317:22;Not classified:2132;H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
22141,Zinc m-toluate,268-459-1,68092-46-6,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,9,H411:6;H318:6;H400:6;Not classified:3
22142,"Disodium 3,3'-[(2,2'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[azo(4,5-dihydro-3-methyl-5-oxo-1H-pyrazole-4,1-diyl)]]bis[4-chlorobenzenesulphonate]",289-549-7,89923-60-4,Not Classified,Notified C&L,2,Not classified:2
22143,"Ethoxybisbenzimidazo[2,1-b:1',2'-j]benzo[lmn][3,8]phenanthroline-6,9-dione",277-315-7,73195-14-9,Not Classified,Notified C&L,1,Not classified:1
22144,N-benzylideneaniline N-oxide,214-509-2,1137-96-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
22145,"Siloxanes and Silicones, di-Me, Me phenethyl",614-120-1,67762-82-7,Not Classified,Notified C&L,5,Not classified:5
22150,"1-(2,4-difluorophenyl)ethan-1-one",206-667-6,364-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
22155,"Fatty acids, coco, sodium salts",263-050-4,61789-31-9,Not Classified,Notified C&L,171,Not classified:136;H315:32;H319:35
22162,Tetrahydrofurfuryl acetate,211-296-8,637-64-9,Acute Tox. 4,Notified C&L,1374,H302:1364;Not classified:10
22163,sodium 2-(dodecanoyloxy)propane-1-sulfonate,700-150-3,156572-81-5,Eye Irrit. 2,REACH registration C&L,14,H319:14
22165,subtilisin,232-752-2,9014-01-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H335:0;H315:0;H334:0;H318:0
22171,"1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-yl acetate",276-542-9,72257-53-5,Not Classified,Notified C&L,88,Not classified:88
22173,(2-benzoyloxy-2-methylbutyl)dimethylammonium chloride,208-541-6,532-59-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;Not classified:1;H312:1
22174,"3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-N,N,N-trimethylanilinium chloride",269-943-5,68391-31-1,Not Classified,REACH registration C&L,41,Not classified:40;H302:1
22175,1-Ethyl-3-methylimidazolium Iodide,609-195-2,35935-34-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:39;H315:40;H318:39;H319:1
22177,"1,3-dimethoxybenzene",205-783-4,151-10-0,Not Classified,REACH registration C&L,270,Not classified:264;H312:4;H335:1;H315:2;H319:2
22178,"O,O-di-sec-butyl hydrogen dithiophosphate",203-501-4,107-55-1,Met. Corr. 1;Skin Corr. 1B,REACH registration C&L,3,H314:2;H290:2;Not classified:1
22181,p-isopropylphenethyl alcohol,233-235-4,10099-57-7,Acute Tox. 4,Notified C&L,88,H302:88
22182,"1-bromo-3,5-bis(trifluoromethyl)benzene",206-334-5,328-70-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,16,H335:13;H315:14;H319:14;Not classified:1;H413:1
22183,m-toluonitrile,210-631-5,620-22-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:40;H315:45;H319:45
22184,4-hexadecyl-1-phenylpyrazolidin-3-one,430-840-7,,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
22185,Erbium trihydroxide,238-696-5,14646-16-3,Not Classified,Notified C&L,2,Not classified:2
22186,"3,3,5-trimethyl-N-(propan-2-yl)-5-[(propan-2-ylamino)methyl]cyclohexamine",454-640-4,156105-38-3,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H373:1;H314:1;H411:1;H318:1
22187,"cis-2,6-dimethylmorpholine",229-353-0,6485-55-8,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,151,H226:149;H302:141;H314:142;H312:147;H318:147;H332:1;H319:1;H311:2;Not classified:1
22188,"1-Propanol, 2-methyl-, C4-6 dicarboxylates",283-755-0,84712-64-1,Not Classified,Notified C&L,28,Not classified:28
22189,"Fatty acids, C8-18 and C18-unsatd., esters with neopentyl glycol",286-072-6,85186-86-3,Not Classified,REACH registration C&L,51,Not classified:51
22192,"Pyridine-2,3-dicarboxylic anhydride",211-834-1,699-98-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134,H335:133;H315:134;H319:134
22193,"Fatty acids, C8-18 and C18-unsatd., aluminum salts",284-286-4,84837-01-4,Not Classified,Notified C&L,7,Not classified:7
22194,Penicillamine,200-148-8,52-67-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:43;H315:46;H319:45;H332:2;H302:2;H360:3;H312:2;H334:2;H361:1;H362:1
22196,Tantalum(5+) ethanolate,228-010-2,6074-84-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,69,H314:45;H226:69;H335:23;H319:23;H315:1
22197,"Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-, (2E)-2-butenedioate (1:1)",616-449-6,773058-82-5,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H302:2;H411:2;H318:2
22200,"Sodium 6-(2-hydroxynaphthylazo)-3,4'-azodibenzenesulphonate",224-084-5,4196-99-0,Not Classified,Notified C&L,8,Not classified:5;H335:3;H315:3;H319:3;H332:1;H302:1;H312:1
22207,"4-amino-3,5-dichlorobenzoic acid",260-468-9,56961-25-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
22210,"4-[(4,8-disulpho-2-naphthyl)azo]naphthalene-1-diazonium chloride",267-995-3,67969-94-2,Not Classified,REACH registration C&L,3,Not classified:3
22212,"2,2-bis(hydroxymethyl)propionic acid",225-306-3,4767-03-7,Eye Irrit. 2;STOT SE 3,REACH registration C&L,783,H335:608;H319:777;H315:34;Not classified:8
22213,N-methylallylamine,210-996-0,627-37-2,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,42,H301:38;H331:38;H225:42;H314:42;H311:38;H332:4;H302:4;H312:4
22218,2-carbamoylphenoxyacetic acid,246-940-7,25395-22-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
22220,Bicyclo[2.2.1]heptane-2-methanol,226-041-6,5240-72-2,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:40;H335:39;H332:39;H302:40;H315:40;H311:40
22221,Strontium 4-[(5-chloro-4-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate (1:1),239-879-2,15782-05-5,Not Classified,REACH registration C&L,471,Not classified:469;H318:1;H412:1
22223,"(RS)-N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide",416-510-5,,Not Classified,REACH registration C&L,58,Not classified:58
22225,"Methyl 5-methyl-1,2-oxazole-4-carboxylate",600-020-5,100047-54-9,Not Classified,Notified C&L,1,Not classified:1
22227,"Benzene, 1-bromo-4-(trimethoxysilyl)-",605-580-4,17043-05-9,,Notified C&L,1,H335:1;H315:1;H319:1
22229,"4,4'-bis[[6-anilino-4-methoxy-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",262-621-5,61136-17-2,Not Classified,Notified C&L,33,Not classified:33
22231,"4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-yl formate",261-117-2,58096-46-1,Not Classified,Notified C&L,116,Not classified:116
22233,6-nitroquinolin-5-ylamine,252-822-6,35975-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42;H302:4
22234,"Acetic acid, ammonium zinc salt",246-492-2,24846-92-2,,Notified C&L,18,H314:17;H410:1;H302:1;H315:1;H319:1
22236,tetracopper hexahydroxide sulphate;tetracopper hexahydroxide sulphate hydrate,215-582-3,1333-22-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0
22237,Cyclohexylmethanol,202-857-8,100-49-2,Not Classified,Notified C&L,2,Not classified:1;H335:1;H227:1;H315:1;H319:1
22239,"4-chloro-3',4'-dimethoxybenzophenone",404-610-1,116412-83-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
22247,"4,4'-[hexane-1,6-diylbis[iminio(1-hydroxyethylene)]]dipyrocatechol sulphate",250-974-8,32266-10-7,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,1,H412:1;H331:1
22249,"16-α,17-α-epoxy-3-β-hydroxypregn-5-en-20-one",213-548-2,974-23-2,Eye Irrit. 2,REACH registration C&L,3,H319:3
22250,"(S, S)-(+)-N, N’-Bis(3, 5-di-tert-butylsalicylidene)-1, 2-cyclohexane diaminato manganese(III) chloride",603-926-9,135620-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40;H332:1;H302:1;H312:1
22252,Cyclohexanehexaone,208-412-4,527-31-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;Not classified:1
22253,(Z)-tetradec-9-enoic acid,208-876-8,544-64-9,Not Classified,Notified C&L,716,Not classified:593;H335:89;H315:95;H319:117
22255,"Benzene, di-C10-14-alkyl derivs., sulfonated, sodium salts",285-586-8,85117-37-9,Eye Dam. 1,REACH registration C&L,2,H318:2
22257,trimethoxyvinylsilane; trimethoxy(vinyl)silane,220-449-8,2768-02-7,Skin Sens. 1B,Harmonised C&L,0,H317:0
22258,"Cuprate(3-), [[]µ-[[]4-[[]2-[[]3,3'-di(hydroxy-[?]O)-4'-[[]2-[[]1-(hydroxy-[?]O)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-[?]N1][[]1,1'-biphenyl]-4-yl]diazenyl-[?]N1]-3-(hydroxy-[?]O)-2,7-naphthalenedisulfonato(7-)]]di-, sodium (1:3)",614-315-1,68140-37-4,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H320:1
22259,"2-cyclopentylidene cyclopentanol;1,1'-bi(cyclopentyliden)-2-ol",434-270-1,6261-30-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H315:0;H318:0
22261,"D-Glucopyranose, oligomers, monotartrate, coco alkyl glycosides",500-534-9,161074-98-2,Not Classified,Notified C&L,1,Not classified:1
22262,Piperazinium dihydrogen phosphate,238-572-0,14538-56-8,Not Classified,Notified C&L,16,Not classified:15;H315:1;H319:1
22264,Dimethyldivinylsilane,234-060-6,10519-87-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:39;H315:41;H319:41;H225:41
22268,"(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one",427-070-9,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
22269,2-chloro-4-methylpyridine,222-951-2,3678-62-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:41;H319:41
22275,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, reaction products with 4-[(4-aminophenyl)azo]benzenesulfonic acid monosodium salt, compds. with N,N'-bis(phenyl, tolyl and xylyl)guanidines",277-959-9,74665-04-6,Acute Tox. 4,Notified C&L,40,H302:40
22278,Heptanoic anhydride,210-940-5,626-27-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,49,H314:48;H318:47;H290:1;H317:1;H411:1
22280,Nitrilotriacetonitrile,230-804-9,7327-60-8,Acute Tox. 3;Acute Tox. 4;STOT RE 2,Notified C&L,181,H301:143;H312:64;H373:84;H315:97;H319:97;H335:38;H302:38
22281,"Methyl (E,E)-hexa-2,4-dienoate",211-712-8,689-89-4,Not Classified,Notified C&L,128,Not classified:90;H315:38;H319:38
22283,1-(1-ethoxyethoxy)hexane,259-184-8,54484-73-0,Not Classified,Notified C&L,88,Not classified:88
22284,"Coconut oil, potassium salt",272-193-1,68783-34-6,Not Classified,Notified C&L,53,Not classified:52;H319:1
22286,Bis(ethylacetylacetate)copper,238-181-5,14284-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H315:42;H319:42
22288,Bis(cyclopentadienyl)magnesium,603-275-0,1284-72-6,Pyr. Sol. 1;Skin Corr. 1B,Notified C&L,137,H250:136;H314:132;H228:54;H261:53;H318:53;H260:23;H252:4;H319:5;H335:5;H315:5
22291,"Potassium hydrogen -5-amino-4-hydroxybenzene-1,3-disulphonate",280-719-6,83763-34-2,Eye Dam. 1,REACH registration C&L,3,H318:3;H314:1
22293,"2,2-diethoxy-1-phenylethan-1-one",228-220-4,6175-45-7,Carc. 2,Notified C&L,65,H351:32;H335:19;H319:14;Not classified:6;H315:6
22294,"N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide)",227-563-7,5888-87-9,Aquatic Chronic 3,REACH registration C&L,36,H412:36
22298,"N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)(2-hydroxyethyl)amino]-4-methoxyphenyl]acetamide",245-895-0,23807-28-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H315:38;H319:38;H317:3;Not classified:1
22299,2-(2-oxoimidazolidin-1-yl)ethyl methacrylate,289-214-5,86261-90-7,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,284,H317:84;H318:111;H335:178;H315:178;Not classified:76;H319:96;H302:93;H225:55
22302,"Dec-1-ene, trimers, hydrogenated",500-393-3,157707-86-3,Asp. Tox. 1,REACH registration C&L,498,H304:498;H226:4;H412:1
22303,"Fatty acids, animal satd. and unsatd., 2-hydroxypropyl esters",309-743-8,100801-61-4,Not Classified,Notified C&L,1,Not classified:1
22304,Non-8-enal,254-622-4,39770-04-2,Not Classified,Notified C&L,88,Not classified:88
22306,Methyl 2-[[2-methyl-3-[4-(1-methylethyl)phenyl]propylidene]amino]benzoate,202-072-0,91-50-9,Not Classified,Notified C&L,90,Not classified:55;H317:35
22307,potassium 2-chloro-3-(benzyloxy)propionate,426-350-8,138666-92-9,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H302:0;H373:0;H318:0
22308,propan-2-ol;isopropyl alcohol;isopropanol,200-661-7,67-63-0,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H336:0;H319:0;H225:0
22313,[3-[[(heptadecafluorooctyl)sulphonyl]amino]propyl]trimethylammonium iodide,216-716-3,1652-63-7,,Notified C&L,3,H335:3;H315:3;H319:3
22315,m-phenylene diisocyanate,204-637-7,123-61-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,45,H319:45;H334:45;H335:45;H332:40;H302:40;H315:45;H312:40;H301:5;H330:4;H331:1
22319,Methyl [S-(E)]-2-[3-[3-[2-(7-chloro-quinolin-2-yl)ethenyl]phenyl]-3-hydroxypropyl]benzoate monohydrate,431-050-5,287930-78-3,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1
22320,"[R(R*,R*)]-2-amino-1-phenylpropane-1,3-diol",256-250-8,46032-98-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
22322,"1,4-Piperazinediethanesulfonic acid, sodium salt (2:3)",600-018-4,100037-69-2,Not Classified,Notified C&L,2,Not classified:2
22324,"(E)-3,7-dimethyl-2,6-octadienylhexadecanoate",421-370-3,3681-73-0,Skin Irrit. 2;Aquatic Chronic 4,Harmonised C&L,0,H315:0;H413:0
22325,"Rifamycin, 3-amino-1,4-dideoxy-1,4-dihydro-1,4-dioxo-(9Cl)",610-723-9,51756-80-0,Aquatic Chronic 3,REACH registration C&L,1,H412:1
22327,Copper oxalate,212-411-4,814-91-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H302:41;H312:41;H413:1
22330,"Formaldehyde, reaction products with sulfonated 1,1'-oxybis[methylbenzene], ammonium salt",302-223-1,94095-18-8,Carc. 2,Notified C&L,1,H351:1
22333,Citronellyl propionate,205-461-3,141-14-0,Not Classified,Notified C&L,1637,Not classified:1637
22340,Methyl 4-methoxybutyrate,608-306-1,29006-01-7,Flam. Liq. 3,Notified C&L,40,H226:40
22346,tert-butyl 3-phenyl-L-alaninate hydrochloride,239-151-4,15100-75-1,Not Classified,Notified C&L,1,Not classified:1
22349,Guazatine acetate,601-341-3,115044-19-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 1;Aquatic Acute 1,Notified C&L,39,H302:39;H330:39;H312:39;H400:39;H335:1;H315:1;H410:1;H318:1
22351,(4S)-1-[(2S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-4-(phenylthio)-L-proline potassium salt,617-274-8,81938-42-3,Repr. 2;Lact.,Notified C&L,1,H362:1;H361:1
22358,"Glycerides, C6-12",297-090-9,93334-17-9,Not Classified,Notified C&L,1,Not classified:1
22359,"Pyridine-2,3-dicarboxylic acid",201-874-8,89-00-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,111,H335:109;H315:85;H319:109;H302:30;H311:5;H318:1
22363,"6-amino-2,4-dichloro-m-cresol",255-033-5,40677-44-9,,Notified C&L,4,H335:4;H315:4;H319:4
22365,"3,4,5,6-tetrachloro-N-[2-(4,5,6,7-tetrachloro-2,3-dihydro-1,3-dioxo-1H-inden-2-yl)-8-quinolyl]phthalimide",250-063-5,30125-47-4,Not Classified,REACH registration C&L,385,Not classified:385
22367,"hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate",410-180-6,157627-99-1,Eye Dam. 1,Harmonised C&L,0,H318:0
22370,"Angelica archangelica, ext.",283-871-1,84775-41-7,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1643,H317:1641;H411:1321;H304:1640;H226:1584;H315:280;H410:135;H400:94;H302:10;H319:2;Not classified:1;H361:1
22371,2-Iodo-4-methylaniline,608-339-1,29289-13-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:39;H301:39;H315:39;H318:39
22374,Phthalic acid,201-873-2,88-99-3,Eye Dam. 1,REACH registration C&L,141,H318:6;H335:132;H315:134;H319:132;H302:11;Not classified:5
22377,(Z)-N-methyl-N-(1-oxo-9-octadecenyl)glycine,203-749-3,110-25-8,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1085,H332:809;H315:1031;H410:713;H318:1009;H400:1014;H413:48;H319:28;H314:22;Not classified:8;H272:7;H335:2
22382,"Marshmallow (Althaea officinalis), ext.",277-254-6,73049-65-7,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,56,H319:55;H226:55;Not classified:1
22383,5-Bromo-2-fluoroaniline,608-331-8,2924-09-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 4,Notified C&L,4,H332:3;H301:2;H311:2;H331:1;H319:2;H302:2;H315:2;H312:2
22384,"Extract residues (coal tar), benzole fraction alk., acid ext.;Light Oil Extract Residues, low boiling;[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85°C to 195°C (185°F to 383°F).]",309-868-8,101316-63-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
22385,"Hydrocarbon waxes (petroleum), oxidized, compds. with 2-(methylamino)ethanol",308-134-4,97862-84-5,Not Classified,Notified C&L,126,Not classified:125;H319:1
22386,(5β)-3β-[(6-deoxy-3-O-methyl-α-L-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide,207-372-5,466-07-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H300:38;H330:38;H310:38
22389,"2'-anilino-6'-[ethyl(3-methylbutyl)amino]-3'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",274-641-1,70516-41-5,Not Classified,REACH registration C&L,10,Not classified:10
22394,"Fatty acids, C8-18 and C18-unsatd., Me esters, distn. residues",271-690-0,68604-39-7,Not Classified,Notified C&L,6,Not classified:6
22398,(isooctanoato-O)(neodecanoato-O)nickel,284-347-5,84852-35-7,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H372:0;H350:0;H334:0;H360:0;H317:0;H410:0;H341:0;H400:0
22399,"(E)-3,7-dimethyl-2,6-octadienenitrile",226-982-2,5585-39-7,Aquatic Chronic 2,Notified C&L,88,H411:88
22400,Tris[2-[2-(2-methoxyethoxy)ethoxy]ethyl] orthoborate,250-418-4,30989-05-0,Repr. 2,REACH registration C&L,181,H361:91;Not classified:90
22403,p-toluidine;4-aminotoluene,203-403-1,106-49-0,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Carc. 2;Aquatic Acute 1,Harmonised C&L,0,H301:0;H351:0;H319:0;H331:0;H400:0;H317:0;H311:0
22405,"N-benzyl-4,5-dihydro-N-phenyl-1H-imidazole-2-methylamine monophosphate",205-831-4,154-68-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H319:39;H335:39;H332:40;H302:41;H315:39;H312:40
22407,"Spinels, copper green",305-837-8,95046-49-4,Not Classified,Notified C&L,7,Not classified:7
22408,"Benzene, ethenyl-, homopolymer, hydrogenated",614-500-7,68441-35-0,Not Classified,Notified C&L,11,Not classified:11
22409,2-chloro-N-(4-methylphenyl)acetamide,435-170-9,16634-82-5,Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H318:0;H400:0
22420,Disodium hydrogen citrate,205-623-3,144-33-2,Not Classified,REACH registration C&L,11,Not classified:11
22421,Nystatin,215-749-0,1400-61-9,Not Classified,Notified C&L,7,Not classified:5;H372:1;H335:1;H300:1
22423,Ethyl L-tyrosinate hydrochloride,223-820-2,4089-07-0,,Notified C&L,7,H335:4;H315:5;H319:5;Not classified:2
22425,"Phosphoric acid, decyl ester",262-255-6,60476-40-6,Skin Corr. 1B,Notified C&L,4,H314:3;H318:1;H315:1
22429,α-(bromomethyl)benzyl alcohol,219-365-4,2425-28-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
22430,(4α)-3β-[[2-O-(6-deoxy-α-L-mannopyranosyl)-α-L-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-28-oic acid,248-166-5,27013-91-8,Acute Tox. 4,Notified C&L,2,H302:2
22431,Sodium 2-aminonaphthalene-1-sulphonate,246-793-9,25293-52-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
22433,"N,N'-dibenzyldithiooxamide",204-561-4,122-65-6,Acute Tox. 3;Aquatic Acute 1,Notified C&L,38,H301:38;H400:38
22434,"1,1'-[ethylidenebis(oxy)]bispentane",235-838-8,13002-08-9,Not Classified,Notified C&L,88,Not classified:88
22438,Methyl DL-cysteinate,256-161-4,44641-43-2,,Notified C&L,2,H335:2;H315:2;H319:2
22444,"1-ethoxy-2,3-difluoro-4-[trans-4-(trans-4-pentylcyclohexyl)-cyclohexyl-benzene",603-007-2,124728-81-0,Not Classified,REACH registration C&L,1,Not classified:1
22445,metolcarb (ISO);m-tolyl methylcarbamate;MTMC,214-446-0,1129-41-5,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
22446,Calcium diricinoleate,229-965-8,6865-33-4,Not Classified,Notified C&L,1,Not classified:1
22447,"1,1-dichloro-2,2-bis(4-ethylphenyl)ethane",200-785-1,72-56-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H400:38;Not classified:3
22449,2-(2-ethylhexoxy)ethanol,607-943-2,26468-86-0,Eye Dam. 1,Notified C&L,94,H318:59;H315:31;H319:33;H302:7;H332:1
22450,Chromium(3+) heptanoate,273-361-7,68957-69-7,Not Classified,Notified C&L,1,Not classified:1
22455,2-(4-(methylsulfonyl)phenyl)acetic acid,618-577-8,90536-66-6,Eye Irrit. 2,Notified C&L,48,H319:48;H335:9;H315:10
22459,cis-Octahydroisoindole,604-559-7,1470-99-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
22460,"Beer, ext.",309-331-8,100209-23-2,Flam. Liq. 2,Notified C&L,37,H225:26;Not classified:10;H226:1
22466,Diantimony tris(sulphate),231-207-6,7446-32-4,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H332:38;H302:38;H411:38
22475,[No public or meaningful name is available],475-280-4,,Not Classified,Notified C&L,1,Not classified:1
22481,4-Acetamido-benzenesulphonic acid azide,606-801-7,2158-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H341:1;H201:1
22484,Disodium 3-[(4-acetamidophenyl)azo]-4-hydroxy-7-[[[[5-hydroxy-6-(phenylazo)-7-sulphonato-2-naphthyl]amino]carbonyl]amino]naphthalene-2-sulphonate,222-348-4,3441-14-3,Not Classified,Notified C&L,121,Not classified:121
22486,"Benzenepropanal, α,α,3-trimethyl-",600-851-3,107737-97-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,25,H319:25;H317:25;H302:25;H315:25;H411:25
22488,Sodium 2-(1-carboxylatoethoxy)-1-methyl-2-oxoethyl isooctadecanoate,266-533-8,66988-04-3,Aquatic Acute 1,REACH registration C&L,64,H400:1;H315:60;H319:60;Not classified:3
22489,"Hydrogen [29H,31H-phthalocyaninesulphonato(3-)-N29,N30,N31,N32]cuprate(1-), compound with dodecylamine (1:1)",277-475-8,73455-75-1,Eye Irrit. 2A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,128,H410:2;H319:2;H400:2;Not classified:126;H315:1
22490,"Disodium 1-amino-4-[[4-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",274-397-6,70209-99-3,Not Classified,REACH registration C&L,28,Not classified:19;H315:8;H319:8;H317:1;H334:1
22494,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, reaction products with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",270-852-8,68479-05-0,Skin Sens. 1,Notified C&L,1,H317:1
22500,3-phenoxybenzoic acid,223-121-2,3739-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,134,H335:133;H315:134;H319:134;H400:129;H317:1;H302:1
22501,"5-[[2-(4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)-4-sulphophenyl]sulphonyl]salicylic acid",228-258-1,6201-75-8,Not Classified,Notified C&L,33,Not classified:33
22502,Bis(2-pyridyl) ketone oxime,216-349-9,1562-95-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
22505,"4,4'-Methylenediphenyl diisocyanate, oligomers",500-040-3,25686-28-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,1201,H351:432;H319:1129;H334:1129;H335:1126;H332:1109;H317:1129;H373:452;H315:1129;Not classified:72;H302:20
22506,Ethyl bromodifluoroacetate,211-567-0,667-27-6,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,49,H314:49;H318:3;H225:47;H226:2
22507,3-methyl-1-phenylpentan-3-ol,233-889-0,10415-87-9,Not Classified,Notified C&L,1635,Not classified:1597;H335:38;H315:38;H319:38
22508,"Rutile, tin zinc",287-559-6,85536-73-8,Not Classified,REACH registration C&L,10,Not classified:10
22514,"3-amino-2,6-xylenol",230-268-6,6994-64-5,Acute Tox. 4;STOT RE 2,Notified C&L,37,H373:37;H302:37;H319:1;H335:1;H332:1;H315:1;H312:1
22522,Dibromodichloromethane,209-829-4,594-18-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
22526,Rubidium tetrahydroborate(1-),243-749-0,20346-99-0,Water-react. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H314:1;H301:1;H261:1;H311:1
22527,N-bromoacetamide,201-181-0,79-15-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:39;H315:40;H319:40;H314:5;H332:1;H302:2;H312:1;H318:1
22528,4-(Methoxycarbonyl)-2-methylthiophen-3-ammonium chloride,619-800-1,66319-02-6,Skin Corr. 1B;Aquatic Chronic 3,REACH registration C&L,2,H314:2;H412:2
22531,Boldenone undec-10-enoate,236-024-5,13103-34-9,Carc. 2,Notified C&L,41,H351:38;H319:2;H335:2;H302:2;H315:2;H312:2;Not classified:1
22533,Proflavine sulphate,209-038-4,553-30-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
22535,2-aminooctanoic acid,218-579-5,2187-07-7,Skin Sens. 1,Notified C&L,38,H317:38
22536,"Poly(oxy-1,4-butanediyl), α-[2-[(9-oxo-9H-thioxanthenyl)oxy]acetyl]-ω-[[2-[(9-oxo-9H-thioxanthenyl)oxy]acetyl]oxy]-",617-225-0,813452-37-8,Not Classified,Notified C&L,69,Not classified:69
22542,Cyclooctanone,207-940-2,502-49-8,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,48,H314:7;H318:3;H335:40;H315:41;H319:41
22543,"2,2,4(or 2,4,4)-trimethylhexane-1,6-diamine",247-063-2,25513-64-8,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,308,H314:307;H317:306;H302:307;H318:40;H412:245;Not classified:1
22548,Glutethimide,201-012-0,77-21-4,Acute Tox. 4,Notified C&L,39,H302:39
22551,"Benzoic acid, 4-(5-hexen-1-yloxy)-",601-373-8,115595-28-3,Not Classified,Notified C&L,1,Not classified:1
22553,"Fatty acids, C8-9, calcium salts",292-907-5,91002-29-8,Not Classified,Notified C&L,1,Not classified:1
22556,"9,10-dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid",207-521-4,478-43-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,137,H335:136;H315:137;H319:137
22557,Tripotassium hydrogen ethylenediaminetetraacetate,241-543-5,17572-97-3,Acute Tox. 4;STOT RE 2,REACH registration C&L,74,H332:10;H373:24;H335:39;H315:39;H319:62;H302:1;Not classified:1
22558,"Propanoic acid, 3-amino-2-hydroxy-",918-962-3,565-71-9,Not Classified,Notified C&L,1,Not classified:1
22570,Starch,232-679-6,9005-25-8,Not Classified,Notified C&L,714,Not classified:657;H332:55;H335:55;H320:54;H411:2;H319:1
22577,tetrakis(phenylmethyl)thioperoxydi(carbothioamide),404-310-0,10591-85-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
22582,Benzoyl isothiocyanate,208-540-0,532-55-8,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,Notified C&L,47,H301:42;H317:40;H318:40;H334:4;H332:5;H302:5;H314:4;H312:5;H319:3;H335:3;H315:3;H331:2;H311:1
22583,2-methyl-5-(1-methylethyl)bicyclo[3.1.0]hexan-2-ol,208-911-7,546-79-2,Not Classified,Notified C&L,114,Not classified:89;H226:25
22586,"Phosphonium, (2-methoxy-2-oxoethyl)triphenyl-, chloride (1:1)",606-843-6,2181-97-7,,Notified C&L,4,H335:4;H315:4;H319:4
22587,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide,618-533-8,90356-78-8,Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,14,H401:1;H317:1;H411:11;H351:10;H360:10;Not classified:2;H335:1;H315:1;H319:1
22589,Tetrahydrofurfuryl propionate,211-297-3,637-65-0,Acute Tox. 4,Notified C&L,1438,H302:1438;H319:1
22590,"(4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide dihydrate",612-168-8,6153-64-6,,Notified C&L,58,Not classified:34;H361:22;H319:23;H362:9;H360:1;H332:1;H302:1;H312:1;H411:1;H335:1;H315:1
22594,"3,7,11-trimethyldodeca-2,6,10-trienyl acetate",249-689-1,29548-30-9,Not Classified,Notified C&L,512,Not classified:511;H317:1
22595,Phenethyl anthranilate,205-098-0,133-18-6,Not Classified,Notified C&L,127,Not classified:89;H335:38;H315:38;H319:38;H400:38
22602,Diazoxide,206-668-1,364-98-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,88,H335:40;H302:88;H315:41;H319:41;H372:35;H360:45;H351:1;H332:1;H361:3;H312:1
22606,"5-chloro-1-methyl-1H-indole-2,3-dione",262-231-5,60434-13-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
22610,p-chlorophenyl dichlorophosphate,212-254-1,772-79-2,Skin Corr. 1B,Notified C&L,43,H314:43;H290:1;H318:1
22612,"N,N'-[(acetylimino)diethane-1,2-diyl]distearamide",286-148-9,85187-61-7,Not Classified,Notified C&L,1,Not classified:1
22616,"Oils, animal, mixed with vegetable oils, sulfurized",273-639-8,68991-19-5,Not Classified,Notified C&L,29,Not classified:29
22619,"Benzene, 1-[(trans,trans)-4'-ethyl[1,1'-bicyclohexyl]-4-yl]-2,3-difluoro-4-methyl-",606-624-5,207598-81-0,Not Classified,Notified C&L,1,Not classified:1
22620,"Lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate",418-870-9,154212-58-5,Not Classified,REACH registration C&L,40,Not classified:2;H332:38;H371:38;H302:38;H312:38
22624,2-bromohexanoyl bromide,259-417-3,54971-26-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38
22626,"Hexa-2,4-dienyl acetate",216-163-8,1516-17-2,Eye Dam. 1,REACH registration C&L,138,H318:138
22627,"2,2,2-trifluoroethyl trichloromethanesulphonate",245-484-6,23199-56-6,,Notified C&L,5,H314:5;H301:1;H351:1;H331:1;H311:1
22630,"2-(2,2,7,7-Tetremethyltricyclo[6.2.1.0((1,6)]undec-5 and 4-en-5-yl)propan-1-ol",482-030-8,1001252-30-7,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1288,H410:1288;H317:1288;H315:1288;H400:1288
22634,"Tetrasodium tripotassium (.my.-((2,2'-((3-imino-6-sulfonatophenyl-(N-methyl)-imino)bis((6-chloro-1,3,5-triazin-4,2-diyl)imino(2-hydroxy-5-sulfonato-3,1-phenylen)azo(phenylmethylen)azo))bis(4-sulfonatobenzoato))-dicuprate(7-)",406-077-0,,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,3,H411:3;H319:3
22640,"Sodium 1,4-dihexyl sulphonatosuccinate",221-109-1,3006-15-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H319:38
22644,"potassium (E,E)-hexa-2,4-dienoate",246-376-1,24634-61-5,Eye Irrit. 2,Harmonised C&L,0,H319:0
22646,Propylene didecanoate,258-814-9,53824-77-4,Not Classified,REACH registration C&L,95,Not classified:95
22652,"pentane-2,4-dione;acetylacetone",204-634-0,123-54-6,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H302:0;H226:0
22653,3-Bromo-4-fluoroaniline,613-829-3,656-64-4,,Notified C&L,9,H319:8;H332:8;H302:8;H315:8;H312:7;H331:1;H301:1;H311:1;H335:2
22654,Methyl 2-bromobenzoate,210-241-5,610-94-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:1;H302:1;H312:1;H335:2;H315:2;H319:2
22660,m-tolualdehyde,210-632-0,620-23-5,Eye Irrit. 2,Notified C&L,269,H319:266;H335:11;H302:8;H315:8;H332:4;H312:1
22662,2-[benzyl-[1-(4-methoxyphenyl)propan-2-yl]amino]-1-(3-nitro-4-phenylmethoxyphenyl)ethanone,610-116-9,43229-66-9,Acute Tox. 4;Carc. 2;Repr. 2;STOT SE 1;STOT RE 1,REACH registration C&L,2,H372:2;H351:2;H332:2;H361:2;H370:2
22668,Magnesium carbonate,208-915-9,546-93-0,Not Classified,REACH registration C&L,989,Not classified:959;H315:20;H319:30
22670,1-(4-chlorophenoxy)-2-nitrobenzene,254-316-0,39145-47-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H317:38;H302:38;H315:38;H318:38
22672,Tetrabutyl orthosilicate,225-305-8,4766-57-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:41;H315:45;H319:45;H314:1;H318:1
22679,1-methylcyclopropanecarboxylic acid,230-020-7,6914-76-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,53,H314:53;H318:39;H290:1
22681,"Oils, herring",268-863-8,68153-06-0,Not Classified,Notified C&L,2,Not classified:2
22682,reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline,420-720-2,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
22685,"Imidodisulfuryl fluoride, potassium salt",604-707-0,14984-76-0,Acute Tox. 4,Notified C&L,2,H302:1;H314:1;H318:1
22690,"1,1'-oxybisdecane",219-533-7,2456-28-2,Not Classified,Notified C&L,2,Not classified:2
22691,Hex-1-en-3-one,216-625-9,1629-60-3,,Notified C&L,5,H335:5;H315:5;H319:5;H225:5
22692,"Lead bis(2,4-dihydroxybenzoate)",255-375-5,41453-50-3,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H360:38;H332:38;H373:38;H302:38;H410:38;H400:38
22696,"α-d-Glucopyranoside, β-d-fructofuranosyl, acetate octadecanoate",257-922-3,52439-69-7,Aquatic Chronic 4,Notified C&L,2,H413:1;Not classified:1
22697,p-phenylenediacetic acid,230-801-2,7325-46-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
22698,Diphenylmethane,202-978-6,101-81-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1659,H410:1590;H400:1554;H411:36;Not classified:34;H304:18
22700,Tetradecyl lactate,215-350-1,1323-03-1,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,254,H411:11;H400:11;Not classified:243;H319:1
22703,4-aminobenzophenone,214-506-6,1137-41-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H302:41;H315:45;H319:45
22711,"1-(3,4-dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxyisoquinolinium chloride",227-560-0,5884-22-0,Not Classified,Notified C&L,2,Not classified:1;H302:1
22715,Albendazole,259-414-7,54965-21-8,Repr. 1B,Notified C&L,144,H360:95;H373:40;H361:43;H335:29;H315:29;H319:29;Not classified:6;H410:6;H332:1;H312:1;H400:4;H362:1;H372:2;H302:2
22717,"2',6'-dihydroxyacetophenone",211-833-6,699-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53,H335:50;H315:51;H319:51;H332:1;H302:2;H312:1
22718,"Orthoboric acid, compound with 2-aminoethanol",247-421-8,26038-87-9,Not Classified,Notified C&L,628,Not classified:607;H302:20;H315:21;H319:21
22719,"4,5-dihydro-1-phenyl-1H-pyrazol-3-amine",222-005-9,3314-35-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H302:38;H319:42
22720,"2,3-dihydro-2,2-dimethyl-6-[[1-naphthyl-4-(phenylazo)]azo]-1H-perimidine",224-087-1,4197-25-5,Muta. 2,Notified C&L,2249,H341:2042;Not classified:182;H371:25;H335:1
22723,"Oxirane, 2-(1-chlorocyclopropyl)-2-[(2-chlorophenyl)methyl]-",603-875-2,134818-68-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H410:33;H317:33;H315:33;H400:33
22724,Mesitylene-2-sulphonyl chloride,212-257-8,773-64-8,Skin Corr. 1B,Notified C&L,49,H314:49;Not classified:1;H290:2;H318:3;H361:1
22725,4-chloro-o-toluidine,202-441-6,95-69-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H350:0;H331:0;H400:0;H410:0;H341:0;H311:0
22726,Gentisic acid,207-718-5,490-79-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:47;H302:47;H315:48;H319:48;H332:1;H312:1;Not classified:1;H412:1
22730,Azaperone,216-715-8,1649-18-9,Acute Tox. 3,Notified C&L,42,H301:42;H311:1;H336:1
22731,d-carvone;(5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one,218-827-2,2244-16-8,Skin Sens. 1,Harmonised C&L,0,H317:0
22732,2-(methylthio)-10H-phenothiazine,231-581-0,7643-08-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H319:2;H317:2;H302:3;H315:2;H410:1;H400:1;Not classified:1;H412:1;H373:1
22734,"Rhatany, Krameria triandra, ext.",283-919-1,84775-95-1,Not Classified,REACH registration C&L,94,Not classified:12;H226:81;H225:1
22735,"Ethene, homopolymer, distn. residues",607-849-1,260255-62-7,Not Classified,Notified C&L,38,Not classified:38
22738,3-iodopropanol,210-995-5,627-32-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H335:39;H332:39;H302:39;H315:39;H312:39
22740,3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole,432-020-4,142623-48-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
22743,"Amides, from C18-24 fatty acids and triethylenetetramine",292-517-5,90623-10-2,Aquatic Chronic 3,Notified C&L,12,H412:10;Not classified:2
22746,Hept-1-yne,211-051-5,628-71-7,Flam. Liq. 2;Asp. Tox. 1,REACH registration C&L,48,H304:46;H225:48;H319:40;H335:39;H315:40
22748,"4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxy-N-phenylnaphthalene-2-carboxamide]",233-354-1,10127-03-4,Not Classified,Notified C&L,1,Not classified:1
22757,"Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)",413-770-1,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H302:0;H314:0;H410:0;H400:0
22758,Bis(sulfosuccinimidyl) suberatesodium salt,617-333-8,82436-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
22760,"4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline",605-994-5,183322-18-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,41,H302:40;H318:39;H332:1;H312:1;H315:1;H319:1
22761,"carfentrazone-ethyl (ISO);ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate",603-291-8,128639-02-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
22764,Hex-3-enedinitrile,214-287-7,1119-85-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H335:38;H332:38;H302:38;H315:39;H312:38;H301:1;H331:1;H311:1
22769,"(6R-trans)-3-(acetoxymethyl)-8-oxo-7-[2-(4-pyridylthio)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, compound with N,N'-dibenzylethylenediamine",266-205-4,66163-79-9,,Notified C&L,2,H317:2;H334:2
22773,"Decene, hydroformylation products",271-137-3,68516-18-7,Aquatic Chronic 3,Notified C&L,17,H412:13;H411:4;H315:4
22775,Quinoline-2-carboxylic acid,202-218-3,93-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:50;H315:52;H319:52;H371:1
22777,"Imidazolium compounds, 2-(C17 and C17-unsatd. alkyl)-1-[2-(C18 and C18-unsatd. amido)ethyl]-4,5-dihydro-1-methyl, Me sulfates",276-810-5,72749-55-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,60,H411:29;H315:60;H318:57;H319:10;H314:7;H410:14;H400:11
22779,4-(aminomethyl)-1-phenethylpiperidin-4-ol dihydrochloride,245-892-4,23804-64-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,3,H317:3;H302:3;H319:3
22781,Tributylmethylammonium chloride,260-135-8,56375-79-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,261,H411:6;H312:59;H315:256;H319:261;H335:198;H413:156;H302:215;H410:55;H400:33
22785,"3,4-dichloro-α,α,α-trifluorotoluene",206-337-1,328-84-7,Aquatic Chronic 2,Notified C&L,154,H411:101;H335:44;H315:44;H319:44;H302:22;Not classified:5;H314:5;H318:1
22791,"α-L-erythro-Pentofuranosyl chloride, 2-deoxy-, 3,5-bis(4-methylbenzoate)",604-255-4,141846-57-3,Not Classified,Notified C&L,7,Not classified:7
22792,"Phenol, polymer with α-(2-aminomethylethyl)-ω-(2-aminomethylethoxy)poly[oxy(methyl-1,2-ethanediyl)] and 2-(chloromethyl)oxirane",614-416-0,68318-44-5,Not Classified,Notified C&L,44,Not classified:31;H317:13;H315:13;H319:13
22795,Sodium 4-hydroxy-3-(2-hydroxy-1-naphthalenylazo)benzenesulphonate,218-246-4,2092-55-9,Not Classified,Notified C&L,1,Not classified:1
22798,Ammonium hydrogen maleate,256-163-5,44742-89-4,Not Classified,Notified C&L,2,Not classified:2
22800,[(vinyloxy)methyl]oxirane,222-950-7,3678-15-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H226:38;H302:38;H315:38;H318:38
22802,Heptatriacontane,230-559-8,7194-84-5,Not Classified,Notified C&L,4,Not classified:4
22811,2-[[4-[(2-cyanoethyl)ethylamino]-o-tolyl]azo]-5-nitrobenzonitrile,282-563-4,84255-17-4,Not Classified,Notified C&L,2,Not classified:2
22812,"4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-β-D-glucopyranosyl-5,7-dihydroxy-",608-227-2,28608-75-5,Not Classified,Notified C&L,1,Not classified:1
22814,Salicylaldehyde,201-961-0,90-02-8,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,3868,H302:3868;H411:162;H319:2193;H315:2199;H312:2093;H341:2089;H335:91;H311:89;H412:24;H371:2;H373:1;H317:2
22817,"Imidazolium compounds, 4,5-dihydro-1-methyl-2-nortallow alkyl-3-(2-tallow amidoethyl), Me sulfates",289-151-3,86088-85-9,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,34,H411:17;H315:34;H319:30;H410:16;H400:13;H318:4;H412:1
22818,"N2,N6-bis(tert-butoxycarbonyl)-L-lysine, compound with dicyclohexylamine (1:1)",239-150-9,15098-69-8,,Notified C&L,1,Not classified:1
22820,[No public or meaningful name is available],473-690-8,,Not Classified,Notified C&L,7,Not classified:7
22821,"p-mentha-1,5-diene",202-792-5,99-83-2,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,1679,H304:1638;H226:1678;H319:41;H334:38;H335:42;H302:41;H315:41;H410:27;H400:25;H317:6;Not classified:2;H411:1
22824,Ketamine,229-804-1,6740-88-1,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H302:1
22826,"Dihydropyrimidine-2,4,5(3H)-trione",207-829-9,496-76-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:42;H315:43;H319:43;H302:1
22828,"Bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate",250-195-3,30431-54-0,Skin Sens. 1B,REACH registration C&L,5,H317:2;H332:3;H302:3;H312:3
22829,Potassium methylsilanetriolate,250-807-9,31795-24-1,Skin Corr. 1A,REACH registration C&L,231,H314:220;H318:152;Not classified:10;H412:2;H335:2;H315:2;H319:1
22835,p-phenylenediamine,203-404-7,106-50-3,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H319:0;H331:0;H400:0;H317:0;H410:0;H311:0
22842,"Acetic acid, 2-[4-(2,4-dimethoxybenzoyl)phenoxy]-",616-203-8,75226-98-1,Not Classified,Notified C&L,1,Not classified:1
22843,"aluminium chloride, anhydrous",231-208-1,7446-70-0,Skin Corr. 1B,Harmonised C&L,0,H314:0
22846,"Benzene, ethylenated, by-products from",271-802-8,68608-82-2,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,134,H304:76;H317:76;H315:101;H410:134;H400:40;H319:58
22851,"Methyl 2-[[3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropylidene]amino]benzoate",202-073-6,91-51-0,Repr. 2;Aquatic Chronic 4,REACH registration C&L,1532,H361:1293;H413:16;H412:1289;H317:1289;Not classified:227
22854,"reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)",423-010-0,,Eye Dam. 1,Harmonised C&L,0,H318:0
22857,"D-Glucopyranose, oligomers, C8-10-alkyl glycosides",500-533-3,161074-97-1,Eye Dam. 1,Notified C&L,137,H318:132;Not classified:5
22859,1-ethynyl-2-(1-methylpropyl)cyclohexyl acetate,253-378-6,37172-05-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,233,H302:233;H312:223;H311:10
22861,(isobutylidene)benzohydrazide,264-274-5,63494-84-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
22863,"Glycerol 1,3-di(acetate)",246-941-2,25395-31-7,Not Classified,Notified C&L,175,Not classified:175
22866,"21-hydroxypregna-1,4,9(11),16-tetraene-3,20-dione 21-acetate",253-497-3,37413-91-5,Not Classified,REACH registration C&L,10,Not classified:8;H319:1;H335:1;H332:1;H302:1;H315:2;H361:2;H312:1;H400:1
22869,"Artemisia vulgaris, ext.",283-874-8,84775-45-1,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Acute Tox. 4;STOT SE 2,Notified C&L,314,H304:286;H226:288;H332:193;H317:285;H302:210;H371:208;H411:103;H341:78;Not classified:27;H331:3;H315:2;H318:1;H319:1;H335:1;H412:1;H316:1;H401:1
22870,imidacloprid (ISO);1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine,428-040-8,138261-41-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0
22871,Prilocaine,211-957-0,721-50-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,68,H412:67;H302:67;H315:63;H319:63;H318:5;H413:1
22874,(±)-3-hydroxy-α-[(methylamino)methyl]benzyl alcohol hydrochloride,205-835-6,154-86-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H302:1;H315:1;H312:1
22876,Direct Yellow 169,407-250-3,,Not Classified,REACH registration C&L,1,Not classified:1
22877,4-methylbenzophenone,205-159-1,134-84-9,STOT RE 2;Aquatic Chronic 3,REACH registration C&L,2614,H412:19;H373:19;Not classified:2153;H302:441;H319:441;H301:1
22878,[(4-methylpyrimidin-2-yl)thio]acetic acid,256-253-4,46118-95-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H335:43;H315:43;H318:38;H319:5;H302:1
22879,"Fatty acids, C16-22, lithium salts",272-194-7,68783-36-8,Not Classified,REACH registration C&L,21,Not classified:21
22882,"Phosphoric acid, di-C12-18-alkyl esters, sodium salts",306-269-3,96690-72-1,Not Classified,Notified C&L,1,Not classified:1
22884,"Sodium 1-amino-9,10-dihydro-9,10-dioxo-4-[m-(vinylsulphonyl)anilino]anthracene-2-sulphonate",238-573-6,14541-90-3,Acute Tox. 4,Notified C&L,38,H302:38
22885,hydrobromide α-amino-γ-butyrolactone,228-614-6,6305-38-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:42;H319:42;H302:1
22886,"1,2,3,9-TETRAHYDRO-3-((2-METHYLIMIDAZOL-1-YL)METHYL)-9-METHYL-4H-CARBAZOL-4-ONETETRAHYDRO",619-449-4,99614-02-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Lact.;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,15,H362:10;H301:12;H319:10;H335:10;H315:10;H410:12;H400:12;H302:2;H318:1
22891,Cyclododecanone,212-595-6,830-13-7,Aquatic Chronic 2,REACH registration C&L,155,H411:155
22896,Triethoxysilylpropyltrimethylammonium chloride,284-463-6,84901-27-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
22897,2-(1-methyl-1H-pyrrol-2-yl)pyridine,208-380-1,525-75-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
22904,Diphenhydramine,200-396-7,58-73-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,4,H302:4;H315:3;H319:3
22906,2-[2-[(1-oxo-2-propenyl)oxy]ethoxy]ethyl 2-(4-chlorobenzoyl)benzoate,279-910-7,82168-34-1,Eye Irrit. 2,Notified C&L,71,H319:71
22912,1-benzyl-4-[(4-chlorophenyl)amino]piperidine-4-carbonitrile,213-545-6,972-20-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H335:38;H315:38;H410:38;H318:38;H400:38
22914,"1-(bromomethyl)-3,5-bis(trifluoromethyl)benzene",250-971-1,32247-96-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,78,H314:78;H226:72;H335:1;H319:2;H225:1;H318:1
22921,"Tetrasodium 3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]",200-786-7,72-57-1,Carc. 1B,Notified C&L,183,H350:181;H360:10;H340:10;H361:4;H410:1;H302:1;H400:1;H335:1;H315:1;H319:1;H226:1;Not classified:1;H351:1
22924,1-{[4-(4-trans-Pentylcyclohexyl)-phenyl]-ethinyl}- 4-trifluormethoxy-benzene,603-970-9,136639-95-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
22928,"3-nitro-2,6-xylenol",230-267-0,6994-63-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
22930,Phthalamide,201-870-6,88-96-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H315:1;H319:1
22936,"2,5-dibromo-3-isopropyl-6-methylbenzoquinone",249-431-8,29096-93-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,194,H335:194;H315:194;H319:194
22939,"3,4-dichlorobenzoyl chloride",221-177-2,3024-72-4,Skin Corr. 1B,Notified C&L,88,H314:88;H290:1;H318:1
22944,"Ethanaminium, 2-hydroxy-N,N-bis(2-hydroxyethyl)-N-methyl-, esters with C16-18 and C18-unsatd. fatty acids, Me sulfates (salts)",605-113-4,157905-74-3,Not Classified,Notified C&L,85,Not classified:83;H315:1;H318:1;H319:1
22946,"Birch, Betula verrucosa, ext.",307-153-5,97552-99-3,Not Classified,Notified C&L,37,Not classified:37
22953,nickel arsenide,248-169-1,27016-75-7,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H372:0;H350:0;H317:0;H410:0;H400:0
22959,"2,2'-[[2-(2-hydroxyethoxy)ethyl]imino]bisethanol",241-604-6,17626-34-5,Eye Dam. 1;STOT RE 2,Notified C&L,32,H373:32;H318:32
22960,2-hydroxy-2-methylbutyric acid,223-120-7,3739-30-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
22974,"Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, thiocyanates",277-255-1,73049-74-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,33,H314:33;H302:33
22975,"1H-Imidazole-1-ethanol, α-[2-(4-chlorophenyl)ethyl]-",614-017-1,67085-11-4,Not Classified,Notified C&L,1,Not classified:1
22977,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with 2,4'-diisocyanatodiphenylmethane, 2,2'-methylenediphenyl diisocyanate and α-hydro-ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)]",500-410-4,158885-25-7,Not Classified,Notified C&L,1,Not classified:1
22980,"bis(diethylamino)-N,N-diethylmethaniminium chloride",482-110-2,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1;H302:1;H314:1;H312:1
22981,acetone;propan-2-one;propanone,200-662-2,67-64-1,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H336:0;H319:0;H225:0
22982,"1,3,4-thiadiazol-2-amine",223-657-7,4005-51-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:40;H302:41;H315:42;H319:42;H301:5;H361:5;H341:5;H332:1;H371:1;H312:1
22983,"Bis(pentane-2,4-dionato-O,O')cadmium",238-730-9,14689-45-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H332:42;H302:42;H410:42;H312:42;H400:42
22988,"(trans,trans)-5-{(4'-Ethyl[1,1'-bicyclohexyl]-4-yl)-difluormethoxy}-1,2,3-trifluorbenzene",606-646-5,208338-49-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
22991,1-[2-[(S)-(4-Chlorophenyl)phenylmethoxy]ethyl]piperidine hydrochloride,606-899-1,220282-83-7,Aquatic Chronic 3,Notified C&L,1,H412:1
22993,"Sodium bis[3-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonamidato(2-)]cobaltate(1-)",286-145-2,85187-58-2,Not Classified,Notified C&L,10,Not classified:10
22994,"3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl methacrylate",218-407-9,2144-53-8,STOT RE 2,REACH registration C&L,98,H373:13;H335:44;H315:46;H319:46;Not classified:39
22997,"Isooctanoic acid, iron salt",274-642-7,70519-09-4,Not Classified,Notified C&L,25,Not classified:25
22999,Salicyl alcohol,201-960-5,90-01-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,100,H335:45;H315:67;H319:66;Not classified:33;H302:1
23001,Dizinc orthosilicate,237-057-8,13597-65-4,Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,41,H410:2;H319:41;H332:39;H335:39
23003,Hexachloroplatinate dihydrogen hydrate,607-848-6,26023-84-7,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,52,H314:51;H301:46;H317:52;H334:52;H318:3;H410:2;H300:1;H400:2;H372:1;H290:1
23018,"Trisodium [3-[[4-[[6-anilino-1-hydroxy-4-sulpho-2-naphthyl]azo]-5-hydroxy-o-tolyl]azo]naphthalene-1,5-disulphonato(5-)]cuprate(3-)",277-955-7,74664-50-9,Aquatic Chronic 3,REACH registration C&L,2,H412:2
23019,Cyclanilide,601-236-2,113136-77-9,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H302:38;H411:38
23021,"Trypsin inhibitor, pancreatic basic",232-994-9,9087-70-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,6,H317:3;H334:3;Not classified:2;H302:1
23023,Lactatophenylmercury,204-560-9,122-64-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H410:38;H310:38;H300:38;H330:38;H400:38
23024,"2,5,8,11 Tetramethyl 6 dodecyn-Produktname : 5,8 Diol Ethoxylate",605-540-6,169117-72-0,Eye Dam. 1,Notified C&L,725,H318:651;H412:199;H319:45;Not classified:22;H317:1;H411:1
23025,"N,N'-bis(2-aminoethyl)ethylenediamine sulphate (1:2)",246-792-3,25291-67-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
23031,Selenium tetrakis(dimethyldithiocarbamate),205-624-9,144-34-3,Not Classified,Notified C&L,5,Not classified:5
23033,"Diphenyl Oxide 4,4'-Bis(sulfonyl azide)",616-116-5,7456-68-0,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,56,H410:56;H201:56;H373:56;H400:56
23035,Sodium 6-amino-5-[[2-[(cyclohexylmethylamino)sulphonyl]phenyl]azo]-4-hydroxynaphthalene-2-sulphonate,251-257-2,32846-21-2,Eye Irrit. 2,REACH registration C&L,60,H319:42;H412:37;Not classified:18
23041,"2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one",608-646-0,3159-07-7,Not Classified,REACH registration C&L,9,Not classified:7;H302:2
23045,"Rifamycin, sodium salt",238-965-7,14897-39-3,Eye Irrit. 2,Notified C&L,2,H319:2;H335:1;H315:1
23052,Perhydropyrimidin-2-one,217-443-2,1852-17-1,Not Classified,Notified C&L,85,Not classified:84;H335:1;H315:1;H319:1
23055,N-ethyl-N-(3-methylphenyl)propionamide,423-640-6,179911-08-1,,Notified C&L,1323,H412:1323;H315:1323;H319:1286
23059,"4'-butyl[1,1'-biphenyl]-4-carbonitrile",258-119-0,52709-83-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H319:1;H332:1;H302:1;H315:1;H312:1;Not classified:1;H413:1
23060,"Cymbopogon winterianus, ext., reaction products with acetone",305-053-6,94333-72-9,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H317:2;H302:2
23062,"2,6-Dichloro-4-fluoroaniline",608-989-6,344-19-4,,Notified C&L,7,H301:7;H319:5;H400:4;H373:4;H315:5;H410:4;H311:7;H331:3
23065,"2',5-dichloro-2-(3-hydroxymethyl-5-methyl-4H-1,2,4-triazol-4-yl)benzophenone",259-023-1,54196-62-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H335:1;H315:1;H319:1
23069,"Methyl 5-deoxy-2,3-O-isopropylidene-β-D-ribofuranoside",245-485-1,23202-81-5,Not Classified,REACH registration C&L,5,Not classified:5
23070,Butyl O-acetylricinoleate,205-393-4,140-04-5,Not Classified,REACH registration C&L,109,Not classified:109
23072,5-chloro-2-methylindole,214-052-9,1075-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H303:1
23076,"Bergamot, Citrus bergamia melarosa, ext.",296-429-8,92704-01-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,64,H304:63;H226:63;H317:63;H315:63;H410:63;H400:63;H371:24;Not classified:1
23077,"Benzenebutanoic acid, 4-chloro-β-methyl-3-nitro-γ-oxo-",617-730-6,85633-96-1,,Notified C&L,2,H319:2;H335:1;H332:2;H302:1;H315:2;H312:1
23078,Morpholin-4-ylamine,224-347-4,4319-49-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,56,H319:50;H335:50;H226:56;H332:40;H302:56;H315:50;H312:40;H314:6;H318:3
23080,Holmium(3+) acetate,247-066-9,25519-09-9,,Notified C&L,5,H335:5;H315:5;H319:5
23085,"5-phenyl-1,10-phenanthroline",228-172-4,6153-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
23088,"4-methyl-2-propyl-1,3-dioxolane",224-420-0,4352-99-2,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,39,H319:38;H226:38;Not classified:1
23093,"2-ethyl-4,5-dimethyloxazole",258-815-4,53833-30-0,Flam. Liq. 3,Notified C&L,1375,H226:1375;H315:65;H319:65;H335:1
23097,Annaline,600-148-1,10101-41-4,Not Classified,Notified C&L,171,Not classified:171
23098,Thiophene-3-malonic acid,244-198-9,21080-92-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,43,H335:40;H315:43;H319:43
23101,bifenazate (ISO);isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate,442-820-5,149877-41-8,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H373:0;H400:0
23102,Dimethyldioctylammonium chloride,226-901-0,5538-94-3,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,138,H301:17;H314:137;H310:16;H410:4;H318:16;H400:114;H302:120;H226:23;Not classified:1;H330:1
23104,"formaldehyde, reaction products with butylphenol",294-145-9,91673-30-2,Skin Sens. 1,Harmonised C&L,0,H317:0
23105,Isometamidium chloride,251-926-9,34301-55-8,,Notified C&L,2,H302:2
23106,4-nitrobenzaldehyde oxime,214-445-5,1129-37-9,Acute Tox. 3,Notified C&L,43,H301:43;H335:5;H315:5;H319:5;H311:1
23108,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, disodium salt, hydrate (2:3)",612-119-0,6132-05-4,Not Classified,Notified C&L,1,Not classified:1
23110,"Aluminium tris(5,7,12,14-tetrahydro-7,14-dioxoquino[2,3-b]acridine-2-sulphonate)",278-207-2,75431-69-5,Not Classified,Notified C&L,129,Not classified:129
23111,3-chloro-2-nitrotoluene,226-354-8,5367-26-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H301:3;H315:3;H319:3
23112,Lanthanum trinitrate,233-238-0,10099-59-9,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,66,H410:11;H318:19;H400:11;H319:46;H335:47;H413:38;H315:47;H272:54;H228:1;Not classified:2
23114,"5'α-benzyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione phosphate",229-182-1,6424-36-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
23115,"(O,1,1,1,2,3,3,3-2H8)propan-2-ol",245-189-2,22739-76-0,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H336:43;H319:43;H225:43;Not classified:1
23116,"1-bromo-2,2-dimethylpropane",211-132-5,630-17-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:44;H315:44;H319:44;H225:44
23118,"2,3-dihydro-2,2-dimethyl-1H-perimidine",424-060-6,6364-17-6,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H302:0;H373:0;H410:0;H400:0
23120,"Bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate",416-140-4,145650-60-8,Not Classified,REACH registration C&L,214,Not classified:3;H413:211
23129,[2H6]ethanol,216-162-2,1516-08-1,Flam. Liq. 2,Notified C&L,48,H225:48;Not classified:1
23131,"Formaldehyde, polymer with cyclohexanone",607-515-5,25054-06-2,Not Classified,Notified C&L,197,Not classified:197
23133,Ethyl vinyl ketone,216-624-3,1629-58-9,Flam. Liq. 2,Notified C&L,1572,H225:1572;H301:44;H331:39;H314:44;H311:44;H330:5
23135,"cis-2,6-Dimethylpiperidine",616-362-3,766-17-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H335:61;H315:61;H319:61;H225:63;H314:2;H318:1
23136,N-methylacetamide,201-182-6,79-16-3,Repr. 1B,Harmonised C&L,0,H360:0
23139,benzylamine,202-854-1,100-46-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H314:0;H302:0;H312:0
23146,"2,3,5,5-tetramethylhexanal",269-940-9,68391-29-7,Not Classified,Notified C&L,89,Not classified:88;H226:1
23147,Niobium boride,234-958-8,12045-19-1,Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H319:38
23151,Bis(p-chlorophenoxy)acetic acid,249-874-7,29815-94-9,Acute Tox. 4,Notified C&L,38,H302:38
23160,Dodecylethyldimethylammonium ethyl sulphate,221-108-6,3006-13-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,121,H302:121;H315:83;H318:83;H400:105;H410:22;H314:16
23161,Dodecyloxirane,221-781-6,3234-28-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,152,H410:87;H315:147;H400:87;H335:55;H319:60;Not classified:5
23162,"1,1,3,3-tetraoctyl-1,3-bis[(1-oxohexadecyl)oxy]distannoxane",288-882-5,85938-47-2,STOT RE 2;Aquatic Chronic 4,Notified C&L,55,H373:55;H413:55
23169,Pentachloroaniline,208-410-3,527-20-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H301:42;H331:39;H373:41;H410:43;H311:42;H400:43;H330:3;H319:1;H315:1
23170,"1,4-Benzenedicarboxylic acid, polymer with N,N'-bis(2- aminoethyl)-1,2-ethanediamine, cyclized, Methylsulfates",614-360-7,68187-22-4,Aquatic Chronic 3,Notified C&L,37,H412:37
23173,"6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol",204-327-1,119-47-1,Repr. 2,REACH registration C&L,806,H361:513;H413:473;Not classified:163;H373:32;H411:60;H400:33;H319:20;H412:3;H335:1;H302:1;H315:1;H410:1;H317:1
23176,"Radish, ext.",283-918-6,84775-94-0,Flam. Liq. 3,Notified C&L,3,H226:3
23177,Cod-liver oil,232-289-6,8001-69-2,Not Classified,Notified C&L,96,Not classified:96
23178,"Phenol, 4-fluoro-, 1-acetate",609-847-6,405-51-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H301:1;H319:1;H335:1;H315:1;H311:1
23179,tri-tert-butyl borate,616-037-6,7397-43-5,Flam. Liq. 3,Notified C&L,38,H226:38
23182,Biotin hydrazide,613-970-0,66640-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
23183,"1-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpenta-1,4-dien-3-ol",259-323-2,54757-48-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H400:2
23186,"Vacuum distillate (shale oil), light",924-360-1,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H319:1;H226:1
23188,(S)-2-amino-N-(2-naphthyl)propionamide,211-956-5,720-82-1,Carc. 1A,Notified C&L,1,H350:1
23194,(2-bromophenyl)diphenylphosphine,263-515-1,62336-24-7,Acute Tox. 4,Notified C&L,40,H302:38;H335:1;H315:2;H319:2
23195,"Amides, from C18-24 fatty acids and triethylenetetramine, acetates",292-518-0,90623-11-3,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
23198,"4-methoxy-α,α-dimethylbenzyl alcohol",231-069-7,7428-99-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
23199,Thiosemicarbazide,201-184-7,79-19-6,Acute Tox. 2;Aquatic Chronic 3,REACH registration C&L,81,H412:24;H300:81;H410:2;Not classified:2;H319:1;H315:1;H312:1;H335:1
23203,methyl (S)-(-)-lactate,248-704-9,27871-49-4,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H335:0;H319:0;H226:0
23212,(S)-(-)-2-Acetoxypropionic Acid,611-964-2,6034-46-4,Acute Tox. 3;Acute Tox. 4;Acute Tox. 2,Notified C&L,40,H301:38;H312:38;H330:38;H335:1;H315:2;H319:2
23214,"Sulfuric acid, mono-C12-16-alkyl esters, compds. with triethanolamine",286-537-3,85252-21-7,Not Classified,Notified C&L,444,Not classified:441;H302:3;H315:3;H318:3
23217,4-hydroxybenzophenone,214-507-1,1137-42-4,STOT RE 2;Aquatic Chronic 3,REACH registration C&L,77,H412:20;H373:20;H341:4;H335:51;H315:52;H319:52;Not classified:1
23218,"17-acetoxy-1β,2β-methanopegna-4,6-diene-3,20-dione",427-820-5,2701-50-0,Not Classified,Notified C&L,1,Not classified:1
23220,"17,21-dihydroxy-16β-methylpregna-1,4,9(11)-triene-3,20-dione",236-830-7,13504-15-9,Not Classified,Notified C&L,1,Not classified:1
23225,Dichlorodecylmethylsilane,241-962-3,18051-88-2,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H290:1;H318:1
23228,6-Bromo-2-pyridine carboxaldehyde,608-952-4,34160-40-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48;H332:2;H302:3;H312:2
23229,Lithium acetate,208-914-3,546-89-4,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,179,H302:35;H319:9;Not classified:102;H361:38;H315:2;H318:2;H332:1
23230,Lactalbumins,232-750-1,9013-90-5,Not Classified,Notified C&L,1,Not classified:1
23235,"D-Glucopyranose, oligomers, C12-14-alkyl glycosides",500-395-4,157707-88-5,Not Classified,Notified C&L,48,Not classified:48
23243,"Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate",227-561-6,5888-33-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,880,H319:759;H335:801;H317:221;H315:759;H410:216;H400:220;H411:612;Not classified:36;H332:2;H336:1
23244,"N,N'-(vinylsilylene)bis(N-methylacetamide)",256-766-3,50791-87-2,Eye Dam. 1;Repr. 2;Aquatic Chronic 3,Notified C&L,22,H412:22;H361:22;H318:22
23247,"1H-Isoindol-1-one, 2,3-dihydro-3,3-bis(4-hydroxyphenyl)-2-phenyl-",455-890-7,6607-41-6,Not Classified,Notified C&L,2,Not classified:1;H413:1
23248,Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate,604-436-8,144690-33-5,Aquatic Chronic 4,REACH registration C&L,2,H413:2
23249,"p,'-[methylenebis(oxy)]ditoluene",241-273-8,17241-24-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H335:38;H302:38;H315:38;H410:38;H318:38;H400:38
23252,"4-[(4-amino-m-tolyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-o-toluidine monohydrochloride",224-086-6,4197-24-4,Acute Tox. 4;Carc. 2,Notified C&L,1,H302:1;H351:1
23254,"3,3,4,4-tetrafluorodihydrofuran-2,5-dione",211-832-0,699-30-9,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H331:38;H225:1;H301:1;H330:1;H311:1
23256,Cobalt titanite green spinel,269-047-4,68186-85-6,Not Classified,REACH registration C&L,900,Not classified:300;H372:148;H350:150;H412:43;H351:441;H317:526;H334:441;H315:2;H373:1
23258,"2,4,6-trimethylpyrylium tetrafluoroborate",212-256-2,773-01-3,Skin Corr. 1B,Notified C&L,43,H314:39;H335:4;H315:4;H319:4;H302:1;H318:1
23259,Ethyl 2-(4-chloro-6-methoxypyrimidin-2-ylcarbamoylsulfamoyl)benzoate,618-690-2,90982-32-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,73,H410:31;H400:15;H332:38;H373:13;H319:3;H315:1
23260,"1,2-dichloro-1,1-difluoroethane",216-714-2,1649-08-7,Eye Irrit. 2,Notified C&L,41,H319:38;Not classified:3
23262,2-[(4-chloro-2-nitrophenyl)azo]-N-(2-chlorophenyl)-3-oxobutyramide,229-355-1,6486-23-3,Not Classified,REACH registration C&L,464,Not classified:462;H302:1;H318:1
23263,3-hydroxybenzyl alcohol,210-633-6,620-24-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H335:44;H315:45;H318:39;H319:6
23265,S-(-)-α-methylbenzyl isocyanate,238-698-6,14649-03-7,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,45,H319:45;H335:45;H334:44;H315:45;H330:39;H331:5;H302:5;H332:1;H301:1
23266,1H-benzimidazole-2-carboxaldehyde,222-004-3,3314-30-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,41,H302:38;H319:41;H335:3;H315:3
23267,4-Methyl-2-propylbenzimidazole-6-carboxylic acid,424-450-6,,,Notified C&L,1,Not classified:1
23270,"2,4-diethoxy-5-methylpyrimidine",230-558-2,7193-87-5,Not Classified,Notified C&L,88,Not classified:88
23274,Erbium(3+) perchlorate,237-840-4,14017-55-1,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39;H272:38;H271:1
23275,(Z)-4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethyl acetate,288-415-5,85721-05-7,Acute Tox. 4,Notified C&L,1,H302:1
23276,"2-[Trans,trans-4'-ethyl(1,1'-bicyclohexyl-4-yl)-5,6-dihydro-4H-1,3-dithiin-1-iumtrifluoromethanesulfonate",609-791-2,401841-66-5,Skin Corr. 1B,Notified C&L,1,H314:1;Not classified:1
23281,(Z)-non-2-en-1-ol,255-376-0,41453-56-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,115,H315:114;H319:114;Not classified:1;H335:1
23282,2-benzylpyridine,202-979-1,101-82-6,Eye Irrit. 2,Notified C&L,44,H319:43;H335:4;H315:5;H302:1
23283,"Reaction mass of 2,6-Dimethyl-3,7-octadiene-2,6-diol and 2,6-Dimethyl-1,7-octadien-3,6-diol",923-775-5,,Not Classified,REACH registration C&L,1,Not classified:1
23285,"N8,N8,3-trimethyl-2,8-phenazinediamine monohydrochloride",209-035-8,553-24-2,Not Classified,Notified C&L,5,Not classified:2;H341:1;H335:1;H315:1;H319:1;H301:1
23286,Strontium 3-hydroxy-4-[(1-sulfonato-2-naphthyl)azo]-2- naphthoate 5/2 hydrate,484-490-5,,Not Classified,REACH registration C&L,3,Not classified:3
23288,4-ammoniophenyl(dimethyl)ammonium oxalate,246-374-0,24631-29-6,Not Classified,Notified C&L,36,Not classified:36
23289,4-(Trifluoromethyl)benzhydrazide,608-934-6,339-59-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
23291,"Benzene, 2,3-difluoro-1-methyl-4-[(trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl]-",606-625-0,207598-83-2,Not Classified,Notified C&L,1,Not classified:1
23294,troclosene potassium,218-828-8,2244-21-5,Ox. Sol. 2;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H335:0;H302:0;H272:0;H410:0;H400:0
23295,Naphthalene-2-sulphonyl chloride,202-219-9,93-11-8,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,93,H411:10;H315:10;H314:83;H290:1;H318:1;H261:1
23297,"Poly[[6-(4-morpholinyl)-1,3,5-triazine-2,4-diyl]-1,4-piperazinediyl]",618-909-1,93058-67-4,Not Classified,Notified C&L,2,Not classified:2
23304,"3,4,5-trimethoxyphenyl isothiocyanate",252-820-5,35967-24-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,43,H319:39;H334:38;H335:39;H332:42;H302:42;H315:39;H312:42;H314:4
23306,5-Fluoro-2-nitrobenzoic Acid,608-702-4,320-98-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
23307,5-butyl-5-ethyltetrahydro-2H-pyran-2-one,267-048-4,67770-79-0,Not Classified,Notified C&L,234,Not classified:234
23312,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecyl methacrylate",218-408-4,2144-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;H331:1;H301:1;H311:1
23313,"2,4-xylidine",202-440-0,95-68-1,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,128,H301:127;H319:38;H373:126;H411:128;H330:39;H311:127;H331:90;H372:2;H341:4;H302:1;H315:1;Not classified:1
23317,"1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-",600-331-6,102625-70-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,10,H332:2;H302:10;H312:2;H335:4;H315:5;H319:4;H412:1;H336:1;H410:1;H400:1;H362:1;H351:1;H341:1
23319,"1,2,4,5-tetrabromo-3,6-bis(pentabromophenoxy)benzene",261-526-6,58965-66-5,Not Classified,Notified C&L,32,Not classified:32
23320,Exifone,257-945-9,52479-85-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H315:1;H319:1
23324,"2,2,2-trifluoro-N-(hydroxymethyl)acetamide",256-698-4,50667-69-1,,Notified C&L,5,H335:5;H315:5;H319:5
23326,"N,N,N',N'-tetramethylacridine-3,6-diamine monohydrochloride, compound with zinc dichloride",233-353-6,10127-02-3,Muta. 2,Notified C&L,46,H341:45;H332:1;H302:2;H312:2;H331:1
23328,"Quaternary ammonium compounds, di-C8-18-alkyldimethyl, diisooctyl phosphates",277-957-8,74664-99-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,47,H315:47;H319:47
23333,"Phosphoric acid, methyl ester, ammonium salt",287-310-1,85480-31-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
23334,L-arabinitol,231-582-6,7643-75-6,Not Classified,Notified C&L,1,Not classified:1
23335,"(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;6-fluoro-2-(2-oxiranyl)chromane",419-620-1,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
23336,8-hydroxy-7-iodoquinoline-5-sulphonic acid,208-938-4,547-91-1,Skin Corr. 1B,Notified C&L,40,H314:40;H290:1;H318:1
23338,Isohexadecanoic acid,251-256-7,32844-67-0,Not Classified,Notified C&L,2,Not classified:2
23342,(1S)-3-(dimethylamino)-1-(2-thienyl)propan-1-ol,603-565-7,132335-44-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H335:2;H315:3;H319:3;H302:2;H332:1;H318:1
23343,"Octanoic acid, monoester with glycerol",247-668-1,26402-26-6,Not Classified,REACH registration C&L,112,Not classified:112
23345,Charcoal,240-383-3,16291-96-6,Not Classified,REACH registration C&L,632,Not classified:586;H228:52
23349,"Fatty acids, C16-18, lithium salts",272-195-2,68783-37-9,Not Classified,REACH registration C&L,67,Not classified:67
23350,"Decane-1,2-diol",214-288-2,1119-86-4,Eye Dam. 1,REACH registration C&L,20,H318:17;Not classified:3
23353,Benzyl acetoacetate,226-416-4,5396-89-4,Eye Irrit. 2,REACH registration C&L,223,H319:8;Not classified:173;H315:37;H412:11
23358,"cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione",427-230-8,5571-36-8,STOT RE 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H373:0;H411:0;H360:0
23359,1-bromocyclopentyl-o-chlorophenyl ketone,229-803-6,6740-86-9,Not Classified,REACH registration C&L,1,Not classified:1
23360,6-(nonylamino)-6-oxo-peroxyhexanoic acid,406-680-9,104788-63-8,Org. Perox. C;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1,Harmonised C&L,0,H318:0;H317:0;H242:0;H400:0
23361,9-decenal,254-624-5,39770-05-3,Skin Irrit. 2,Notified C&L,1491,H315:1490;Not classified:1
23363,3-3-diphenylpropylamine,226-984-3,5586-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:44;H315:45;H319:45;Not classified:2
23364,(1R)-1-(4-chlorophenyl)ethan-1-amine,608-077-8,27298-99-3,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,127,H301:88;H331:84;H317:123;H315:123;H411:127;H318:123;H302:39;H330:39;H314:4
23365,Dodecan-2-one,228-222-5,6175-49-1,Aquatic Chronic 2,Notified C&L,39,H411:38;H319:1;H335:1;H317:1;H302:1;H315:1;H400:1
23366,"2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepinium (p-tolylsulphonate)",257-164-3,51376-18-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
23367,Triphenylethylene,200-395-1,58-72-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:41;H302:42;H319:42;H400:41;H373:3;H335:1;H332:1;H315:1
23368,"Quaternary ammonium compounds, tri-C6-12-alkylmethyl, chlorides",276-811-0,72749-59-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,10,H314:10;H302:10
23370,"Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 120°C (158°F to 248°F).]",309-745-9,100801-63-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
23372,Sodium 2-[(2-ethylhexyl)oxy]-1-[[(2-ethylhexyl)oxy]methyl]ethyl sulphate,263-447-2,62174-79-2,Not Classified,Notified C&L,9,Not classified:9
23375,"chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione",223-003-0,3691-35-8,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H372:0;H360:0;H410:0;H310:0;H300:0;H330:0;H400:0
23377,p-benzoquinone,203-405-2,106-51-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H301:0;H319:0;H331:0;H335:0;H315:0;H400:0
23378,Methylenebis(diphenylarsine),244-639-5,21892-63-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H301:38;H400:38;H331:38
23382,"Dioctyl maleate, branched",287-673-6,85566-63-8,Aquatic Chronic 4,REACH registration C&L,6,H413:2;Not classified:4
23383,"Benzene, methyl-, C6-12-alkyl derivs.",271-803-3,68608-83-3,Not Classified,Notified C&L,1,Not classified:1
23386,"(2R,3R)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl-3,4,5-trihydroxybenzoate",619-381-5,989-51-5,Not Classified,Notified C&L,7,Not classified:3;H317:3;H302:3;H411:3;H319:3;H312:1;H401:1
23387,"α,α,α,α',α',α'-hexafluoro-5-nitroxylene",206-336-6,328-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H315:40;H319:40;H332:1;H302:1;H312:1
23388,Succinimide,204-635-6,123-56-8,Not Classified,REACH registration C&L,254,Not classified:13;H335:240;H315:240;H319:240;H302:1
23389,Sodium acrylate,231-209-7,7446-81-3,Aquatic Acute 1,REACH registration C&L,368,H400:259;H410:59;H411:96;Not classified:58;H315:51;H319:51;H335:26
23391,1-chlorotetradecane,219-368-0,2425-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
23393,"2,4-dimethoxybenzoic acid",202-074-1,91-52-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
23396,Methyl 2-hexyl-3-oxocyclopentanecarboxylate,253-379-1,37172-53-5,Not Classified,REACH registration C&L,1638,Not classified:1582;H304:55;H332:55;H373:55;H302:55;H312:55;H411:55;H315:1;H319:1
23402,"1,1,1-trifluoro-5-methylhexane-2,4-dione",250-415-8,30984-28-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H226:2
23406,Lead oxalate,212-413-5,814-93-7,,Notified C&L,4,H360:4;H332:4;H373:4;H302:4;H410:4;H400:4
23411,4-(pyrrolidin-1-yl)pyridine,219-534-2,2456-81-7,Acute Tox. 3;Skin Corr. 1B,Notified C&L,45,H314:45;H301:45;H318:2;H331:1;H311:1
23412,Triisopropylsilane,464-880-1,6485-79-6,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,4,H319:4;H335:3;H226:4;H317:1;H315:4
23416,Methyl cyclohex-1-ene-1-carboxylate,242-331-5,18448-47-0,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H227:1;H315:1;H319:1
23419,Di-1-adamantylchlorophosphine,605-093-7,157282-19-4,Water-react. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H261:38;H318:39;H301:1;H332:1
23421,2-chloro-1-(4-hydroxyphenyl)ethan-1-one,228-613-0,6305-04-0,Acute Tox. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H301:38
23422,"5,6-Dihydro-2-[trans,trans-4'-propyl(1,1'-bicyclohexyl-4-yl)-4H-1,3-dithiin-1-iumtrifluoromethanesulfonate",609-186-3,358732-12-4,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,2,H314:2;H318:2
23423,"2,2'-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]bisethanol",221-179-3,3025-41-0,Not Classified,Notified C&L,22,Not classified:22
23424,4'-aminobenzanilide,241-603-0,17625-83-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
23425,p-[4-(trifluoromethyl)phenoxy]phenol,254-549-8,39634-42-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
23426,trans-4-methoxycinnamic acid,212-594-0,830-09-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H335:48;H315:49;H319:49
23431,5-chloro-2-nitrobenzyl alcohol,277-241-5,73033-58-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
23437,Benzyl anthranilate,279-911-2,82185-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:2;H315:3;H319:3
23438,"Butanamide, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(2,1-diazenediyl)]bis[N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-",616-600-6,78245-94-0,,Notified C&L,34,Not classified:34
23439,"2-Di-tert-butylphosphino-2'-(N,N-dimethylamino)biphenyl",607-073-3,224311-49-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H335:42;H413:38;H315:42;H319:42
23440,Ethyl 3-bromo-2-oxocyclohexanecarboxylate,250-065-6,30132-23-1,Flam. Liq. 2,Notified C&L,39,H225:38;H335:1;H227:1;H315:1;H319:1
23442,[μ-[(oxydiethylene phthalato)(2-)]]diphenylmercury,301-792-3,94070-93-6,Not Classified,Notified C&L,6,Not classified:5;H373:1;H410:1;H310:1;H300:1;H330:1;H400:1
23443,"dinobuton (ISO);2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate",213-546-1,973-21-7,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H301:0;H400:0
23444,4-methylpiperazin-1-ylamine dihydrochloride hydrate,255-031-4,40675-60-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,127,H319:127;H335:127;H332:127;H302:127;H315:127;H312:127
23450,Iohexol,266-164-2,66108-95-0,Not Classified,Notified C&L,3,Not classified:2;H315:1;H319:1
23451,"Cinnamomum zeylanicum, ext.",283-479-0,84649-98-9,Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,1718,H350:1171;H319:1663;H304:129;H317:1671;H411:129;H341:1171;H412:1140;H312:405;H315:540;H226:77;H311:52;Not classified:46;H410:3;H335:4;H351:3;H302:1;H371:1;H400:2;H316:1;H227:1;H303:1;H402:1;H313:1;H225:1;H334:2;H340:2;H318:1
23453,"Ribonucleic acids, yeast",277-256-7,73049-77-1,Not Classified,Notified C&L,1,Not classified:1
23454,"(1-hydroxyethylidene)bisphosphonic acid, compound with 2-aminoethanol (1:1)",287-243-8,85443-51-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H315:24;H319:24;Not classified:1
23457,Tin distearate,230-266-5,6994-59-8,,Notified C&L,6,H335:5;H302:5;H315:5;H319:5;Not classified:1
23458,17α-hydroxy-2-(hydroxymethylene)pregn-4-en-20-yn-3-one,220-513-5,2787-02-2,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 3,REACH registration C&L,1,H362:1;H412:1;H351:1;H360:1
23462,Phthalamic acid,201-871-1,88-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
23463,Hexadecane,208-878-9,544-76-3,Asp. Tox. 1,REACH registration C&L,1827,H304:1771;H335:53;H315:62;H319:60;Not classified:3;H314:1
23468,2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene,411-730-8,93071-94-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
23469,"Fatty acids, C16-18 and C18-unsatd., Me esters, distn. residues",271-692-1,68604-41-1,Not Classified,REACH registration C&L,36,Not classified:36
23471,Disodium oxybis[methylbenzenesulphonate],277-242-0,73037-34-0,Not Classified,REACH registration C&L,2,Not classified:2
23474,"Formaldehyde, polymer with phenol and butan-1-ol",619-213-0,96446-41-2,Skin Sens. 1,Notified C&L,5,H317:5
23475,3-[(4-anilinophenyl)azo]benzenesulphonic acid,223-658-2,4005-68-9,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,83,H318:83;H302:83;H332:83;H312:83
23477,"D-Glucopyranose, oligomers, octyl glycosides",500-532-8,161074-96-0,Not Classified,Notified C&L,1,Not classified:1
23479,"reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol",444-430-0,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
23481,"Ethyl (2E,4Z)-2,4-decadienoate",221-178-8,3025-30-7,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1712,H410:91;H315:1711;H400:92;H412:1616;H319:45;H411:50;Not classified:1
23482,(Z)-N-methyl-9-octadecenamide,274-945-4,70858-46-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
23486,"D-Glucose, 6-(dihydrogen phosphate), barium salt",261-463-4,58823-95-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H301:1;H331:1
23487,"5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid",431-250-2,171850-30-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
23489,Tin(II) oxalate,212-414-0,814-94-8,Not Classified,REACH registration C&L,284,Not classified:29;H372:8;H334:8;H332:8;H317:8;H373:8;H314:8;H318:187;H302:68;H312:68
23496,"3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooct-1-ene",246-791-8,25291-17-2,STOT RE 1,REACH registration C&L,218,H372:5;Not classified:169;H335:42;H315:43;H319:43;H225:44
23498,"Naphthalenesulfonic acids, reaction products with formaldehyde and sulfonylbis[phenol], ammonium salts",302-189-8,94094-87-8,Not Classified,Notified C&L,2,Not classified:2
23504,C.I. Acid Brown 366,616-427-6,77031-22-2,Not Classified,Notified C&L,1,Not classified:1
23505,Cobalt arsenide,248-168-6,27016-73-5,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H301:1;H400:1;H331:1
23507,"2-(2-hydroxy-3,5-dinitroanilino)ethanol",412-520-9,99610-72-7,Flam. Sol. 2;Acute Tox. 4;Repr. 2,Harmonised C&L,0,H302:0;H361:0;H228:0
23517,reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane,434-420-4,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H318:0;H400:0
23519,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 2-(chloromethyl)oxirane",608-489-8,30499-70-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,376,H412:211;H317:369;H315:347;H319:328;H411:91;H360:41;H314:22;H318:41;Not classified:6;H341:5;H332:2;H335:1;H302:1;H312:1
23521,Sodium [1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(1-),261-691-4,59307-49-2,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,155,H412:89;H319:89;Not classified:46;H411:20;H317:1
23530,chloroform;trichloromethane,200-663-8,67-66-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Carc. 2;STOT RE 1;Repr. 2,Harmonised C&L,0,H372:0;H351:0;H319:0;H331:0;H302:0;H315:0;H361:0
23534,Methyl 2-cyano-3-ethoxyacrylate,249-432-3,29096-99-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
23535,"Disodium 6-[[2,4-dihydroxy-3-[(4-nitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(2-hydroxy-3-nitro-5-sulphonatophenyl)azo]naphthalene-2-sulphonate",306-584-6,97337-89-8,Not Classified,Notified C&L,20,Not classified:20
23537,Epiestriol,208-937-9,547-81-9,,Notified C&L,2,H360:2;H372:1;H350:1
23539,Methylmercury hydroxide,214-667-2,1184-57-2,,Notified C&L,4,H373:4;H410:4;H310:4;H300:4;H330:4;H400:4
23541,Sodium 2-[[2-amino-8-hydroxy-6-[(methylanilino)sulphonyl]-1-naphthyl]azo]-5-(chloroacetamido)benzenesulphonate,274-395-5,70209-97-1,Skin Sens. 1,REACH registration C&L,1,H317:1
23542,"Cholesta-3,5-diene",212-021-4,747-90-0,Acute Tox. 4,Notified C&L,38,H302:38
23543,"(Z)-N-methyl-N-(1-oxo-9-octadecenyl)glycine, compound with 2,2',2''-nitrilotri(ethanol) (1:1)",241-727-5,17736-08-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,77,H412:3;H315:34;H410:3;H318:33;H400:32;Not classified:43;H319:1
23549,Dexamethasone 21-(disodium phosphate),219-243-0,2392-39-4,Acute Tox. 4;Repr. 2;STOT RE 2,REACH registration C&L,129,H373:24;H302:104;H361:104;H351:99;H332:17;H360:25;H317:1;H362:1;H372:1
23551,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane, p-tert-butylphenol-modified",614-575-6,68527-32-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,23,H317:23;H315:23;H319:23;H411:1
23552,Acid Hydrolysate of Casein (Bovine),922-402-3,,Not Classified,Notified C&L,2,Not classified:2
23556,(Z)-anethole,247-181-4,25679-28-1,Skin Sens. 1,Notified C&L,101,H317:100;H410:1;H301:1
23557,1-[2-chloro-4-(4-chlorophenyl)butyl]imidazole,614-018-7,67085-12-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H312:2
23559,benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate,402-240-5,102561-46-6,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H411:0
23561,ALIPHATIC AMINE,613-243-8,63512-71-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:38;H319:38
23565,1-[4-(2-methylpropyl)phenyl]ethan-1-one,254-159-8,38861-78-8,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,127,H401:2;H317:126;H315:85;H411:127;H226:42
23566,Tetrapropylammonium hydrogen sulfate,611-366-1,56211-70-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
23569,3-chloro-6-nitrotoluene,226-355-3,5367-28-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H302:40;H319:40;H412:2;H335:1;H315:1
23570,"1-Butene, homopolymer",618-361-3,9003-28-5,Not Classified,Notified C&L,1,Not classified:1
23574,Ergometrine hydrogen maleate,204-953-5,129-51-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H331:38;H301:39;H311:38;H332:1;H302:1;H361:1;H315:1;H317:1
23575,(pentafluorophenoxy)acetic acid,238-964-1,14892-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
23577,"Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {}{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}}-{}{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}}chromate (III);by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{}{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}}chromate (III);by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{}{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}} chromate (III)",419-230-1,,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
23579,"2',4'-dihydroxypropiophenone",227-329-4,5792-36-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
23581,tert-butylamine hydrochloride,233-009-5,10017-37-5,Acute Tox. 4,Notified C&L,38,H302:38
23582,"Estra-1,3,5(10),7-tetraene-3,17β-diol",222-633-3,3563-27-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H312:38;H372:1;H360:1;H350:1
23585,"4,4'-bipyridyl",209-036-3,553-26-4,Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,136,H301:136;H411:90;H311:96;H335:40;H315:40;H319:40;H371:1;H373:1;H332:1;H312:1;Not classified:1;H331:1
23587,Trimethyl(tetradecyl)ammonium chloride,224-958-6,4574-04-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78,H335:43;H315:45;H319:45;Not classified:31;H314:2;H302:2;H312:2;H400:2
23588,2-ethyl-5-methylthiophene,609-821-4,40323-88-4,Not Classified,Notified C&L,93,Not classified:88;H226:5
23592,4-(decanoyloxy)benzoic acid,617-941-3,86960-46-5,Not Classified,Notified C&L,33,Not classified:33
23594,"Eugenia caryophyllata, ext., reaction products with formaldehyde",305-054-1,94333-73-0,Not Classified,Notified C&L,52,Not classified:52
23596,p-vinylbenzoic acid,214-053-4,1075-49-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:49;H315:51;H319:51;H302:5;Not classified:2;H411:1
23597,N-(chloromethyl)phthalimide,241-541-4,17564-64-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H301:39;H319:76;H335:75;H317:39;H315:76
23599,Butyl ricinoleate,205-785-5,151-13-3,Aquatic Chronic 3,REACH registration C&L,5,H412:2;Not classified:3
23601,nickel bis(isononanoate),284-349-6,84852-37-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H372:0;H350:0;H334:0;H360:0;H317:0;H410:0;H341:0;H400:0
23602,"2,6-Dibromo-4-fluoroaniline",608-987-5,344-18-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:44;H335:43;H332:44;H302:44;H315:44;H312:44
23605,Terbium(3+) acetate,247-065-3,25519-07-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
23606,hydrogenated stearyl olive oil esters,921-548-5,,Acute Tox. 3;Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H301:2;H319:2;H400:2
23607,"O,O-diisopropyl hydrogen dithiophosphate",203-503-5,107-56-2,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,REACH registration C&L,87,H314:87;H290:2;H302:87;H413:1;H318:86;H412:1
23612,"N,N-bis(2-chloroethyl)-p-toluenesulphonamide",255-677-7,42137-88-2,Acute Tox. 3,Notified C&L,44,H301:38;H335:4;H315:5;H319:5;Not classified:1
23613,"Sulfamic acid, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",603-385-9,13008-20-3,Not Classified,Notified C&L,1,Not classified:1
23615,[7-hydroxy-8-[(2-methoxyphenyl)azo]-2-naphthyl]trimethylammonium chloride,269-941-4,68391-30-0,Not Classified,REACH registration C&L,4,Not classified:4
23617,"Imidazolium compounds, 4,5-dihydro-2-(hydrogenated nortallow alkyl)-1-[2-(hydrogenated tallow amido)ethyl]-1-methyl, Me sulfates",294-563-1,91723-55-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,14,H315:14;H318:14
23623,"Amides, from diethylenetriamine and hydrogenated tallow",272-926-5,68920-82-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,20,H315:17;H319:17;Not classified:3
23624,"1-naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, conjugate acid, (1S,4S)-",616-709-9,79617-99-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H302:1;H319:1
23625,4-(2-furyl)butan-2-one,211-831-5,699-17-2,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H227:1;H302:1;H315:1
23626,"Sulfuric acid, mono-C15-18-branched alkyl esters, sodium salts",283-060-2,84539-70-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,36,H315:36;H318:36;H400:36
23631,"Formaldehyde, reaction products with bisphenol A and phenol",294-144-3,91673-29-9,Not Classified,Notified C&L,3,Not classified:3
23633,reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate,413-500-2,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0;H318:0
23635,"4-Brom-2,6-difluorbenzoesäure",605-988-2,183065-68-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,48,H302:39;H319:47;H335:8;H315:8;Not classified:1;H318:1
23637,"1,2,3,4-tetrahydro-1,1,6-trimethylnaphthalene",207-490-7,475-03-6,Aquatic Chronic 2,Notified C&L,89,H411:79;Not classified:10;H335:2;H315:2;H319:2
23642,"4-trans-[4-trans-(3,4-Difluorphenyl)-cyclohexyl]-cyclohexancarbaldehyd",604-491-8,145767-92-6,Not Classified,REACH registration C&L,2,Not classified:2
23646,Acetohydroxamic acid,208-913-8,546-88-3,Repr. 1B,Notified C&L,48,H360:48
23649,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt, hydrate (1:3:2)",612-118-5,6132-04-3,Not Classified,Notified C&L,432,Not classified:415;H413:10;H319:6;H312:1
23650,"2,4,5-Trimethyl-2,5-dihydrooxazole",607-131-8,22694-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1443,H335:1405;H315:1405;H319:1443;H226:119
23652,"N-isopropylpropane-1,3-diamine",222-127-2,3360-16-5,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39;H318:1
23653,(E)-3-phenylprop-2-enal,604-377-8,14371-10-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:39;H317:45;H315:45;H319:45;Not classified:3;H312:1
23654,Metandienone,200-787-2,72-63-9,Not Classified,Notified C&L,115,Not classified:91;H362:24;H360:24
23655,4-cyanophenyl 4-hexylbenzoate,256-767-9,50793-85-6,,Notified C&L,5,H302:5;H332:1;H312:1
23659,"4-chloro-3,5-dinitrobenzoic acid",204-290-1,118-97-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46,H315:46;H319:46;H335:7
23663,"Lanthanum chloride, anhydrous",233-237-5,10099-58-8,Met. Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,176,H290:54;H317:137;H411:137;H318:137;H335:37;H315:37;H319:37;Not classified:2
23664,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid",610-929-9,5300-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,41,H335:40;H315:41;H319:41;H360:40;H361:1;H302:1;H410:1;H341:1;H400:1
23668,p-(methoxymethyl)anisole,216-161-7,1515-81-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
23670,benzonitrile,202-855-7,100-47-0,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H312:0
23672,"(Z)-[2-[4-(1,2-diphenylbut-1-enyl)phenoxy]ethyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate",259-415-2,54965-24-1,Acute Tox. 4;Carc. 1B;Repr. 1B,Notified C&L,78,H302:76;H360:75;H350:76;H362:31;H372:5;H410:9;H400:5;H341:3;H351:1;H319:1;H334:1;H335:1;H332:2;H317:1;H315:1;H312:2;H340:1;Not classified:1;H373:1;H411:1
23673,Methyl O-acetylricinoleate,205-392-9,140-03-4,Not Classified,Notified C&L,8,Not classified:7;H319:1
23681,"Benzene, di-C12-14-alkyl derivs.",271-068-9,68515-26-4,Not Classified,Notified C&L,13,Not classified:13
23682,Ethyl diphenylglycolate,257-713-7,52182-15-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:39;H302:39;H315:40;H318:39;H319:1
23685,"Methyl 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate",228-171-9,6153-44-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
23690,"Balsams, copaiba",232-288-0,8001-61-4,Asp. Tox. 1,Notified C&L,1508,H304:1496;Not classified:11;H317:4;H315:2;H302:1
23694,"1,4-Benzenedicarboxylic acid, 1,4-dimethyl ester, polymer with 1,4-cyclohexanedimethanol and 1,2-ethanediol",607-767-6,25640-14-6,Not Classified,Notified C&L,2,Not classified:2
23696,"1-(1,3-THIAZOL-2-YL)PROPAN-1-ONE",610-101-7,43039-98-1,Acute Tox. 4,Notified C&L,1375,H302:1287;Not classified:87;H335:1;H315:1;H319:1
23698,Potassium (2S-trans)-3-[[[2-(formylamino)thiazol-4-yl]oxoacetyl]amino]-2-methyl-4-oxoazetidine-1-sulphonate,289-372-5,88023-65-8,Not Classified,REACH registration C&L,1,Not classified:1
23705,2-Fluoro-4-hydroxybenzonitrile,617-324-9,82380-18-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,44,H302:43;H411:42;H318:42;H335:2;H315:2;H319:2;H332:1
23709,(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate,407-840-0,100011-37-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0
23710,4-(methylsulphonyl)-2-nitrophenol,202-560-3,97-10-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H301:1;H319:1;H331:1;H335:1;H315:1;H311:1
23711,Ammonium 3-nitrosulphanilate,256-697-9,50667-33-9,Not Classified,Notified C&L,1,Not classified:1
23716,"Trimethylhexane-1,6-diamine",247-134-8,25620-58-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1541,H314:1536;H317:1536;H302:1484;H412:1412;H318:354;H410:71;Not classified:5;H335:1;H312:1
23718,"4,4-dimethoxybutylamine",407-690-6,19060-15-2,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H314:0;H317:0;H302:0;H412:0
23719,"Fatty acids, C16-18 and C18-unsatd., tetraesters with pentaerythritol",271-694-2,68604-44-4,Not Classified,REACH registration C&L,78,Not classified:78
23720,Barium bis(2-ethylhexanoate),219-535-8,2457-01-4,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,218,H332:128;H302:211;H361:21;H318:15;H413:2
23724,Bis(4-bromophenyl) sulphide,222-240-7,3393-78-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
23725,C.I. Acid Brown 298,602-520-9,12234-78-5,Not Classified,Notified C&L,2,Not classified:2
23736,"Reaction Mass of N-[3-(trimethoxysilyl)propyl]-1,3-benzenedimethanamine and {3-[(2,2-dimethoxy-1,2-azasilolidin-1-yl)methyl]phenyl}methanamine",439-510-7,,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H318:1
23739,"Carbonochloridic acid, 3-chloropropyl ester",613-087-0,628-11-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;STOT RE 2,Notified C&L,38,H331:38;H317:38;H302:38;H315:38;H373:38;H318:38
23741,Bis(3-hydroxy-p-tolylammonium) sulphate,233-901-4,10422-66-9,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,7,H332:6;H302:6;H411:7;H319:1;H335:1;H317:1;H315:1
23742,"(Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine",303-725-3,94213-23-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,57,H332:2;H302:3;H312:2;Not classified:53;H317:1;H413:1
23743,1-methylpiperidin-4-ol,203-406-8,106-52-5,Eye Irrit. 2,REACH registration C&L,103,H319:11;H335:46;H315:47;Not classified:52;H318:38;H314:2
23745,2-fluorobenzoic acid,207-158-1,445-29-4,Skin Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:9
23749,"Tallow, Me esters",272-743-0,68910-48-5,Not Classified,Notified C&L,2,Not classified:2
23760,"Glycerides, palm-oil mono-, hydrogenated, acetates",297-462-0,93572-32-8,Aquatic Chronic 3,REACH registration C&L,8,H412:1;Not classified:7
23761,"(thiodi-4,1-phenylene)-bis-(diphenylbis)(OC-6,11)hexafluoroantimonate",680-222-8,89452-37-9,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,53,H332:47;H302:47;H411:46;H317:5;H410:2;H400:3;H412:1
23765,4-methylresorcinol,207-827-8,496-73-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,128,H335:128;H315:128;H319:128
23766,6-methylpyridin-2-ol,221-919-5,3279-76-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:43;H315:44;H319:44;Not classified:1
23768,"Molybdic acid, compounds with di-tridecylamine (1:1), branched",442-990-0,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H315:1;H318:1;H400:1
23769,"Poly(oxy-1,2-ethanediyl), a,a'-[[](octyloxy)phosphinylidene]bis[[][?]-hydroxy-",611-504-0,57344-01-1,,Notified C&L,50,Not classified:38;H315:11;H319:11;H314:1
23776,"[1S-(1α,2α,3aβ,4α,8aβ,9R*)]-decahydro-1,5,5,8a-tetramethyl-1,2,4-methenoazulene",214-504-5,1137-12-8,Aquatic Acute 1,Notified C&L,48,H400:48;H410:10
23779,"tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)",405-040-6,63500-71-0,Eye Irrit. 2,Harmonised C&L,0,H319:0
23780,4-(aminomethyl)pyrocatechol hydrobromide,240-382-8,16290-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
23781,Sodium hydrogen m-sulphonatobenzoate,241-602-5,17625-03-5,Eye Dam. 1,REACH registration C&L,51,H318:4;H335:45;H315:46;H319:46;H301:1;H311:1
23783,"2,5-dihydro-5-oxo-1H-pyrazole-3-carboxylic acid",253-681-3,37832-55-6,,Notified C&L,1,H335:1;H315:1;H319:1
23785,"2,6-bis(4-chlorobenzylidene)cyclohexan-1-one",242-725-7,18989-82-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
23789,"Gum benzoin, Siam, ext.",617-615-0,84696-18-4,Not Classified,Notified C&L,25,Not classified:25
23790,Benzil,205-157-0,134-81-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,562,H315:560;H319:552;H335:542;H331:8;H400:8;H332:8;H302:9;Not classified:11;H311:8
23794,reaction mass of: succinic acidmonopersuccinic aciddipersuccinic acidmonomethyl ester of succinic acidmonomethyl ester of persuccinic aciddimethyl succinate glutaric acidmonoperglutaric aciddiperglutaric acidmonomethyl ester of glutaric acidmonomethyl ester of perglutaric aciddimethyl glutarate adipic acidmonoperadipic aciddiperadipic acidmonomethyl ester of adipic acidmonomethyl ester of peradipic aciddimethyl adipatehydrogen peroxidemethanolwater,432-790-1,847871-03-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 2,Harmonised C&L,0,H332:0;H371:0;H302:0;H314:0;H312:0
23796,"Sodium 1-amino-9,10-dihydro-4-[[4-[[(4-methylphenyl)sulphonyl]oxy]phenyl]amino]-9,10-dioxoanthracene-2-sulphonate",267-990-6,67969-88-4,Aquatic Chronic 1,REACH registration C&L,21,H410:1;Not classified:20
23798,"Hydrocarbons, C4, 1,3-butadiene-free, polymd., triisobutylene fraction",293-263-8,91053-01-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2,REACH registration C&L,35,H315:35;H304:35;H226:35
23799,6-Acetamidopyridine-2-carboxylic acid,608-016-5,26893-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
23803,Dodecyl 5-oxo-L-prolinate,245-224-1,22794-26-9,Eye Irrit. 2,REACH registration C&L,3,H319:2;Not classified:1
23815,Pentacosyl alcohol,247-427-0,26040-98-2,Not Classified,Notified C&L,1,Not classified:1
23818,Sodium anisate,208-634-1,536-45-8,Not Classified,REACH registration C&L,13,Not classified:13
23823,Undec-1-yne,218-825-1,2243-98-3,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,39,H413:38;H319:38;H304:1
23825,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(hexadecyloxy)-, sodium salt",608-923-6,33939-65-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,44,H315:44;H318:44
23826,2-Amidinopyrimidine hydrochloride,604-087-1,138588-40-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H302:1;H312:1;H335:1;H315:1;H319:1
23828,4-phenylpyrimidine,222-345-8,3438-48-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,195,H302:194;H319:195;H315:1
23831,Butalbital,201-017-8,77-26-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,43,H317:40;H302:40;H301:3;H331:1
23832,N-[3-[Tris(trimethylsiloxy)silyl]propyl]acrylamide,812-480-6,115258-10-1,Eye Irrit. 2,Notified C&L,1,H319:1
23834,"Cobalt, borate 2-ethylhexanoate complexes",295-032-7,91782-60-4,Skin Sens. 1A;Eye Irrit. 2;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,40,H319:10;H360:15;H317:18;H411:15;H400:40;H318:5;H410:25;H302:3;H314:3
23839,"Antimony, compound with nickel (1:1)",234-827-5,12035-52-8,,Notified C&L,5,H351:4;H334:4;H332:5;H317:4;H302:5;H411:5
23841,"reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate",438-310-7,,Self-react. C;Acute Tox. 4;STOT RE 2;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H373:0;H302:0;H361:0;H412:0;H242:0
23846,Furfuryl(purin-6-yl)amine,208-382-2,525-79-1,Muta. 2,Notified C&L,153,H341:141;Not classified:9;H335:2;H302:2;H315:2;H319:2;H334:1
23848,"2,2,4,4-tetramethyl-7-oxa-3,20-diazadispiro[5.1.11.2]-henicosan-21-one",264-780-6,64338-16-5,Eye Dam. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,144,H332:68;H373:52;H410:52;H318:68;H400:52;Not classified:76
23851,2-benzylpiperidine,251-255-1,32838-55-4,Acute Tox. 4,Notified C&L,41,H302:40;H335:2;H315:2;H319:1;H318:1
23853,"9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium perchlorate",236-099-4,13161-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43;H302:1
23857,(2-methoxyphenyl)acetonitrile,230-314-5,7035-03-2,,Notified C&L,6,H412:5;H301:5;H319:1;H332:1;H302:1;H315:1;H312:1
23859,"1,3,3-trimethoxypropene",241-547-7,17576-35-1,Not Classified,Notified C&L,1,Not classified:1
23864,1-(2-pyridylazo)-2-naphthol,201-637-9,85-85-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:46;H315:47;H319:47;Not classified:1
23867,6-allyl-o-cresol,222-124-6,3354-58-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
23876,Trifluoromethansulfonamide,431-270-1,,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1,Notified C&L,1,H301:1;H318:1;H311:1
23877,Verapamil,200-145-1,52-53-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,52,H331:52;H301:52;H311:52
23878,(p-nitrobenzyl)triphenylphosphonium bromide,220-444-0,2767-70-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
23881,C.I. Acid Red 315,602-076-6,12220-47-2,Not Classified,Notified C&L,2,Not classified:1;H411:1;H315:1;H319:1
23882,triethoxyisobutylsilane,402-810-3,17980-47-1,Skin Irrit. 2,Harmonised C&L,0,H315:0
23886,"glutamic acid, reaction products with N-(C",403-950-8,164907-72-6,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H314:0;H302:0;H330:0;H400:0
23888,"triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoate",603-146-9,126535-15-7,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H351:0;H400:0
23895,Acetone hydrazone,226-110-0,5281-20-9,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Carc. 2;Aquatic Chronic 2,Notified C&L,1,H301:1;H351:1;H331:1;H226:1;H314:1;H411:1;H311:1
23899,"Tris(pentane-2,4-dionato-O,O')gadolinium",238-186-2,14284-87-8,,Notified C&L,1,H335:1;H315:1;H319:1
23903,Bis(2-methoxyphenyl) carbonate,209-034-2,553-17-3,Not Classified,Notified C&L,2,Not classified:2
23904,"(5α)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride",257-924-4,52446-24-9,Eye Dam. 1;STOT SE 3,REACH registration C&L,6,H336:3;H318:3;Not classified:1;H332:1;H317:1;H302:1;H334:1;H335:1;H315:1;H319:1
23908,"Benzoic acid, 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H- xanthen-9-yl]-, ethoxylated, sulfate (1:1) (salt) (1 - 2,5 mol EO)",600-290-4,102262-18-0,Aquatic Chronic 3,Notified C&L,172,H412:172
23910,4-trans-Propylcyclohexancarbonic acid-(4-methoxyphenyl)ester,614-085-2,67589-38-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
23911,methyl acetate,201-185-2,79-20-9,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H336:0;H319:0;H225:0
23918,"Amides, tallow, hydrogenated, N,N'-(iminodi-2,1-ethanediyl)bis-, reaction products with formaldehyde and urea",287-313-8,85480-34-8,Not Classified,Notified C&L,1,Not classified:1
23919,2-(4-isopropylphenyl)propionaldehyde,251-920-6,34291-99-1,Skin Sens. 1,Notified C&L,88,H317:88
23920,"1,2,3-trifluoro-5-nitrobenzene",266-447-0,66684-58-0,Acute Tox. 2,Notified C&L,45,H300:38;H319:6;H332:5;H302:6;H315:6;H312:6;H331:2;H301:1;H311:1
23921,5-ethylthiophene-2-carbaldehyde,253-252-0,36880-33-8,Acute Tox. 4,Notified C&L,90,H302:89;H319:2;H335:1;H332:1;H315:2;H312:1
23927,"Silane, 3-buten-1-yltriethoxy-",611-580-5,57813-67-9,,Notified C&L,1,H335:1;H315:1;H319:1
23928,"D-Glucitol, 1-deoxy-1-(methylamino)-, (βS)-3,4-dichloro-β-cyanobenzenepropanoate (1:1)",605-161-6,158751-54-3,,Notified C&L,1,H332:1;H302:1;H312:1
23929,"Benzenesulfonic acid, mono-C11-13-branched alkyl derivs., sodium salts",271-808-0,68608-89-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,58,H302:58;H315:58;H312:48;H411:56;H318:58;H400:48
23931,5-[[4-[[[[2-methoxy-4-[(3-sulphophenyl)azo]phenyl]amino]carbonyl]amino]phenyl]azosalicylic acid,256-338-6,47834-75-3,Not Classified,Notified C&L,1,Not classified:1
23933,Calcium (S)-2-hydroxypropionate,248-953-3,28305-25-1,Not Classified,REACH registration C&L,33,Not classified:8;H319:25
23935,"(E)-3,7-dimethylocta-1,5,7-trien-3-ol",258-818-0,53834-70-1,Not Classified,Notified C&L,61,Not classified:61
23937,"5,6-dihydro-3,6-dimethyl-4H-benzofuran-2-one",279-462-2,80417-97-6,Acute Tox. 4,Notified C&L,258,H302:258
23938,C.I. Fluorescent Brightener 119,602-866-0,12270-52-9,Not Classified,Notified C&L,2,Not classified:2
23941,"2-(2-Ethoxyphenyl)-5-methyl-7-propylimidazo-[5,1-f][1,2,4]triazin-4(3H)-one",607-089-0,224789-21-3,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H317:3;H411:3
23942,"1-(3,3-dimethylcyclohexyl)ethan-1-one",246-799-1,25304-14-7,Not Classified,Notified C&L,264,Not classified:252;H411:12;H315:12;H319:11
23945,"[R(R*,R*)]-2,3-bis[(4-methylbenzoyl)oxy]succinic acid",251-131-7,32634-66-5,Eye Irrit. 2,REACH registration C&L,19,H319:14;Not classified:5;H335:5;H315:6
23949,Pramocaine hydrochloride,211-293-1,637-58-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,82,H335:81;H302:82;H315:81;H319:81
23953,"Ethyl 3,4-bis(2-methoxyethoxy)benzoate",605-991-9,183322-16-9,Not Classified,Notified C&L,1,Not classified:1
23955,Hept-2-yne,214-285-6,1119-65-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:39;H315:39;H319:39;H225:44;H332:1;H302:1;H312:1;H304:1
23956,"bis(2,4,4-trimethylpentyl)dithiophosphonic acid",420-160-9,107667-02-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H331:0;H226:0;H302:0;H314:0;H411:0
23961,"2-chloro-1,3,2-dioxaphospholane",212-499-4,822-39-9,Skin Corr. 1B;STOT SE 3,Notified C&L,44,H314:44;H335:38;H318:1;H290:1;H412:1
23964,mecetronium etilsul­fate;,221-106-5,3006-10-8,Skin Corr. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H410:0;H318:0;H400:0
23965,polysiloxane,614-121-7,67762-85-0,Not Classified,Notified C&L,97,Not classified:95;H319:2;H335:2;H332:2;H302:2;H315:2;H312:2
23966,2-benzylphenol,249-361-8,28994-41-4,Not Classified,REACH registration C&L,45,Not classified:1;H335:43;H315:44;H319:44
23969,"1-benzyl hydrogen (2S-trans)-4-hydroxypyrrolidine-1,2-dicarboxylate",236-831-2,13504-85-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
23972,"3-[(1,2-dimethyl-1H-indol-3-yl)azo]-1,5-dimethyl-2-phenyl-1H-pyrazolium chloride",289-546-0,89923-55-7,Not Classified,Notified C&L,25,Not classified:25
23979,"17-Acetoxy-1,4,6-pregnatriene-3,20-dione",607-988-8,2668-75-9,Not Classified,Notified C&L,1,Not classified:1
23980,Zirconium bis(2-ethylhexanoate) oxide,239-157-7,15104-99-1,Skin Irrit. 2,Notified C&L,2,H315:1;Not classified:1
23981,"[[(phosphonomethyl)imino]bis[(ethylenenitrilo)bis(methylene)]]tetrakisphosphonic acid, sodium salt",244-751-4,22042-96-2,Not Classified,Notified C&L,561,Not classified:319;H290:103;H315:87;H319:88;H413:47;H314:16;H318:6
23982,"Bis(D-gluconato-O1,O2)manganese",229-350-4,6485-39-8,Eye Irrit. 2,Notified C&L,94,H319:91;Not classified:3
23983,Ethylenediurea,217-441-1,1852-14-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
23984,"Thaumatococcus daniellii, ext.",290-369-6,90131-57-0,,Notified C&L,1,H334:1
23988,"Bicyclo[2.2.1]heptane, 2-ethyl-5-methoxy-",602-893-8,122795-41-9,Aquatic Chronic 2,Notified C&L,79,H411:79
23990,"2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)",229-962-1,6864-37-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3;Aquatic Chronic 2,Harmonised C&L,0,H331:0;H302:0;H314:0;H411:0;H311:0
23991,"N,N,N',N'-tetramethylethylenediamine",203-744-6,110-18-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H314:0;H302:0;H332:0;H225:0
23995,"2-nitro-4,5-bis(benzyloxy)phenylacetonitrile",410-970-0,117568-27-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
23996,Nortriptyline,200-788-8,72-69-5,Acute Tox. 4,Notified C&L,38,H302:38
23997,"[1R-(1α,2β,3α,5α)]-pinane-3-methylammonium chloride",261-114-6,58096-22-3,Acute Tox. 3,Notified C&L,38,H301:38
24003,"Copper, diamminebis(nitrato-kO)",604-942-9,15414-04-7,Expl. 1.3;Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2,H203:2;H302:2;H317:2;H319:2
24006,ROSOXIME,437-520-6,,Not Classified,Notified C&L,60,Not classified:60
24007,2-hydroxypropyl methacrylate,213-090-3,923-26-2,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H319:0
24011,2-(2H-benzotriazol-2-yl)-4-dodecylphenol,221-548-9,3142-42-5,,Notified C&L,1,Not classified:1
24015,"4,5-dimethyl-2-propyloxazole",258-817-5,53833-32-2,Flam. Liq. 3,Notified C&L,1,H226:1
24016,3-aminopropiononitrile,205-786-0,151-18-8,Acute Tox. 4;Repr. 2,Notified C&L,43,H302:42;H361:42;H314:5;H301:1;H318:1
24017,1-methylheptyl acrylate,256-005-5,42928-85-8,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,4,H319:4;H335:4;H317:4;H315:3;H411:3
24020,Methyl DL-prolinate,257-714-2,52183-82-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:39;H318:39
24021,3-methyl-4-nitropyridine 1-oxide,214-050-8,1074-98-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,44,H351:39;H319:39;H335:39;H332:44;H302:44;H315:39;H312:40;H341:4;H311:4
24023,"Ethyl 2,3-anhydro-4,5-dideoxy-3-C-methylpentonate",222-880-7,3647-33-4,Eye Irrit. 2,Notified C&L,38,H319:38
24026,"(R)-12-hydroxyoleic acid, monoester with glycerol",215-353-8,1323-38-2,Not Classified,Notified C&L,8,Not classified:8
24030,Rhodium phosphate,267-420-6,67859-71-6,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H290:2;H318:1
24032,2-(phenylmethylene)heptyl acetate,231-339-4,7493-78-9,Not Classified,Notified C&L,233,Not classified:233
24037,3'-hydroxypropiophenone,236-027-1,13103-80-5,,Notified C&L,1,H315:1;H319:1
24039,[No public or meaningful name is available],446-410-7,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H315:1;H319:1
24041,"1,3-diiodopropane",210-993-4,627-31-6,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,50,H317:2;H302:3;H411:2;H335:46;H315:47;H319:48;Not classified:1;H332:1;H312:1
24044,Pentamethonium iodide,226-111-6,5282-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24046,"2,2',6,6'-Tetrabromo-4,4'-isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and 2,4,6-tribromophenol",500-399-6,158725-44-1,Not Classified,REACH registration C&L,6,Not classified:6
24050,Pentachlorobenzonitrile,620-151-1,20925-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,158,H335:157;H315:158;H319:158;H332:1;H302:1;H312:1
24053,Cinnamyl cinnamate,204-566-1,122-69-0,Not Classified,Notified C&L,1603,Not classified:1602;H332:1;H312:1;H360:1;H319:1
24054,Dimethyl dodecanedioate,217-050-6,1731-79-9,Not Classified,Notified C&L,25,Not classified:25
24057,2-ethylhexyl isobutyrate,252-341-1,35061-61-1,Flam. Liq. 3,Notified C&L,88,H226:88
24059,7-methylcoumarin,219-499-3,2445-83-2,Not Classified,Notified C&L,3,Not classified:2;H335:1;H315:1;H319:1
24060,"Syrups, corn, hydrogenated",270-337-8,68425-17-2,Not Classified,REACH registration C&L,114,Not classified:114
24063,Phenyl m-tolyl ether,222-716-4,3586-14-9,Aquatic Chronic 2,Notified C&L,157,H411:157
24064,Disulphur decafluoride,227-204-4,5714-22-7,Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2,Notified C&L,1,H314:1;H330:1;H318:1
24066,Disodium dihydrogen (3-amino-1-hydroxypropylidene)bisphosphonate,260-647-1,57248-88-1,Acute Tox. 4;STOT SE 2,Notified C&L,5,H371:2;H302:5;H335:1;H315:1;H319:1
24068,Naphthalenesulfonic acids,268-860-1,68153-01-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,132,H314:129;H302:83;H318:86;H411:37;H351:37;Not classified:3
24071,"2,3-dihydroxypropyl hexanoate",207-943-9,502-53-4,Not Classified,Notified C&L,2,Not classified:2
24072,Zinc diarsenide,234-956-7,12044-55-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H301:42;H400:38;H331:42;H373:4
24073,4-vinylpyridine,202-852-0,100-43-6,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,178,H301:131;H331:4;H226:141;H317:140;H314:58;H411:85;H318:5;H311:8;H319:83;H315:83;H330:93;Not classified:37;H334:15;H300:10;H332:4;H413:1;H341:1;H335:1
24074,"Hydrogen tetrasodium bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]cobaltate(5-)",274-871-2,70776-55-5,Not Classified,Notified C&L,48,Not classified:38;H317:10
24075,Dibismuth molybdenum hexaoxide,236-955-7,13565-96-3,Not Classified,Notified C&L,38,Not classified:38
24081,[No public or meaningful name is available],454-360-2,,Not Classified,Notified C&L,33,Not classified:33
24084,4-(4-chlorophenyl)-3-methyl-4-oxo-butanoic acid,610-810-1,52240-25-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:1;H315:2;H319:2
24089,1-iodohexadecane,208-879-4,544-77-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H335:38;H315:39;H319:39;H400:38
24090,Zinc tetraoctadecyl bis(phosphate),240-752-9,16700-97-3,,Notified C&L,2,Not classified:2
24092,4'-bromoacetophenone,202-799-3,99-90-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,51,H319:50;H335:49;H334:39;H302:42;H315:50;Not classified:1;H332:1
24094,"trans-4-[[(2-amino-3,5-dibromophenyl)methyl]amino]cyclohexan-1-ol hydrochloride",245-899-2,23828-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,68,H335:57;H315:57;H319:60;Not classified:3;H411:3;H332:2;H302:2;H312:2;H361:1;H412:1
24095,Bismuth 2-propylvalerate,262-199-2,60364-28-5,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.,Notified C&L,1,H362:1;H302:1;H351:1;H360:1
24097,"7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-",617-457-2,83380-47-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2,Notified C&L,61,H334:52;H332:52;H317:52;H302:52;H312:52;H341:61;H361:9
24098,"Acetic acid ethenyl ester,1-ethenyl-2-pyrrolidinone",607-540-1,25086-89-9,Aquatic Chronic 4,Notified C&L,390,H413:156;Not classified:182;H302:51;H332:1;H319:2;H312:1;H225:1
24099,"5-methyl-2-[[]4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid",600-521-9,104098-48-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H410:83;H400:83
24102,5-chloro-2-oxobenzoxazoline-6-sulphonyl chloride,227-326-8,5791-05-9,Acute Tox. 4;Skin Corr. 1C;STOT SE 3,Notified C&L,1,H314:1;H302:1;H335:1
24104,asbestos,616-471-6,77536-66-4,Carc. 1A;STOT RE 1,Harmonised C&L,0,H372:0;H350:0
24105,camphechlor (ISO);toxaphene,232-283-3,8001-35-2,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H351:0;H335:0;H315:0;H410:0;H312:0;H400:0
24106,"Quaternary ammonium compounds, ethyldimethyltallow alkyl, Et sulfates",271-759-5,68607-26-1,,Notified C&L,1,H302:1;H315:1;H318:1
24110,"1-Propanaminium, 3-amino-N,N,N-trimethyl-, N-C12-18 acyl derivs., Me sulfates",271-063-1,68514-93-2,Eye Irrit. 2,Notified C&L,54,H319:41;H336:13;H315:26;H318:13
24112,Zirconium tetraiodide,237-780-9,13986-26-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H314:43;H318:39
24114,Sodium sulphooctadecanoate,268-062-3,67998-94-1,Eye Dam. 1,Notified C&L,51,H318:51;H315:1
24115,Tris(2-hydroxyethyl)ammonium dihydrogen phosphate,244-192-6,21071-31-8,Not Classified,Notified C&L,2,Not classified:2
24116,(R)-Bis [(3-carboxy-2-hydroxypropyl) trimethyl Ammonium] L-tartrate,609-282-5,36687-82-8,Not Classified,Notified C&L,90,Not classified:85;H335:3;H315:5;H319:5
24118,"Poly(oxy-1,2-ethanediyl), .alpha.-dodecyl-.omega.-hydroxy-, phosphate, sodium salt",610-044-8,42612-52-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,63,H315:63;H319:61;H318:2
24121,Diprophylline,207-526-1,479-18-5,Acute Tox. 4,Notified C&L,58,H302:58;H332:16
24123,"Amines, C12-14-branched alkyl, 4-[(5-cyano-1-ethyl-5,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)azo]-1,3-benzenedisulfonate",304-811-3,94279-65-9,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,279,H317:268;H411:277;H319:193;Not classified:2
24127,Calcium nitrite,237-424-2,13780-06-8,Acute Tox. 3;Eye Dam. 1,REACH registration C&L,163,H301:56;H318:5;H410:47;H302:47;H400:100;Not classified:58;H372:32;H340:32;H319:53;H371:53;H361:32;H373:21;H272:23
24128,"1,3-didecyl-2-methyl-1H-imidazolium chloride",274-948-0,70862-65-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:40;H315:40;H319:40;H314:7;H302:7;H400:7
24135,2-(para-chlorophenyl)glycineamide,420-830-0,102333-75-5,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
24137,"2-ethylhexanoic acid, compound with tributylamine (1:1)",261-460-8,58823-74-8,Not Classified,Notified C&L,5,Not classified:5
24139,Pivalaldehyde,211-134-6,630-19-3,Flam. Liq. 2;Skin Irrit. 2;STOT SE 3,REACH registration C&L,63,H335:58;H315:59;H225:63;H319:3
24142,"N,N-diethylbenzylamine",212-251-5,772-54-3,Acute Tox. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H301:38;H318:1
24147,4-Fluoro-2-methoxybenzaldehyde,610-222-5,450-83-9,,Notified C&L,8,H335:7;H315:8;H319:8
24150,Ethyl 4-dimethylaminobenzoate,233-634-3,10287-53-3,Repr. 1B;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,219,H411:73;H360:68;Not classified:146;H302:3
24152,"Tall oil, compd. with triethanolamine",268-453-9,68092-29-5,Eye Irrit. 2A,REACH registration C&L,16,H319:13;H315:3;Not classified:2;H412:1
24153,Methyl 3-nitro-p-toluate,230-886-6,7356-11-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H317:39;H302:39;H319:1;H335:1;H315:1
24157,"Amides, from ammonia-1,2-dichloroethane reaction product triethylenetetramine fraction and C18-24-fatty acids, acetates",292-511-2,90623-05-5,Not Classified,Notified C&L,1,Not classified:1
24159,4-[(3-chlorophenyl)azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide,244-635-3,21889-27-0,Not Classified,Notified C&L,33,Not classified:33
24163,"Boletus edulis, ext.",283-478-5,84649-97-8,Not Classified,Notified C&L,2,Not classified:2
24165,"4-Nonylphenol, ethoxylated",500-045-0,26027-38-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,380,H411:203;H302:284;H315:306;H319:301;H335:97;H410:59;H317:38;H318:59;Not classified:7;H412:1
24166,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6α,7β(R*)]]-",263-751-5,62893-20-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,50,H317:49;H334:48;H332:2;H319:1;H335:1;H302:1;H315:1
24167,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, sulfo [[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]sulfonyl derivs.",277-257-2,73049-92-0,Not Classified,REACH registration C&L,115,Not classified:75;H335:33;H315:33;H319:33;H334:5;H317:4
24168,"2-ethyl-2,3-dihydro-2-methyl-1H-perimidine",424-380-6,43057-68-7,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H373:0;H302:0;H400:0
24171,"(S)-N,N,α-trimethylbenzylamine",241-310-8,17279-31-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H302:39;H319:39;H335:1;H315:1;H332:1;H312:1
24172,"4,6-diaminopyrimidine-2-thiol",213-721-2,1004-39-3,,Notified C&L,5,H335:5;H315:5;H319:5
24178,"2,3,4,5,6-pentafluoro-α-methylbenzyl alcohol",212-597-7,830-50-2,,Notified C&L,4,H315:4;H319:4
24179,3-(4-methoxy phenyl)-3-methoxy propionic acid methyl ester,614-925-8,69098-08-4,Flam. Liq. 3;Aquatic Chronic 2,Notified C&L,1,H411:1;Not classified:1;H226:1
24180,"potassium 2,5-dichlorobenzoate",415-700-5,184637-62-5,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H302:0;H318:0
24182,"2,2'-(p-phenylenediethene-2,1-diyl)bisbenzonitrile",235-835-1,13001-39-3,Aquatic Chronic 4,REACH registration C&L,144,H413:98;Not classified:46
24184,"Pyrrolo[3,4-c]pyrrole-1,4-dione, 3,6-bis[4-(1,1-dimethylethyl)phenyl]-2,5-dihydro-",617-601-4,84632-59-7,Not Classified,Notified C&L,6,Not classified:5;H413:1
24187,"(Z,Z)-1,1,3,3-tetraoctyl-1,3-bis[(1-oxooctadec-9-enyl)oxy]distannoxane",288-880-4,85938-46-1,STOT RE 2;Aquatic Chronic 4,Notified C&L,55,H373:55;H413:55
24197,"Benzenesulfonic acid, C10-16-alkyl derivs., calcium salts",271-529-4,68584-23-6,Skin Sens. 1B,REACH registration C&L,569,H317:465;Not classified:4;H413:44;H315:81;H319:63;H412:35;H318:37
24198,"Sulfurous acid, monosodium salt, reaction products with formaldehyde and 4,4'-sulfonylbis[phenol]",292-243-6,90583-42-9,Not Classified,Notified C&L,2,Not classified:2
24200,Strontium oxalate,212-415-6,814-95-9,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,49,H302:49;H312:49
24202,1-ethynylcyclohexanol,201-100-9,78-27-3,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,196,H302:195;H315:157;H319:185;H311:195;H332:1;H312:1
24210,"4-IODO-2,6-DIMETHYLANILINE",609-884-8,4102-53-8,Not Classified,Notified C&L,4,Not classified:2;H319:1;H335:1;H332:1;H302:1;H315:1;H312:1;H373:1;H411:1
24217,"2',4'-Dichloro-2-(3-pyridyl)acetophenone (E,Z)-O-methyloxime",618-138-0,88283-41-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,194,H410:156;H302:194;H400:156
24219,"Fatty acids, castor-oil, hydrogenated, calcium lithium salts",271-695-8,68604-45-5,Not Classified,Notified C&L,2,Not classified:2
24222,"Carbamic acid, (2-hydroxypropyl)-, compd. with 1-amino-2-propanol (1:1)",605-539-0,169115-74-6,Eye Dam. 1,REACH registration C&L,1,H318:1
24223,"Naphthalenesulfonic acid, polymer with formaldehyde, sodium salt",618-665-6,9084-06-4,Not Classified,Notified C&L,636,Not classified:290;H315:287;H319:308;H318:157;H412:37;H335:1
24224,"6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl phenyl carbonate",610-114-8,43200-88-0,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,4,H362:4;H336:4;H373:4;H302:4;H361:4;H411:4
24225,Amoxicillin,248-003-8,26787-78-0,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,58,H317:58;H334:57;H412:1;H332:1
24228,4'-nitrobenzanilide,222-241-2,3393-96-2,Eye Irrit. 2,Notified C&L,39,H319:39;H335:1;H315:1
24229,Bis(2-ethylhexyl) tetrabromophthalate,247-426-5,26040-51-7,Not Classified,REACH registration C&L,23,Not classified:4;H319:19
24232,Benzylepinephronhydrochlorid,608-664-9,317351-39-6,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
24233,"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid compound with-2 (diethyl amino) ethyl4-aminobenzoate monohydrate",612-112-2,6130-64-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,155,H317:154;H334:116;Not classified:1;H302:1;H319:1
24235,reaction mass of: (E)-oxacyclohexadec-12-en-2-one;(E)-oxacyclohexadec-13-en-2-one;a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one,422-320-3,34902-57-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
24241,1-(p-chlorophenyl)acetone,226-986-4,5586-88-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H332:1;H302:1;H312:1
24246,4-bromobenzenethiol,203-407-3,106-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:44;H315:43;H319:43;H314:6;H301:7;H331:2;H311:3;H302:1;H318:1;H330:1
24250,"Phosphonic acid, mixed C12-20-alkyl and C14-18-unsatd. alkyl derivs.",300-326-6,93925-25-8,Not Classified,REACH registration C&L,2,Not classified:2
24251,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(dodecyloxy)-, sodium salt",608-922-0,33939-64-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,35,H315:35;H318:35
24252,Cyclohexylethylcarbamoyl chloride,263-753-6,62899-75-6,Acute Tox. 4;Acute Tox. 3,REACH registration C&L,1,H302:1;H331:1
24258,"chrysoidine monohydrochloride;4-phenylazophenylene-1,3-diamine monohydrochloride",208-545-8,532-82-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H315:0;H410:0;H341:0;H318:0;H400:0
24260,(1S)-1-(4-Bromophenyl)ethanamine,608-076-2,27298-97-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,48,H332:39;H317:39;H302:39;H314:48;H411:39;H318:2;H401:1
24261,2-fluorobenzamide,207-157-6,445-28-3,,Notified C&L,5,H335:5;H315:5;H319:5
24262,C.I. Solvent Yellow 174,609-217-0,362043-93-4,Not Classified,Notified C&L,1,Not classified:1
24263,"2,2'-bioxirane;1,2:3,4-diepoxybutane",215-979-1,1464-53-5,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;Muta. 1B;Carc. 1B,Harmonised C&L,0,H301:0;H350:0;H340:0;H314:0;H330:0;H311:0
24265,1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,257-166-4,51384-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
24267,p-phenetidinium chloride,211-292-6,637-56-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
24268,2-[2-[4-[2-(4-cyanophenyl)vinyl]phenyl]vinyl]benzonitrile,235-834-6,13001-38-2,Aquatic Chronic 4,REACH registration C&L,159,H413:98;Not classified:60;H412:1
24269,"1,4-difluoro-2-nitrobenzene",206-663-4,364-74-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47;H332:6;H373:4;H302:7;H312:6
24276,Disodium [6-hydroxy-5-[(2-hydroxy-5-sulphophenyl)azo]naphthalene-2-sulphonato(4-)]cuprate(2-),276-423-1,72152-71-7,Aquatic Chronic 2,REACH registration C&L,1316,H411:4;Not classified:1312
24278,"Toluene-3,4-dithiol",207-828-3,496-74-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H335:42;H302:43;H315:43;H318:39;H319:4;H332:4;H312:4;Not classified:3
24283,"Bis(3,3,5-trimethylcyclohexyl) phthalate",253-682-9,37832-65-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24290,"9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one hydrochloride",619-448-9,99614-01-4,,Notified C&L,2,H302:1;H410:1;H301:1;H318:1;H400:1
24295,[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromium,274-480-7,70236-49-6,Aquatic Chronic 3,Notified C&L,6,H412:3;H317:2;H411:2;H319:2;Not classified:1
24296,4-Bromo-Isoindoline HCl,618-839-1,923590-95-8,Acute Tox. 4,REACH registration C&L,41,H302:1;H335:40;H315:40;H319:40
24297,Strontium bis(2-ethylhexanoate),219-536-3,2457-02-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Repr. 2,REACH registration C&L,52,H361:19;H302:15;H315:37;H318:14;Not classified:7;H413:2;H317:1
24298,(2-ethoxy-2-oxoethyl)triphenylphosphonium chloride,241-548-2,17577-28-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
24299,"2,6-bis(o-chlorobenzylidene)cyclohexan-1-one",242-724-1,18989-81-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38
24300,profoxydim (ISO);2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one,604-105-8,139001-49-3,Skin Sens. 1;Carc. 2;Repr. 2,Harmonised C&L,0,H317:0;H361:0;H351:0
24303,"Dibutyl hydrogen phosphorate, compound with 4-tetrapropyleneaniline (1:1)",268-570-5,68127-32-2,Not Classified,Notified C&L,1,Not classified:1
24304,"α,4-dichloro-α-phenyltoluene",205-158-6,134-83-8,Skin Corr. 1,REACH registration C&L,48,H314:47;H335:39;H318:40;H317:5;H410:5;H400:4;Not classified:1;H302:1;H411:1
24305,"2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]",429-090-3,61551-69-7,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
24307,Dimercury diiodide,239-409-6,15385-57-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H373:39;H410:39;H310:39;H300:39;H330:39;H400:39
24309,Thiophene-2-ethylamine,250-196-9,30433-91-1,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,REACH registration C&L,46,H314:7;H302:40;H335:41;H319:39;H332:39;H315:39;H312:39;H318:1;H301:1;H412:1
24310,"Fatty acids, C18-unsatd., trimers, compds. with oleylamine",604-612-4,147900-93-4,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,153,H317:70;H302:46;H411:153;H373:46;H315:101;H372:24
24313,2-(1-methylpropyl)-1-vinylcyclohexyl acetate,253-377-0,37172-02-4,Skin Irrit. 2,Notified C&L,1444,H315:1359;Not classified:85
24315,4-(1-naphthylazo)-1-naphthol,220-178-5,2653-72-7,Not Classified,Notified C&L,1,Not classified:1
24318,"Hydrocarbons, C4, 1,3-butadiene-free, polymd., tetraisobutylene fraction",293-262-2,91053-00-8,Asp. Tox. 1,REACH registration C&L,3,H304:3
24323,1-aminocyclopentane-1-carboxylic acid,200-144-6,52-52-8,Acute Tox. 3,Notified C&L,50,H301:47;H335:5;H315:5;H319:5;H302:3;H331:1;H311:1
24324,Calcium sulfate hemihydrate,600-067-1,10034-76-1,,Notified C&L,39,Not classified:39
24326,"Isooctadecanoic acid, mono- and diesters with glycerol",306-657-2,97358-80-0,Not Classified,REACH registration C&L,5,Not classified:5
24329,Dyclonine hydrochloride,208-633-6,536-43-6,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:38;H301:38;H315:39;H318:39;H302:1
24330,Undecanonitrile,218-826-7,2244-07-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:40;H335:38;H332:39;H302:40;H315:40;H312:39
24331,2-chloro-5-(trifluoromethyl)benzonitrile,206-338-7,328-87-0,Acute Tox. 4,REACH registration C&L,46,H302:7;H335:39;H315:44;H319:44;H332:4;H311:5;H312:1;H301:1;H331:1
24333,"Benzene, 2-bromo-1-chloro-4-methyl-",611-500-9,57310-39-1,,Notified C&L,2,H332:1;H302:1;H312:1;H335:1;H315:1;H319:1
24335,"Cobalt, borate propionate complexes",295-033-2,91782-61-5,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 4;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,29,H360:3;H332:3;H317:7;H302:7;H411:3;H318:3;H400:29;H410:26;H314:4
24336,Butylchlorodimethylsilane,423-700-1,1000-50-6,Flam. Liq. 3;Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H290:1;H318:1;H226:2
24339,4-methylpyrimidine,222-344-2,3438-46-8,Flam. Liq. 3,Notified C&L,46,H226:46;H335:1;H315:2;H319:2;H360:1
24340,"Fatty acids, tallow, hydrogenated, isotridecyl esters",285-552-2,85116-99-0,Not Classified,Notified C&L,8,Not classified:8
24341,"3-hydroxy-2,4-dimethoxybenzaldehyde",250-970-6,32246-34-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H302:38;H319:38
24349,"1-carboxy-7-(dimethylamino)-3,4-dihydroxyphenoxazin-5-ium chloride",216-345-7,1562-85-2,Acute Tox. 4,Notified C&L,43,H302:39;H335:4;H315:4;H319:4;H332:1;H312:1
24350,"Oils, mint, Mentha citrata",614-793-1,68917-15-7,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,26,H412:25;H315:25;H411:1;Not classified:1
24352,"2-methyl-4H-3,1-benzoxazin-4-one",208-381-7,525-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24353,"Toxins, botulin, A",297-253-4,93384-43-1,Acute Tox. 1,Notified C&L,40,H300:40;Not classified:1;H330:2;H310:1
24355,"Poly(oxy-1,2-ethanediyl), a-phosphono-[?]-(tridecyloxy)-, potassium salt (1:2)",614-413-4,68311-04-6,,Notified C&L,1,H315:1;H319:1
24357,"Polyphosphoric acids, 2-butoxyethyl esters",271-062-6,68514-82-9,,Notified C&L,1,Not classified:1
24359,[(p-tolyloxy)methyl]oxirane,218-574-8,2186-24-5,Skin Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0;H315:0;H341:0
24360,"2,4-dihydro-2-(4-nitrophenyl)-5-(1-pyrrolidinyl)-3H-pyrazol-3-one",250-347-9,30818-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24363,peracetic acid . . . %,201-186-8,79-21-0,Flam. Liq. 3;Org. Perox. D;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H226:0;H332:0;H302:0;H314:0;H312:0;H242:0;H400:0
24364,"1-(tert-butyl) hydrogen (S)-5-oxopyrrolidine-1,2-dicarboxylate",258-362-2,53100-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
24368,(2H6)acetone,211-563-9,666-52-4,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H336:48;H319:47;H225:51;Not classified:1;H335:1;H373:1;H361:1
24369,Dihydrogen hexafluorozirconate(2-),234-666-0,12021-95-3,Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,REACH registration C&L,145,H301:97;H331:97;H290:57;H314:144;H311:97;H302:35;Not classified:1;H312:1;H330:1
24370,1-(bromomethyl)-4-phenoxybenzene,253-253-6,36881-42-2,,Notified C&L,1,H314:1
24371,"4,4'-diphenyl-2,2'-bipyridine",228-174-5,6153-92-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24374,Phosphinidynetrimethanol,220-445-6,2767-80-8,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:40;H301:40;H315:40;H318:39;H319:1;H317:1
24378,INDOSOL RUBINOL SF-RG,400-330-9,,Not Classified,Notified C&L,31,Not classified:31
24379,Chloroethoxymagnesium,247-251-4,25764-17-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
24380,1-hydroxy-1H-pyrazole,279-854-3,81945-73-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
24384,"Alcohols, C8-10 (even numbered) dimers, ethers with polyethylene glycol mono-Bu ether",604-616-6,147993-59-7,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,31,H410:23;H315:31;H319:8;H400:8;Not classified:1
24388,Diethyl diethylmalonate,201-016-2,77-25-8,Not Classified,REACH registration C&L,1,Not classified:1
24389,Fluorescence. Brightener 191,602-867-6,12270-53-0,Aquatic Chronic 3,Notified C&L,2,H412:2
24393,3-benzyloxane,458-610-1,60466-73-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H319:2
24394,(R)-butan-2-ol,238-967-8,14898-79-4,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3;STOT SE 3,Harmonised C&L,0,H336:0;H335:0;H319:0;H226:0
24395,"dixanthogen;O,O-diethyl dithiobis(thioformate)",207-944-4,502-55-6,Acute Tox. 4,Harmonised C&L,0,H302:0
24396,"3-[[2-[[3-(acetylmethylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]benzoyl]amino]acetyl]amino]-5-[[(2-hydroxyethyl)amino]carbonyl]-2,4,6-triiodo- benzoic acid triethylammonium salt",927-786-6,,Not Classified,REACH registration C&L,1,Not classified:1
24397,"Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-, potassium salt (1:1)",608-447-9,301646-59-3,Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1
24398,"Matte, precious metal",308-506-6,98072-52-7,Skin Sens. 1;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,2,H372:2;H351:2;H360:2;H317:2;H411:2
24399,Erbium(3+) acetate,247-067-4,25519-10-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
24401,"Naphtha (petroleum), steam-cracked middle arom.;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",271-138-9,68516-20-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
24404,Chlorodioctylaluminium,230-800-7,7325-26-0,Pyr. Liq. 1;Skin Corr. 1A,Notified C&L,16,H250:16;H314:16
24412,Sodium tris(1-methylethyl)naphthalenesulphonate,215-351-7,1323-19-9,Skin Corr. 1B,Notified C&L,41,H314:38;Not classified:3
24413,"Disodium 16,17-dimethoxyanthra[9,1,2-cde]benzo[rst]pentaphene-5,10-diyl bis(sulphate)",219-809-7,2538-84-3,Not Classified,Notified C&L,3,Not classified:3
24414,p-bromophenethylamine,277-636-2,73918-56-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H314:43;H318:40
24421,"Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with ethanolamine",309-087-2,99924-49-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,33,H315:33;H318:29;H319:4;H302:3;H412:1
24428,1-(4-(phenylazo)phenylazo)-2-naphthol,201-638-4,85-86-9,Not Classified,Notified C&L,250,Not classified:174;H335:42;H413:38;H315:75;H319:42;H318:33;H341:4;H317:1
24429,Bis(2-(2-butoxyethoxy)ethyl) adipate,205-465-5,141-17-3,Not Classified,REACH registration C&L,168,Not classified:166;H335:1;H315:1;H319:1;H400:1
24430,"1,4-dibromobutane-2,3-dione",228-615-1,6305-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H315:38;H319:38;H314:4;H302:4
24431,"Trisodium 4-hydroxy-5-[[4-[[1-hydroxy-6-(phenylamino)-3-sulphonato-2-naphthyl]azo]-5-methoxy-2-methylphenyl]azo]naphthalene-2,7-disulphonate",222-125-1,3354-97-0,Not Classified,Notified C&L,6,Not classified:6
24439,3-methylbutan-1-ol,204-633-5,123-51-3,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,2632,H335:2182;H226:2615;H332:2145;H315:1808;H318:265;H319:1827;H302:455;H336:17;H314:1;H370:1
24444,Chitin,215-744-3,1398-61-4,Not Classified,Notified C&L,3,Not classified:3
24450,Cerium(4+) perchlorate,238-290-8,14338-93-3,Ox. Sol. 2,Notified C&L,38,H272:38
24451,"4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi-1,3,2-dioxaborolane",615-925-0,73183-34-3,Not Classified,REACH registration C&L,134,Not classified:91;H319:33;H335:33;H332:21;H317:20;H302:23;H315:33;H314:20;H341:7;H312:3;H412:2
24457,"5-acetylamino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenecarboxamide",445-830-8,31127-80-7,Not Classified,REACH registration C&L,7,Not classified:6;H315:1;H319:1
24459,"Oligomer of 4,4-bis(1,1,3,3-tetramethylbutyl)diphenylamine with N-(4-(2,4,4-trimethylpentan-2-yl)phenyl)naphthalen-1-amineor (according to REACH Guidance on substance identification)Reaction mass of N,N,N'-tri(4-(1,1,3,3-tetramethyl-butyl)phenyl-N'-(di(4-(1,1,3,3-tetramethylbutyl)phenyl)amino)-naphthylhydrazine, N,N,N'-tri(4-(1,1,3,3-tetramethyl-butyl)phenyl-N'-(bis-(di(4-(1,1,3,3-tetramethylbutyl)phenyl)amino))-naphthylhydrazine, N,N,N'-tri(4-(1,1,3,3-tetramethyl-butyl)phenyl-N'-(bis(N''-(4-(1,1,3,3-tetramethylbutyl)phenyl)amino)-N''-naphthyl)naphthylhydrazine, N,N,N'-tri(4-(1,1,3,3-tetramethyl-butyl)phenyl-N'-[x-(di-(4-(1,1,3,3-tetramethylbutyl)phenyl)amino-(4-(1,1,3,3-tetramethylbutyl)phenyl)-amino)naphthylamino)naphthyl-hydrazine, tetrakis 4-(1,1,3,3-tetra-Methyl-butyl)phenylhydrazine and N,N,N'-tris(4-(1,1,3,3-tetramethyl-butyl)phenyl-N'-naphthylhydrazine",415-860-6,68938-84-1,Aquatic Chronic 4,Notified C&L,7,H413:6;Not classified:1
24462,"tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate",407-620-4,33610-13-8,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H334:0
24468,"3,3'-(3,7,12,17-tetramethyl-8,13-divinylporphine-2,18-diyl)di(propionic acid)",209-033-7,553-12-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,101,H335:101;H315:101;H319:101
24470,m-fluorobenzamide,207-247-5,455-37-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
24472,tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate,406-073-9,131013-81-5,Acute Tox. 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H301:0
24473,5-Fluoro-1-indanone,615-057-2,700-84-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:45;H335:44;H332:39;H302:39;H315:45;H312:39
24476,"Propanol, oxybis-, oligomeric reaction products with 1,1'-methylenebis[isocyanatobenzene], propylene glycol monomethacrylate-blocked",923-201-3,,Not Classified,Notified C&L,1,Not classified:1
24479,"dimethylcyclopropane-1,1-dicarboxylate",414-240-2,6914-71-2,Aquatic Chronic 3,Harmonised C&L,0,H412:0
24482,N-(butoxymethyl)acrylamide,217-442-7,1852-16-0,Acute Tox. 4;Skin Sens. 1A;Acute Tox. 4;Muta. 1B;Carc. 1B;Repr. 2;STOT RE 1,REACH registration C&L,120,H372:4;H350:42;H340:4;H332:4;H317:4;H302:82;H361:42;H312:71;H301:38;H319:38;H331:38;H335:38;H315:38;H311:38
24485,"Hydrocarbons, C13-C18, n-alkanes, isoalkanes, cyclics, <2% aromatics",928-253-0,,Asp. Tox. 1,REACH registration C&L,2,H304:2
24487,"Trisodium 5-(acetylamino)-4-hydroxy-3-[[4-[[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]carbonyl]phenyl]azo]naphthalene-2,7-disulphonate",279-463-8,80419-51-8,Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,18,H335:13;H334:13;H320:9;H319:7;Not classified:2
24488,Pivalonitrile,211-133-0,630-18-2,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,REACH registration C&L,48,H331:43;H301:43;H225:48;H311:43;H319:5;H335:4;H332:4;H302:5;H315:5;H312:4
24491,Tetrapropylammonium perchlorate,239-874-5,15780-02-6,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38;H272:38
24492,Ethyl 6-Chloronicotinate,610-463-6,49608-01-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:51;H315:52;H319:52
24499,isobutyl acetate,203-745-1,110-19-0,Flam. Liq. 2,Harmonised C&L,0,H225:0
24500,D-lysine,213-091-9,923-27-3,Not Classified,Notified C&L,1,Not classified:1
24502,"2,5-dibromothiophene",221-547-3,3141-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:45;H315:47;H319:47;H317:5;H300:6;H341:5;H301:1;H332:1;H312:1
24503,"1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-",604-140-9,139481-72-4,Not Classified,REACH registration C&L,13,Not classified:3;H410:9;H302:10;H400:9
24512,"3,3-Ethylenedioxy-17 alpha-hydroxy-5-androstene-17 beta-carbonitrile",617-449-9,83196-58-1,Not Classified,Notified C&L,1,Not classified:1
24516,3-phenylpropyl cinnamate,204-565-6,122-68-9,Not Classified,Notified C&L,266,Not classified:266
24518,"Heptane-2,6-dione",236-832-8,13505-34-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
24523,"Octahydro-4,7-methano-1H-indenecarbaldehyde",250-333-2,30772-79-3,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,136,H317:30;H411:30;Not classified:106
24526,α-[2-(methylamino)ethyl]benzyl alcohol,255-679-8,42142-52-9,Acute Tox. 4,REACH registration C&L,84,H302:47;H314:33;H315:4;H318:4;H335:1;H319:1
24528,"[N,N,N',N',N'',N''-hexaethyl-29H,31H-phthalocyaninetrimethylaminato(2-)-N29,N30,N31,N32]copper",249-125-4,28654-73-1,Skin Sens. 1B,REACH registration C&L,349,H317:286;Not classified:63
24531,"Nitriles, C16-22",268-861-7,68153-02-6,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,36,H410:34;H315:34;H400:5
24532,Cyclobutanecarbonyl chloride,225-680-8,5006-22-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,49,H314:49;H226:49
24533,Phenyltrimethylammonium tribromide,224-127-8,4207-56-1,Skin Corr. 1B,Notified C&L,44,H314:44;H318:2
24534,2-chloro-4-iodotoluene,281-024-0,83846-48-4,,Notified C&L,6,H335:4;H315:6;H319:6
24536,"Methyl dihydrogen phosphate, compound with 4-tert-dodecylaniline (1:2)",265-949-7,65859-40-7,Not Classified,Notified C&L,1,Not classified:1
24537,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",206-069-5,298-93-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2,Notified C&L,46,H335:43;H341:42;H315:43;H319:43;H332:2;H302:2;H312:2;Not classified:1
24538,"3,6-dimethyloctan-3-ol",205-787-6,151-19-9,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,125,H411:77;H315:115;H319:77;H335:38;H318:38;Not classified:10
24539,Didocosyl sebacate,255-730-4,42233-75-0,Not Classified,REACH registration C&L,19,Not classified:19
24540,4-(2-chloroethyl)morpholinium chloride,222-881-2,3647-69-6,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,97,H301:97;H412:49;H317:95;H314:96;H312:96;H341:11;H300:1;Not classified:2;H318:1
24541,"Alkene, polymer with 1-dodecene, distn. Residues, hydrogenated, C24-56 fraction",618-141-7,883233-48-5,Not Classified,REACH registration C&L,8,Not classified:8
24546,Dilanthanum(3+) trisulphate,233-239-6,10099-60-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:2;H315:2;H319:2;Not classified:1
24550,"Phosphoric acid, decyl octyl ester",269-041-1,68186-45-8,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,527,H314:509;H318:467;H315:18
24551,Dizinc pyrophosphate,231-203-4,7446-26-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,61,H410:58;H400:58;H411:3;H319:1;H335:1;H315:1
24556,"2-O-β-D-glucopyranosyl-(3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-β-D-glucopyranoside",258-118-5,52705-93-8,Acute Tox. 4,Notified C&L,42,H302:41;Not classified:1
24557,Silver cyanate,222-006-4,3315-16-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:39;H302:43;H312:39;H400:4;H319:1;H315:1
24558,emamectin benzoate (ISO); (4’’R)-4’’-deoxy-4’’-(methylamino)avermectin B1 benzoate,605-015-1,155569-91-8,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT SE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,232,H301:231;H372:192;H331:230;H400:231;H370:192;H410:230;H318:192;H311:230;H319:39;Not classified:1
24563,Ethyl D-glucoside,250-112-0,30285-48-4,Not Classified,Notified C&L,1,Not classified:1
24565,Chlorquinaldol,200-789-3,72-80-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,68,H335:67;H302:67;H315:42;H319:67;H317:25;H410:24;H400:25;H301:1;H332:1
24567,3-chloropropan-1-ol,210-992-9,627-30-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,REACH registration C&L,144,H336:7;H319:84;H335:79;H302:27;H315:80;Not classified:61;H361:9;H412:9;H341:9;H331:1;H332:1;H312:1
24568,"Oils, fish, oxidized, sulfited, sodium salts",308-507-1,98072-53-8,Not Classified,Notified C&L,17,Not classified:17
24571,"2,2'-oxybisbutane",229-961-6,6863-58-7,Flam. Liq. 3,Notified C&L,40,H226:39;H412:1;H225:1
24577,2-ethyl-N-methyl-N-(3-methylphenyl)butanamide,446-190-2,406488-30-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H317:0;H302:0;H315:0;H411:0
24586,"Reaction mass of N-(6-aminohexyl)-12-hydroxyoctadecanamide and N,N'-hexane-1,6-diylbis(12-hydroxyoctadecanamide)",472-570-2,,Aquatic Chronic 4,Notified C&L,1,H413:1
24587,"Formaldehyde, oligomeric reaction products with 4,4'-isopropylidenediphenol and m-phenylenebis (methylamine)",500-607-5,161278-17-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,94,H413:1;H317:23;H302:23;H314:23;H312:23;Not classified:71;H412:22
24588,4-nitro-o-phenetidine,240-431-3,16383-89-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24601,α-chlorotoluene;benzyl chloride,202-853-6,100-44-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Carc. 1B;STOT RE 2,Harmonised C&L,0,H350:0;H331:0;H335:0;H373:0;H302:0;H315:0;H318:0
24605,Diarsenic tritelluride,234-955-1,12044-54-1,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,174,H410:174;H301:174;H400:170;H331:174;H373:4
24606,4-(1-naphthyl)-4-oxobutanoic acid,222-631-2,3562-99-0,Acute Tox. 4;Aquatic Acute 1,Notified C&L,41,H302:40;H400:40;Not classified:1
24607,p-isopropylphenol,202-798-8,99-89-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,1428,H332:1376;H302:1428;H312:1376;H314:1427;H334:41;H318:37;H412:2;H317:2;H315:1;H402:1
24608,"D-Glucopyranose, oligomers, branched decyl glycosides",500-530-7,161074-94-8,Not Classified,Notified C&L,1,Not classified:1
24609,pebulate (ISO);N-butyl-N-ethyl-S-propylthiocarbamate,214-215-4,1114-71-2,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
24615,"2-ethyl-2-[[(1-oxopentyl)oxy]methyl]propane-1,3-diyl divalerate",201-088-5,78-15-9,Not Classified,Notified C&L,1,Not classified:1
24616,Hydroxybenzenesulphonic acid,215-587-0,1333-39-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,257,H314:252;H302:189;H312:142;H290:43;H318:49;H412:8;Not classified:4;H332:1;H341:1
24619,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane, reaction products with diethylenetriamine",600-617-0,1049000-76-1,Not Classified,Notified C&L,19,Not classified:19
24620,"(4R,6S)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-ol",604-572-8,147128-77-6,Not Classified,REACH registration C&L,1,Not classified:1
24621,"Phenyl 4-(2H-naphtho[1,2-d]triazol-2-yl)stilbene-2-sulphonate",230-264-4,6994-51-0,Not Classified,Notified C&L,1,Not classified:1
24623,"1H-Pyrrole-2,5-dione, 1,1'-[methylenebis(2-ethyl-6-methyl-4,1-phenylene)]bis-",424-600-0,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,13,H410:13;H400:13
24628,"Glycerol, propoxylated",500-044-5,25791-96-2,Not Classified,REACH registration C&L,1115,Not classified:1055;H302:37;H335:20;H315:23;H319:23
24629,4-hydroxypentan-2-one,224-003-3,4161-60-8,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H227:1;H315:1;H319:1
24630,"Chromate(3-), [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)]-, trisodium",280-689-4,83748-23-6,Not Classified,Notified C&L,38,Not classified:25;H317:5;H319:10;H412:6;H318:3;H411:1
24631,"Tannins, compds. with 4,4'-[(4-methyl-1,3-phenylene)bis(azo)]bis[6-methyl-1,3-benzenediamine]",270-338-3,68425-18-3,Acute Tox. 4;Skin Irrit. 2,Notified C&L,25,H312:25;H315:25
24633,2-bromo-4-(trifluoromethyl)benzoic acid,206-339-2,328-89-2,,Notified C&L,9,H335:8;H315:9;H319:9;H332:1;H302:2;H312:1
24635,"Dodecylphenoxybenzene, disulpho derivative",268-061-8,67993-50-4,Skin Corr. 1B,Notified C&L,1,H314:1
24637,4-amino-α-methylbenzyl alcohol,238-613-2,14572-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24639,"[S-(R*,S*)]-N-(3-amino-2-hydroxy-4-phenylbutyroyl)-L-leucine",261-529-2,58970-76-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
24640,(2-ethoxy-1-methyl-2-oxoethyl)-5-[[]2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate,616-466-9,77501-63-4,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,72,H312:38;H411:38;H302:34;H413:33;H410:1;H400:1
24646,"3,9-dihydroxy-6H-benzofuro[3,2-c][1]benzopyran-6-one",207-525-6,479-13-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H302:39;H315:39;H319:39
24648,Calcium hydrogensulphite,237-423-7,13780-03-5,Not Classified,REACH registration C&L,11,Not classified:11
24649,Dizirconium silicide,235-389-8,12211-03-9,Not Classified,Notified C&L,1,Not classified:1
24653,Dicesium molybdate,237-056-2,13597-64-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,229,H335:196;H315:196;H319:196;Not classified:33;H361:1
24655,"1,1,2,2-tetramethyldisilane",212-416-1,814-98-2,Flam. Liq. 2,Notified C&L,38,H225:38
24667,"Trisodium 4-[[5-[[(2,3-dichloro-6-quinoxalinyl)carbonyl]amino]-2-sulphonatophenyl]azo]-4,5-dihydro-1-(2-methyl-4-sulphonatophenyl)-5-oxo-1H-pyrazole-3-carboxylate",276-370-4,72139-14-1,Eye Irrit. 2;Resp. Sens. 1,Notified C&L,36,H334:31;H319:31;Not classified:5
24670,"5,6-dimethylbenzimidazol-2-ylamine",249-430-2,29096-75-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24671,Zinc disalicylate,240-380-7,16283-36-6,Not Classified,Notified C&L,4,Not classified:2;H302:2;H317:1;H315:1;H410:1;H318:1
24675,2-ethylbutyl cyclopent-1-ene-1-acetate,268-454-4,68092-41-1,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,88,H302:88;H411:88
24679,"N-(2-aminopropyl)propane-1,2-diamine",230-885-0,7356-00-5,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H314:38;H302:38
24682,"Slags, lead reverbatory smelting",273-800-2,69029-58-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Muta. 1B;Carc. 1B;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H362:2;H372:2;H350:2;H340:2;H360:2;H332:2;H302:2;H315:2;H410:2;H318:2;H400:2
24684,S-(Phenylmethyl) (ethyl-(3-methylbutan-2-yl)amino)methanethioate,617-761-5,85785-20-2,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,38,H411:38;H331:38
24686,"Ethyl (Z,Z,Z)-9-[(4-ethoxy-1,4-dioxobut-2-enyl)oxy]-9-octyl-4,7,11-trioxo-3,8,10-trioxa-9-stannatetradeca-5,12-dien-14-oate",258-089-9,52671-36-0,Aquatic Chronic 4,Notified C&L,14,H413:13;H302:1;H315:1;H319:1
24690,"Diethyl sulphate, compound with N-methyl-N-[4-[(1-methyl-1H-1,2,4-triazol-5-yl)azo]phenyl]benzylamine (1:1)",263-444-6,62163-53-5,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,130,H411:87;H319:95;H412:42;H302:43;H318:34;Not classified:1
24695,Coconut oil,232-282-8,8001-31-8,Not Classified,Notified C&L,530,Not classified:529;H225:1
24697,"α,α,α-trifluoro-p-toluenesulphonamide",212-596-1,830-43-3,,Notified C&L,7,H335:5;H315:5;H319:6;H332:1;H302:2;H314:1;H312:1
24700,"Hexaethyl 2,2',2''-[(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tris(6,1-hexanediyliminocarbonyl)]trismalonate",299-990-7,93919-07-4,Not Classified,Notified C&L,83,Not classified:83
24704,3-ethylpent-1-yn-3-amine,221-784-2,3234-64-8,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H314:38;H225:38
24706,"2-Furanacetic acid, .alpha.-(methoxyimino)-, ammonium salt (1:1), (.alpha.Z)-",619-259-1,97148-39-5,Flam. Sol. 2,Notified C&L,1,H228:1
24707,"4'-(pentyloxy)[1,1'-biphenyl]-4-carbonitrile",257-875-9,52364-71-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:39;H335:38;H332:39;H315:39;H312:39;H302:2;Not classified:1;H413:1
24719,"6-fluoro-4-oxo-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid",600-643-2,105300-40-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
24722,"2-(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethan-1-ol fumarate",924-097-2,,Acute Tox. 4;Eye Dam. 1;Repr. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1;H361:1;H318:1
24723,"1-(4-chlorophenyl)-2-[[3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl]methylamino]ethan-1-one monohydrochloride",248-002-2,26786-32-3,Acute Tox. 4;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H302:38;H335:38;H413:38;H370:1
24724,"Fatty acids, castor-oil, hydrogenated, lithium salts",271-696-3,68604-46-6,Not Classified,Notified C&L,4,Not classified:4
24727,"3,5-dichloropyridine",219-537-9,2457-47-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H335:43;H302:43;H315:44;H318:38;H319:6;H311:4;H332:1
24728,"1,4-bis(ethylamino)anthraquinone",230-263-9,6994-46-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,53,H335:51;H413:38;H315:51;H319:51;Not classified:2
24729,Potassium hydrogen 5(or 6)-carboxylato-4-hexylcyclohex-2-ene-1-octanoate,268-571-0,68127-33-3,Eye Irrit. 2,Notified C&L,557,H319:466;H314:60;Not classified:26;H315:25;H412:5;H335:1
24733,Methyl 2-[(1-oxopropyl)amino]benzoate,247-136-9,25628-84-6,Not Classified,Notified C&L,88,Not classified:88
24734,"Carbonic acid, compound with phenylguanidine (1:1)",229-729-4,6685-76-3,Not Classified,REACH registration C&L,10,Not classified:8;H317:1;H302:1;H411:1;H318:1;H335:1;H315:1;H319:1
24739,1-(2-methyl-4-(2-methylphenylazo)phenylazo)-2-naphthol,201-635-8,85-83-6,Skin Sens. 1,REACH registration C&L,390,H317:19;H315:209;H319:293;Not classified:75;H351:17;H341:18;H335:6;H332:3;H302:2;H312:3
24743,Rhodinyl butyrate,205-462-9,141-15-1,Not Classified,Notified C&L,88,Not classified:88
24744,"Reaction product of Aluminium triisopropanolate, stearic acid, benzoic acid and azelaic acid",927-266-9,,Not Classified,Notified C&L,3,Not classified:3
24745,"1-phenyloctadecane-1,3-dione",241-313-4,17281-74-2,Not Classified,Notified C&L,1,Not classified:1
24747,"Fatty acids, C8-18 and C18-unsatd., esters with trimethylolpropane",286-075-2,85186-89-6,Not Classified,REACH registration C&L,66,Not classified:55;H315:11;H318:11
24749,3-(hydroxyphenylphosphinyl)propanoic acid,411-200-6,14657-64-8,Eye Dam. 1,Harmonised C&L,0,H318:0
24751,"Chromate(1-), bis[4-[[4-(ethylsulfonyl)-2-hydroxyphenyl]azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]-, compd. with 1,6-hexanediamine (2:1)",310-133-9,69997-91-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,120,H410:87;H400:87;Not classified:33
24756,"Benzeneacetic acid, α-amino-2-chloro-, methyl ester, hydrochloride (1:1), (αS)-",606-736-4,213018-92-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
24757,"Poly(oxy-1,2-ethanediyl), a,a'-(iminodi-2,1-ethanediyl)bis[w-hydroxy-, N-[3-(C9-11-isoalkyloxy)propyl] derivs., C10-rich",606-839-4,218141-23-2,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,22,H314:22;H302:22;H410:22
24759,Carbidopa,249-271-9,28860-95-9,Not Classified,REACH registration C&L,74,Not classified:2;H335:62;H315:62;H319:62;H351:9;H360:9;H302:1;H317:1;H341:2;H413:1
24762,"Cadmium sulfide (CdS), solid soln. with zinc sulfide, copper chloride-doped",270-977-8,68512-49-2,Acute Tox. 4;Muta. 2;Carc. 1B;Repr. 2;STOT RE 1;Aquatic Acute 1,Notified C&L,1,H372:1;H350:1;H302:1;H361:1;H410:1;H341:1;H400:1
24765,1-ethoxypentadecane,614-831-7,68951-67-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,296,H302:244;H411:121;H318:276;H315:165;H410:89;H400:186;H412:37;H319:20
24767,3-Bromo-4-methylthiophene,608-463-6,30318-99-1,Not Classified,Notified C&L,2,Not classified:1;H335:1;H315:1;H319:1
24768,Aluminium caesium bis(sulphate),238-184-1,14284-36-7,Not Classified,Notified C&L,25,Not classified:25
24774,Naphthyl dihydrogen phosphate,214-502-4,1136-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
24775,"1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine",618-567-3,9050-31-1,Not Classified,Notified C&L,2,Not classified:1;H413:1
24776,asbestos,616-473-7,77536-68-6,Carc. 1A;STOT RE 1,Harmonised C&L,0,H372:0;H350:0
24778,"1-Octanol, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-, 1-(dihydrogen phosphate)",611-565-3,57678-01-0,Not Classified,Notified C&L,1,Not classified:1
24779,"Decanoic acid, ester with triglycerol trioctanoate",614-915-3,69070-60-6,Not Classified,Notified C&L,1,Not classified:1
24781,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with 2-[(2-aminoethyl)amino]ethanol, di-Me sulfate-quaternized",292-848-5,91001-75-1,Aquatic Chronic 3,Notified C&L,8,H412:6;Not classified:1;H411:1
24785,Ethyl (dimethylamino)oxoacetate,240-755-5,16703-52-9,Acute Tox. 4;Eye Dam. 1;Resp. Sens. 1,Notified C&L,39,H302:38;H334:38;H318:38;Not classified:1
24787,"2,6-di-tert-butyl-p-cresol",204-881-4,128-37-0,Aquatic Chronic 1,REACH registration C&L,6385,H410:5337;H400:2627;H413:404;Not classified:319;H302:438;H312:165;H319:311;H335:156;H332:107;H315:271;H373:120;H351:18;H340:16;H361:23;H317:47;H370:41;H331:8;H311:8;H411:15;H412:2;H334:1;H350:1;H341:4;H301:1
24791,"Phosphinic acid, P-(methylphenyl)-, potassium salt (1:1)",606-658-0,208534-39-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,84,H302:83;H318:83;Not classified:1
24793,N-(2-ethylhexyl)-3-oxobutyramide,251-253-0,32837-36-8,Skin Irrit. 2,Notified C&L,33,H315:33
24797,Tamol NNO,611-319-5,55840-60-3,,Notified C&L,33,Not classified:33
24800,Colocynthin,215-745-9,1398-78-3,Acute Tox. 2,Notified C&L,38,H300:38
24801,4-chlorobenzohydrazide,208-632-0,536-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:43;H315:44;H319:44;H332:1;H302:1;H312:1
24805,"3,4-dimethylcyclopent-2-en-1-one",250-199-5,30434-64-1,Not Classified,Notified C&L,88,Not classified:88
24806,Compound 7518,443-330-4,,Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H372:1;H319:1;H400:1
24808,"Poly(oxy-1,2-ethanediyl), a-2-propen-1-yl-w-hydroxy-",608-071-5,27274-31-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,809,H315:675;H319:676;H226:489;Not classified:132;H312:1;H302:1;H318:1
24809,"2H-3,1-Benzoxazine-2,4(1H)-dione, 1-[3-(trifluoromethyl)phenyl]-",605-269-3,1618-64-0,Not Classified,REACH registration C&L,2,Not classified:2
24814,"Naphthalene-1-sulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",299-493-5,93892-12-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
24815,"2,2',2'',2'''-[1,2-ethanediylidenetetrakis(thio)]tetraacetic acid",232-998-0,10003-69-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
24817,5-butyl-5-ethylbarbituric acid,201-019-9,77-28-1,Acute Tox. 3,Notified C&L,39,H301:38;H302:1
24818,"2,2-dimethylpropane-1,3-diyl methylcyclohex-4-ene-1,2-dicarboxylate",286-141-0,85187-50-4,Not Classified,Notified C&L,9,Not classified:9
24821,"6,10-dimethylundeca-5,9-dien-2-one",211-711-2,689-67-8,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1680,H411:1679;H315:1680;H319:1
24823,3-chloro-2-hydroxypropyl methacrylate,236-097-3,13159-52-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,48,H317:41;H302:47;H315:41;H318:41;H372:6;H351:6;H319:6;H331:6;H360:6;H370:6;H341:6;Not classified:1
24824,2-bromo-5-chloronitrobenzene,255-421-4,41513-04-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H302:4
24832,Amantadine hydrochloride,211-560-2,665-66-7,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Repr. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,186,H402:3;H412:135;H302:185;H361:140;H314:135;H318:133;H336:47;H362:1;H360:2;H413:1;H301:1;H372:1;H315:1;H319:1
24834,"Furan, 3-[(2-furanylmethyl)dithio]-2-methyl-",600-920-8,109537-55-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,87,H317:87;H315:87;H319:87
24835,"2,4-dichlorophenyl benzenesulphonate",202-562-4,97-16-5,Acute Tox. 4;Acute Tox. 3,Notified C&L,38,H302:38;H311:38
24836,1-isopropylnaphthalene,228-177-1,6158-45-8,Asp. Tox. 1,Notified C&L,1,H304:1
24843,"(2RS,3SR)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (1R)-10-camphorsulphonate",917-473-2,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Repr. 1B;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,1,H360:1;H317:1;H302:1;H373:1;H412:1;H318:1
24846,Lanatoside B,241-545-6,17575-21-2,Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,1,H301:1;H373:1;H331:1
24851,"Sodium hydrogen 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bisphenolate S,S-dioxide",252-057-8,34487-61-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,64,H335:53;H315:54;H319:53;Not classified:10;H302:2
24852,"Nickel fluoride (NiF2), tetrahydrate",604-130-4,13940-83-5,Skin Sens. 1;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,50,H372:50;H350:50;H360:50;H334:50;H317:50;H410:50;H341:50;H400:50;H332:8;H302:8;H315:8;H318:8
24858,2-amino-6-hydroxy-5-methyl-1H-pyrimidin-4-one,229-597-8,6627-65-2,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H317:38;H315:38;H318:38
24859,DL-β-mercaptovaline,200-147-2,52-66-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H302:43;H315:43;H319:43
24863,"2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazoniol-5-yl]ethyl dihydrogen diphosphate",205-230-7,136-09-4,Skin Sens. 1,REACH registration C&L,1,H317:1
24864,3-Chloro-4-hydroxybenzaldehyde,607-340-4,2420-16-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,47,H335:46;H317:42;H302:42;H315:47;H318:42;H319:5;H412:1
24866,l-carvone;(5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one,229-352-5,6485-40-1,Skin Sens. 1,Harmonised C&L,0,H317:0
24871,"Paraffin waxes (coal), brown-coal-high-temp. tar;Coal Tar Extract;[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C",295-454-1,92045-71-1,Carc. 1B,Harmonised C&L,0,H350:0
24874,4-chlorobenzenethiol,203-408-9,106-54-7,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 1;Aquatic Chronic 2,REACH registration C&L,61,H314:60;H302:57;H315:1;H319:1;H332:4;H312:4;H318:2;H301:3;H411:3
24875,Hexakis[μ-(acetato-O:O')]-μ3-oxo-triangulo-triruthenium acetate,259-653-7,55466-76-7,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H410:4;H318:4;H400:4
24878,Ethyl 3-[[5-(acetylamino)-2-methoxyphenyl]amino]butyrate,275-590-8,71519-94-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H319:38
24886,"(1R,2R)-(-)-1,2-Cyclohexanediamine",606-556-6,20439-47-8,Skin Corr. 1B,Notified C&L,48,H314:48;H317:6;H318:2
24888,Tonzonium bromide,209-032-1,553-08-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H332:38;H302:38;H315:38;H312:38;H318:38
24889,"(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride",616-702-0,79559-97-0,Acute Tox. 4;Aquatic Acute 1,Notified C&L,84,H302:83;H400:78;H361:12;H410:3;H317:1;H312:3;H332:2;H412:1;H319:2;H351:2;H335:1;H315:1
24890,Bromisoval,207-825-7,496-67-3,Acute Tox. 4,Notified C&L,3,H302:3
24894,"1,5-Pentanediamine, 2-methyl-, reaction products with 2-ethyl-1,4-butanediamine and glycidyl tolyl ether",291-813-1,90480-76-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,60,H335:59;H317:58;H315:57;H319:57;H301:1;H314:3;H410:1;H318:1;H400:1;H332:2;H302:2;H312:2
24906,Bis[2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium] sulphate,266-449-1,66693-25-2,,Notified C&L,11,H302:8;H319:10;Not classified:1
24908,"Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;Refinery gas;[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",273-269-7,68955-33-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H220:0;H350:0;Not classified:0
24910,"Amines, coco alkyl, oleates",287-315-9,85480-36-0,Skin Corr. 1B;Aquatic Acute 1,Notified C&L,31,H314:31;H400:31
24913,methyl chloroformate,201-187-3,79-22-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,H302:0;H225:0;H314:0;H312:0;H330:0
24914,Pendecamaine,251-306-8,32954-43-1,Eye Irrit. 2,Notified C&L,7,H319:7
24918,"Amides, from ethylenediamine and tallow",273-186-6,68953-10-6,Not Classified,Notified C&L,8,Not classified:8
24920,"1,4-anhydro-2,5-dideoxy-2-(methoxycarbonyl)-1-thiopent-3-ulose",619-801-7,66319-07-1,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,35,H317:35;H302:35
24928,methyl 2-amino-5-fluorobenzoate,608-681-1,319-24-4,,Notified C&L,9,H412:6;H319:3;H335:2;H332:1;H302:1;H315:3
24929,α-chloro-4-nitro-o-cresol,221-012-4,2973-19-5,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
24930,"2,2'-Bis-dibenzo[d,f][1,3,2]dioxaphosphepin-6-yloxy)-3,3',5,5'-tetra(tertbutyl)-biphenyl",482-400-9,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,112,H317:111;H413:112
24932,"Ferrate(1-), [3-[[3-[[4-[[3-[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]-2,5-dimethylphenyl]azo]-2,4-dihydroxyphenyl]azo]-4-hydroxybenzenesulfonamidato(2-)][3-[[5-[[4-[[3-[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]-2,5-dimethylphenyl]azo]-2,4-dihydroxyphenyl]azo]-4-hydroxybenzenesulfonamidato(2-)]-, hydrogen, tris(2-hydroxypropanoate) (salt)",279-460-1,80410-35-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,31,H411:31;H319:31
24933,Silicon nitride,234-787-9,12033-60-2,Not Classified,Notified C&L,2,Not classified:2
24934,"(1S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one",225-160-0,4695-62-9,Not Classified,Notified C&L,274,Not classified:265;H226:9
24935,"Triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)silane",435-230-4,101947-16-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
24942,tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate,440-060-9,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
24943,p-tolylhydrazinium(1+) chloride,211-295-2,637-60-5,Acute Tox. 3;Skin Irrit. 2;STOT SE 3,Notified C&L,131,H335:127;H301:131;H315:128;H319:45;H331:3;H317:2;Not classified:2;H311:3;H351:1;H302:1;H350:1;H400:1;H410:1
24948,"Castor oil, hydrogenated, calcium sodium salt",272-929-1,68920-96-7,Not Classified,Notified C&L,1,Not classified:1
24955,2-methyloctanoic acid,221-104-4,3004-93-1,Skin Corr. 1C,Notified C&L,443,H314:442;H302:1;H315:1;H318:1
24956,4-fluoro-2-nitroaniline,206-666-0,364-78-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:45;H335:44;H332:45;H302:45;H315:45;H312:45
24957,"(R)-(-)-1,1'-Bi-2-naphthol bis(trifluoro-methanesulfonate)",603-149-5,126613-06-7,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
24960,3-fluorobenzoic acid,207-248-0,455-38-9,Skin Irrit. 2;STOT SE 3,Notified C&L,90,H335:56;H315:57;Not classified:33;H319:8
24961,[(m-tolyloxy)methyl]oxirane,218-575-3,2186-25-6,Skin Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0;H315:0;H341:0
24965,Prolonium iodide,204-630-9,123-47-7,,Notified C&L,2,H302:1;H315:1;H319:1
24966,Sodium/potassium-7-[(E)-{2-acetamido-4-[(E)-(4-{[4-chlor-6-({2-[(4-fluor-6- {[substitutedphenyl]amino}- heteromonocyclyl)amino]propyl}amino)- heteromonocyclyl]amino}-1-naphthyl)diazenyl]-5-methoxyphenyl}diazenyl]- naphthalinpolysulfonate,466-490-7,,Skin Sens. 1;Repr. 2,Notified C&L,1,H317:1;H361:1
24973,"5-(morpholinomethyl)-3-[(5-nitro-2-furfurylidene)amino]oxazolidin-2-one [R-(R*,R*)]-tartrate (1:1)",238-293-4,14343-71-6,Acute Tox. 4;Carc. 2,Notified C&L,38,H302:38;H351:38
24976,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with methyl 2-methyl-2-propenoate",607-756-6,25608-33-7,Not Classified,Notified C&L,98,Not classified:98
24980,"1,2,4-Benzenetricarboxylic acid, mixed branched tridecyl and isodecyl esters",615-086-0,70225-05-7,Not Classified,Notified C&L,16,Not classified:16
24983,"Fatty acids, C12-20, ethoxylated",614-763-8,68908-68-9,Not Classified,Notified C&L,7,Not classified:7
24984,"2,4-dimethylbenzyl acetate",263-518-8,62346-96-7,Not Classified,Notified C&L,88,Not classified:54;H315:34;H319:34
24985,"Poplar, Populus nigra, ext.",283-509-2,84650-39-5,Flam. Liq. 3,Notified C&L,88,H226:88
24986,"1,3-Oxathiolane-2-methanol, benzoate",604-346-9,143338-44-7,Not Classified,Notified C&L,33,Not classified:33
24989,Ethyl 4-isocyanatobenzoate,250-344-2,30806-83-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,42,H319:42;H334:42;H335:42;H332:38;H302:42;H315:42;H312:38;H331:4
24990,Acetone semicarbazone,203-746-7,110-20-3,Acute Tox. 3,Notified C&L,43,H301:42;H302:1
24993,Sodium ethyl sulphate,208-910-1,546-74-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:38;H319:39;H315:1
24996,Diisopropyl sulphate,221-011-9,2973-10-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Carc. 2,Notified C&L,1,H351:1;H302:1;H314:1;H312:1;H318:1
24997,"2,7-(bis(2-arsonophenylazo))-1,8-dihydroxynaphthalene-3,6-disulphonic acid",216-788-6,1668-00-4,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:43;H301:43;H400:43;H331:43
25000,Gambier,232-285-4,8001-48-7,Not Classified,Notified C&L,2,Not classified:1;H317:1
25004,Methyl pentadecanoate,230-430-6,7132-64-1,Not Classified,Notified C&L,4,Not classified:2;H318:2
25013,"Butanoic acid, 4-[(carboxymethyl)amino]dodecenyl-4-oxo-, reaction products with glycerol and sodium hydroxide",276-740-5,72623-95-1,Not Classified,Notified C&L,9,Not classified:9
25015,"Fatty acids, C16-18 and C18-unsatd., Bu esters, epoxidized",307-157-7,97553-03-2,Not Classified,Notified C&L,441,Not classified:441
25021,Dichloromethyl(2-phenylethyl)silane,212-253-6,772-65-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,67,H314:40;H318:39;Not classified:27;H290:1
25022,4-nitropyrocatechol,222-009-0,3316-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43;H302:5;H332:1;H312:1
25026,Octadecyl 3-[[3-(dodecyloxy)-3-oxopropyl]thio]propionate,236-025-0,13103-52-1,Not Classified,Notified C&L,15,Not classified:14;H412:1
25027,"Phosphoric acid, 2-ethylhexyl ester, sodium salt",269-044-8,68186-64-1,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,76,H314:18;H318:27;Not classified:38;H315:20;H319:11
25033,"Hydroxyoctadecanoic acid, monoester with glycerol",215-355-9,1323-42-8,Not Classified,REACH registration C&L,53,Not classified:53
25047,cyclopentyl 2-phenylethyl ether,428-340-9,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0
25051,5-cyclohexadecen-1-one,253-568-9,37609-25-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1606,H410:59;H400:59;Not classified:1547
25053,3-buten-1-ol,210-991-3,627-27-0,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,132,H318:85;H411:83;H315:130;H226:132;H335:46;H319:47;H302:2;H332:1;H312:1
25058,Disodium methylarsonate,205-620-7,144-21-8,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:38;H301:38;H400:39;H331:38;H302:1
25060,3-(chlorodimethylsilyl)propyl methacrylate,246-377-7,24636-31-5,Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,70,H314:70;H410:8;H318:32;H400:8;H290:1
25061,6-nitro-o-toluic acid,236-833-3,13506-76-8,,Notified C&L,7,H335:6;H315:7;H319:7
25062,Hept-6-enoic acid,214-283-5,1119-60-4,Skin Corr. 1B,Notified C&L,43,H314:43
25063,"2,2'-iminodiethanol, compound with hexadecyl dihydrogen phosphate",310-207-0,61693-41-2,Eye Irrit. 2,Notified C&L,36,H319:36
25066,Isobutyl cinnamate,204-564-0,122-67-8,Not Classified,Notified C&L,262,Not classified:262
25067,"1,2-Ethanediamine, N1,N2-bis(2-aminoethyl)-, 2-hydroxy-3-phenoxypropyl derivs.",614-361-2,68187-28-0,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H314:1;H317:1
25070,"1,2-Ethanediamine, N-(2-aminoethyl)-, reaction products with glycidyl Ph ether",291-221-3,90366-78-2,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;STOT SE 3;STOT SE 3,REACH registration C&L,62,H331:1;H226:1;H317:62;H371:1;H314:2;H318:62;H315:60
25072,"L-Valine, N-[[(1,1-dimethylethyl)amino]carbonyl]-3-methyl-",600-257-4,101968-85-8,Not Classified,Notified C&L,1,Not classified:1
25074,"Sulfurous acid, monosodium salt, reaction products with formaldehyde, sulfonylbis[phenol] and urea, sodium salts",292-245-7,90583-45-2,Aquatic Chronic 3,Notified C&L,33,H412:33
25075,Triethylammonium diethyldithiocarbamate,219-240-4,2391-78-8,,Notified C&L,4,H335:4;H315:4;H319:4
25077,Zirconium Chloro hydroxyl lactate oxo sodium complexes,605-715-7,174206-15-6,Not Classified,Notified C&L,69,Not classified:67;H335:1;H373:1;H315:2;H319:2;H332:1;H302:1;H312:1
25078,Tungsten zinc tetraoxide,237-053-6,13597-56-3,,Notified C&L,4,H335:4
25079,benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate,426-070-6,67299-45-0,Aquatic Chronic 3,Harmonised C&L,0,H412:0
25080,4-oxopimelic acid,207-941-8,502-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
25089,"N-benzoylglycine, compound with 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane (1:1)",227-206-5,5714-73-8,,Notified C&L,3,H317:2;H315:1;H319:1
25091,4-isopropylaniline,202-797-2,99-88-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,46,H301:1;H331:1;H314:2;H311:1;H410:2;H400:1;H335:38;H315:43;H319:43;H332:6;H373:4;H302:7;H312:7
25093,Isopropyl acrylate,211-710-7,689-12-3,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,3,H314:2;H225:2;H335:1;H411:1;H315:1;H319:1
25096,Triethoxy-2-thienylsilane,625-503-8,17984-89-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
25099,"4,4'-METHYLENEBIS(FURFURYL N-PHENYLCARBAMATE)",611-971-0,60387-40-8,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,38,H317:38;H302:38;H413:38
25118,"Sage, Salvia hispanica, ext.",297-250-8,93384-40-8,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2,H304:2;H226:2;H317:2;H302:2;H411:2
25122,"(1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyloxy-2,1-ethanediyl) diacrylate",260-130-0,56361-55-8,Not Classified,Notified C&L,1,Not classified:1
25127,Zinc oxalate,208-934-2,547-68-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:42;H312:42;Not classified:1
25129,Sodium dodecyl sulphate,205-788-1,151-21-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2711,H412:898;H302:2549;H315:2665;H318:1426;H335:1015;H228:961;H332:323;H319:1077;H312:124;H311:146;Not classified:22;H314:21;H400:17;H317:5;H334:1;H411:4;H373:1;H224:1;H300:1;H336:1
25131,"(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride",425-260-6,244634-31-9,Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H373:0;H318:0
25132,1-methylpyrrolidine-2-ethylamine,257-169-0,51387-90-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H335:40;H302:41;H315:40;H318:42;H314:2
25139,Benzbromarone,222-630-7,3562-84-3,Acute Tox. 3,Notified C&L,53,H301:52;H361:9;H411:11;H332:2;H302:1
25143,"1,2-dibromotetrachloroethane",211-136-7,630-25-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H335:50;H315:51;H319:51;H302:7
25144,"Boldo, ext.",283-476-4,84649-96-7,Asp. Tox. 1;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1384,H351:1286;H411:1381;H341:1286;H304:1381;H301:84;H226:50;H317:96;H315:46;H311:46;H312:38;H319:1;Not classified:1
25147,"Succinic acid, compound with L-lysine (1:1)",246-945-4,25399-74-0,Not Classified,Notified C&L,1,Not classified:1
25148,"Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene](3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium(II)",611-032-5,536724-67-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41,H302:40;H315:41;H319:40;H312:40;H413:1;H332:2;H335:1
25149,"2-ethyl-2-[[(1-oxoheptyl)oxy]methyl]propane-1,3-diyl bisheptanoate",201-089-0,78-16-0,Not Classified,REACH registration C&L,6,Not classified:6
25154,2-(2-chloroethoxy)acetic acid,604-645-4,14869-41-1,Not Classified,Notified C&L,2,Not classified:1;H314:1;H335:1
25156,"Aspartic acid, N,N'-[methylenebis(2-methyl-4,1-cyclohexanediyl)]bis-, 1,1',4,4'-tetraethyl ester",603-947-3,136210-32-7,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,183,H412:182;H317:182;Not classified:1
25157,"Agrimony, Agrimonia eupatoria, ext.",283-870-6,84775-40-6,Not Classified,Notified C&L,4,Not classified:3;H226:1
25163,"Trisodium [[[[3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]amino]sulphonyl]tris(aminosulphonyl)-29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]nickelate(3-)",276-491-2,72229-81-3,,Notified C&L,8,Not classified:8
25164,"1-benzyl-4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine, salt with p-toluenesulfonic acid",606-457-8,201855-54-1,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H373:2;H315:2;H401:2;H411:2
25165,"4'-(heptyloxy)[1,1'-biphenyl]-4-carbonitrile",257-876-4,52364-72-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H335:38;H332:38;H315:39;H312:38
25167,1-naphthyl acetate,212-599-8,830-81-9,Eye Dam. 1,Notified C&L,45,H318:41;H335:4;H315:5;H319:4
25168,Octadecyl myristate,221-785-8,3234-81-9,Not Classified,Notified C&L,25,Not classified:25
25169,Potassium O-isobutyl dithiocarbonate,235-837-2,13001-46-2,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,4,H319:2;H228:2;H302:2;H315:2;H312:2;Not classified:2
25178,2-ethylbutyric anhydride,259-187-4,54502-37-3,Skin Corr. 1B,Notified C&L,39,H314:39
25181,"1-carbamoyl-7-(diethylamino)-3,4-dihydroxyphenoxazin-5-ium chloride",216-346-2,1562-90-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
25182,"Propanenitrile, 3-(tridecyloxy)-, branched and linear",270-853-3,68479-06-1,Aquatic Chronic 2,Notified C&L,34,H411:34
25183,1-(cyanomethyl)pyridinium chloride,241-312-9,17281-59-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H335:42;H332:38;H302:38;H315:43;H312:38;H301:5;H331:1;H311:1
25186,"2,6,10,10-tetramethyl-1-oxaspiro[4.5]dec-6-ene",253-031-9,36431-72-8,Not Classified,Notified C&L,162,Not classified:161;H315:1;H319:1
25188,Trimagnesium diarsenide,234-954-6,12044-49-4,,Notified C&L,4,H410:4;H301:4;H373:4;H331:4
25189,Lithium dimethylamide,222-714-3,3585-33-9,Pyr. Sol. 1;Water-react. 2;Skin Corr. 1B,Notified C&L,42,H250:42;H261:38;H314:42;H252:4;H336:4;H260:4;H304:4;H373:4;H411:4
25190,"N-methyl-2,2,2-trifluoroacetamide",212-417-7,815-06-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
25191,nickel titanium trioxide,234-825-4,12035-39-1,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H317:0;H350:0;H372:0
25193,"2-(3,4-dihydroxyphenyl)valeramide",205-830-9,154-62-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
25194,Reactive Red F66813,405-900-0,,Not Classified;Not Classified,REACH registration C&L,1,Not classified:1
25195,Palladium sulphate,236-957-8,13566-03-5,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,103,H290:6;H302:61;H314:48;H410:2;H318:6;H400:2;H317:1
25196,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[(2-methoxyphenyl)azo]-3-oxobutyramide",279-914-9,82199-12-0,Not Classified,REACH registration C&L,239,Not classified:238;H335:1;H319:1
25199,Chlorophenylsilane,224-124-1,4206-75-1,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H226:38
25202,nitroethane,201-188-9,79-24-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H226:0
25203,Ethyl 3-amino-1H-pyrazole-4-carboxylate,230-262-3,6994-25-8,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,47,H302:4;H319:5;H410:41;H317:40;H400:40;H315:3;H335:2;H332:1;H312:1
25210,3-(2-chlorophenyl)-5-methylisoxazole-4-carbonyl chloride,247-137-4,25629-50-9,Skin Corr. 1;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,11,H314:11;H317:6;H319:6
25213,4-piperidylpyridine,220-447-7,2767-90-0,Acute Tox. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H301:38
25220,"1,1,1,3,3-Pentafluoropropane (R245fa)",419-170-6,460-73-1,Press. Gas (Liq.),REACH registration C&L,452,H280:451;Not classified:1
25221,"1,4-Benzenedisulfonic acid, 2-[2-(4-amino-2,5-dimethylphenyl)diazenyl]-",611-841-3,59487-20-6,Not Classified,REACH registration C&L,2,Not classified:2
25226,5-allyl-5-(1-methylbutyl)-2-thiobarbituric acid,201-018-3,77-27-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H331:38;H301:38;H311:38
25227,"Spinels, cobalt nickel zinc grey",305-835-7,95046-47-2,Not Classified,Notified C&L,7,Not classified:7
25238,"Naphthalenesulfonic acids, reaction products with formaldehyde and sulfonylbis[phenol], sodium salts",300-260-8,93924-64-2,Aquatic Chronic 3,Notified C&L,63,H412:33;H411:30
25239,asbestos,616-472-1,77536-67-5,Carc. 1A;STOT RE 1,Harmonised C&L,0,H372:0;H350:0
25241,"Hydrocarbons, C",308-131-8,97862-81-2,Carc. 1B,Harmonised C&L,0,H350:0
25242,"N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide",604-266-4,142001-63-6,STOT RE 2,Notified C&L,1,H373:1
25246,1-(4-chlorophenyl)-1-phenylacetone,255-813-5,42413-59-2,Not Classified,Notified C&L,1,Not classified:1
25247,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with 2-amino-2-(hydroxymethyl)-1,3-propanediol",292-849-0,91001-76-2,Not Classified,REACH registration C&L,25,Not classified:25
25250,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with butane- 1,3-diol, 2,4'-diisocyanatodiphenylmethane, 2,2'-oxydiethanol and propane-1,2-diol",500-415-1,158885-29-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,83,H351:83;H319:83;H334:83;H335:83;H332:83;H317:83;H373:83;H315:83
25255,Bromomethyl p-chlorophenyl ketone,208-631-5,536-38-9,Skin Corr. 1B,Notified C&L,64,H314:63;H302:9;H318:4;H319:1;H317:1;H315:1;H290:1
25259,"3-(9,10-ethano-9(10H)-anthryl)acrylaldehyde",254-154-0,38849-09-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,2,H332:1;H302:2;H319:1;H312:1
25263,2-(pyridin-3-yl)ethan-1-amine,671-720-6,20173-24-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H335:38;H315:38;H318:39;H314:7
25267,"Phosphoric acid, mono- and bis(C16 and C18-unsatd. alkyl) esters",307-095-0,97489-51-5,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,10,H314:1;H318:7;H315:6;H319:3
25268,Calcium D-saccharate tetrahydrate,611-592-0,5793-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
25270,Ethyl 4-Iodobenzoate,429-550-3,51934-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H315:2;H319:2
25276,"1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid",924-100-7,,Not Classified,Notified C&L,1,Not classified:1
25277,"Fatty acids, C16-18, esters with diethylene glycol",285-550-1,85116-97-8,Not Classified,REACH registration C&L,19,Not classified:18;H302:1
25278,(2-chlorophenyl)glycolic acid,233-900-9,10421-85-9,Not Classified,Notified C&L,55,Not classified:55
25279,"2-(2-Hydroxy-3-((2-(3-indolyl)-1,1-dimethylethyl)amino)propoxy)benzonitrile hydrochloride",615-111-5,70369-47-0,Acute Tox. 3,Notified C&L,1,H301:1
25281,"Trisodium 5-[[3-[(2-bromo-1-oxoallyl)amino]benzoyl]amino]-3-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4-hydroxynaphthalene-2,7-disulphonate",274-399-7,70210-01-4,Not Classified,Notified C&L,4,Not classified:4
25285,"2,2'-(piperazine-1,4-diyl)bis(ethanesulphonic) acid",227-057-6,5625-37-6,Not Classified,REACH registration C&L,72,Not classified:69;H335:3;H315:3;H319:3
25286,2-chlororesorcinol,228-256-0,6201-65-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H318:38
25287,"p-mentha-1,3-diene",202-795-1,99-86-5,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1865,H319:101;H226:1865;H317:46;H302:1864;H411:1843;H304:1782;H335:57;H315:80;H360:22;H332:44;H361:22
25289,Spiromesifen,608-196-5,283594-90-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,195,H410:195;H317:195;H400:195;H332:38
25290,3-thenoyl chloride,255-420-9,41507-35-1,Flam. Sol. 2;Skin Corr. 1B,Notified C&L,39,H314:39;H228:39
25296,"N-amino-1,3-oxazolidin-2-one sulphate",251-307-3,32957-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
25308,"2,3,3,3-Tetrafluoroprop-1-ene",616-220-0,754-12-1,Flam. Gas 1;Press. Gas (Comp.),Notified C&L,63,H280:63;H220:63
25309,bis(η,412-000-1,125051-32-3,Flam. Sol. 1;STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H373:0;H361:0;H411:0;H228:0
25312,"p-nitrophenyl dihydrogen phosphate, compound with cyclohexylamine (1:2)",257-949-0,52483-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
25324,"5-(diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium chloride",279-852-2,81921-84-8,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,8,H410:4;H301:7;H400:4;H411:3;H318:3;Not classified:1
25327,Undecanedioic acid,217-440-6,1852-04-6,Eye Irrit. 2,REACH registration C&L,604,H319:598;H315:98;H335:46;Not classified:6
25335,2-(acryloyloxy)ethyl 6-hydroxyhexanoate,279-461-7,80413-54-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;Not classified:1;H315:1;H319:1
25336,1-acetyl-4-(4-fluorobenzoyl)piperidine,247-069-5,25519-77-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
25342,"Imidazole, sodium derivative",226-988-5,5587-42-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,40,H332:40;H302:40;H314:40;H312:40;H318:40
25343,"4-(2,6,6-trimethylcyclohex-1-ene-1-yl)-but-3-ene-2-one",238-969-9,14901-07-6,Aquatic Chronic 2,REACH registration C&L,2471,H411:2427;H400:446;H315:88;Not classified:5;H412:1;H319:1;H335:1;H334:1;H317:1
25344,"2,5-dimethylpiperazine",203-409-4,106-55-8,Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H314:1;H311:1
25347,(3-bromopropyl)benzene,211-294-7,637-59-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,74,H335:29;H315:74;H319:74;H302:39
25349,"Tetrasodium 2,2'-[(1,4-dioxo-2-butene-1,4-diyl)bis[imino(2-methyl-4,1-phenylene)azo]]bis[5-[(4-sulphonatophenyl)azo]benzenesulphonate]",276-540-8,72252-60-9,Not Classified,Notified C&L,31,Not classified:31
25350,5-fluoroanthranilic acid,207-159-7,446-08-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:48;H315:49;H319:49
25351,"Fatty acids, coco, 2-sulfoethyl esters, sodium salts",263-052-5,61789-32-0,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,863,H412:207;H319:852;H315:125;H335:36;Not classified:10;H318:1
25354,4-methyl-o-phenylenediamine,207-826-2,496-72-0,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Muta. 2;Carc. 1B;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,261,H301:202;H350:194;H319:243;H332:211;H317:193;H361:116;H373:116;H312:253;H411:193;H341:122;H335:41;H302:59;H315:51;H412:17;Not classified:2
25355,"Poly(oxy-1,2-ethanediyl), a-[[]bis(octyloxy)phosphinyl]-[?]-hydroxy-",611-505-6,57344-02-2,,Notified C&L,50,Not classified:38;H315:11;H319:11;H314:1
25356,"Trisodium hydrogen [5-[[[7-[(5-chloro-2-hydroxy-3-sulphophenyl)azo]-8-hydroxy-3,6-disulpho-1-naphthyl]amino]sulphonyl]salicylato(6-)]cuprate(4-)",276-421-0,72152-68-2,Not Classified,Notified C&L,2039,Not classified:2039
25357,"Tributyl(2,4,5-trichlorophenoxy)stannane",277-638-3,73927-98-7,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H301:38;H372:38;H319:38;H315:38;H410:38;H312:38;H400:38
25358,4-fluoro-3-nitroaniline,206-665-5,364-76-1,Acute Tox. 4,Notified C&L,47,H302:46;H335:6;H315:8;H319:8;H411:1;H332:1;H312:1;H351:1;H228:1;H317:1;H373:1;H341:1
25359,N-[2-[(2-bromo-6-cyano-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide,219-807-6,2537-62-4,Not Classified,Notified C&L,72,Not classified:62;H317:10
25360,"3,3'-dithiobispropionic acid",214-284-0,1119-62-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:50;H315:51;H319:51;H314:1;H318:1
25365,"10,12-dihydrobenz(de)imidazo(4',5':5,6)benzimidazo(1,2-a)isoquinoline-8,11-dione",408-170-1,,Not Classified,Notified C&L,2040,Not classified:2040
25366,"Bis(2-ethylhexyl) hydrogen phosphate, compound with 2-aminoethanol (1:1)",294-567-3,91731-99-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H318:2
25378,"Ethane-1,2-diylbis[dichloromethylsilane]",222-123-0,3353-69-3,Skin Corr. 1A;Eye Dam. 1;STOT SE 3,REACH registration C&L,39,H314:39;H335:1;H318:1
25381,4-(1-oxo-2-propenyl)-morpholine,610-626-1,5117-12-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;STOT RE 2,Notified C&L,62,H317:62;H302:62;H373:62;H318:62
25384,"1,7,8,9-tetrahydro-8-thioxo-6H-purin-6-one",228-617-2,6305-94-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H319:38
25387,Amfepramone hydrochloride,205-156-5,134-80-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,49,H332:38;H302:49;H312:38;H360:9
25388,"1-(6-amino-1,3-benzodioxol-5-yl)ethan-1-one hydrochloride",301-288-3,93983-01-8,,Notified C&L,4,H335:4;H315:4;H319:4
25389,Citronellyl butyrate,205-463-4,141-16-2,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1652,H410:12;H317:13;H400:12;Not classified:1598;H335:40;H315:41;H319:40
25390,"Fatty acids, C16-18 and C18-unsatd., isooctyl esters, epoxidized",307-159-8,97553-05-4,Not Classified,REACH registration C&L,86,Not classified:86
25391,"4(3H)-Pyrimidinone, 5-amino-6-hydroxy-2-methyl-",619-375-2,98797-08-1,Not Classified,Notified C&L,1,Not classified:1
25394,Lanatoside C,241-546-1,17575-22-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,43,H331:40;H301:41;H311:40;H300:2;H330:3;H310:1;H373:2;H372:1
25396,Isobutyl nonan-1-oate,250-411-6,30982-03-7,Not Classified,Notified C&L,1,Not classified:1
25397,"2,7-Naphthalenedisulfonic acid, 4-hydroxy-5-[[4-[[4-[[5-hydroxy-6-[(2-methoxy-5-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-5-methoxy-2-methylphenyl]azo]-, tetrasodium salt",274-482-8,70236-51-0,Aquatic Chronic 3,Notified C&L,43,H412:31;H317:8;Not classified:4
25399,1-Decene-1-sulfonic,609-979-4,41999-41-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,450,H302:450;H315:450;H318:450
25401,"2,2,4,6,6-pentamethylhept-3-ene",204-631-4,123-48-8,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,38,H413:38;H318:38
25402,Tantalum mononitride,234-788-4,12033-62-4,Not Classified,Notified C&L,3,Not classified:3
25403,"Benzenesulfonic acid, mono-C11-13-branched alkyl derivs.",271-807-5,68608-88-8,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,113,H314:113;H302:91;H411:91;H318:113;H311:83
25406,"Leuco polysulfided 4-[(2,4-dinitrophenyl)amino]phenol",310-132-3,61902-31-6,Not Classified,REACH registration C&L,39,Not classified:39
25407,4-[(4-Methyl-1-piperazinyl)methyl]-N- [4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-13phenyl]benzamide methanesulfonate,606-892-3,220127-57-1,Acute Tox. 4,Notified C&L,113,H302:93;H351:17;H360:15;H411:2;H373:2;H361:4;H332:2;H412:2;H312:1;H362:2;H341:2;H372:2;H335:3;H315:1;H319:1;Not classified:1
25408,"Trisodium (2S-trans)-[18-carboxy-20-(carboxymethyl)-13-ethyl-12-formyl-2,3-dihydro-3,7,17-trimethyl-8-vinyl-21H,23H-porphine-2-propionato(5-)-N21,N22,N23,N24]cuprate(3-)",248-950-7,28302-36-5,Not Classified,Notified C&L,1,Not classified:1
25409,Pentolonium tartrate,200-146-7,52-62-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H302:39;H315:39;H319:39
25410,Arylethylphenylpolyglykolether,600-560-1,104376-75-2,Aquatic Chronic 2,Notified C&L,324,H411:211;H412:74;Not classified:39;H318:1
25411,"Fatty acids, C16-18 and C18-unsatd., esters with sorbitol",286-074-7,85186-88-5,Not Classified,Notified C&L,4,Not classified:4
25415,"Citric acid, (144H)-praseodymium salt",261-972-1,59885-87-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
25422,"Titanium, bis (5-2,4-cyclopentadien-1-yl)bis(4-methoxyphenyl)-",601-790-5,12156-55-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,1,H336:1;H319:1;H335:1;H304:1;H315:1;H225:1;H410:1;H400:1
25423,4-Bromo-2-methylpyridine,624-896-3,22282-99-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48,H335:43;H302:46;H315:48;H318:40;H319:8;H332:5;H312:5
25424,4-Methylthiazole-5-carboxaldehyde,617-314-4,82294-70-0,Eye Dam. 1,Notified C&L,40,H318:38;H315:2;H319:2;H335:1;H302:1
25426,"Benzenesulfonamide, 5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, hydrochloride (1:1)",617-011-7,80223-99-0,,Notified C&L,1,H302:1
25427,2-[[4-[(2-cyano-3-nitrophenyl)azo]-m-tolyl](2-acetoxyethyl)amino]ethyl acetate,250-061-4,30124-94-8,Not Classified,REACH registration C&L,27,Not classified:21;H317:6
25430,"3,4-difluorobenzoic acid",207-249-6,455-86-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H302:40;H315:47;H319:47
25434,N-allylmethacrylamide,218-576-9,2186-33-6,,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
25439,2-(2-oxopyrrolidin-1-yl)butanamide,642-997-0,33996-58-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,40,H302:39;H411:39;H319:39;Not classified:1;H335:1;H315:1
25441,N-[(2-chlorophenyl)methyl]thiophene-2-ethylamine hydrochloride,262-327-7,60612-23-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H410:2;H302:4;H400:2;H319:2;H335:2;H332:1;H315:2;H312:1
25442,"5-phenyl-1,3,4-oxadiazole-2(3H)-thione",221-103-9,3004-42-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43;H302:1
25443,"(S)-bis(lactato-O1,O2)iron",289-080-8,85993-25-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,401,H335:389;H302:389;H315:389;H319:399;Not classified:2
25444,nickel triuranium decaoxide,239-876-6,15780-33-3,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H317:0;H350:0;H372:0
25445,"Stearic acid, monoester with propane-1,2-diol",215-354-3,1323-39-3,Not Classified,REACH registration C&L,194,Not classified:156;H413:38
25448,"1,3,6-Naphthalenetrisulfonic acid, 7-[2-[2-[(aminocarbonyl)amino]-4-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-, sodium salt",474-870-9,,Not Classified,REACH registration C&L,7,Not classified:7
25449,"Cyclopropaneacetic acid, 1-(mercaptomethyl)-, methyl ester",604-878-1,152922-73-1,,Notified C&L,1,H335:1;H315:1;H319:1
25453,"2,3-dihydro-1,3,3-trimethyl-2-methylene-1H-pyrrolo[2,3-b]pyridine",255-371-3,41450-85-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
25454,"N,N-dimethyl-4-(2-pyridylazo)aniline",236-026-6,13103-75-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
25470,Octyltrichlorosilane,226-112-1,5283-66-9,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,94,H314:94;H318:24;H290:1;H225:1;H335:1;Not classified:1
25473,"1H-Indole-1-acetic acid, 5-chloro-, ethyl ester",608-105-9,27512-72-7,Skin Corr. 1B;Acute Tox. 4,Notified C&L,39,H314:39;H332:39;H302:1;H312:1
25474,"2-Hydroxyethyl methacrylate, ethoxylated",500-042-4,25736-86-1,Not Classified,Notified C&L,114,Not classified:73;H315:41;H319:1
25475,"1,1-hydrazoformamide",203-747-2,110-21-4,,Notified C&L,38,Not classified:33;H335:5;H315:5;H319:5
25477,1-N-Boc-3-pyrrolidinone,600-204-5,101385-93-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,50,H335:47;H302:42;H315:50;H318:39;H319:11;H332:1;H312:1
25478,"Octahydro-4,7-methano-1H-indenemethyl acetate",250-331-1,30772-69-1,Not Classified,Notified C&L,261,Not classified:250;H411:11;H315:10
25480,"Quaternary ammonium compounds, C20-22-alkyltrimethyl, chlorides",271-756-9,68607-24-9,Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,144,H373:143;H315:144;H410:12;H318:143;H400:130;H411:114;H412:13;H319:1;H312:1
25482,Glycinamide hydrochloride,216-789-1,1668-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:3;H315:3;H319:3;Not classified:1
25485,"Androsta-4,9(11)-diene-17-carbonitrile, 17-hydroxy-3-oxo-, (17a)-",617-448-3,83196-56-9,Repr. 2;STOT RE 2,REACH registration C&L,1,H373:1;H361:1
25487,N-(1-Methylethyl)-2-propanamine magnesium salt,624-900-3,23293-23-4,Water-react. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Notified C&L,63,H314:63;H302:63;H261:38;H332:63;H260:25;H225:25
25489,Monalazone disodium,262-810-2,61477-95-0,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,2,H317:2;H315:2;H318:2;H290:1
25490,2-(chloromethyl)anisole,230-312-4,7035-02-1,Skin Corr. 1B,Notified C&L,42,H314:42;H318:2
25492,"Fatty acids, C14-22 and C16-22-unsatd., isooctyl esters, epoxidized",307-158-2,97553-04-3,Not Classified,Notified C&L,6,Not classified:6
25499,3-phenoxyaniline,222-715-9,3586-12-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H335:43;H332:39;H302:43;H315:43;H312:39
25501,"2-hydroxypropane-1,3-diyl dipalmitate",207-942-3,502-52-3,Not Classified,Notified C&L,2,Not classified:2
25502,(allyloxy)benzyl alcohol,249-127-5,28655-62-1,Acute Tox. 4,Notified C&L,193,H302:177;Not classified:16
25503,"3,3-dimethyl-2-oxobutyric acid",212-418-2,815-17-8,Skin Corr. 1B,Notified C&L,50,H314:47;Not classified:3;H318:4;H290:2
25510,"Gall (plant tumor), Chinese, ext.",296-353-5,92502-64-2,Not Classified,Notified C&L,1,Not classified:1
25511,"Phosphoric acid, isooctyl ester, sodium salt",269-043-2,68186-56-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
25512,"3,5-dimethyl-1-phenyl-1H-pyrazole-4-carbaldehyde",244-750-9,22042-79-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H332:1;H302:1;H312:1
25514,α-hydroxybenzylphosphinic acid,258-116-4,52705-43-8,Skin Corr. 1B,Notified C&L,38,H314:38
25516,Tetraethyl thiourea,610-055-8,4274-15-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
25518,(3S-trans)-3-benzyloxy carbonylamino-2-methyl-4-oxo-1-azetidine sulfonic acid,919-222-2,,Skin Sens. 1,Notified C&L,1,H317:1
25523,"2,5-xylyloxyacetic acid",230-887-1,7356-41-4,Acute Tox. 4,Notified C&L,42,H302:38;H335:4;H315:4;H319:4
25531,Undec-2-enol,253-569-4,37617-03-1,Not Classified,Notified C&L,126,Not classified:88;H410:38;H319:38;H400:38
25533,"1,36-Hexatriacontanediol",603-264-0,128244-40-6,Not Classified,Notified C&L,22,Not classified:22
25534,"Benzo[1,2-b:4,5-b']difuran-2,6-dione, 3-phenyl-7-(4-propoxyphenyl)-",616-723-5,79694-17-0,Not Classified,Notified C&L,33,Not classified:33
25538,"3,5-diamino-2,6-dimethoxypyridine dihydrochloride",260-062-1,56216-28-5,Acute Tox. 3;Skin Sens. 1;STOT RE 2,Notified C&L,12,H301:9;H317:8;H373:8;Not classified:3;H319:2;H411:1
25550,"Bis[5-(diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium] tetrachlorozincate(2-)",279-851-7,81921-77-9,,Notified C&L,8,H412:8;H302:8;H319:8
25555,3-CHLORO-6-HYDRAZINOPYRIDAZINE,605-647-8,17284-97-8,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,46,H317:41;H302:42;H318:41;H335:4;H315:4;H319:4;H314:2;H332:2;H312:2
25564,"Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;Coal Tar Extract;[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C",295-455-7,92045-72-2,Carc. 1B,Harmonised C&L,0,H350:0
25568,Cornmint oil,614-794-7,68917-18-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,173,H317:76;H315:76;H411:75;H302:59;Not classified:44;H319:6;H304:2;H410:1
25570,"(2S)-Oxiranecarboxylic acid, methyl ester",601-557-8,118712-39-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39;H351:1;H341:1
25571,3-methyl-5-oxopentyl acetate,927-505-7,101153-84-8,Not Classified,REACH registration C&L,1,Not classified:1
25573,"1,1-diethylguanidine hydrochloride",214-213-3,1114-39-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H318:38
25575,"1,1,1,2-tetrachloroethane",211-135-1,630-20-6,Acute Tox. 4;Acute Tox. 1;Eye Irrit. 2;Acute Tox. 3,Notified C&L,10,H331:5;H302:7;H319:4;H310:4;Not classified:3;H332:2;H351:2;H318:3;H412:1;H312:1;H315:1
25576,p-cymene,202-796-7,99-87-6,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2120,H319:218;H335:217;H304:1961;H226:2112;H315:268;H361:32;H411:1838;H412:8;H302:5;Not classified:3;H317:1;H410:1;H332:1;H312:1;H225:1;H331:1
25579,Reaction mass of 1-(spiro[4.5]dec-7-en-7-yl)pent-4-en-1-one and 1-(spiro[4.5]dec-6-en-7-yl)pent-4-en-1-one,438-060-9,224031-70-3,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1303,H317:1303;H411:1;H400:1303;H410:1302
25583,4-Bromo-1H-indole,610-851-5,52488-36-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:40;H315:41;H319:41;H332:2;H302:2;H312:2
25588,Inosine,200-390-4,58-63-9,Not Classified,REACH registration C&L,21,Not classified:19;H302:1;H341:1;H335:1;H315:1;H319:1
25600,"hydrazobenzene;1,2-diphenylhydrazine",204-563-5,122-66-7,Acute Tox. 4;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H350:0;H400:0
25601,"Pyrimidine-2,4,6-triyltriamine",213-720-7,1004-38-2,Aquatic Chronic 3,REACH registration C&L,128,H412:84;H335:43;H315:44;H319:44
25603,"4,4'-(p-phenylenediethene-2,1-diyl)bisbenzonitrile",235-836-7,13001-40-6,Not Classified,Notified C&L,90,Not classified:90
25605,"Amines, ditallow alkyl",272-191-0,68783-24-4,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H314:32;H410:32;H400:32;Not classified:7;H315:5
25606,tert-butylamine hydrobromide,262-253-5,60469-70-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
25618,2-[2-(2-methoxyethoxy)ethoxy]ethylamine,277-952-0,74654-07-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
25619,"3,10-bis[(4-amino-2,5-disulphophenyl)amino]-6,13-dichlorotriphenodioxazine-4,11-disulphonic acid",279-008-3,78925-22-1,Not Classified,REACH registration C&L,16,Not classified:15;H412:1;H317:1
25620,"5,5'-diphenyl-3,3'-bis(4-nitrophenyl)-2,2'-(3,3'-dimethoxybiphenyl-4,4'-ylene)ditetrazolium dichloride",206-067-4,298-83-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H335:56;H302:59;H315:57;H319:58;H332:10;H312:10;Not classified:2;H351:1;H371:1
25621,sodium hydride,231-587-3,7646-69-7,Water-react. 1,Harmonised C&L,0,H260:0
25622,nickel oxalate,208-933-7,547-67-1,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H372:0;H350:0;H317:0;H410:0;H400:0
25624,"Sodium 1,4-bis(2,6-dimethylheptyl) sulphonatosuccinate",264-016-1,63217-13-0,Not Classified,Notified C&L,6,Not classified:5;H412:1;H315:1;H318:1
25630,Dinonyl adipate,205-789-7,151-32-6,Not Classified,Notified C&L,3,Not classified:3
25631,"Zinc, desilverizing skims",273-802-3,69029-60-3,Carc. 1B;Repr. 1A;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,7,H410:7;H372:7;H360:7;H350:7
25633,"1,3-Benzenedicarboxylic acid, 4-amino-",608-911-0,33890-03-8,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1
25636,Methyl [(phenylmethylene)amino]benzoate,253-685-5,37837-44-8,Not Classified,Notified C&L,112,Not classified:112
25637,trilead bis(orthophosphate),231-205-5,7446-27-7,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0,H410:0;H373:0;H360:0;H400:0
25640,Cyclohexyl isobutyrate,214-448-1,1129-47-1,Not Classified,Notified C&L,1,Not classified:1
25652,Octadecyl laurate,221-786-3,3234-84-2,Not Classified,Notified C&L,8,Not classified:8
25654,"(±)-1-Benzyl-4-(4-fluoro-phenyl)-3-hydroxymethyl-1,2,3,6-tetrahydro-pyridine, salt with benzenesulfonic acid",606-458-3,201855-55-2,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H317:2;H373:2;H315:2;H402:2
25655,"2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propanesulphonic acid",269-993-8,68399-81-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:41;H315:41;H319:41;Not classified:2
25656,4-phenylazobenzoic acid,216-347-8,1562-93-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
25659,"Oils, halibut liver",232-284-9,8001-46-5,Not Classified,Notified C&L,1,Not classified:1
25665,Flavone,208-383-8,525-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
25666,"2,4,6-trimethoxybenzaldehyde",212-598-2,830-79-5,,Notified C&L,6,H335:5;H315:6;H319:6
25673,styrene,202-851-5,100-42-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT RE 1;Repr. 2,Harmonised C&L,0,H372:0;H319:0;H226:0;H332:0;H361:0;H315:0
25680,nickel tin trioxide;nickel stannate,234-824-9,12035-38-0,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H317:0;H350:0;H372:0
25686,"2-Propenoic acid, 2-ethylhexyl ester, reaction products with C10-rich and C9-11-branched and linear alc.- and 2-phenoxyethanol- and polypropylene glycol mono-Bu ether-blocked",620-042-9,947686-91-1,Skin Irrit. 2,Notified C&L,19,H315:19
25689,"Soybean oil, sulfonated, sodium salt",272-356-7,68815-14-5,,Notified C&L,3,Not classified:2;H315:1;H318:1
25693,Pentaerythritol tetraoleate,242-960-5,19321-40-5,Not Classified,REACH registration C&L,43,Not classified:43
25697,Dibromostyrene,250-802-1,31780-26-4,Not Classified,Notified C&L,1,Not classified:1
25698,"fluquinconazole (ISO);3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one",411-960-9,136426-54-5,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H372:0;H301:0;H331:0;H315:0;H410:0;H312:0;H400:0
25700,6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid,404-550-6,130263-41-1,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
25702,"Pentapotassium bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]cobaltate(5-)",279-312-6,79817-89-3,Not Classified,Notified C&L,1,Not classified:1
25707,"Reaction product of Eicosanedioic acid, Docosanoic acid and Glycerin",478-910-6,,Not Classified,REACH registration C&L,1,Not classified:1
25709,1-Phenyl-1-(2-pyridinyl)ethanol hydrochloride (1:1),606-318-1,19478-81-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H335:48;H302:10;H315:48;H319:48
25713,Chloropyramine,200-421-1,59-32-5,Acute Tox. 4,REACH registration C&L,39,H302:39;H319:38;H335:38;H334:38;H315:38
25715,"Oxazolidine-2,5-dione",218-570-6,2185-00-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,2,H335:1;H315:1;H318:1;Not classified:1
25716,"5-carboxy-4-hexylcyclohex-2-ene-1-octanoic acid, compound with 2,2',2''-nitrilotriethanol",269-360-6,68227-48-5,Not Classified,Notified C&L,24,Not classified:24
25719,"Butanoic acid, 4-amino-4-oxosulfo-, N-coco alkyl derivs., monosodium salts, compds. with triethanolamine",308-662-5,98171-53-0,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,127,H315:100;H318:84;Not classified:27;H319:16
25721,"1,2,3,4,5,6-hexamethylbicyclo(2,2,0)hexa-2,5-diene",231-576-3,7641-77-2,Flam. Liq. 3,Notified C&L,38,H226:38
25723,"3,4-dimethoxybenzyl alcohol",202-212-0,93-03-8,Acute Tox. 4,REACH registration C&L,151,H302:148;Not classified:3
25725,"Borate(1-), tris(acetato-.kappa.O)hydro-, sodium, (T-4)-",435-580-8,56553-60-7,Flam. Sol. 1;Self-react. E;Water-react. 1;Skin Irrit. 2;Eye Dam. 1;Repr. 1B,REACH registration C&L,20,H260:19;H360:19;H228:16;H315:17;H242:16;H318:20;H302:3
25727,1-[5(or 6)-methyl-7(or 8)-(1-methylethyl)bicyclo[2.2.2]oct-5-en-2-yl]ethan-1-one,269-524-7,68259-33-6,Not Classified,Notified C&L,1544,Not classified:1544
25729,"Oils, castoreum",232-427-5,8023-83-4,Not Classified,Notified C&L,145,Not classified:145
25730,"Disodium 4-hydroxynaphthalene-2,7-disulphonate",243-754-8,20349-39-7,Not Classified,REACH registration C&L,87,Not classified:85;H315:2;H319:2
25739,"2-[(1,3-dioxoisoindol-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropane-1-carboxamide",692-500-6,105310-75-6,Acute Tox. 3;Skin Irrit. 2,Notified C&L,1,H301:1;H315:1
25740,"2,5-dimethoxyaniline",203-040-9,102-56-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,REACH registration C&L,81,H332:35;H373:40;H302:36;H312:35;H301:45;H331:5;H311:5;H315:2;H319:2;H335:1
25741,2-naphthoyl chloride,218-822-5,2243-83-6,Skin Corr. 1B,Notified C&L,56,H314:56;H290:8;H318:3;Not classified:1
25742,"4,8-dioxa-2,2,6,6,10,10-hexahydroxymethylundecane-1,11-diol",201-097-4,78-24-0,Not Classified,Notified C&L,7,Not classified:7
25743,3-benzylidenephthalide,209-388-8,575-61-1,Not Classified,Notified C&L,3,Not classified:3
25748,"Propanedioic acid, 1-(3,3-dimethylcyclohexyl)ethyl ethyl ester",455-260-1,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1
25749,"Amides, from C18-24 fatty acids, N,N-dimethyl-1,3-propanediamine and hydrogenated tallow fatty acids, compds. with di-Me sulfate",292-521-7,90623-14-6,Aquatic Chronic 2,Notified C&L,2,H411:1;Not classified:1
25750,"Hexanedioic acid, 1,6-diisooctadecyl ester",613-043-0,62479-36-1,Not Classified,Notified C&L,1,Not classified:1
25751,"Citric acid, iron(2+) salt",245-625-1,23383-11-1,Not Classified,Notified C&L,2,Not classified:2
25753,"Diethyl 4,4'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4,5-dihydro-5-oxo-1-phenyl-1H-pyrazole-3-carboxylate]",228-788-3,6358-87-8,Flam. Sol. 2,REACH registration C&L,164,H228:34;Not classified:130
25758,Tetraammineplatinum dihydroxide,239-719-1,15651-37-3,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H410:83;H317:83;H318:84;H400:83;H314:1
25759,Tantalum hydride,237-770-4,13981-95-8,,Notified C&L,4,H260:4;H335:4;H319:4;H228:4
25760,6-Bromobenzo[b]thiophene,605-681-3,17347-32-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,39,H413:38;H302:38;H319:39;H315:1
25763,Hexacosane,211-124-1,630-01-3,,Notified C&L,10,H315:5;Not classified:5
25765,2-(4-nitrophenoxy)ethanol,240-422-4,16365-27-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
25768,"2,6-Difluoro-4-hydroxybenzonitrile",602-955-4,123843-57-2,,Notified C&L,3,H331:2;H301:2;H311:2;H319:2;H335:1;H332:1;H302:1;H315:2;H312:1
25770,Dibutyl hydrogen phosphate,203-509-8,107-66-4,Skin Corr. 1A;Eye Dam. 1;Carc. 2,REACH registration C&L,803,H314:712;H351:43;H318:493;Not classified:69;H315:21;H290:3;H413:2;H336:1;H335:1;H302:1
25775,Methylphenidate hydrochloride,206-065-3,298-59-9,Acute Tox. 4;Resp. Sens. 1,Notified C&L,61,H302:60;H334:41;H412:9;H351:9;H317:8;H336:8;H319:3;H332:2;H315:3;H312:2;H341:3;H301:1;H331:1;H311:1;H372:1;H228:1
25782,"1-ethyl-N,N-diisopropylpropylamine",272-102-5,68714-10-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39
25784,L-malic acid,202-601-5,97-67-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1471,H315:170;H319:1434;H335:63;Not classified:9;H318:5;H302:3
25787,Sodium [(2-methoxyphenyl)amino]methanesulphonate,262-812-3,61480-14-6,Not Classified,REACH registration C&L,2,Not classified:2
25790,4-nitro-m-toluidine,210-247-8,611-05-2,,Notified C&L,6,H301:6;H331:6;H373:5;H411:5;H311:6;H319:1;H315:1
25791,"α-d-Glucopyranoside, β-d-fructofuranosyl, (Z)-9-octadecenoate",258-098-8,52683-61-1,Not Classified,Notified C&L,31,Not classified:31
25794,"2-Pentanone-4methyl-,O,O’,O”-(ethenylsilylidyne)trioxime",421-860-7,,Not Classified,REACH registration C&L,3,Not classified:3
25797,2-methyl-5-(1-methylvinyl)cyclohexan-1-one,231-857-0,7764-50-3,Not Classified,Notified C&L,1437,Not classified:1398;H335:39;H315:39;H319:39
25798,Zinc iron chromite brown spinel,269-050-0,68186-88-9,Not Classified,REACH registration C&L,141,Not classified:58;H413:83
25800,"Fatty acids, C8-18-branched and linear, esters with trimethylolpropane",288-726-6,85883-76-7,Not Classified,REACH registration C&L,20,Not classified:20
25802,11-thiabenzo[a]fluorene,205-948-0,239-35-0,Not Classified,Notified C&L,3,Not classified:3
25807,"Phosphoric acid, mixed lauryl and myristyl esters",270-197-8,68412-59-9,Skin Corr. 1B,Notified C&L,3,H314:3
25810,Triisopropylsilyl acrylate,457-670-6,157859-20-6,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,51,H317:51;H315:9;H411:9;H410:20;H400:20;H319:1
25812,Sisomicin,251-018-2,32385-11-8,Acute Tox. 4;Acute Tox. 4;Repr. 1B,REACH registration C&L,4,H332:4;H312:4;H360:4
25819,"1-bromo-2,4,6-trifluorobenzene",219-125-9,2367-76-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46;H226:46
25821,"Synthetase, acyl coenzyme A",232-747-5,9013-18-7,Resp. Sens. 1,Notified C&L,1,H334:1
25823,toluene-α-thiol,202-862-5,100-53-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1595,H302:1595;H319:1513;H330:83;H410:43;H400:40;H315:4;H227:2
25826,"2-(2,3-Dichlorophenyl)-2-guanidinyliminoacetonitrile",617-611-9,84689-20-3,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
25830,(chloromethyl)dimethylsilane,221-556-2,3144-74-9,Flam. Liq. 2,Notified C&L,38,H225:38
25833,Ammonium iron(III) citrate,214-686-6,1185-57-5,Not Classified,REACH registration C&L,1543,Not classified:28;H315:1515;H319:1432;H302:83;H318:83;H335:100
25834,"Shellac, Et ester",271-767-9,68607-68-1,Not Classified,Notified C&L,1,Not classified:1
25835,mercury difulminate;mercuric fulminate;fulminate of mercury;fulminate of mercury [≥ 20 % phlegmatiser],211-057-8,628-86-4,,,0,H201:0;H301:0;H331:0;H400:0;H373:0;H410:0;H311:0
25836,5-methyl-4-(4-nitrophenylazo)resorcinol,210-150-0,607-96-5,Skin Sens. 1;Eye Irrit. 2,Notified C&L,39,H317:38;H319:39
25838,"2-Propenenitrile, polymer with 1,2-ethanediamine",608-174-5,28183-82-6,Not Classified,REACH registration C&L,2,Not classified:2
25839,N-acetyl-β-alanine,221-185-6,3025-95-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
25844,(4R)-1-(tert-butoxycarbonyl)-4-hydroxy-L-proline,604-011-7,13726-69-7,Not Classified,REACH registration C&L,10,Not classified:8;H335:2;H315:2;H319:2
25845,"Petrolatum (petroleum), oxidized, barium salt",270-347-2,68425-33-2,,Notified C&L,1,Not classified:1
25850,Strontium dihydride,237-065-1,13598-33-9,Water-react. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,176,H319:175;H260:176;H335:175;H261:170;H315:175;H302:4
25852,Dioctyl disulphide,212-494-7,822-27-5,Eye Irrit. 2,Notified C&L,66,H319:50;H332:25;H317:26;H315:25;Not classified:15
25860,"4-chloro-3,5-dimethylphenol",201-793-8,88-04-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0;H315:0;H319:0
25861,(Z)-2-formamido-α-(methoxyimino)thiazol-4-acetic acid,265-958-6,65872-43-7,Not Classified,REACH registration C&L,40,Not classified:2;H335:38;H315:38;H319:38
25862,Trihydrogen trifluoro[phosphato(3-)-O]borate(3-),237-149-8,13669-76-6,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3;STOT RE 1,REACH registration C&L,122,H372:84;H335:122;H332:84;H290:84;H302:84;H314:122;H318:84
25864,"N,N''-naphthalene-1,5-diylbis[N',N'-dimethylurea]",277-235-2,73019-17-7,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H302:38;H400:38
25865,"Tetrasodium hydrogen 2-phosphonatobutane-1,2,4-tricarboxylate",266-442-3,66669-53-2,Not Classified,REACH registration C&L,123,Not classified:87;H315:25;H319:36;H314:11;H302:11
25867,"3a,4,7,7a-tetrahydro-1H-indene",221-260-3,3048-65-5,Eye Irrit. 2,Notified C&L,43,H319:38;H304:4;H226:5
25868,2-bromo-2-(bromomethyl)pentanedinitrile,252-681-0,35691-65-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1516,H317:865;H302:1498;H315:1107;H318:1255;H400:583;H335:197;H411:274;H330:226;H410:72;H314:103;H319:62;Not classified:14;H332:4;H412:1
25871,2-ethyl-p-cresol,223-361-8,3855-26-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H302:38;H318:38
25872,3-chlorophthalic anhydride,204-179-8,117-21-5,Eye Dam. 1,Notified C&L,6,H318:5;H335:2;H315:2;H319:1
25873,"2',4'-DIFLUOROACETANILIDE",609-757-7,399-36-0,Acute Tox. 4,Notified C&L,45,H302:38;H335:6;H315:7;H319:7
25878,"Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with methyl β-D-glucopyranoside (4:1)",612-557-2,61849-72-7,Not Classified,Notified C&L,53,Not classified:53
25882,"1,2-dibromotetrafluoroethane",204-711-9,124-73-2,Ozone 1,Notified C&L,38,H420:38
25886,"1,1-Difluoretylen-hexafluorpropenpolymer",618-470-6,9011-17-0,,Notified C&L,58,Not classified:44;H411:14
25893,Lithium chloride,231-212-3,7447-41-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1099,H302:1016;H315:725;H319:860;Not classified:61;H335:157;H360:97;H332:59;H312:95;H411:55;H362:36;H370:6;H412:6;H350:4;H373:9;H330:4;H317:3;H301:1;H311:1
25895,"Alcohols, C9-11",613-644-8,64641-46-9,,Notified C&L,1,H335:1
25898,Sodium diisopropylnaphthalenesulphonate,215-343-3,1322-93-6,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,406,H314:18;H302:405;H412:41;H318:187;H332:271;H335:322;H319:197;H413:24;H315:12
25899,(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile,430-760-2,219861-18-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H411:0
25900,"Lubricating oils, refined used",270-697-6,68476-77-7,Not Classified,Notified C&L,8,Not classified:8
25903,Bis(amidinourea) sulphate,209-697-8,591-01-5,Acute Tox. 4,Notified C&L,40,H302:39;H335:2;H315:2;H319:2
25908,"Benzeneethanol, 2,5-diamino-",618-981-4,93841-24-8,Not Classified,Notified C&L,1,Not classified:1
25909,"Butane-1,2-dithiol",240-290-8,16128-68-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
25912,(carboxymethyl)dimethyl-3-[(1-oxotetradecyl)amino]propylammonium hydroxide,261-684-6,59272-84-3,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,39,H302:1;H318:23;H411:20;H319:8;Not classified:8
25913,"Amides, coco, N,N'-ethylenebis-",288-006-1,85631-57-8,Not Classified,Notified C&L,18,Not classified:18
25915,3-acetylthiazolidine-4-carboxylic acid,225-713-6,5025-82-1,Eye Dam. 1,REACH registration C&L,51,H318:6;H302:39;H319:44;H335:4;H315:5;Not classified:1
25916,Benzyl hydrogen phthalate,219-771-1,2528-16-7,Eye Irrit. 2,Notified C&L,41,H319:41;H335:1;H315:1
25917,"Octadecanoic acid, compd. with N-cyclohexylcyclohexanamine (1:1)",608-579-7,31098-06-3,Not Classified,Notified C&L,24,Not classified:24
25920,"Barberry, Berberis vulgaris, ext.",283-473-8,84649-92-3,Flam. Liq. 3,Notified C&L,1,H226:1
25921,Sodium 5-oxo-L-prolinate,249-277-1,28874-51-3,Not Classified,REACH registration C&L,153,Not classified:153
25923,Etofylline,208-269-8,519-37-9,Acute Tox. 4,Notified C&L,45,H302:45;H335:1;H315:1;H319:1
25924,Sodium octadecyl sulphate,214-295-0,1120-04-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:42;H319:42;Not classified:1
25926,"Hydrocarbons, C",295-444-7,92045-62-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
25928,"2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl",417-960-5,,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H315:0;H410:0;H318:0;H400:0
25930,2-(1-(hydroxymethyl)cyclopropyl)acetonitrile,604-877-6,152922-71-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
25933,"Guanosine 5'-(tetrahydrogen triphosphate), 2'-deoxy-, trisodium salt",300-026-5,93919-41-6,Not Classified,Notified C&L,2,Not classified:2
25937,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, hexanedioate",614-676-5,68647-16-5,Not Classified,Notified C&L,36,Not classified:36
25940,"3'-amino-3'-deoxy-N,N-dimethyladenosine",200-388-3,58-60-6,STOT RE 2,Notified C&L,46,H373:45;H332:1;H302:1;H312:1
25942,Sodium 2-methylprop-2-ene-1-sulphonate,216-341-5,1561-92-8,Not Classified,REACH registration C&L,214,Not classified:174;H335:40;H317:38;H315:40;H319:40
25945,2-Butyl-5-chloro-1H-imidazole-4-carboxaldehyde,617-494-4,83857-96-9,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,40,H317:39;H411:40;H302:1
25946,4-(diethylamino)benzoic acid,226-582-8,5429-28-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
25950,3-chloro-2-methylpropionitrile,231-624-3,7659-45-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,70,H332:38;H302:70;H312:38
25951,4-(2-hydroxyphenyl)but-3-en-2-one,227-957-9,6051-53-2,Acute Tox. 4,Notified C&L,38,H302:38
25953,(chloromethyl)dimethylvinylsilane,240-758-1,16709-86-7,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H302:38;H315:42;H225:42
25955,"Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, trisodium salt",606-202-0,19019-43-3,Eye Irrit. 2,Notified C&L,247,H319:189;H314:55;H318:55;H373:20;H302:2;Not classified:1
25956,"4,4-diethoxybutanenitrile",242-263-6,18381-45-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
25958,Octocrilene,228-250-8,6197-30-4,Aquatic Chronic 1,REACH registration C&L,619,H410:129;H413:450;H412:24;Not classified:16
25960,"4,5-dihydroxy-1,3-bis(hydroxymethyl)imidazolidin-2-one",217-451-6,1854-26-8,Not Classified,Notified C&L,152,Not classified:150;H317:2;H315:1;H319:1;H351:1;H341:1
25961,N-(4-(chloromethyl)tiazole-2-yl)guanidine hydrochloride,617-583-8,84545-70-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,52,H315:52;H319:52
25962,Dibutyl phenyl phosphate,219-772-7,2528-36-1,,Notified C&L,43,Not classified:41;H319:2;H335:2;H332:2;H302:2;H315:2;H312:2
25964,"Trimethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane",288-657-1,85857-16-5,Not Classified,REACH registration C&L,6,Not classified:2;H335:3;H315:4;H319:4
25966,"6,6'-(2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diyldiethylene)bis(1,3,5-triazine--2,4-diamine)",245-064-2,22535-90-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
25967,N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate,421-130-8,156679-41-3,Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H318:0;H400:0
25972,"Ethyl 3,3-diethoxypropionate",234-223-1,10601-80-6,Not Classified,Notified C&L,2,Not classified:2
25978,4-chlorobutyl phenyl ether,220-174-3,2651-46-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H317:38;H315:38;H318:38
25979,"Urea, N-octyl-N'-[4-[[4-[[(octylamino)carbonyl]amino]phenyl]methyl]phenyl]-",602-904-6,122886-55-9,Not Classified,Notified C&L,1,Not classified:1
25980,"Dodecanoic acid, C12-15-alkyl esters",306-653-0,97358-76-4,Not Classified,Notified C&L,1,Not classified:1
25985,2-amino-4-bromobenzoic acid,244-025-7,20776-50-5,Acute Tox. 3,Notified C&L,43,H301:41;H315:2;H319:3;H331:1;H335:1;H311:1;H302:1
25989,Potassium chloride,231-211-8,7447-40-7,Not Classified,Notified C&L,767,Not classified:720;H412:23;H319:16;H335:4;H315:4;H314:4;H225:4;H373:6;H302:1;H411:1
25990,N-[2-[(2-hydroxyethyl)amino]ethyl]octanamide,264-187-2,63451-15-0,Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H301:1;H302:1;H400:1
25995,"Oxirane, 2-methyl-, polymer with oxirane, ether with 1,2,3-propanetriol (3:1), polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",604-089-2,138626-39-8,Not Classified,Notified C&L,21,Not classified:21
25996,Ferrous chloride terahydrate,603-870-5,13478-10-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,68,H314:65;H302:68;H290:2;H318:3;H315:1;H332:1;H312:1
25997,ETHYLE NORVALINATE S HCl,482-890-4,,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1,H317:1;H319:1
25999,4-nitroso-m-cresol,210-405-6,615-01-0,Eye Irrit. 2,Notified C&L,38,H319:38
26000,"4,4'-Methylenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and propylenediamine",500-417-2,158885-32-6,Skin Corr. 1B;Skin Sens. 1,Notified C&L,2,H314:1;H317:1;Not classified:1
26001,potassium titanium oxide (K2Ti6O13),601-721-9,12056-51-8,Carc. 2,Notified C&L,2,H351:1;Not classified:1
26005,"2,2'-[1,4-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(8-hydroxy-3,6-disulphonaphthalene-1,7-diyl)azo]]bisnaphthalene-1,5-disulphonic acid",299-262-9,93858-30-1,Not Classified,Notified C&L,2,Not classified:2
26007,3-phenylpropyl acetate,204-569-8,122-72-5,Not Classified,REACH registration C&L,322,Not classified:318;H411:4
26009,"RG2 (Formaldehyde,polymer with 2-methylphenol, 3-methylphenol, 4-methylphenol and phenol)",609-952-7,41701-84-2,Skin Sens. 1B,Notified C&L,11,H317:11
26010,"Dihydro-4,4-dimethyl-2H-pyran-2,6(3H)-dione",223-998-1,4160-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
26013,"tecnazene (ISO);1,2,4,5-tetrachloro-3-nitrobenzene",204-178-2,117-18-0,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H302:0;H400:0
26015,"Tetrachloropyrimido[5,4-d]pyrimidine",251-318-3,32980-71-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26016,"Adenosine 5'-(trihydrogen diphosphate), 5'→5'-ester with 3-(aminothioxomethyl)-1-β-D-ribofuranosylpyridinium--ate",223-828-6,4090-29-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
26020,"6-methyl-2-(4-methylcyclohex-3-enyl)hept-2,5-diene",241-610-9,17627-44-0,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1,Notified C&L,280,H317:280;H315:280;H304:280;H332:25;H411:25;H351:1;H319:1;H335:1
26021,"2,6,6-trimethylcyclohex-2-ene-1-carbaldehyde",207-080-8,432-24-6,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H302:38;H411:38
26022,(Bromomethyl)cyclopentane,609-523-4,3814-30-0,,Notified C&L,5,H335:5;H315:5;H319:5;H226:3;H332:3;H302:4;H312:3
26024,Diheptyl phthalate,222-885-4,3648-21-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,42,H335:38;H361:42;H315:38;H319:38
26031,1-hydrazino-3-(methylthio)propan-2-ol,238-332-5,14359-97-8,Not Classified,REACH registration C&L,8,Not classified:6;H319:2;H332:2;H302:2;H315:2;H312:2
26032,"1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl diester hydrochloride",603-682-3,132866-11-6,Acute Tox. 3,Notified C&L,49,H301:43;H302:6;H332:1;H319:1;H361:1;H413:1;H317:1
26038,Barium wolframate not of a kind used as a luminophore,232-114-3,7787-42-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H302:39
26041,Cyclopentanone oxime,214-749-8,1192-28-5,,Notified C&L,5,H302:4;H335:1;H315:1;H319:1
26047,"Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 1,3-dihydro-1,3,3-trimethyl-6'-(1-piperidinyl)-",601-321-4,114747-45-4,Aquatic Chronic 2,Notified C&L,2,H411:2
26048,Calcium dihydrogen ethylenediaminetetraacetate,235-534-5,12264-18-5,Not Classified,Notified C&L,2,Not classified:2
26049,2-bromo-2-methylbutane,208-071-1,507-36-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H225:40
26051,Benzaldehyde oxime,213-261-2,932-90-1,,Notified C&L,8,H335:7;H315:8;H319:8;H302:2;H312:2;H332:1
26052,"methyl 6-chloro-4-hydroxy-2H-thieno (2,3-e)(1,2)thiazine-3-carboxylate 1,1-dioxide",618-612-7,906522-88-1,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
26053,"1,2-dihydro-2-oxonicotinic acid",210-198-2,609-71-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48
26054,(Z)-2-amino-α-(methoxyimino)thiazol-4-acetic acid,265-957-0,65872-41-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53,H335:51;H315:52;H319:52;Not classified:1
26057,(2R)-2-amino-4-hydroxybutanoic acid,611-961-6,6027-21-0,Not Classified,Notified C&L,2,Not classified:1;H335:1;H315:1;H319:1
26067,"3-dodecyl-1-(2,2,6,6-tetramethyl-4-piperidyl)pyrrolidine-2,5-dione",279-242-6,79720-19-7,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,405,H373:1;H302:123;H314:221;H410:362;H318:127;H400:362;H332:38;H312:38;Not classified:5;H335:4
26068,"Oxydi-2,1-ethanediyl bismethacrylate",219-099-9,2358-84-1,Skin Sens. 1,Notified C&L,219,H317:136;H412:47;H335:40;H315:40;H319:63;Not classified:20;H318:1
26069,"Alkyl chlorides, C10-12",292-470-0,90622-67-6,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,5,H410:5;H351:5;H400:5
26070,C.I. Solvent Brown 44,612-924-7,61969-45-7,Aquatic Chronic 3,Notified C&L,88,H412:83;Not classified:5
26071,Bithionol,202-565-0,97-18-7,Acute Tox. 2,Notified C&L,195,H300:195;H319:1;H315:1
26072,"1,2,3,5-tetrafluorobenzene",219-126-4,2367-82-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H225:40
26074,4-(fluorosulphonyl)benzoic acid,207-243-3,455-26-5,Skin Corr. 1B,Notified C&L,39,H314:39
26077,Tebupirimfos,619-195-4,96182-53-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1,Notified C&L,41,H300:41;H400:41;H330:41;H310:41;H410:3
26078,"Fatty acids, C8-10, reaction products with epoxidized soybean oil, ethoxylated",606-999-5,223592-40-3,Not Classified,Notified C&L,1,Not classified:1
26081,2-nitrocinnamaldehyde,215-988-0,1466-88-2,,Notified C&L,5,H335:4;H315:5;H319:5
26082,2-(1-cyano-1-methylethyl)azocarboxamide,233-638-5,10288-28-5,Self-react. C;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H242:1
26086,Sepia (dye),278-691-5,77465-45-3,Not Classified,Notified C&L,1,Not classified:1
26090,5-methyl-2-pyridone,213-713-9,1003-68-5,Not Classified,REACH registration C&L,48,Not classified:4;H335:43;H302:38;H315:44;H318:38;H319:6
26092,"Quaternary ammonium compounds, di-C12-15-alkyldimethyl, chlorides",272-746-7,68910-56-5,Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1,Notified C&L,2,H314:2;H318:2;H400:2
26093,"Eicosan-1-ol, ethoxylated",500-049-2,26636-39-5,Not Classified,Notified C&L,84,Not classified:84
26096,Disodium adenosine 5'-phosphate hydrate,224-961-2,4578-31-8,Not Classified,Notified C&L,12,Not classified:12
26101,Bucrilate,213-958-1,1069-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
26104,"2,3-dimethylbut-2-ene",209-263-8,563-79-1,Flam. Liq. 2;Asp. Tox. 1,REACH registration C&L,49,H304:46;H225:49;H335:1;H315:1;H319:1
26106,"Rape oil, sulfated, sodium salt",281-978-8,84082-30-4,Eye Dam. 1,REACH registration C&L,45,H318:3;H315:28;H319:30;Not classified:12
26107,thionyl dichloride;thionyl chloride,231-748-8,7719-09-7,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H314:0;H302:0;H332:0
26109,6-methylchrysene,216-942-2,1705-85-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,53,H410:38;H302:38;H400:38;H371:12;Not classified:3
26111,Polymethylsilsesquioxane (11 microns),614-610-5,68554-70-1,Not Classified,Notified C&L,45,Not classified:43;H335:1;H315:1;H319:2
26113,"Bismuth(3+) tripotassium bis[2-hydroxypropane-1,2,3-tricarboxylate]",260-872-5,57644-54-9,Not Classified,Notified C&L,3,Not classified:3
26115,"Shale, expanded, aggregates",269-827-4,68334-37-2,Not Classified,Notified C&L,19,Not classified:19
26120,2-amino-5-nitrobenzophenone,217-207-9,1775-95-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H335:45;H315:46;H319:46;H302:1
26124,"Fatty acids, olive-oil, mixed esters with glycerol and isodecanol, oxidized",307-161-9,97553-07-6,Not Classified,Notified C&L,1,Not classified:1
26125,ethylene oxide;oxirane,200-849-9,75-21-8,Press. Gas;Flam. Gas 1;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Acute Tox. 3;STOT SE 3;STOT SE 3;Muta. 1B;Carc. 1B;STOT RE 1;Repr. 1B,Harmonised C&L,0,H301:0;H336:0;H372:0;H350:0;H340:0;H331:0;H335:0;H360:0;H314:0;H220:0;Not classified:0;H318:0
26126,Phenoxymethylpenicillin,201-722-0,87-08-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H317:2;H334:2
26127,Methyl 2-nitro-p-tolyl ether,204-296-4,119-10-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H302:40;H319:39;H335:1;H332:1;H315:1;H312:1
26132,(9S)-9-amino-9-deoxyerythromycin,406-790-7,26116-56-3,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H318:0;H400:0
26134,2-methylglutaric acid,210-521-7,617-62-9,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,6,H314:1;H302:1;H412:1;H318:1;H335:5;H315:5;H319:5
26135,"N,N'-propane-1,3-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionamide]",274-157-0,69851-61-2,Not Classified,REACH registration C&L,131,Not classified:131
26136,Tris(ethylenediamine)rhodium trichloride,237-846-7,14023-02-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
26138,(2S)-N-Boc-amino-non-8-enoic Acid Dicyclohexylamine salt,600-695-6,,,Notified C&L,1,Not classified:1
26141,2-Fluoro-4-methoxyphenol,605-485-8,167683-93-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26145,2-[[4-[(2-cyano-3-nitrophenyl)azo]phenyl](2-cyanoethyl)amino]ethyl acetate,235-418-4,12223-39-1,Not Classified,Notified C&L,2,Not classified:2
26151,Barium (Z)-hexadec-9-enoate,266-773-3,67627-67-2,Not Classified,Notified C&L,1,Not classified:1
26152,"Hydrogen bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-), compound with 2,2'-(dodecylimino)bis[ethanol] (1:1)",282-442-6,84215-37-2,Skin Sens. 1,Notified C&L,1,H317:1
26156,"Fatty acids, C12-20, C12-16-alkyl esters",292-911-7,91002-33-4,Not Classified,Notified C&L,2,Not classified:2
26157,"3-hydroxy-2,2-bis(hydroxymethyl)propyl stearate",201-096-9,78-23-9,Not Classified,Notified C&L,1,Not classified:1
26161,2-chloro-6-fluorobenzoyl chloride,279-162-1,79455-63-3,,Notified C&L,7,H314:7;H290:2;H318:2
26163,Tin methane sulfonic acid,610-996-4,53408-94-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,95,H314:94;H317:94;H302:94;H411:94;Not classified:1
26171,"bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate",442-980-6,127474-91-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
26172,"thiophanate-methyl (ISO);1,2-di-(3-methoxycarbonyl-2-thioureido)benzene",245-740-7,23564-05-8,Skin Sens. 1;Acute Tox. 4;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H332:0;H317:0;H410:0;H341:0;H400:0
26173,"4,4'-(2-furylmethylene)bis[N,N-dimethylaniline]",260-927-3,57751-98-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
26174,Diammonium tridecaoxotetramolybdate(2-),235-385-6,12207-64-6,Acute Tox. 4,Notified C&L,7,H302:7;H335:2;H315:2;H319:2
26179,"lenacil (ISO);3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione",218-499-0,2164-08-1,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H351:0;H400:0
26180,"Chromate(3-), bis[3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-1-naphthalenesulfonato(3-)]-, potassium sodium",290-934-7,90294-49-8,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
26183,"Octahydro-4,4,8,8-tetramethyl-4a,7-methano-4aH-naphth[1,8a-b]oxirene",268-066-5,67999-56-8,Not Classified,Notified C&L,113,Not classified:113
26187,"1,3-butadienyl acetate",216-159-6,1515-76-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H226:42;H302:42;H315:42;H311:42
26188,"Disodium 3-[[2,4-bis(2-methylphenoxy)phenyl]azo]-4-hydroxy-5-[[(p-tolyl)sulphonyl]amino]naphthalene-2,7-disulphonate",274-402-1,70210-05-8,Not Classified,REACH registration C&L,2078,Not classified:2078
26189,"N,N'-(5,12,17,18,23,24-hexahydro-5,12,17,24-tetraoxodinaphth[2,3-i:2',3'-i']indeno[7,1-ab:3,2-b']dicarbazole-6,11-diyl)bis(benzamide)",306-591-4,97337-97-8,Not Classified,Notified C&L,10,Not classified:10
26190,1-chloro-3-(dichloromethyl)benzene,239-206-2,15145-69-4,,Notified C&L,4,H314:4
26192,Disilver tungsten tetraoxide,236-708-3,13465-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
26193,"2,3-dimethylbenzofuran",223-245-7,3782-00-1,Acute Tox. 4,Notified C&L,1374,H302:1374
26196,"Roselle, ext.",283-920-7,84775-96-2,Not Classified,Notified C&L,65,Not classified:37;H315:28;H319:28
26197,4-(3-methoxyphenyl)-1-methylpiperidine-4-carbonitrile,226-742-7,5460-79-7,,Notified C&L,6,H319:6;H335:6;H332:6;H302:6;H315:5;H312:6
26198,cis-4-tert-butylcyclohexyl acetate,233-881-7,10411-92-4,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,130,H317:36;H302:36;H411:107
26199,Lithium benzoate,209-042-6,553-54-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,150,H302:148;H315:65;H318:65;Not classified:2
26201,N-(5-chloro-2-methoxyphenyl)-2-[(2-methoxy-4-nitrophenyl)azo]-3-oxobutyramide,240-131-2,15993-42-7,Not Classified,Notified C&L,127,Not classified:127
26202,Norethandrolone,200-153-5,52-78-8,Carc. 2;Repr. 2;Lact.;STOT RE 1,Notified C&L,1,H362:1;H373:1;H361:1;H351:1
26204,(methoxymethyl)triphenylphosphonium chloride,223-664-5,4009-98-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,51,H411:6;H302:51;H315:51;H319:51;H335:44;H332:1;H312:1
26207,"9-methoxyfuro[3,2-g]chromen-7-one",206-066-9,298-81-7,Skin Sens. 1,Notified C&L,304,H317:250;H302:60;Not classified:36;H335:10;H315:10;H319:10;H350:7;H318:4;H334:1;H340:3;H314:2;H341:2;H371:1;H373:1;H351:1;H360:1
26212,"Petroleum, sulfurized",272-355-1,68815-10-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26213,chromium yttrium oxide (1:1:3),601-809-7,12182-76-2,Not Classified,REACH registration C&L,2,Not classified:2
26216,4-hydroxy-5-methylfuran-3(2H)-one,242-961-0,19322-27-1,Acute Tox. 4,Notified C&L,1376,H302:1365;Not classified:11
26217,"3,3'-dithiodi-D-valine",244-107-2,20902-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
26220,"Savory, Satureja hortensis, ext.",283-922-8,84775-98-4,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1608,H304:1571;H226:1571;H317:1572;H302:1572;H314:1287;H411:1387;H315:310;H318:207;H311:285;H319:79;Not classified:10
26223,Silicon tetraiodide,236-706-2,13465-84-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;Repr. 1B,Notified C&L,43,H301:43;H334:39;H360:39;H317:39;H314:43;H311:39
26224,2-methoxyphenyl butyrate,223-899-3,4112-92-9,Not Classified,Notified C&L,88,Not classified:88
26227,Isopropyl 2-bromo-2-methylpropionate,257-158-0,51368-55-9,Flam. Liq. 3;Skin Sens. 1;Muta. 1B;Aquatic Chronic 2,REACH registration C&L,62,H317:8;H411:8;H340:8;H226:9;Not classified:52;H335:1;H315:2;H319:2
26228,"1-Pyrrolidinecarboxylic acid, 3-amino-, phenylmethyl ester, (3R)-",602-786-6,122536-73-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H302:38;H315:39;H319:39
26230,"5-amino-1,4-benzodioxane",605-229-5,16081-45-1,,Notified C&L,2,H301:1;H319:2;H331:1;H335:2;H315:2;H311:1;H332:1;H302:1;H312:1
26232,6-aminobenzothiazole-2-thiol,231-184-2,7442-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
26234,"2-[2-[(4-ethoxyphenyl)amino]vinyl]-1,3,3-trimethyl-3H-indolium acetate",276-536-6,72252-43-8,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,2,H314:2;H411:2
26236,2-quinolone,200-420-6,59-31-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133,H335:132;H302:128;H315:133;H319:95;H318:38
26237,Tri-p-tolyl phosphite,210-639-9,620-42-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26238,Bromomethyl acetate,209-696-2,590-97-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39;H226:39
26240,"4,4'-[hexane-1,6-diylbis[imino(1-hydroxy-2,1-ethanediyl)]]bispyrocatechol dihydrochloride",224-354-2,4323-43-7,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,1,H412:1;H331:1
26242,"1,3-dichloro-4-nitrobenzene",210-248-3,611-06-3,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1B;Muta. 2;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,57,H350:10;H317:17;H302:16;H411:17;H341:12;H311:17;H335:40;H315:40;H319:40;H351:1;H361:1;H371:1;H301:2;H331:2;H332:1;H312:1
26245,"N-[3-(5-thioxo-2,5-dihydro-1H-tetrazol-1-yl)phenyl]benzamide",416-670-6,,Flam. Sol. 1;Eye Dam. 1,Notified C&L,2,H228:2;H318:2
26250,"6-pentyl-1,3,5-triazine-2,4-diamine",221-928-4,3283-17-8,Not Classified,Notified C&L,1,Not classified:1
26253,Sodium 4-(methoxycarbonyl)phenolate,225-714-1,5026-62-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,524,H412:184;H315:191;H318:411;H302:184;Not classified:37;H319:34;H372:6;H335:6;H332:6;H312:2;H320:1
26254,"2-[[4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethyl acetate",252-564-4,35441-14-6,Not Classified,REACH registration C&L,2,Not classified:2
26257,5-amino-1-methyl-1H-pyrazole-4-carbonitrile,610-989-6,5334-41-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
26260,m-cyanobenzoic acid,217-511-1,1877-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H335:134;H315:135;H319:135;H302:6
26261,Butylethylmagnesium,263-454-0,62202-86-2,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,162,H250:162;H260:162;H314:162;H318:138;H252:3
26266,3-thienylacetonitrile,237-433-1,13781-53-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:43;H335:39;H332:43;H302:43;H315:43;H312:43;H331:2;H301:2;H311:2
26267,"2,4,6-trimethylphenol",208-419-2,527-60-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,187,H335:37;H317:3;H302:3;H373:37;H314:153;H312:3;H411:76;H318:81;H315:34;H301:7;H331:7;H412:8;H341:7;H311:7
26269,"sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate",430-090-0,205764-96-1,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
26272,Octacosane,211-125-7,630-02-4,Not Classified,Notified C&L,7,Not classified:7
26274,dimethyldioctadecylammonium chloride;DODMAC,203-508-2,107-64-2,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H318:0;H400:0
26276,acetamiprid (ISO);(E)-N,603-921-1,135410-20-7,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
26278,4-methylpyridine 1-oxide,213-712-3,1003-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
26282,2-amino-2-methylpropionic acid,200-544-0,62-57-7,Not Classified,REACH registration C&L,61,Not classified:4;H319:57
26285,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate",617-130-4,80621-81-4,Acute Tox. 4;Acute Tox. 4;STOT SE 3,Notified C&L,17,H332:10;H312:10;H335:10;Not classified:4;H361:4;H410:1;H351:1;H400:1
26286,"Boric acid (H3BO3), reaction products with diethanolamine",290-817-0,90268-17-0,Not Classified,Notified C&L,7,Not classified:4;H319:2;H302:2;H315:2;H373:1;H318:1
26288,"1,2,3,4-tetrahydro-5-hydroxynaphthalen-1-one",248-958-0,28315-93-7,,Notified C&L,7,H335:5;H315:6;H319:6;Not classified:1
26291,"Cuprate(5-), [μ3-[3-[[6-[[3,3'-dihydroxy-4'-[(1-hydroxy-3,6-disulfo-2-naphthalenyl)azo][1,1'-biphenyl]-4-yl]azo]-1,5-dihydroxy-7-sulfo-2-naphthalenyl]azo]-4-hydroxy-2,7-naphthalenedisulfonato(11-)]]tri-, pentasodium",275-952-5,71735-53-0,Eye Irrit. 2,Notified C&L,31,H319:31
26294,"[2S-[2α,5α,6β(S*)]]-6-[[[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",262-811-8,61477-96-1,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,13,H317:12;H334:10;H412:2;H302:1;H341:1
26296,"2,6-Dichloro-4-trifluoromethylaniline",607-349-3,24279-39-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45,H332:44;H317:43;H302:44;H315:44;H410:43;H400:42;H331:1;H301:1;H311:1;H319:1;H335:1;H312:1
26298,2-acetamidopropionic acid,202-602-0,97-69-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
26299,(Z)-hex-2-enoic acid,217-205-8,1775-43-5,Skin Corr. 1B,Notified C&L,1425,H314:1425;H318:36;H335:11;Not classified:1
26302,"2,5-dimethoxybenzaldehyde",202-211-5,93-02-7,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H335:45;H315:46;H334:38;H319:46
26308,Indole-5-carboxylic acid,216-799-6,1670-81-1,,Notified C&L,7,H335:6;H315:7;H319:7;H302:1;H312:1
26309,cobalt nickel gray periclase;C.I. Pigment Black 25;C.I. 77332,269-051-6,68186-89-0,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H317:0;H350:0;H372:0
26311,"Urea, reaction products with glyoxal",296-667-2,92908-38-8,Not Classified,Notified C&L,3,Not classified:3
26314,Calcium (Z)-hexadec-9-enoate,266-774-9,67627-68-3,Not Classified,Notified C&L,1,Not classified:1
26315,"5-chloro-1,3-dimethylpyrazole",611-147-0,54454-10-3,,Notified C&L,5,H335:4;H315:4;H319:4;H226:1
26316,2-[2-(dimethylamino)ethoxy]ethanol,216-940-1,1704-62-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,253,H314:214;H312:174;H318:229;H302:23;H315:1
26318,Acetic thioanhydride,221-774-8,3232-39-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39;H226:39
26319,Fenothiocarb,613-091-2,62850-32-2,Acute Tox. 4;Aquatic Acute 1,Notified C&L,39,H302:39;H400:39;H332:1;H371:1;H410:1
26320,florphenicol,620-107-1,76639-94-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,2,H332:1;H302:1;H412:1;H312:1;Not classified:1
26321,"3-carboxy-1,4-dimethyl-1H-pyrrole-2-acetic acid",251-476-3,33369-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
26322,"4-methoxybenzene-1,2-diamine dihydrochloride",261-801-0,59548-39-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:44;H315:44;H319:44;H332:6;H302:6;H312:6
26323,"3,3-dimethylphthalide",216-878-5,1689-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:2;H315:2;H319:2
26324,"4,6-dimethyl-1H-pyrimidin-2-one hydrochloride",251-919-0,34289-60-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
26326,"Nuclease, micrococcal",232-748-0,9013-53-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H319:1;H335:1;H334:1;H317:1;H315:1
26328,2-aminoethanol hydrobromide,245-624-6,23382-12-9,Acute Tox. 4,REACH registration C&L,2,H332:2
26331,"N-[3-(dimethylamino)propyl]-N,N',N'-trimethylpropane-1,3-diamine",223-362-3,3855-32-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,137,H412:43;H302:132;H314:133;H318:109;H311:66;H312:66;Not classified:4
26333,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-N-phenylbutyramide]",228-787-8,6358-85-6,Not Classified,REACH registration C&L,372,Not classified:371;H412:1
26334,"N-(2-chloroethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-N-ethyl-m-toluidine",264-439-1,63741-10-6,Not Classified,REACH registration C&L,45,Not classified:11;H317:34;H411:2
26335,"reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.",421-290-9,,STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H373:0;H413:0
26338,"Glycerides, C10-18",288-123-8,85665-33-4,Not Classified,Notified C&L,2,Not classified:2
26342,Tetraethylammonium acetate,214-687-1,1185-59-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H315:4;H319:4
26343,"lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)",414-250-7,149564-66-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H318:0
26344,Sodium ethyl phosphonate,444-960-2,,Not Classified,REACH registration C&L,1,Not classified:1
26348,Tris-(2-hydroxy-4-heteropolycycle-carboxylato-O´O) salt,423-870-7,,Not Classified,Notified C&L,1,Not classified:1
26352,"2,5-Furandione polymer with methoxyethene",618-469-0,9011-16-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,294,H315:135;H319:257;Not classified:37
26353,"Soaps, stocks, acidulated",271-768-4,68607-87-4,Not Classified,REACH registration C&L,5,Not classified:5
26354,Iminodiacetonitrile,211-058-3,628-87-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,99,H319:99;H335:98;H332:94;H302:99;H315:99;H412:55;H312:93
26355,α-iodo-p-nitrotoluene,221-557-8,3145-86-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H302:38;H319:38
26358,Cloprostenol,255-028-8,40665-92-7,Acute Tox. 4,Notified C&L,2,H302:1;H317:1;H334:1;H360:1
26359,Lanthanum nitrate hexahydrate,600-351-5,10277-43-7,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:46;H315:46;H319:47;H272:48;H318:2;H332:1;H302:1;H312:1
26363,1-vinyloxyhexadecane,212-495-2,822-28-6,Aquatic Chronic 3,Notified C&L,91,H412:91
26364,"N,N'-bis(2,3-dihydroxypropyl)-5-nitrobenzene-1,3 dicarboxamide",616-392-7,76820-34-3,Not Classified,REACH registration C&L,2,Not classified:2
26365,Aciclovir,261-685-1,59277-89-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,93,H335:67;H315:71;H319:71;Not classified:14;H412:7;H341:2;H351:1;H317:2;H361:1
26366,trimethylsilyl undec-10-enoate,607-358-2,24338-09-8,Not Classified,Notified C&L,1,Not classified:1
26367,"2-methoxybenzene-1,4-diammonium sulphate",266-443-9,66671-82-7,,Notified C&L,1,H301:1;H319:1;H335:1;H332:1;H315:1
26368,N-(chloroacetyl)-3-phenyl-DL-alanine,231-858-6,7765-11-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26372,"Barosma betulina, ext.",283-474-3,84649-93-4,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1472,H304:1460;H317:1471;H302:1468;H315:1458;H410:1346;H400:1345;H411:114;H226:59;H412:11;H225:1
26377,"Amides, tallow, N,N'-ethylenebis-",288-007-7,85631-58-9,Not Classified,Notified C&L,7,Not classified:7
26378,N-[2-(dimethylamino)ethyl]methacrylamide,235-990-5,13081-44-2,,Notified C&L,1,H335:1;H315:1;H319:1
26383,"Poly[oxycarbonyloxy-1,4-phenylene(1-methylethylidene)-1,4-phenylene]",607-454-4,24936-68-3,Not Classified,Notified C&L,1,Not classified:1
26384,"2,5-dimethylhexane 2,5-dihydroperoxide",221-184-0,3025-88-5,Org. Perox. A,Notified C&L,43,H240:38;Not classified:4;H318:1;H242:1
26385,Trichlorogermane,214-673-5,1184-65-2,Flam. Liq. 2;Skin Corr. 1A;Eye Dam. 1;STOT SE 3,Notified C&L,1,H314:1;H335:1;H318:1;H225:1
26386,2-cyclohexylphenol,204-322-4,119-42-6,Skin Corr. 1C;Aquatic Chronic 1,REACH registration C&L,112,H314:74;H410:45;H335:38;H315:38;H318:89;H400:38;H411:33
26387,2'-Chloro-4'-fluoroacetanilide,609-756-1,399-35-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
26390,1-(3-ethylpyrazinyl)ethan-1-one,251-316-2,32974-92-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1448,H332:1286;H302:1374;H312:1286;H335:72;H315:73;H319:73;Not classified:1
26391,"6-methoxy-2,3-dimethylquinoxalin-5-amine",251-019-8,32387-83-0,,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
26394,2-methylindoline,229-971-0,6872-06-6,Not Classified,REACH registration C&L,74,Not classified:16;H335:42;H315:43;H319:43;H302:16;H411:9;H412:4;H332:1;H312:1
26395,"1,3,3,5,5,7-hexamethyl-1,1,7,7-tetraphenyltetrasiloxane",230-013-9,6904-66-1,Acute Tox. 4,Notified C&L,1,H312:1
26396,2-chloronaphthalene,202-079-9,91-58-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,160,H335:157;H315:157;H319:157;Not classified:3
26397,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-amino-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-, (6R,7R)-, tetrafluoroborate(1-) (1:1)",616-588-2,78110-99-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
26399,2-[(4-chloro-2-nitrophenyl)amino]ethanol,413-280-8,59320-13-7,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
26401,Octadecyl 3-mercaptopropionate,250-801-6,31778-15-1,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,72,H317:17;H302:72;H315:55;H319:55
26402,Timonacic sodium,252-332-2,35041-11-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H332:38;H302:38;H315:38;H312:38
26404,(dimethylcyclohexyl) hydrogen phthalate,215-344-9,1322-94-7,,Notified C&L,1,H315:1
26405,Potassium tetrakis(p-chlorophenyl)borate(1-),238-723-0,14680-77-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
26407,Dichloro(methyl)(vinyl)silane,204-710-3,124-70-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,166,H331:77;H302:77;H225:83;H314:83;H318:17;Not classified:83;H335:38;H290:1
26408,"D-Ribose, 5-(dihydrogen phosphate), disodium salt",242-140-7,18265-46-8,Not Classified,Notified C&L,4,Not classified:4
26411,(dimethylstannylene)bis(thioethylene) dioleate,267-411-7,67859-63-6,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Chronic 4,Notified C&L,56,H373:56;H302:56;H413:55;H312:55;H317:1;H361:1;H410:1;H400:1
26413,"Pentasodium bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]cobaltate(5-)",279-311-0,79817-88-2,Not Classified,Notified C&L,7,Not classified:6;H318:1
26416,Ethyl(phenylethyl)benzene,265-241-8,64800-83-5,Not Classified,Notified C&L,5,Not classified:5
26417,8-(phenylamino)-5-[[4-[(5-sulpho-1-naphthyl)azo]-1-naphthyl]azo]naphthalene-1-sulphonic acid,250-102-6,30255-64-2,Not Classified,Notified C&L,2,Not classified:2
26419,"Phenol, sulfonated",277-962-5,74665-14-8,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,11,H335:4;H290:4;H302:4;H314:11;H318:10;H341:6
26421,4-aminophthalimide,222-948-6,3676-85-5,,Notified C&L,5,H335:4;H315:5;H319:5
26423,Molasses,270-698-1,68476-78-8,Not Classified,Notified C&L,227,Not classified:227
26426,"zeolite, silica and titanium based, crystalline, synthetic, non fibrous",930-991-3,,Not Classified,REACH registration C&L,2,Not classified:2
26428,2-methylphloroglucinol,201-792-2,88-03-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H317:38;H315:38;H318:38
26431,"N,N-dimethyl-N'-(2,2,6,6-tetramethylpiperidin-4-yl)propane-1,3-diamine",278-817-9,78014-16-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H315:1;H318:1
26433,"Dipotassium p-[4,5-dihydro-4-[[5-hydroxy-3-methyl-1-(4-sulphonatophenyl)-1H-pyrazol-4-yl]methylene]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",304-408-2,94266-02-1,Not Classified,Notified C&L,1,Not classified:1
26435,"Oils, avocado",232-428-0,8024-32-6,Not Classified,Notified C&L,184,Not classified:143;H335:38;H315:41;H319:41
26440,"Benzamide, N-(aminothioxomethyl)-",449-480-7,614-23-3,Skin Sens. 1;Acute Tox. 4,Notified C&L,15,H332:13;H317:13;H302:1;Not classified:1
26443,Trimethyloctadecylammonium bromide,214-294-5,1120-02-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H317:3;H302:4;H315:44;H410:2;H318:3;H400:2;H335:40;H319:41;H411:1
26445,2-methylthiophene-3-thiol,219-770-6,2527-76-6,Not Classified,Notified C&L,88,Not classified:88
26451,"Hydrocarbons, C",295-443-1,92045-61-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
26457,Chlorhexidine di(acetate),200-302-4,56-95-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,105,H410:95;H301:53;H411:60;H319:60;H302:42;H400:42;Not classified:2;H335:2;H318:2
26459,"[1S-[1α,4aα,5α,7α(E),7aα]]-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[(allyl-1-oxo-3-phenyl)oxy]cyclopenta[c]pyran-1-yl-β-D-glucopyranoside",242-881-6,19210-12-9,Acute Tox. 4,Notified C&L,42,H302:40;Not classified:2
26460,Trimethylsilyl trifluoromethanesulphonate,248-565-4,27607-77-8,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,58,H314:54;H226:53;Not classified:4;H335:5;H332:2;H318:3;H225:1;H331:1
26463,"2-Pyrrolidinone, 1-tallow alkyl derivs.",274-303-3,70084-70-7,Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H314:1;H317:1;H410:1;H400:1
26466,"mesotrione (ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione",600-533-4,104206-82-8,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H373:0;H361:0;H400:0
26467,Cristobalite,238-455-4,14464-46-1,STOT RE 2,Notified C&L,1212,H373:334;H372:548;Not classified:124;H350:209;H332:78;H351:72;H370:37;H411:5;H335:5;H319:6;H413:1;H371:1;H317:1;H315:1;H341:1
26468,2-acetamidoacrylic acid,226-583-3,5429-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H332:1;H302:1;H312:1
26469,Dimethicodiethylbenzalmalonate,426-000-4,207574-74-1,Acute Tox. 2;Aquatic Chronic 4,Notified C&L,14,H413:14;H330:14
26470,"1-Cyclopropyl-6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",453-850-3,,Acute Tox. 4;Eye Irrit. 2;Repr. 1B,Notified C&L,1,H302:1;H360:1;H319:1
26471,Dibenzyl (1-methyl-4-oxoimidazolidin-2-ylidene)phosphoramidate,242-880-0,19208-69-6,Eye Irrit. 2,REACH registration C&L,2,H319:2
26472,S-propyl chlorothioformate,237-656-4,13889-92-4,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H314:38;H302:38;H226:38
26474,ethyl 3-oxo-4-(2-(tritylamino)ethoxy)butanoate,619-692-6,156366-26-6,,Notified C&L,1,Not classified:1
26475,Cyclopent-1-ene-1-acetonitrile,245-182-4,22734-04-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H312:38;H301:1;H319:1;H331:1;H315:1;H311:1
26481,2-cyclohexylpropionic acid,227-956-3,6051-13-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H318:38
26483,2-(4-Fluorobenzyl)-thiophene,613-391-3,63877-96-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,127,H335:127;H302:127;H315:127;H318:127
26486,"Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;Heavy Fuel oil;[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C",272-187-9,68783-13-1,Carc. 1B,Harmonised C&L,0,H350:0
26488,Sodium propanolate,229-895-8,6819-41-6,Flam. Sol. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,41,H314:41;H228:37;H318:41;H336:4;H290:4;H225:4
26489,1-methylcyclohexane-1-carboxylic acid,214-371-3,1123-25-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,3,H302:1;H315:3;H318:1;H319:2;H335:1
26493,Acetoxytrimethylplumbane,227-200-2,5711-19-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H360:38;H400:38;H373:38;H410:38;H300:38;H330:38;H310:38
26494,Methyl 5-Hexenoate,607-297-1,2396-80-7,Flam. Liq. 3;Acute Tox. 4,Notified C&L,39,H302:39;H226:39
26497,"1-Propanol, 2-ethoxy-, 1-acetate",611-507-7,57350-24-0,Not Classified,Notified C&L,68,Not classified:68
26502,"Benzene, 4-bromo-2-iodo-1-methyl-",607-853-3,260558-15-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
26508,Icosamethylnonasiloxane,220-175-9,2652-13-3,Not Classified,Notified C&L,5,Not classified:5
26510,Tetraphenylarsonium chloride,208-070-6,507-28-8,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H301:42;H400:42;H331:38;H330:4
26511,"2-aminoethanol, salt with phosphoric acid",249-905-4,29868-05-1,Not Classified,Notified C&L,30,Not classified:29;H314:1;H302:1;H332:1;H312:1
26518,Chromium III,605-220-6,16065-83-1,Skin Sens. 1A,Notified C&L,1,H317:1
26519,Bis(2-chloroethyl) [2-[[(2-chloroethoxy)(2-chloroethyl)phosphinyl]oxy]ethyl]phosphonate,261-459-2,58823-09-9,Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,44,H412:33;H373:33;H302:44;H361:33;H332:1;H312:1
26523,"5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one maleate",281-277-7,83898-65-1,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,9,H412:7;H302:9;H362:1;H361:2
26525,Copper dichloride,231-210-2,7447-39-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,476,H302:391;H315:465;H312:307;H411:292;H318:366;H400:401;H301:80;H335:137;H410:170;H319:99;H332:31;H290:16;Not classified:7;H314:5;H317:3;H361:4;H330:1;H331:1;H311:1
26528,"Tris[bis(2-ethylhexyl)dithiocarbamato-S,S']antimony",240-130-7,15991-76-1,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1031,H332:1024;H302:503;H411:483;H301:521;H413:145;Not classified:7
26530,Magnesium uranium(4+) hexaacetate,243-905-8,20596-93-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,1,H301:1;H373:1;H331:1
26532,"3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1)",258-527-9,53404-28-7,Aquatic Chronic 3,Harmonised C&L,0,H412:0
26538,Palladium(2+) dipotassium disulphite,269-702-4,68310-13-4,,Notified C&L,1,H335:1;H315:1;H319:1
26540,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with 2,4'-diisocyanatodiphenylmethane and α,α',α''-1,2,3-propanetriyltris[ω-hydroxypoly [oxy(methyl-1,2-ethanediyl)]]",500-416-7,158885-30-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Carc. 2,Notified C&L,2,H351:2;H319:2;H317:2;H302:2;H315:2
26542,"9,10-dioxoanthracene-1,5-disulphonic acid",204-177-7,117-14-6,Not Classified,Notified C&L,1,Not classified:1
26544,"2,3-dichloro-6-nitrobenzaldehyde",616-245-7,75618-41-6,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1,H314:1;H411:1
26545,"1,1,1,2,2,3,3,4,5,5,5-undecafluoro-4-(trifluoromethyl)pentane",206-575-6,355-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:2;H315:2;H319:2;Not classified:1
26550,Adenosine,200-389-9,58-61-7,Not Classified,REACH registration C&L,48,Not classified:15;H315:32;H319:32;H302:1;H341:1;H335:1
26556,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with 2-[(2-aminoethyl)amino]ethanol, di-Et sulfate-quaternized",292-846-4,91001-74-0,,Notified C&L,63,H315:62;H318:62;Not classified:1
26558,"2,2'-oxybis[5,5-dimethyl-1,3,2-dioxaphosphorinane] 2,2'-disulphide",223-829-1,4090-51-1,Not Classified,REACH registration C&L,82,Not classified:68;H413:14
26560,Methyl (E)-octadec-11-enoate,228-251-3,6198-58-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
26562,"2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite",423-560-1,161717-32-4,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
26563,"4,4'-(2-ethyl-2-nitropropane-1,3-diyl)bismorpholine",217-450-0,1854-23-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,20,H400:20;H317:20;H302:20;H315:20;H410:20;H318:20;H311:20
26566,"Glutamic acid, monosodium salt",608-719-7,32221-81-1,Not Classified,Notified C&L,1,Not classified:1
26569,POTASSIUM ABIETOYL HYDROLYZED SOY PROTEIN,614-034-4,672297-74-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26573,"1-benzyl-2,2,6,6-tetramethylpiperidin-4-ol",257-718-4,52185-71-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
26574,Diundecyl phthalate,222-884-9,3648-20-2,Not Classified,REACH registration C&L,76,Not classified:66;H412:9;H410:1
26576,"2,3-dimethylbut-1-ene",209-262-2,563-78-0,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,84,H304:84;H225:84;H319:22;H335:22;H315:22
26591,"cis-1,2-dimethylcyclopentane",214-748-2,1192-18-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,63,H302:38;H318:38;H304:22;H225:22;Not classified:3
26599,"Spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine], 6'-(2,3-dihydro-1H-indol-1-yl)-1,3-dihydro-1,3,3-trimethyl-",601-320-9,114747-44-3,Aquatic Chronic 2,Notified C&L,1,H411:1
26601,2-cyclohexylideneethanol,213-260-7,932-89-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1;H226:1
26602,Tribromsalan,201-723-6,87-10-5,Acute Tox. 4,Notified C&L,1,H302:1
26604,"4-(acetoxy)-α,α,4-trimethylcyclohexylmethyl acetate",243-464-1,20009-20-5,Not Classified,Notified C&L,88,Not classified:88
26606,"22,23-dihydroavermectin B1a",615-075-0,70161-11-4,Acute Tox. 2;Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Acute 1,Notified C&L,27,H373:26;H361:27;H312:26;H300:27;H400:27;H410:1
26607,Succinic acid,203-740-4,110-15-6,Eye Dam. 1,REACH registration C&L,2291,H318:1815;H319:369;Not classified:79;H335:78;H315:72;H340:31;H350:31;H304:31;H311:11;H314:3;H332:1;H302:1;H312:1
26610,"2,4-diaminoanisole;4-methoxy-m-phenylenediamine",210-406-1,615-05-4,Acute Tox. 4;Muta. 2;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H350:0;H341:0
26615,"Actinomycin D, 3A-(4-oxo-l-proline)-",242-636-3,18865-48-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Repr. 2,Notified C&L,38,H361:38;H300:38;H330:38;H310:38
26616,"9,10-Anthracenedione, 1,4-bis[(2,6-diethyl-4-methylphenyl)amino]-",612-923-1,61969-44-6,Not Classified,Notified C&L,36,Not classified:36
26617,"5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt",414-410-6,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
26618,"dichlofenthion (ISO);O-,4-dichlorophenyl O,O-diethyl phosphorothioate",202-564-5,97-17-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H400:0
26622,"2,4,6-trifluoroaniline",206-660-8,363-81-5,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48,H335:42;H228:47;H302:45;H315:47;H312:45;H318:41;H319:7;H332:6;H373:5
26623,"1,2,3-Propanetriol, homoplymer, decanoate",616-105-5,74504-65-7,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,8,H317:6;H315:6;H319:7;Not classified:1
26627,"2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium sulphate (2:1)",281-440-2,83949-80-8,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:2;H301:2;H319:2;H400:2
26631,"α,α,α-trifluoro-p-toluic acid",207-242-8,455-24-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47;H302:1
26632,N-4-piperidylbenzamide,251-759-1,33953-37-6,,Notified C&L,7,H335:5;H315:6;H319:6;Not classified:1
26633,Calcium magnesium dicarbonate,230-274-9,7000-29-5,Not Classified,Notified C&L,52,Not classified:52
26634,Sodium [3-(5-chloro-2-methylphenyl)-1-methyltriazen-2-yl]acetate,266-760-2,67599-13-7,Not Classified,Notified C&L,9,Not classified:9
26635,2-(chloromethyl)tetrahydrofuran,221-102-3,3003-84-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:45;H319:45;H226:46;H351:1;H331:1;H302:1;H361:1
26637,2-acetoxybenzoic anhydride,215-987-5,1466-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:40;H319:40;H302:1
26638,Fluoren-9-ol,216-879-0,1689-64-1,Aquatic Chronic 2,Notified C&L,1,H411:1
26643,"Dihydrogen [29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cuprate(2-), compound with 2,2',2''-nitrilotriethanol (1:2)",268-208-6,68035-71-2,Not Classified,Notified C&L,2037,Not classified:2037
26644,Aluminium trititanium dodecachloride,234-421-8,12003-13-3,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,45,H314:45;H318:41;H250:38;H332:38;H302:38;H312:38;H290:1
26649,phosphorus trichloride,231-749-3,7719-12-2,Acute Tox. 2;Skin Corr. 1A;Acute Tox. 2;STOT RE 2,Harmonised C&L,0,H314:0;H373:0;H300:0;H330:0
26650,"4,5-dihydro-6-methyl-2-phenylpyridazin-3(2H)-one",224-962-8,4578-58-9,Eye Irrit. 2,Notified C&L,38,H319:38
26651,Sodium hippurate,208-548-4,532-94-5,Not Classified,Notified C&L,1,Not classified:1
26652,Picolinoyl Chloride Hydrochloride,675-819-5,39901-94-5,Acute Tox. 4,Notified C&L,43,H302:39;H314:5;H290:2;H318:2;H332:1;H312:1
26653,"Fatty acids, C8-18-branched and linear, esters with neopentyl glycol",288-724-5,85883-74-5,Not Classified,Notified C&L,7,Not classified:7
26654,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with butyl 2-propenoate and ethenylbenzene",608-366-9,29497-14-1,,Notified C&L,1,Not classified:1
26661,4-hydroxynicotinic acid,210-197-7,609-70-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44,H302:38;H315:44;H319:44;H335:6
26666,"trans-2,3,4-trimethoxycinnamic acid",251-388-5,33130-03-9,,Notified C&L,5,H335:4;H315:5;H319:5
26671,"[2-[ethyl[3-methyl-4-[(3-phenyl-1,2,4-thiadiazol-5-yl)azo]phenyl]amino]ethyl]trimethylammonium methyl sulphate",248-957-5,28313-51-1,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,36,H317:2;H302:36;H411:2;H319:36;H412:33
26672,DL-glutamic acid monohydrate,210-522-2,617-65-2,Not Classified,Notified C&L,38,Not classified:38
26673,(±)-menthone,214-049-2,1074-95-9,Aquatic Chronic 3,REACH registration C&L,195,H412:148;H317:46;H315:46;H226:36;H411:1;H319:1
26677,Bis[2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium] tetrachlorozincate,274-158-6,69852-41-1,Not Classified,Notified C&L,41,Not classified:32;H411:7;H319:7;H302:2
26680,"[1R-[1α(R*),2β,4aβ,8aα]]-2-hydroxy-α,2,5,5,8a-pentamethyl-α-vinyldecahydronaphthalene-1-propan-1-ol",208-194-0,515-03-7,Not Classified,REACH registration C&L,131,Not classified:130;H319:1
26682,"O-[4-[(dimethylamino)sulphonyl]phenyl] O,O-dimethyl thiophosphate",200-154-0,52-85-7,Acute Tox. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41,H312:41;H300:38;H319:38;H315:38;H301:3
26684,2-dimethylaminomethyl-5-methoxyindole,240-669-8,16620-52-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H302:1
26688,"Distillates (coal tar), benzole fraction, BTX-rich;Light Oil Redistillate, low boiling;[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75°C to 200°C (167°F to 392°F).]",309-984-9,101896-26-8,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
26695,"2,3-dihydro-1,4-benzodioxin-5-ol",233-639-0,10288-36-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
26696,Pyrene-1-butyric acid,222-354-7,3443-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
26698,N-[2-(3-carbamoyl-4-hydroxyphenyl)-2-oxoethyl]-N-(4-phenylbut-2-yl)ammonium chloride,700-288-4,96441-14-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,REACH registration C&L,3,H335:2;H361:2;H315:2;H319:3;H332:1;H302:1;H312:1
26699,5-amino-9-(diethylamino)benzo[a]phenoxazin-7-ium perchlorate,258-489-3,53340-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
26700,"Naphthalene-1,6-diol",209-386-7,575-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,265,H335:200;H315:201;H319:201;Not classified:64
26701,"3-hydroxy-2,2-bis(hydroxymethyl)propyl (R)-12-hydroxyoleate",201-095-3,78-22-8,Not Classified,Notified C&L,5,Not classified:5
26702,2-dimethylaminoethyl methacrylate,220-688-8,2867-47-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0;H302:0;H315:0;H312:0
26706,2-Bromo-5-methoxyaniline,611-853-9,59557-92-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H332:1;H302:1;H312:1
26707,Barium toluate,299-833-2,93904-98-4,Not Classified,Notified C&L,1,Not classified:1
26708,"2,2'-thiobis(ethylamine)",212-810-3,871-76-1,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
26709,Ammonium trivanadium octaoxide,235-384-0,12207-63-5,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,3,H301:3;H372:2;H331:3;H335:3;H361:2;H411:3;H318:3
26711,3-hydroxybenzoic acid,202-726-5,99-06-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:47;H302:46;H315:48;H319:48;H332:1;H312:1
26712,"Rape oil, sulfated, compd. with ethanolamine",281-977-2,84082-29-1,Not Classified,Notified C&L,4,Not classified:4
26713,"Reaction product of 4,4'-methylenediphenyl diisocyanate (EC 202-966-0) and amines, coco alkyl (EC 262-977-1)",921-398-0,,,Notified C&L,1,H413:1
26718,"Dimethoxymethyl(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane",288-658-7,85857-17-6,Skin Corr. 1B,Notified C&L,1,H314:1
26719,"Chromate(3-), bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-5-sulfobenzoato(3-)]-, lithium sodium",290-933-1,90294-48-7,,Notified C&L,34,Not classified:34
26722,7-bromo-5-chloroquinolin-8-ol,231-574-2,7640-33-7,Acute Tox. 4,Notified C&L,39,H302:39
26725,Tribenzylamine,210-638-3,620-40-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1434,H319:1434;H335:1433;H302:3;H315:1434;H410:2;H400:2
26726,zinc bis(dibutyldithiocarbamate),205-232-8,136-23-2,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H335:0;H317:0;H315:0;H410:0;H400:0
26729,"isopropyl [(S)-1-{[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate; benthiavalicarb-isopropyl",605-799-5,177406-68-7,Skin Sens. 1;Carc. 2,Notified C&L,227,H317:227;H351:227;H319:35;H332:35;H400:35;H412:17
26732,"Alkanes, C10-13, desulfurized",273-644-5,68991-51-5,Not Classified,Notified C&L,2,Not classified:2
26735,Keratins,269-409-1,68238-35-7,Not Classified,Notified C&L,38,Not classified:38
26738,Isopropyl nicotinate,209-043-1,553-60-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
26741,Methyl 8-nitro-6-quinolyl ether,201-633-7,85-81-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,41,H351:40;H319:41;H335:40;H332:41;H302:41;H315:41;H312:41
26742,Basic Violet 1,616-846-4,8004-87-3,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,182,H410:109;H301:51;H318:111;H400:112;H302:128;H351:58;H319:26;H314:2;H411:2;Not classified:1;H315:1
26748,"3β-hydroxy-2'-methyl-16β-5'H-pregn-5-eno[17,16-d]oxazol-20-one",237-845-1,14022-55-0,STOT RE 2,REACH registration C&L,2,H373:2
26749,"Sodium 2,4,6-trichlorophenolate",223-246-2,3784-03-0,Acute Tox. 4;Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H331:2;H302:2;H311:2
26757,"Propane-1,2,3-triyl 2-ethylhexanoate",230-896-0,7360-38-5,Aquatic Chronic 3,REACH registration C&L,69,H412:20;Not classified:49
26759,2-(2-chloroethoxy)ethanol,211-059-9,628-89-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,78,H315:73;H319:29;H335:58;H318:48;H351:4
26760,Hexacarbonylvanadium,237-849-3,14024-00-1,,Notified C&L,4,H301:4;H330:4
26761,"9-(2-carboxyphenyl)-3,6-bis(ethylamino)-2,7-dimethylxanthylium perchlorate",263-686-2,62669-66-3,Flam. Sol. 2,Notified C&L,2,H228:1;H315:1;H319:1;H272:1
26762,"Sisymbrium officinale, ext.",283-923-3,84775-99-5,Flam. Liq. 3,Notified C&L,1,H226:1
26763,Ethylidenecyclohexane,213-711-8,1003-64-1,Flam. Liq. 3,Notified C&L,38,H226:38
26766,"Raffinates (petroleum), reformer, Lurgi unit-sepd.;Low boiling point modified naphtha;[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C",270-349-3,68425-35-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
26768,"1,4-Benzodioxane-2-carboxylic acid",609-276-2,3663-80-7,,Notified C&L,8,H335:6;H315:7;H319:7;H302:1
26772,(±)-3-(dimethylamino)-2-methylpropiophenone,257-159-6,51371-02-9,Skin Sens. 1,Notified C&L,38,H317:38
26773,(Z)-oct-4-ene,231-578-4,7642-15-1,,Notified C&L,5,H335:4;H315:5;H319:5;H225:5;H304:1
26775,Beeswax,616-889-9,8006-40-4,Not Classified,Notified C&L,1,Not classified:1
26776,Sulfaquinoxaline,200-423-2,59-40-5,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,46,H317:40;H302:45;H334:40;H341:1;Not classified:1
26779,"(-)-[R-(R*,S*)]-6-fluoro-3,4-dihydro-2-(2-oxiranyl)-2H-1-benzopyran",603-315-7,129050-26-6,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H317:2;H411:2;H319:1;H315:1;H412:1;H341:1
26786,"4,11-Triphenodioxazinedisulfonic acid, 3,10-bis[(2-aminoethyl)amino]-6,13-dichloro-",611-962-1,60316-87-2,Not Classified,Notified C&L,4,Not classified:4
26788,"1,4-Butanediol, 1-[4-[2-(dimethylamino)ethoxy]phenyl]-1,2-diphenyl-",618-300-0,89778-79-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H312:1
26790,4-chloro-5-sulphamoylsalicylic acid,238-602-2,14556-98-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:41;H315:41;H319:41
26791,Calcitonin (salmon),256-342-8,47931-85-1,Acute Tox. 3,Notified C&L,43,H301:39;H332:3;H317:4;H334:4;H319:1;H315:1;H335:1
26792,"1,1-diethoxycyclohexane",216-798-0,1670-47-9,Aquatic Chronic 3,Notified C&L,1451,H412:1287;Not classified:120;H335:40;H315:40;H319:40;H226:42
26794,"6-amino-2,4-xylenol",255-380-2,41458-65-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H302:1;H315:1;H312:1
26795,Dimethylphosphinic acid,221-927-9,3283-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
26796,"Oils, palm kernel",232-425-4,8023-79-8,Not Classified,Notified C&L,200,Not classified:200
26801,"Naphthalenesulfonic acids, reaction products with formaldehyde, ammonium salts",300-259-2,93924-63-1,,Notified C&L,36,Not classified:35;H319:1
26806,"5-methylindole-2,3(1H)-dione",210-152-1,608-05-9,Not Classified,Notified C&L,4,Not classified:1;H335:3;H315:2;H319:3
26807,S-2-Benzothiazolyl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminothioacetate,457-660-1,104797-47-9,Skin Sens. 1B;Aquatic Chronic 3;Self-react. G,REACH registration C&L,3,H412:1;H317:3;Not classified:1;H410:2;H351:2;H400:2
26808,2-chloro-3-methylthiophene,238-296-0,14345-97-2,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,46,H302:45;H226:46;H318:38;H332:5;H312:4;H315:1;H319:1
26810,"α-D-Glucopyranoside, β-D-fructofuranosyl O-α-D-galactopyranosyl-(1.fwdarw.6)-, hydrate (1:5)",605-771-2,17629-30-0,Not Classified,Notified C&L,27,Not classified:27
26812,"2-methyl-2-propylpropane-1,3-diol",201-099-5,78-26-2,Not Classified,REACH registration C&L,18,Not classified:2;H332:9;H302:16;H312:9;H317:4;H319:6;H303:1
26816,(Z)-N-octadec-9-enylhexadecan-1-amide,240-367-6,16260-09-6,Not Classified,REACH registration C&L,39,Not classified:38;H335:1;H315:1;H319:1
26817,"D-Glucitol, ethoxylated",500-121-3,53694-15-8,Not Classified,Notified C&L,20,Not classified:18;H302:2;H318:2
26821,"3H-Naphtho[2,1-b]pyran, 3,3-diphenyl-",609-998-8,4222-20-2,Aquatic Chronic 2,Notified C&L,1,H411:1
26824,6-hydroxynicotinic acid,225-682-9,5006-66-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,95,H335:94;H315:95;H319:95
26825,Sodium bis(2-butoxyethyl) phosphate,278-149-8,75239-49-5,Not Classified,Notified C&L,33,Not classified:33
26828,Potassium hexahydroxoantimonate,235-387-7,12208-13-8,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,50,H332:50;H302:50;H411:49;Not classified:1
26829,2-methylundecanol,234-067-4,10522-26-6,Skin Sens. 1,Notified C&L,87,H317:87
26832,5-Benzoylpentanoic Acid,609-926-5,4144-62-1,Eye Irrit. 2,Notified C&L,43,H319:43;H335:4;H315:5
26840,Wollastonite (Ca(SiO3)),237-772-5,13983-17-0,Not Classified,Notified C&L,682,Not classified:559;H335:122;H334:60;H319:122;H373:57;H315:1
26841,2-methoxyphenyl phenylacetate,223-898-8,4112-89-4,Not Classified,Notified C&L,89,Not classified:89
26842,Trimethyloxosulphonium iodide,217-204-2,1774-47-6,Acute Tox. 5;Eye Irrit. 2B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,44,H401:8;H303:8;H411:13;H320:8;H335:25;H315:27;H319:27;Not classified:4;H302:1
26846,4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate,429-000-2,159235-16-2,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
26849,2-butynoic acid,209-695-7,590-93-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,142,H314:142;H318:134;H302:2;H332:2;H312:2;H290:1
26850,"cyazofamid (ISO);4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide",601-671-8,120116-88-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0
26851,Decenoic acid,615-866-0,72881-27-7,Not Classified,Notified C&L,136,Not classified:126;H315:10;H319:10
26852,Dimethyl (p-methoxybenzylidene)malonate,231-185-8,7443-25-6,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,38,H411:35;H319:38
26854,5-chloro-2-nitrophenol,210-249-9,611-07-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,4,H302:4;H411:4;H319:4
26857,"Tall oil, maleated",268-859-6,68152-93-2,Skin Irrit. 2;Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,36,H317:2;H315:3;H411:2;Not classified:30;H319:3;H335:1;H412:1
26858,"(4aR,4bS,6aS,7aS,8aS,8bR,8cR)-2-methoxy-4a,6a-dimethyl-4,4a,4b,5,6,6a,7a,8,8a,8b,8c,9-dodecahydrocyclopropa[4,5]cyclopenta[1,2-a]phenanthren-7(3H)-one",607-934-3,26441-40-7,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H373:2;H315:2;H401:2;H411:2
26860,"Platinum, chloro octanol complexes",270-195-7,68412-56-6,Not Classified,Notified C&L,5,Not classified:5
26861,"Decan-1-ol, ethoxylated",500-046-6,26183-52-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,2275,H302:2012;H318:2119;Not classified:90;H315:161;H319:66;H312:3;H400:1;H412:1
26866,"2,2-dimethyl-1,3-propanediyl didecanoate",248-688-3,27841-06-1,Not Classified,REACH registration C&L,7,Not classified:7
26868,"Iron, citrate diphosphate ammonium complexes",286-696-9,85338-23-4,Not Classified,Notified C&L,1,Not classified:1
26869,"Fatty acids, C16-18, 2-tetradecyloctadecyl esters",306-801-4,97404-36-9,Not Classified,Notified C&L,1,Not classified:1
26870,p-(octyloxy)phenol,223-243-6,3780-50-5,,Notified C&L,5,H335:4;H315:5;H319:5
26879,benzaldehyde,202-860-4,100-52-7,Acute Tox. 4,Harmonised C&L,0,H302:0
26882,"3,4,5-trimethylphenol",208-418-7,527-54-8,Skin Corr. 1B,Notified C&L,45,H314:45
26883,"trans,trans-buta-1,3-diene-1,4-dicarboxylic acid",222-724-8,3588-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:45;H315:46;H319:46;Not classified:3
26884,3-nitrophenylacetic acid,217-512-7,1877-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
26889,benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate,427-470-3,137864-22-3,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0
26891,"Dodecanoic acid, monoester with oxybis[propanediol]",619-220-9,96499-68-2,Not Classified,REACH registration C&L,2,Not classified:2
26892,Thiophene-3-ethanol,237-434-7,13781-67-4,Not Classified,REACH registration C&L,3,Not classified:2;H335:1;H315:1;H319:1
26893,Methyl 5-amino-o-anisate,245-230-4,22802-67-1,,Notified C&L,1,H335:1;H315:1;H319:1
26895,"Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, mono-C8-10-alkyl ethers, phosphates, sodium salts",614-627-8,68585-39-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60,H315:60;H319:60
26898,"complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H",427-390-9,,Skin Sens. 1,Harmonised C&L,0,H317:0
26899,Fenticlor,202-568-7,97-24-5,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H335:38;H413:38;H317:38;H315:39;H318:38;H319:1
26902,"dichlorvos (ISO);2,2-dichlorovinyl dimethyl phosphate",200-547-7,62-73-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H301:0;H317:0;H311:0;H330:0;H400:0
26903,[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl](2-hydroxypropyl)dimethylammonium acetate,279-919-6,82205-20-7,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:2;H317:2;H318:2;H400:2;Not classified:1
26905,S-(3-chloro-2-methyl-3-oxopropyl) ethanethioate,265-242-3,64805-64-7,Skin Corr. 1B,Notified C&L,5,H314:5;H315:5
26908,"Rosin, hydrogenated, reaction products with acetic acid and triethylenetetramine, benzylated",271-765-8,68607-40-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,59,H314:59;H302:59;H318:59;H400:59
26909,"Butyl 2-[[3-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-hydroxy-1-naphthyl]azo]benzoate",250-800-0,31778-10-6,Not Classified,REACH registration C&L,137,Not classified:137
26910,"2-amino-2-(hydroxymethyl)propane-1,3-diol hydrochloride",214-684-5,1185-53-1,Not Classified,REACH registration C&L,193,Not classified:86;H335:103;H315:106;H319:106
26911,"Exo-2,3-epoxynorbornane",221-558-3,3146-39-2,Flam. Sol. 1,Notified C&L,38,H228:38
26915,"1-[4-(1H-benzimidazol-2-yl)phenyl]-1H-pyrrole-2,5-dione",248-173-3,27030-97-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26917,"3,12,16,17-tetrachloroviolanthrene-5,10-dione",228-914-7,6373-20-2,Not Classified,Notified C&L,11,Not classified:11
26920,p-(allyloxy)benzaldehyde,255-027-2,40663-68-1,Skin Sens. 1,Notified C&L,42,H317:38;H315:4;H319:4
26922,(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile,430-770-7,128173-52-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H411:0
26923,"2,2'-[oxybis(2,1-ethanediyloxy)]bisacetic acid",237-655-9,13887-98-4,Eye Dam. 1,REACH registration C&L,39,H318:39
26926,7-nitro-N-(benzyl)benzofurazan-4-amine,242-261-5,18378-20-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
26928,"Fish, ext.",307-382-0,97615-94-6,Not Classified,Notified C&L,27,Not classified:27
26932,1-piperonylpiperazine,250-968-5,32231-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:39;H315:40;H319:40;H314:4
26935,"2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate",279-452-8,80387-97-9,Skin Sens. 1;Aquatic Chronic 3;Repr. 1B,Harmonised C&L,0,H412:0;H317:0;H360:0
26936,Trimethylpropylammonium bromide,220-172-2,2650-50-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3
26937,5(or 6)-methyl-7(or 8)-(1-methylethyl)bicyclo[2.2.2]oct-5-ene-2-carbaldehyde,269-522-6,68259-31-4,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1543,H317:1543;H411:1302
26942,"Fatty acids, soya, hydrogenated",296-755-0,93028-62-7,Not Classified,Notified C&L,8,Not classified:8
26944,Quinoline-3-carbaldehyde,237-147-7,13669-42-6,Skin Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:6
26948,"Amides, from diethylenetriamine and tallow fatty acids",292-523-8,90623-16-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26949,1-(thiazol-2-yl)ethan-1-one,246-134-5,24295-03-2,Acute Tox. 4,Notified C&L,1568,H302:1403;Not classified:162;H317:45;H319:52;H335:6;H315:8;H334:1;H332:1;H312:1
26950,4'-methoxybutyrophenone,223-995-5,4160-51-4,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1
26954,Sodium dicyanoaurate,239-320-2,15280-09-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H310:42;H300:42;H330:42;H400:42
26957,"Decanoic acid, mixed esters with dipentaerythritol, heptanoic acid and octanoic acid.",453-480-2,,Not Classified,Notified C&L,1,Not classified:1
26961,Ethylidenecyclopentane,218-413-1,2146-37-4,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3,Notified C&L,42,H336:38;H304:38;H225:38;H224:4
26964,Brown DK 1558,461-480-9,,Skin Sens. 1,Notified C&L,37,H317:37
26965,Potassium 7-hydroxynaphthalenesulphonate,250-101-0,30252-40-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
26967,"Spearmint, Mentha spicata crispa, ext.",308-804-6,98561-44-5,Asp. Tox. 1,Notified C&L,53,H304:53
26970,"Benzenamine, 4-fluoro-N-[[4-(phenylmethoxy)phenyl]methylene]-",615-134-0,70627-52-0,,Notified C&L,1,H335:1;H315:1;H319:1
26975,"bis(4-tert-butylphenyl)iodonium [(1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl]methanesulfonate",448-180-3,,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1;H400:1
26979,"3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea",411-970-3,79881-89-3,Acute Tox. 4;STOT RE 2,Harmonised C&L,0,H373:0;H302:0
26986,"Poly(oxy-1,2-ethanediyl), a-[2-[bis(2-aminoethyl)methylammonio]ethyl]-w-hydroxy-, N,N'-ditallow acyl derivs., Me sulfates (salts)",614-453-2,68410-69-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H315:1;H319:1;H318:1
26987,Phenethyl propionate,204-567-7,122-70-3,Not Classified,REACH registration C&L,1565,Not classified:1565
26989,"Amines, C12-14-tert-alkyl",273-279-1,68955-53-3,Met. Corr. 1;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,903,H410:834;H400:759;H290:566;H302:902;H317:902;H314:903;H330:789;H318:774;H311:902;H372:121;H331:113;H335:1
26991,C12-16-(even numbered)-alkyl-dimethylammonium lactate,700-421-6,,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H314:3;H302:3;H410:2;H400:3
26994,3-methyl-4-phenyl-3-buten-2-one,217-599-1,1901-26-4,Not Classified,Notified C&L,88,Not classified:88
26995,Trinickel bis[tetracosa-μ-oxododecaoxo[μ12-[phosphato(3-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]dodecamolybdate(3-)],235-531-9,12263-13-7,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7,H351:7;H332:7;H317:7;H302:7;H410:7;H400:7
26996,2-Chloro-6-aminopurine,606-011-2,1839-18-5,Acute Tox. 4,Notified C&L,42,H302:42;H335:2;H315:2;H341:1;H318:1;H319:1
27000,Chrome antimony titanium buff rutile,269-052-1,68186-90-3,Not Classified,REACH registration C&L,653,Not classified:479;H332:132;H302:168;H411:142;H226:6
27003,"2,2-bis(hydroxymethyl)propane-1,3-diyl distearate",235-991-0,13081-97-5,Not Classified,Notified C&L,131,Not classified:131
27006,Reactive Blue 9605,439-670-8,,Not Classified,Notified C&L,1,Not classified:1
27009,2-[(acetyloxy)methoxy]ethyl acetate,261-686-7,59278-00-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,6,H302:5;H315:5;H319:5;H335:2;H332:2;H312:2;Not classified:1
27025,"1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone, 4,11-diamino-, 2-(C11-14-branched and linear alkyl) derivs.",619-151-4,955944-18-0,Not Classified,Notified C&L,1,Not classified:1
27028,8-amino-7-methylquinoline,412-760-4,5470-82-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H302:0;H411:0;H312:0
27029,dicopper tetranitrate pentahydrate,606-197-5,19004-19-4,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,82,H302:77;H315:73;H272:76;H410:39;H318:38;H400:39;H319:35;Not classified:5;H314:4
27031,"D-Glucopyranose, 1-(dihydrogen phosphate), disodium salt",251-315-7,32972-46-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H301:38;H319:38;H331:38;H335:38;H315:38;H311:38
27032,"2,2,4,4,6-pentamethylheptane",263-451-4,62199-62-6,Flam. Liq. 3,Notified C&L,4,H226:4
27034,"Hydrocarbons, C",295-446-8,92045-64-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
27037,Copper carbonate,214-671-4,1184-64-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,129,H410:83;H302:127;H400:125;Not classified:2;H315:1;H319:1
27040,2-ethylhexyl mercaptoacetate,231-626-4,7659-86-1,Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,240,H410:195;H317:195;H302:235;H400:192;H319:39;H335:38;H226:38;H332:38;H315:39;Not classified:5
27042,5-nitro-o-cresol,226-580-7,5428-54-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H332:5;H302:6;H311:5
27051,"2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone",424-210-0,23911-85-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
27053,5-NQD,406-450-8,,Carc. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H351:1
27054,"Naphthalenesulfonic acids, reaction products with formaldehyde, ammonium sodium salts",293-350-0,91078-67-0,Not Classified,Notified C&L,55,Not classified:55
27056,"4-Methyl-3-amino-2-(methoxycarbonyl)-4,5-dihydrothiophene",603-030-8,125089-02-3,Acute Tox. 4;Muta. 2,REACH registration C&L,3,H302:2;H341:2;H335:1;H315:1;H319:1
27058,Trihexyl phosphate,219-774-8,2528-39-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H410:2;H400:2;H335:4;H315:4;H319:4;Not classified:1
27065,"6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)trihexanoic acid",279-505-5,80584-91-4,Not Classified,REACH registration C&L,591,Not classified:591
27067,Sucralfate,259-018-4,54182-58-0,Not Classified,REACH registration C&L,5,Not classified:5
27070,"Phosphoric acid, mixed Bu and iso-Bu esters, sodium salts",307-091-9,97489-48-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
27072,"Resin acids and Rosin acids, calcium zinc salts",269-825-3,68334-35-0,Not Classified,REACH registration C&L,78,Not classified:78
27074,"N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide",435-860-1,214417-91-1,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
27076,Vanadium trifluoride,233-169-6,10049-12-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,43,H301:43;H331:39;H314:43;H318:38;H311:39;H330:4
27080,"1-Propanaminium, N,N,N-trimethyl-, N-(oxidized polyethylene) derivs., Me sulfates",602-992-6,124358-44-7,Not Classified,Notified C&L,37,Not classified:37
27094,"Tris(pentane-2,4-dionato-O,O')lanthanum",238-187-8,14284-88-9,,Notified C&L,1,H335:1;H315:1;H319:1
27097,4'-methylbutyrophenone,223-996-0,4160-52-5,Acute Tox. 4,Notified C&L,38,H302:38
27103,Sodium 6-amino-5-[[4-chloro-2-(trifluoromethyl)phenyl]azo]-4-hydroxynaphthalene-2-sulphonate,260-925-2,57741-47-6,Eye Irrit. 2,REACH registration C&L,66,H319:7;H318:32;Not classified:18;H412:9
27106,CBC-33F,441-120-7,102714-93-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
27107,(pentafluorophenyl)acetic acid,211-497-0,653-21-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
27108,"(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid",617-180-7,80875-98-5,Not Classified,REACH registration C&L,13,Not classified:3;H335:9;H315:9;H319:9
27110,dioctyltin dilaurate,222-883-3,3648-18-8,STOT RE 1;Repr. 1B,Harmonised C&L,0,H372:0;H360:0
27112,"reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate",431-830-5,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
27113,1-(2-hydroxy-5-methylphenyl)dodecan-1-one oxime,433-200-5,50652-76-1,Aquatic Chronic 4,Notified C&L,1,H413:1
27117,N-butylphthalimide,216-157-5,1515-72-6,Eye Irrit. 2,Notified C&L,96,H319:55;Not classified:39;H302:12;H315:16;H317:2;H412:1
27134,"6,7-dimethyl-1H-pteridin-4-one",238-725-1,14684-54-9,Acute Tox. 4,Notified C&L,38,H302:38
27136,fumaric acid,203-743-0,110-17-8,Eye Irrit. 2,Harmonised C&L,0,H319:0
27138,Nitroxoline,223-662-4,4008-48-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,141,H301:134;H319:140;H331:134;H335:139;H315:140;H311:134;H302:7;H332:1;H312:1
27140,"2,6,6-trimethylcyclohex-2-en-1-one",243-465-7,20013-73-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
27141,Molybdenum dioxide,242-637-9,18868-43-4,Not Classified,REACH registration C&L,90,Not classified:85;H332:5;H302:5;H335:5;H319:5;H312:1
27144,"Toxins, botulin, B",297-255-5,93384-44-2,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H300:1;H330:1;H310:1
27145,3-fluoroacetophenone,207-245-4,455-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
27147,"[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthyl]methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride",218-572-7,2185-86-6,Acute Tox. 4,Notified C&L,40,H302:40
27149,"1-Azaspiro[[]4.5]dec-3-en-2-one, 3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-, cis-",606-522-0,203312-38-3,Aquatic Chronic 2,Notified C&L,39,H411:39;H317:1;H319:1
27152,Potassium bis[2-[(2-ethylhexyl)oxy]ethyl] phosphate,284-354-3,84852-42-6,Acute Tox. 5;Acute Tox. 5,Notified C&L,15,H303:15;H333:15
27156,"Distilled acetalization product between glucose and C12, C14, C18, C20 ,C22 alcohol",921-820-3,,Not Classified,Notified C&L,1,Not classified:1
27157,"2-sec-butyl-4,7-dihydro-1,3-dioxepin",258-488-8,53338-06-0,Acute Tox. 4,Notified C&L,113,H302:113
27162,(4-methoxyphenoxy)acetic acid,217-513-2,1877-75-4,Acute Tox. 4,Notified C&L,44,H302:39;H335:6;H315:6;H319:6
27164,5-fluoro-2-nitroaniline,219-128-5,2369-11-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Notified C&L,42,H301:40;H331:40;H373:38;H412:38;H311:40;H302:2;H312:2;H319:2;H332:1;H315:2;H335:1
27166,[nitrilotris(methylene)]trisphosphonic acid N-oxide,239-940-3,15834-10-3,Skin Corr. 1B,Notified C&L,100,H314:53;Not classified:41;H315:4;H319:6;H290:2
27167,Sodium 2-hydroxyethanesulphonate,216-343-6,1562-00-1,Not Classified,REACH registration C&L,148,Not classified:147;H315:1;H319:1
27169,p-phenoxytoluene,216-944-3,1706-12-3,,Notified C&L,1,H335:1;H315:1;H319:1
27170,Ethyl o-tolylacetate,254-871-9,40291-39-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
27172,"Rape oil, sulfated, ammonium salt",281-976-7,84082-28-0,Not Classified,REACH registration C&L,36,Not classified:6;H315:30;H319:30
27173,"2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane",411-210-0,89544-48-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H315:0;H400:0
27176,Isobutyramide,209-265-9,563-83-7,Acute Tox. 4,Notified C&L,42,H302:39;H335:2;H315:2;H319:2;Not classified:1
27177,3-dimethylaminophenol,202-727-0,99-07-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47;H302:7;H312:7;H332:3
27178,dinickel phosphide,234-828-0,12035-64-2,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H372:0;H350:0;H317:0;H410:0;H400:0
27181,"Disodium 2,4-dihydroxy-5-[(2-hydroxy-3-nitro-5-sulphonatophenyl)azo]benzoate",276-412-1,72152-59-1,Not Classified,Notified C&L,2040,Not classified:2040
27182,"Ethylenediamine, ethoxylated and propoxylated",500-047-1,26316-40-5,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,325,H317:292;H319:312;Not classified:13;H335:6;H315:9
27184,Dibutylbis[(1-oxoneodecyl)oxy]stannane,246-702-2,25168-22-3,Muta. 2;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,113,H372:111;H360:111;H410:112;H341:111;H400:109;Not classified:2;H317:2;H370:2;H314:2;H318:2;H319:2;H302:2;H315:2;H412:1;H312:2;H373:1
27186,1-(2-oxopropyl)pyridinium bromide,241-316-0,17282-41-6,,Notified C&L,4,H335:4;H315:4;H319:4
27187,cyclopropane,200-847-8,75-19-4,Press. Gas;Flam. Gas 1,Harmonised C&L,0,H220:0;Not classified:0
27189,"N,N'-hexane-1,6-diyldistearamide",223-897-2,4112-25-8,Not Classified,Notified C&L,441,Not classified:441
27193,"O,O-diethyl O-(1,6-dihydro-6-oxo-1-phenylpyridazin-3-yl) thiophosphate",204-298-5,119-12-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:42;H302:42;H312:3
27200,Etomidate,251-385-9,33125-97-2,Acute Tox. 4;Aquatic Acute 1,Notified C&L,215,H302:215;H400:213;H332:17;H410:1;H411:1
27201,"Hydrocarbons, C4, 1,3-butadiene-free",293-260-1,91052-98-1,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,3,H280:3;H220:3
27204,"Aurate(1-), tetrachloro-, hydrogen, trihydrate (8CI)",605-557-9,16961-25-4,Skin Corr. 1B;Skin Sens. 1,Notified C&L,49,H314:49;H317:49;H302:1;H318:2
27208,Ethyl 3-furoate,210-403-5,614-98-2,Flam. Liq. 3,Notified C&L,39,H226:39
27213,Polignate Sodium,617-124-1,8061-51-6,Not Classified,Notified C&L,561,Not classified:452;H319:109
27214,Cinchocaine,201-632-1,85-79-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H302:38;H318:39;H301:1;H401:1
27216,"(2-chloro-1,1-dimethylethyl)benzene",208-197-7,515-40-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H335:45;H315:46;H319:46
27217,"Formaldehyde, polymer with methanol and 1,3,5-triazine-2,4,6-triamine",600-342-6,102736-57-2,Not Classified,Notified C&L,1,Not classified:1
27218,"Cymbopogon nardus, ext., reaction products with acetone",305-049-4,94333-69-4,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,76,H226:51;H317:76;H315:76;H411:76;H318:76
27220,"Hexasodium 2,2'-[azobis[(2-sulphonato-4,1-phenylene)vinylene(3-sulphonato-4,1-phenylene)]]bis[2H-naphtho[1,2-d]triazole-5-sulphonate]",235-416-3,12222-60-5,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,17,H412:10;H319:10;Not classified:7
27221,Seleninobenzoic acid,230-271-2,6996-92-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H301:40;H331:40;H373:39;H410:40;H400:40
27224,"1H,3H,5H-Oxazolo[3,4-c]oxazole, 3,5-bis(2,4-dimethyl-3-cyclohexen-1-yl)dihydro-",700-437-3,1196069-20-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,13,H317:13;H411:13
27225,4-Isopropoxybenzaldehyde,606-183-9,18962-05-5,,Notified C&L,6,H335:5;H315:6;H319:6
27228,Isobutyric anhydride,202-603-6,97-72-3,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,349,H331:91;H314:249;H318:195;H311:155;H301:64;H302:71;H312:71;Not classified:33;H335:11;H290:1
27231,"Trisodium bis[6-amino-4-hydroxy-3-[(2-hydroxy-3,5-dinitrophenyl)azo]naphthalene-2-sulphonato(3-)]chromate(3-)",278-025-3,74920-95-9,Not Classified,Notified C&L,6,Not classified:5;H412:1
27235,"Formaldehyde, reaction products with 5 - amino - 1,3,3, - trimethylcyclohexanemethanamine and triethylenetetramine",600-749-9,1064696-75-8,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H314:1;H317:1;H412:1
27240,3-chlorobenzenesulphonyl chloride,220-753-0,2888-06-4,Skin Corr. 1B,Notified C&L,80,H314:80;H335:1;H319:1;H290:1;H318:1
27242,Stearanilide,211-290-5,637-54-7,Skin Sens. 1,Notified C&L,38,H317:38
27243,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2-(chloromethyl)oxirane, 2-methyl-2-propenoate, reaction products with formaldehyde-phenol polymer",614-207-4,68002-44-8,,Notified C&L,2,Not classified:2
27244,2-thienylacetonitrile,244-104-6,20893-30-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,131,H335:42;H302:45;H315:47;H319:47;H412:83;H301:86;H330:84;H332:44;H312:44;H311:2;H331:1
27245,Nonacosane,211-126-2,630-03-5,Not Classified,Notified C&L,5,Not classified:5
27247,cis-4-(isopropyl)cyclohexanemethanol,237-539-8,13828-37-0,Not Classified,Notified C&L,1606,Not classified:1534;H317:72;H315:50
27259,Pentyl heptanoate,231-342-0,7493-82-5,Not Classified,Notified C&L,137,Not classified:137
27261,Siparuna Guianensis extract,466-320-1,845276-94-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,25,H317:25;H411:25;H304:25
27262,"Quaternary ammonium compounds, bis(hydroxyethyl)methyltallow alkyl, chlorides, salts with bentonite",608-949-8,341537-63-1,Not Classified,Notified C&L,1,Not classified:1
27263,"Disodium 4-[[2,4-dihydroxy-5-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]phenyl]azo]benzenesulphonate",274-404-2,70210-07-0,Eye Irrit. 2,Notified C&L,4,H319:3;Not classified:1
27264,Beryllium chloride,232-116-4,7787-47-5,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,38,H301:38;H372:38;H350:38;H319:38;H335:38;H317:38;H315:38;H410:38;H411:38;H330:38;H400:38
27265,4-Butylmorpholine,600-109-9,1005-67-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1;H302:1;H315:1;H312:1
27266,"2,3-dihydrofuran",214-747-7,1191-99-7,Flam. Liq. 2,REACH registration C&L,49,H225:49;H302:5;H319:6;H335:1;H315:1
27268,6-fluoro-2-methylquinoline,214-439-2,1128-61-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,45,H315:45;H318:38;H335:5;H319:7
27269,Silver (I) hexafluorophosphate,247-428-6,26042-63-7,Skin Corr. 1B,Notified C&L,47,H314:47;H400:4;H318:3;H290:1
27270,"(2R,4S,5R)-2-Hydroxymethyl-5-ethylquinuclidine",606-880-8,219794-81-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38
27272,"1-bromo-2,3,4,5-tetrafluorobenzene",214-048-7,1074-91-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38;H226:38
27273,"2,2,2-tribromoethane-1,1-diol",208-073-2,507-42-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
27274,"2-hydroxy-N-1H-1,2,4-triazol-3-ylbenzamide",253-021-4,36411-52-6,Not Classified,REACH registration C&L,8,Not classified:7;H302:1;H304:1
27277,2-methoxy-1-naphthonitrile,240-133-3,16000-39-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38
27279,3-(3'-trifluoromethyl)phenoxy)benzaldehyde,278-976-4,78725-46-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
27282,Haloperidol,200-155-6,52-86-8,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,144,H301:142;H319:133;H335:131;H317:130;H361:132;H315:133;H410:7;H400:7;H336:7;Not classified:3;H360:1;H331:1;H372:1
27283,"Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;Methylnaphthalene Oil;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225°C to 255°C (437°F to 491°F).]",309-985-4,101896-27-9,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
27285,Isobutyl octanoate,226-744-8,5461-06-3,Not Classified,Notified C&L,88,Not classified:88
27286,Carbamazepine,206-062-7,298-46-4,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,269,H317:257;H302:261;H334:252;H362:9;H361:24;H410:5;H351:7;H332:3;H412:8;H319:1;H360:3;H312:1;Not classified:1
27288,"1,2-bis(2-methoxyphenoxy)ethane",209-040-5,553-45-7,Aquatic Acute 1,Notified C&L,38,H400:38
27290,dinotefuran (ISO); 1-methyl-2-nitro-3-(tetrahydro-3-furylmethyl)guanidine,605-399-0,165252-70-0,Acute Tox. 4,Notified C&L,310,H302:281;H410:112;H400:111
27291,Sodium 4-hydroxyphenylglycolate,273-967-1,69322-01-6,Not Classified,REACH registration C&L,33,Not classified:33
27293,Tripotassium hexakis(cyano-C)manganate,237-848-8,14023-90-6,Acute Tox. 3,Notified C&L,38,H301:38
27294,Cinnarizine,206-064-8,298-57-7,Not Classified,Notified C&L,71,Not classified:54;H410:10;H315:11;H360:9;H400:10;H317:4;H319:2;H335:2;H332:2;H302:3;H336:1
27295,Copper(2+) isononanoate,277-015-6,72915-82-3,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1;H400:1
27296,"3,5-dimethylbenzylamine",278-974-3,78710-55-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,2,H412:2;H332:2;H302:2;H314:2;H312:2;H227:1
27300,4-Cyanophenylhydrazine Hydrochloride,608-230-9,2863-98-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,49,H319:49;H335:46;H332:43;H302:47;H315:49;H312:43;H301:2;H372:2;H350:2;H331:2;H400:2;H317:2;H341:2;H311:2
27305,Tetrasodium [μ-[3-[[2-amino-5-hydroxy-6-[(2-hydroxy-5-nitro-3-sulphophenyl)azo]-7-sulpho-1-naphthyl]azo]-2-hydroxy-5-sulphobenzoato(8-)]]dichromate(4-),276-538-7,72252-58-5,Not Classified,REACH registration C&L,1315,Not classified:1315
27308,(Z)-oct-2-ene,231-577-9,7642-04-8,Flam. Liq. 2;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,45,H411:38;H315:39;H225:45;H304:1;H335:1;H319:1
27309,Mepyramine maleate,200-422-7,59-33-6,Acute Tox. 4,REACH registration C&L,46,H302:46;H335:40;H315:40;H319:40;H411:2
27310,"Disodium 5-acetamido-3-(4-acetamidophenyl)azo-4-hydroxynaphthalene-2,7-disulphonate",224-352-1,4321-69-1,Not Classified,Notified C&L,13,Not classified:12;H319:1
27311,3-bromopropionic acid,209-694-1,590-92-1,Skin Corr. 1B,Notified C&L,53,H314:53;H302:8;H332:1;H290:1;H312:1;H341:1;H318:2
27313,Nonyl beta -D-glucopyranoside,615-042-0,69984-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
27315,1-phenyl-3-(thiazol-2-yl)thiourea,238-970-4,14901-16-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H318:38
27316,Reaction mass of (2-hydroxy-1-methyl-ethyl) carbamate and 2-hydroxypropyl carbamate,614-981-3,69493-47-6,Eye Irrit. 2A,REACH registration C&L,4,H319:4
27318,"p-(2,3-epoxypropoxy)-N,N-bis(2,3-epoxypropyl)aniline",225-716-2,5026-74-4,Acute Tox. 4;Skin Sens. 1A;Muta. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,167,H317:167;H302:93;H373:44;H412:8;H341:107;H351:60;H319:89;H335:60;H315:123;H411:95;H312:3;H400:1;H334:1;H361:1
27322,"4,4'-cyclohexylidenedianiline",221-926-3,3282-99-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
27326,1-(Trimethylsilyl)-1-hexyne,609-554-3,3844-94-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38;H226:38
27329,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl methanesulfonate,700-367-3,35130-97-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,90,H317:90;H302:90;H318:89;H319:1
27330,"Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, octadecyl ester, (3β,20β)-Octadecyl 3-hydroxy-11-oxoolean-12-en-29-oate",419-580-5,,Not Classified,REACH registration C&L,5,Not classified:5
27334,4-(dodecyloxy)benzoic acid,219-004-0,2312-15-4,,Notified C&L,6,H335:5;H315:6;H319:6
27335,"Dibenzo[a,i]carbazole",205-949-6,239-64-5,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H302:38;H351:38;H400:38;H373:3;H330:3;H310:3
27336,"2,2'-[ethylenebis(oxy)]bisacetic acid",245-516-9,23243-68-7,Skin Corr. 1B,Notified C&L,6,H314:3;H318:2;H319:1;H335:1;H332:1;H302:1;H315:1
27337,"N,N'-thiobisphthalimide",231-856-5,7764-29-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H302:1;H315:1;H319:1
27339,Tripotassium hexanitritocobaltate,237-435-2,13782-01-9,Not Classified,Notified C&L,4,Not classified:4
27340,Silver hexafluoroantimonate(1-),247-429-1,26042-64-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,48,H332:46;H302:46;H411:44;H314:10;H318:3
27342,7-anilino-4-hydroxynaphthalene-2-sulphonic acid,204-320-3,119-40-4,Not Classified,REACH registration C&L,78,Not classified:27;H319:51;H335:4;H373:2;H315:2;H372:1;H351:1;H317:1;H412:1;H341:1
27343,"1,2,3,5-tetramethylbenzene",208-417-1,527-53-7,Eye Irrit. 2,Notified C&L,118,H319:115;H315:26;Not classified:3
27347,"Toluene diisocyanate, oligomeric reaction products with 2,2'-oxydiethanol and propylidenetrimethanol",500-120-8,53317-61-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,229,H317:215;H319:215;H410:14;H413:13
27349,2-(2-hydroxy-1-oxopropoxy)propionic acid,210-520-1,617-57-2,,Notified C&L,33,Not classified:33
27355,"3,6-diamino-9-[2-(methoxycarbonyl)phenyl]xanthylium chloride",263-687-8,62669-70-9,Acute Tox. 4,Notified C&L,1,H302:1
27357,Ethyl piperidine-3-carboxylate,225-681-3,5006-62-2,Skin Irrit. 2,REACH registration C&L,49,H315:49;H335:46;H319:47;H227:1
27362,2-CHLORO-N-P-TOLYL-ACETAMIDE,605-437-6,16634-82-5,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H317:38;H318:38;H400:38
27363,3-methyl-2-pyridone,213-710-2,1003-56-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H335:43;H302:43;H315:44;H318:39;H319:5
27364,"3-(diethylamino)-7-imino-7H-[1]benzopyrano[3',2':3,4]pyrido[1,2-a]benzimidazole-6-carbonitrile",257-885-3,52372-39-1,Aquatic Chronic 3,REACH registration C&L,113,H412:18;H317:3;Not classified:90;H319:2;H332:1;H302:1;H315:2;H312:1;H335:1
27365,"Rape oil, bisulfited, sodium salt",281-975-1,84082-27-9,Skin Irrit. 2,Notified C&L,44,H315:31;Not classified:13
27373,"Propanenitrile, 3,3'-iminobis-, N-tallow alkyl derivs.",270-194-1,68412-52-2,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,35,H412:35;H315:35
27375,(2S)-2-Aminobutyramide Hydrochloride,471-490-5,7682-20-4,Not Classified,REACH registration C&L,5,Not classified:4;H315:1;H319:1
27377,"2,2'-[[3-chloro-4-[(2,6-dibromo-4-nitrophenyl)azo]phenyl]imino]bisethanol",262-813-9,61480-15-7,Not Classified,Notified C&L,16,Not classified:9;H411:6;H412:1
27383,"2,2-dimethylpropane-1,3-diyl bisheptanoate",248-687-8,27841-04-9,Not Classified,Notified C&L,20,Not classified:20
27386,"Iron, citrate diphosphate sodium complexes",286-697-4,85338-24-5,Not Classified,Notified C&L,1,Not classified:1
27388,N-ethyl-N-methylcarbamoyl chloride,479-390-3,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,5,H317:5;H302:5;H315:5;H318:4;H350:1;H319:1;H335:1;H330:1
27394,2-acetylcyclopentan-1-one,216-797-5,1670-46-8,Acute Tox. 4,Notified C&L,129,H302:129
27410,p-formylbenzenesulphonic acid,226-349-0,5363-54-2,Skin Corr. 1B,Notified C&L,1,H314:1
27412,"Helichrysum arenarium, ext.",288-125-9,85665-35-6,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,151,H317:126;H411:26;H304:26;H412:75;H410:25;H319:50;H400:25
27415,Deuterium hydride,237-773-0,13983-20-5,Flam. Gas 1;Press. Gas (Comp.),Notified C&L,83,H280:83;H220:83
27417,"Schiff bases, C11-14-tert-alkyl methylene",271-766-3,68607-67-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,447,H319:1;H317:1;H302:447;H315:1;H410:1;H400:1;H332:446;H314:446;H312:446;H318:446
27419,DEXTRAN SULFATE,618-471-1,9011-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:45;H315:45;H319:45;Not classified:2
27420,Trimethoxy(methyl)silane,214-685-0,1185-55-3,Flam. Liq. 2,REACH registration C&L,1119,H225:1086;H335:551;H315:726;H319:684;H317:210;Not classified:23;H221:20;H302:22;H332:7;H226:4;H224:4
27422,Calcium terephthalate,240-291-3,16130-76-0,Not Classified,Notified C&L,2,Not classified:2
27424,trans-4-tert-butylcyclohexyl acetate,217-598-6,1900-69-2,Aquatic Chronic 2,Notified C&L,112,H411:112
27429,4-methylimidazole,212-497-3,822-36-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,288,H336:35;H319:49;H335:37;H302:249;H315:49;H351:149;H314:232;H318:119;H311:161;H312:91;H331:30;H317:30;Not classified:7
27433,"Amides, from triethylenetetramine and vegetable-oil fatty acids",273-278-6,68955-49-7,Not Classified,Notified C&L,2,Not classified:2
27441,"9-Octadecenoic acid (Z)-, ester with oxybis[propanediol] (2:3)",289-147-1,86088-80-4,Not Classified,REACH registration C&L,48,Not classified:48
27443,"(Z)-N-(3-aminopropyl)-N'-9-octadecenylpropane-1,3-diamine",249-276-6,28872-01-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,14,H373:1;H302:14;H314:14;H410:1;H411:1;H318:1;H400:14
27447,7-oxoheptanoic acid,252-790-3,35923-65-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
27452,bis(N-methyl-N-phenylhydrazine)sulfate,423-170-1,618-26-8,Flam. Liq. 2;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H372:0;H317:0;H302:0;H225:0;H410:0;H318:0;H400:0
27455,STI571 F8,465-100-2,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1;H302:1
27456,"Ferrate(1-), bis[4-[2-[5-chloro-2-(hydroxy-κO)phenyl]diazenyl-κN1]-3-(hydroxy-κO)-N-phenyl-2-naphthalenecarboxamidato(2-)]-, ammonium (1:1)",600-605-5,104815-18-1,Not Classified,Notified C&L,19,Not classified:19
27457,"Alcohols, C12-14, propoxylated",614-449-0,68409-59-6,Not Classified,Notified C&L,49,Not classified:48;H315:1;H319:1
27459,"rac-[(2R,4R)-2-(2,4-DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL]METHYL METHANESULFONATE MONOHYDROCHLORIDE",445-550-6,155661-07-7,Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Muta. 2;Repr. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,2,H301:2;H317:2;H361:2;H373:2;H410:2;H341:2;H318:2
27462,"Avens, Geum urbanum, ext.",283-472-2,84649-91-2,Flam. Liq. 3,Notified C&L,1,H226:1
27465,N2-[(phenylmethoxy)carbonyl]-L-glutamine,220-173-8,2650-64-8,Not Classified,Notified C&L,1,Not classified:1
27471,Sodium 2-methyl-2-[(1-oxoallyl)amino]propanesulphonate,225-948-4,5165-97-9,Not Classified,REACH registration C&L,294,Not classified:227;H413:56;H315:11;H319:1
27477,"Disodium 5-[[2,4-dihydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonate",229-361-4,6487-04-3,Not Classified,Notified C&L,13,Not classified:13
27478,Perhydroacenaphthene,218-412-6,2146-36-3,Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,4,H413:4;H304:4
27479,"Petrolatum (petroleum), oxidized, calcium salt",270-348-8,68425-34-3,Not Classified,REACH registration C&L,44,Not classified:43;H319:1
27481,"Exo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol",204-712-4,124-76-5,Flam. Sol. 2,REACH registration C&L,1608,H228:1601;H315:60;H335:4;H319:6;H225:1;H226:1
27483,"p-mentha-1,4(8)-diene",209-578-0,586-62-9,Asp. Tox. 1;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2308,H410:454;H317:1758;H304:2263;H400:451;H226:1779;H315:1328;H411:1856;H319:36;Not classified:2;H302:2;H335:1
27492,dichlorophen (ISO),202-567-1,97-23-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H319:0;H400:0
27494,"2-Cyclopropyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",603-153-7,126689-01-8,Flam. Liq. 3,Notified C&L,54,H226:52;H319:3;H335:3;H332:1;H302:2;H315:3;H312:1;H225:1
27499,"Acetic acid, 2-chloro-, C8-18-alkyl esters",615-314-9,71617-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H302:1;H315:1;H319:1
27501,"1,4,7,10-tetraazacyclododecane disulfate",412-080-8,112193-77-8,Acute Tox. 4;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0;H335:0;H318:0
27510,Barium decanoate,236-016-1,13098-41-4,Not Classified,Notified C&L,1,Not classified:1
27512,"Disodium [1-[(2-hydroxy-3,5-dinitrophenyl)azo]-2-naphtholato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)",274-487-5,70236-55-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,94,H410:25;H400:27;H411:47;Not classified:20;H319:8;H315:2;H412:1
27513,Copper chromite black spinel,269-053-7,68186-91-4,Not Classified,REACH registration C&L,207,Not classified:207
27515,Sodium hexadecyl sulphate,214-292-4,1120-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,63,H335:38;H315:61;H319:39;H318:23;Not classified:1
27517,"Acid chlorides, C12-18",286-989-1,85408-29-3,Skin Corr. 1B,Notified C&L,1,H314:1
27521,"2,2-dichloro-N,N-dimethyl-3-oxobutyramide",245-068-4,22543-26-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:39;H317:39;H302:39;H315:39;H318:39
27522,Benzyldimethyl[3-[(1-oxooctadecyl)amino]propyl]ammonium chloride,265-880-2,65694-10-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,25,H302:22;H315:22;H318:22;H400:22;Not classified:3
27523,p-tolyl octanoate,261-803-1,59558-23-5,Acute Tox. 4,Notified C&L,1601,H302:1601;H315:1
27526,"Fatty acids, coco, esters with diethanolamine",274-305-4,70084-81-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2,H412:1;H315:2;H319:1;H373:1;H318:1
27527,Butanol Sammelprodukt 33.,918-257-0,,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,Notified C&L,1,H336:1;H335:1;H302:1;H315:1;H225:1;H318:1
27531,Diisotridecyl adipate,247-660-8,26401-35-4,Not Classified,REACH registration C&L,187,Not classified:187
27536,Benzyltrimethylammonium chloride,200-300-3,56-93-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 4;Muta. 2;Aquatic Chronic 3,REACH registration C&L,228,H301:197;H332:158;H412:134;H341:136;H311:149;H315:55;H319:55;H314:19;H302:25;H400:15;Not classified:5;H335:4;H336:1;H318:1
27538,Ethyl 2-ethylacetoacetate,210-151-6,607-97-6,,Notified C&L,1290,H335:1287;H315:1289;H319:1289;Not classified:1
27540,"Hydrocarbons, C",295-445-2,92045-63-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
27544,2-(undec-10-enoylamino)-3-phenylpropanoic acid,446-800-7,175357-18-3,Eye Dam. 1,REACH registration C&L,4,H318:4
27545,reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran,412-450-9,131766-73-9,Skin Sens. 1,Harmonised C&L,0,H317:0
27547,5-chloropyrimidin-2-amine,226-581-2,5428-89-7,Acute Tox. 3;Eye Dam. 1,Notified C&L,47,H301:39;H318:39;H335:9;H315:9;H319:8;H331:1;H311:1;H302:2
27551,"1,1-bis(phenethyloxy)ethane",204-568-2,122-71-4,Not Classified,Notified C&L,259,Not classified:259
27552,1-(2-furyl)hexanone,238-333-0,14360-50-0,Not Classified,Notified C&L,116,Not classified:90;H315:26;H319:26;H335:1
27556,8-hydroxy-5-methyl-quinoline sulphate,921-636-3,,Skin Corr. 1A,REACH registration C&L,2,H314:2
27557,"2,4,6,7,8-pentaoxa-3,5-diphospha-1-silatricyclo[3.1.1.11,3]octane 3,5-dioxide",237-538-2,13827-38-8,Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H318:1
27559,2-acetyl-10-[3-[4-(2-hydroxyethyl)piperazinyl]propyl]-10H-phenothiazine dimaleate,227-202-3,5714-00-1,Eye Irrit. 2,Notified C&L,48,H319:38;H302:10;H318:10;H331:10
27567,"Phosphoric acid, mixed Bu and iso-Bu mono- and diesters",307-092-4,97489-49-1,Skin Corr. 1B,Notified C&L,1,H314:1
27569,"Tall oil, compd. with ethanolamine",268-069-1,68002-54-0,Aquatic Chronic 2,REACH registration C&L,6,H411:4;H315:1;H319:1;Not classified:1
27571,tert-butyl hypochlorite,208-072-7,507-40-4,Flam. Liq. 2;Self-heat. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,47,H314:41;H251:3;H318:3;H225:47;H250:38;H334:38;H271:38
27572,"N,N-dimethyl-o-toluidine",210-199-8,609-72-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H301:0;H331:0;H373:0;H412:0;H311:0
27573,"Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, acetates",269-824-8,68334-33-8,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,58,H410:38;H318:38;H400:38;H314:20;H315:2;H411:2
27576,phosphate ester of polyoxyalkylated fatty alcohol,614-696-4,68649-29-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,104,H315:103;H318:87;H319:16;Not classified:1
27580,"1,1,1,2,2-pentafluoro-6,6-dimethylheptane-3,5-dione",218-411-0,2145-68-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1;H302:1;H315:1;H312:1
27581,"Undec-10-enoic acid, compound with 2-tridecylamine (1:1)",250-731-6,31613-93-1,Acute Tox. 4,Notified C&L,1,H302:1
27582,2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate,239-203-6,15141-18-1,Skin Sens. 1,Notified C&L,2,H317:2
27583,"2,4-dichlorotoluene-α-thiol",261-687-2,59293-67-3,,Notified C&L,6,H319:6;H331:5;H335:5;H302:5;H315:6;H301:1;H311:1
27584,Salinomycin sodium salt hydrate,611-309-0,55721-31-8,Acute Tox. 3,Notified C&L,41,H301:41;H315:2;H411:1;H331:1;H319:1;H317:1
27589,Atropine methonitrate,200-156-1,52-88-0,Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H300:38;H330:38
27590,"2-(8-heptadecenyl)-N-[2-[2-(8-heptadecenyl)-4,5-dihydro-1H-imidazol-1-yl]ethyl]-4,5-dihydro-1H-imidazole-1-ethylamine",223-661-9,4008-41-7,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,4,H314:4;H317:3;H410:3;H302:1
27593,"1,2-Cyclohexanedicarboxylic acid, 1-[2-[(1-oxo-2-propen-1-yl)oxy]ethyl] ester",611-451-3,57043-35-3,Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,21,H314:21;H412:21
27594,N-(chloroacetyl)-DL-valine,223-827-0,4090-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H315:40;H319:40
27595,Europium(3+) acetate,214-670-9,1184-63-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
27596,"Fatty acids, C12-18 and C18-unsatd., reaction products with 2-[(2-aminoethyl)amino]ethanol and urea",292-844-3,91001-72-8,Not Classified,Notified C&L,1,Not classified:1
27599,Beryllium nitrate,237-062-5,13597-99-4,Ox. Sol. 2;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,39,H301:39;H372:39;H350:39;H319:39;H334:38;H335:39;H317:39;H315:39;H272:38;H411:39;H330:39
27600,6-hydroxy-2-naphthoic acid,240-759-7,16712-64-4,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,103,H412:86;H302:87;H318:86;H335:91;Not classified:8;H315:9;H319:9
27607,Manganese tris(4-oxopent-2-en-2-oate),238-188-3,14284-89-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H302:42;H315:42;H319:42;H332:2;H312:2
27609,"1,5-dihydroxyanthraquinone",204-175-6,117-12-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:39
27612,"Benzene-1,2,4,5-tetracarboxylic acid",201-879-5,89-05-4,Eye Irrit. 2,Notified C&L,125,H319:100;H335:45;H315:46;Not classified:24;H317:1;H334:1;H318:1
27615,(pentafluorophenyl)acetonitrile,211-498-6,653-30-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:47;H335:41;H332:45;H302:45;H315:47;H312:45;H301:2;H331:2;H311:2
27618,"Asparagus, ext.",283-471-7,84649-90-1,Flam. Liq. 3,Notified C&L,2,H226:1;Not classified:1
27621,3-nitrotoluene,202-728-6,99-08-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,51,H331:43;H301:43;H373:46;H311:50;H411:10;H332:4;H302:8;H330:4;H319:1;H371:1;H361:1
27624,Dimethyl chloromalonate,249-275-0,28868-76-0,Skin Corr. 1B,Notified C&L,41,H314:40;H335:1;H315:1;H319:1;H290:1;H318:1
27628,N-benzylphenethylamine,222-882-8,3647-71-0,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,44,H314:1;H302:1;H411:1;H318:1;H335:43;H315:43;H319:43
27630,"6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)trihexanoic acid, compound with 2,2',2''-nitrilotriethanol (1:3)",279-506-0,80584-92-5,Not Classified,REACH registration C&L,165,Not classified:165
27631,4-chloro-N-methylaniline,213-262-8,932-96-7,Flam. Liq. 3;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,44,H318:38;H412:38;H335:39;H226:39;H319:6;H332:5;H373:4;H302:5;H315:6;H312:5
27632,"Reaction product of 1,5-naphthylene diisocyanate (221-641-4) and cyclohexylamine (203-629-0)",923-466-5,,Flam. Sol. 1,REACH registration C&L,2,H228:2
27635,(±)-1-methylbutylamine,264-269-8,63493-28-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H314:38;H226:38
27639,Clodinafop,601-312-5,114420-56-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,89,H302:89;H411:89;H319:89
27641,maleic acid,203-742-5,110-16-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;STOT SE 3,Harmonised C&L,0,H319:0;H335:0;H317:0;H302:0;H315:0
27644,"2,6-dimethyloct-7-en-2-yl formate",246-788-1,25279-09-8,Skin Irrit. 2,REACH registration C&L,293,H315:293;H319:289
27645,"3,3-diphenylpropanol",243-466-2,20017-67-8,Acute Tox. 4,Notified C&L,1,H302:1
27648,Ethyl 2-furoate,210-404-0,614-99-3,Not Classified,Notified C&L,88,Not classified:88
27650,3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal,425-370-4,93957-50-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0
27652,"Trichloro(2,4,4-trimethylpentyl)silane",242-262-0,18379-25-4,Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,1,H314:1;H301:1;H318:1
27657,trans-2-methylcyclohexanol,231-186-3,7443-52-9,Acute Tox. 4,Harmonised C&L,0,H332:0
27662,"Tall oil, disproportionated",268-858-0,68152-92-1,,Notified C&L,33,Not classified:33
27667,"Oxirane, ethyl-, (R)-",609-448-7,3760-95-0,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Carc. 2,Notified C&L,40,H351:40;H332:40;H302:40;H225:40;H314:39;H312:40;H319:1;H335:1;H373:1;H315:1;H361:1
27668,Benzoyl fluoride,207-244-9,455-32-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,47,H314:47;H226:47;H290:1;H318:1
27669,trans-hex-3-ene,236-261-4,13269-52-8,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,44,H304:44;H225:44;H302:1
27674,(S)-[dihydro-2-oxo-3-furyl]ammonium chloride,218-571-1,2185-03-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,196,H335:195;H315:196;H319:196
27675,3-aminobenzyl alcohol,217-514-8,1877-77-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H302:4
27676,"3-phenyl-1H-naphtho[2,1-b]pyran-1-one",227-958-4,6051-87-2,Acute Tox. 4,Notified C&L,38,H302:38
27682,Metoclopramide,206-662-9,364-62-5,Acute Tox. 4;STOT SE 1,REACH registration C&L,50,H302:50;H370:10;H362:39
27684,"Jojoba, ext., hydrogenated",296-292-4,92457-12-0,Not Classified,REACH registration C&L,20,Not classified:20
27685,4-(5-methyl-1-methylene-4-hexenyl)-1-(4-methylpent-3-enyl)cyclohexene,208-546-3,532-87-6,Not Classified,Notified C&L,119,Not classified:119
27686,trinickel disulfide;nickel subsulfide,234-829-6,12035-72-2,Skin Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H372:0;H350:0;H317:0;H410:0;H341:0;H400:0
27688,"(Z)-Octadec-9-enylamine, ethoxylated",500-048-7,26635-93-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,890,H302:871;H314:196;H410:187;H318:686;H400:802;H315:549;H361:83;H411:46;H319:42;Not classified:4
27689,reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;1-(3-isopropylphenyl)-1-phenylethane;1-(2-isopropylphenyl)-1-phenylethane,430-690-2,52783-21-8,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0
27692,"Isonicotinic acid, potassium salt",607-551-1,25108-37-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
27693,"Diisooctyl 4,4'-[(dibutylstannylene)bis(oxy)]bis[4-oxoisocrotonate]",246-701-7,25168-21-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Repr. 1B;STOT RE 1,Notified C&L,35,H372:28;H319:27;H360:28;H302:27;H315:27;H341:28;H410:13;H400:13
27699,"Fatty acids, C6-12, esters with propylene glycol",288-722-4,85883-73-4,Not Classified,Notified C&L,7,Not classified:7
27701,PIGMENT ADDITIVE 009,432-260-1,,Not Classified,Notified C&L,2,Not classified:2
27702,"1H-Indole-5,6-diol, 2,3-dihydro-, hydrobromide (1:1)",604-103-7,138937-28-7,Not Classified,Notified C&L,1,Not classified:1
27704,"(S)-2-(2-Chlorophenyl)-2-(6,7-Dihydrothieno [3,2-c]Pyridin-5-(4H)-yl)Acetic acid Hydrochloride",604-442-0,144750-42-5,Acute Tox. 4,Notified C&L,40,H302:39;H315:1;H319:1
27707,"Methyl penta-2,4-dienoate",216-158-0,1515-75-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38;H226:38
27708,calcium carbide,200-848-3,75-20-7,Water-react. 1,Harmonised C&L,0,H260:0
27709,"Terephthalic acid, lithium salt",248-955-4,28313-49-7,Not Classified,Notified C&L,1,Not classified:1
27725,"Hydrocarbons, C4, 1,3-butadiene-free, polymd., dibutylene fraction",293-261-7,91052-99-2,Asp. Tox. 1;Skin Irrit. 2,REACH registration C&L,35,H315:1;H304:35;H225:33
27729,1-Aminocyclobutanecarboxylic Acid Hydrochloride,619-316-0,98071-16-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
27736,"3-(diethylamino)-7-oxo-7H-[1]benzopyrano[3',2':3,4]pyrido[1,2-a]benzimidazole-6-carbonitrile",257-884-8,52372-36-8,Skin Sens. 1,REACH registration C&L,81,H317:6;Not classified:75
27741,"3,3,4,4,5,5,5-heptafluoropentan-2-one",206-577-7,355-17-9,,Notified C&L,7,H335:6;H315:6;H319:6;H225:5;H226:2
27744,"4,7-dihydro-2-methyl-2-(3-methylbutyl)-1,3-dioxepin",258-487-2,53338-05-9,Not Classified,Notified C&L,88,Not classified:88
27746,Disodium C-[2-[(1-oxooctadecyl)amino]ethyl] sulphonatosuccinate,285-345-7,85081-55-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H318:1
27747,"1,4-Phenylenebis[(4-fluorophenyl)methanone",619-535-1,68418-51-9,Acute Tox. 4,REACH registration C&L,3,H302:3
27748,[3-(dodecyloxy)-2-hydroxypropyl]bis(2-hydroxyethyl)methylammonium chloride,228-253-4,6200-40-4,Acute Tox. 4,Notified C&L,3,H302:3
27750,(pentabromophenyl)methyl acrylate,261-767-7,59447-55-1,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,40,H413:38;H319:40;H317:2
27753,"(1S)-2-(benzylamino)-1-[(2R)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol",603-316-2,129050-27-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:1;H315:1;H318:1;H400:1;Not classified:1
27757,"2,5-dimethylanisole",216-943-8,1706-11-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:39;H302:39;H315:39;H318:39
27762,"Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides, reaction products with polyethylenepolyamines and tall-oil fatty acids, humates hydrochlorides",272-745-1,68910-55-4,Not Classified,REACH registration C&L,61,Not classified:61
27764,C.I. Solvent Red 9,609-352-5,37219-71-9,Aquatic Chronic 2,Notified C&L,83,H411:83
27765,(tosyloxy)acetonitrile,238-604-3,14562-04-0,Eye Irrit. 2,Notified C&L,38,H319:38
27766,3-methylbutan-2-one;methyl isopropyl ketone,209-264-3,563-80-4,Flam. Liq. 2,Harmonised C&L,0,H225:0
27767,m-chlorophenylhydrazine hydrochloride,219-005-6,2312-23-4,Acute Tox. 4;Resp. Sens. 1,Notified C&L,46,H302:45;H334:38;H335:4;H315:6;H319:6;H331:1;H301:1;H311:1;H317:1
27769,Perrhenic acid,237-380-4,13768-11-1,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,137,H314:137;H290:11;H302:95;H318:95;H332:83
27771,Phentermine hydrochloride,214-821-9,1197-21-3,Acute Tox. 3,Notified C&L,139,H301:139
27772,"1H-Pyrazole-3-carbonitrile, 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-",601-665-5,120068-79-3,,Notified C&L,1,H372:1;H301:1;H410:1;H311:1;H330:1;H400:1
27774,Hexatriacontane,211-127-8,630-06-8,Not Classified,Notified C&L,40,Not classified:40
27776,Bis(2-ethoxyethyl) phthalate,210-090-5,605-54-9,Not Classified,Notified C&L,3,Not classified:3
27777,Chromium difluoride,233-168-0,10049-10-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H314:43;H318:38;H302:4;H332:4;H312:4
27778,2-(ar-ethylphenyl)butyraldehyde,269-407-0,68228-11-5,Not Classified,Notified C&L,88,Not classified:88
27783,7-ethoxy-4-methylcoumarin,201-721-5,87-05-8,Not Classified,Notified C&L,90,Not classified:90
27785,"5,6,7,7a-tetrahydro-4,4,7a-trimethylbenzofuran-2(4H)-one",239-390-4,15356-74-8,Acute Tox. 2,Notified C&L,1549,H300:1548;H301:1
27786,Disodium 3-[[ethyl[4-[[4-[(3-sulphonatophenyl)azo]-1-naphthyl]azo]phenyl]amino]methyl]benzenesulphonate,274-403-7,70210-06-9,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,126,H411:51;H318:51;H412:45;H315:39;Not classified:30
27790,"N,N-bis(2-hydroxyethyl)decan-1-amide",205-234-9,136-26-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,21,H410:20;H315:20;H318:20;Not classified:1
27791,Isononane,252-053-6,34464-40-9,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,9,H304:9;H226:9
27793,4-hydroxy-3-nitrobenzonitrile,221-899-8,3272-08-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H332:38;H302:38;H315:38;H312:38
27796,Calcium Ligno Sulphonate = Ca Lignin,617-125-7,8061-52-7,Aquatic Chronic 4,Notified C&L,229,H413:112;Not classified:117
27797,"Cellulose, 2-(diethylamino)ethyl ether",618-482-1,9013-34-7,Not Classified,Notified C&L,2,Not classified:2
27800,"1-AMINO-4-BROMO-9,10-DIOXO-9,10-DIHYDRO-ANTHRACENE-2-CARBOXYLIC ACID",613-296-7,6363-90-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H335:38;H302:38;H315:38;H400:38
27806,2-benzyloxyphenol,228-461-5,6272-38-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
27808,Nicotinohydrazide,209-041-0,553-53-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:40;H315:41;H319:41;H351:5
27815,"Balsams, Peru",232-352-8,8007-00-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1558,H317:1518;H302:1376;H411:1485;H315:42;H373:14;H400:15;H412:13;H316:2;H402:1;H303:2;H401:3;Not classified:1;H319:2;H318:1
27816,"1,4-dibromo-2-(trifluoromethyl)benzene",231-620-1,7657-09-2,,Notified C&L,6,H335:5;H315:6;H319:6;H332:1;H302:1;H312:1
27817,"3,4-dichlorotoluene",202-447-9,95-75-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,82,H302:73;H411:45;H410:33;H335:3;H315:3;H319:3;Not classified:1
27823,3-ethoxypropionic acid,224-357-9,4324-38-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H315:1;H318:1
27827,Tin titanium zinc oxide,485-430-0,923954-49-8,Not Classified,REACH registration C&L,87,Not classified:87
27831,2-Amino-6-methoxypurine,606-576-5,20535-83-5,Acute Tox. 4;Muta. 2;Repr. 2,Notified C&L,4,H302:4;H361:2;H341:3;H335:1;H318:1;H319:1;H332:1;H315:1;H312:1
27839,2-ethylidenedecan-1-al,265-244-4,64825-20-3,Skin Irrit. 2,Notified C&L,88,H315:88
27841,"Decanoic acid, mixed esters with butyric acid, dipentaerythritol and octanoic acid",296-984-6,93165-95-8,Not Classified,Notified C&L,1,Not classified:1
27844,"4,9-dihydro-4-(1-methylpiperidin-4-ylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophene-10-one fumarate",252-100-0,34580-14-8,Not Classified,Notified C&L,104,Not classified:53;H302:51;H410:3;H400:3
27846,"1,2-Ethanediol, polymer with α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl), 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and 2-[(4-nonylphenoxy)methyl]oxirane",603-513-3,131794-65-5,Not Classified,Notified C&L,55,Not classified:55
27847,"4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",223-993-4,4159-77-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
27848,Povidone,618-363-4,9003-39-8,Not Classified,Notified C&L,372,Not classified:363;H319:7;H335:6;H360:6;H302:6;H315:6;H310:6;H336:2;H373:1;H412:1
27850,"Sodium 1,4-dicyclohexyl sulphonatosuccinate",245-629-3,23386-52-9,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,87,H315:69;H318:4;H319:79;Not classified:4
27852,"Avermectin b1, 4''-deoxy-4''-(methylamino)-, (4''R)-, benzoate (salt)",619-974-9,137512-74-4,Acute Tox. 3;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,51,H410:50;H301:51;H330:33;H400:51;H372:18;H331:17;H370:17;H318:18;H332:1;H312:1
27853,"Sodium 3,9-diethyltridecan-6-yl sulphate",221-925-8,3282-85-7,Acute Tox. 4,Notified C&L,39,H302:39
27857,Disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][N-[7-hydroxy-8-[(2-hydroxy-5-nitrophenyl)azo]-1-naphthyl]acetamidato(2-)]chromate(2-),274-488-0,70236-56-5,Aquatic Chronic 2,Notified C&L,13,H411:13
27858,Aluminium orthophosphate,232-056-9,7784-30-7,Not Classified,REACH registration C&L,616,Not classified:293;H335:219;H315:188;H319:188;H314:103;H332:33;H318:8;H302:1;H312:1
27859,"Hydrocarbons, C",300-257-1,93924-61-9,Carc. 1B,Harmonised C&L,0,H350:0
27863,3-amino-2-fluoropropionic acid,223-318-3,3821-81-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H318:38
27866,"2,3,3,3-tetrafluoro-2-[1,1,2,3,3,3-hexafluoro-2-[1,1,2,2-tetrafluoro-2-(fluorosulphonyl)ethoxy]propoxy]propionyl fluoride",223-824-4,4089-58-1,Skin Corr. 1B,Notified C&L,1,H314:1
27868,"2-(3-methoxypropyl)-9(or 10)-methylbenzimidazo[2,1-b]benzo[lmn][3,8]phenanthroline-1,3,6(2H)-trione",258-094-6,52673-15-1,Aquatic Chronic 3,REACH registration C&L,1,H412:1
27869,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with 2-[(2-aminoethyl)amino]ethanol",292-843-8,91001-71-7,Skin Sens. 1;Repr. 1B;Aquatic Chronic 3,Notified C&L,32,H412:29;H317:30;H360:30;H315:1;H319:1;Not classified:1;H411:1
27871,Methyl 2-iodobenzoate,210-243-6,610-97-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,84,H335:82;H315:83;H319:83;H332:1;H302:1;H312:1
27873,"Amides, C16-18 and C18-unsatd., N,N'-ethylenebis-",273-277-0,68955-45-3,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,17,H412:10;H318:10;Not classified:7
27875,"(±)-2-amino-N-(2,6-dimethylphenyl)propionamide hydrochloride",275-361-2,71395-14-7,Acute Tox. 4,Notified C&L,40,H302:40
27881,"1,9-decadiene",216-711-6,1647-16-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,60,H319:50;H335:49;H226:59;H315:50;H400:54;H410:9;Not classified:2
27884,"Tetrasodium 4,4'-bis[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazol-4-yl]azo][1,1'-biphenyl]-2,2'-disulphonate",277-018-2,72927-70-9,Not Classified,Notified C&L,2,Not classified:2
27885,"4-Thia-1-azabicyclo [3.2.0] heptane -2-caboxylic acid, 6-[[[3-(2,6- dichlorophenyl)-5-methyl-4-isoxazolyl] carbonyl] amino]-3,3- dimethyl-7-oxo-, monosodium salt, monohydrate, [2S-(2alpha, 5alpha, 6-beta)]-",603-794-2,13412-64-1,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H335:42;H315:42;H334:45;H319:42;H317:5;H302:1;H341:1
27886,"Olive oil, sulfated, potassium salt",293-420-0,91079-32-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:2;H319:3
27887,"2,4-dibromo-1-fluorobenzene",215-860-4,1435-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
27888,N-butyltriphenylphosphonium bromide,918-205-7,,Acute Tox. 3;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H301:1;H411:1;H319:1
27889,"N-methyl-N-[5-(benzylamino)penta-2,4-dienylidene]aniline hydrochloride",237-774-6,13984-07-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H332:38;H302:38;H315:38;H312:38
27892,N-tert-butylacrylamide,203-505-6,107-58-4,Acute Tox. 4,REACH registration C&L,658,H302:658;H319:446;H335:4;H315:5
27895,Karbutilate,225-439-7,4849-32-5,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H400:1
27896,C.I. Solvent Red 218,617-319-1,82347-07-7,Not Classified,Notified C&L,1,Not classified:1
27897,[R-(Z)]-N-[3-(dimethylamino)propyl]-12-hydroxy-9-octadecenamide,243-835-8,20457-75-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,35,H315:35;H410:35;H411:2;H318:35;H400:2
27898,Olive oil,232-277-0,8001-25-0,Not Classified,Notified C&L,1488,Not classified:1474;H317:13;H319:1;H226:1
27900,"1,3-dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazol-2-one",218-415-2,2147-83-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:1;H335:1
27904,"Dodecylbenzenesulphonic acid, compound with morpholine (1:1)",235-090-2,12068-08-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,84,H315:63;H319:60;H314:20;H412:3;H302:4;H318:3;Not classified:1
27910,"Polymethylenepolyphenylene polyisocyanate, oligomeric reaction products with propoxylated glycerol (>1 <6.5 mol PO)",500-207-0,68400-69-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;STOT RE 2,Notified C&L,38,H319:25;H334:38;H335:25;H332:25;H317:38;H373:25;H315:25
27913,"1,1,1-trimethyl-N-[(trimethylsilyl)oxy]silylamine",245-188-7,22737-37-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39;H318:1
27915,Non-3-yn-1-ol,250-573-8,31333-13-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
27916,Tricesium vanadate,251-916-4,34283-69-7,,Notified C&L,4,H319:4;H335:4;H332:4;H302:4;H315:4
27917,"Benzenesulfonic acid, dodecyl-, cerium(3+) salt, basic",271-535-7,68584-29-2,Not Classified,Notified C&L,9,Not classified:9
27920,(±)-2-propylpiperidine,221-801-3,3238-60-6,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,39,H301:39;H351:38;H331:39;H226:38;H311:39
27924,potassium perchlorate,231-912-9,7778-74-7,Ox. Sol. 1;Acute Tox. 4,Harmonised C&L,0,H271:0;H302:0
27925,"Pentaphosphoric acid, sodium salt",242-631-6,18859-55-7,Not Classified,Notified C&L,2,Not classified:2
27928,"2,2,2-trifluoroethyl p-toluenesulphonate",207-085-5,433-06-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:43;H315:44;H319:44;H331:1;H301:1;H311:1
27929,Benzo[a]fluorene,205-944-9,238-84-6,Not Classified,Notified C&L,4,Not classified:3;H410:1;H400:1
27935,2-Bromo-5-hydroxy-4-methoxybenzaldehyde,608-407-0,2973-59-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
27936,Sodium stearate,212-490-5,822-16-2,Not Classified,Notified C&L,523,Not classified:366;H315:99;H318:97;H319:53;H412:7;H411:6
27938,"Benzenamine, 2-ethyl-N-(2-ethylphenyl)-, (tripropenyl) derivs.",271-800-7,68608-77-5,Not Classified,Notified C&L,58,Not classified:58
27939,Sulindac,253-819-2,38194-50-2,Acute Tox. 3;Skin Sens. 1;Resp. Sens. 1;Repr. 2,Notified C&L,77,H301:75;H361:40;H317:40;H334:40;H360:35;H373:35;H319:35;H302:1;H341:1;Not classified:1
27940,Tetrabutylammonium thiocyanate,222-943-9,3674-54-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H312:38;H315:1;H319:1
27941,ALCOHOLS C6-C12 ETHOXYLATED,614-481-5,68439-45-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,2254,H302:1661;H318:2110;H315:141;H319:135;H335:60;Not classified:5;H312:3;H412:1;H400:1
27944,C.I. Mordant Yellow 59,609-391-8,37293-46-2,Not Classified,Notified C&L,2037,Not classified:2037
27945,"Silybum marianum, ext.",283-298-7,84604-20-6,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,15,H412:2;H317:2;Not classified:8;H226:2;H335:2;H315:2;H319:2;H225:1
27951,Lithium oleate,230-960-8,7384-22-7,Not Classified,REACH registration C&L,9,Not classified:9
27953,Dimethyldioctylammonium bromide,221-189-8,3026-69-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
27956,"Isooctyl (2,4-dichlorophenoxy)acetate",246-704-3,25168-26-7,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H317:38;H302:38;H400:38;H351:3;H301:3;H315:3;H319:3
27958,Sorbitan,235-671-0,12441-09-7,Not Classified,Notified C&L,514,Not classified:514
27965,"Digitalis lanata, ext.",289-787-1,90028-00-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
27967,Trilead dicitrate,208-141-1,512-26-5,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H360:1;H332:1;H373:1;H302:1;H410:1;H400:1
27969,"Residues (petroleum), hydrogenated steam-cracked naphtha;Cracked gasoil;[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 °C to 350 °C (32 °F to 662 °F).]",295-514-7,92062-00-5,Carc. 1B,Harmonised C&L,0,H350:0
27971,Sodium pivalate,214-678-2,1184-88-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,17,H335:17;H315:17;H319:17
27972,"2,3-dihydro-5,6-dimethyl-1,4-dithiin 1,1,4,4-tetraoxide",259-572-7,55290-64-7,Acute Tox. 4,Notified C&L,41,H302:41
27982,"2,9-bis[4-(phenylazo)phenyl]anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",221-264-5,3049-71-6,Not Classified,REACH registration C&L,170,Not classified:170
27983,[3-(dimethylamino)propyl](triphenyl)phosphonium bromide hydrobromide (1:1:1),608-135-2,27710-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H335:42;H315:42;H319:42
27985,Allylamine Hydrochloride,600-035-7,10017-11-5,Acute Tox. 3,Notified C&L,40,H301:39;H314:1;H318:1
27987,Bis[2-[(5-chloro-2-pyridyl)azo]-5-(diethylamino)phenolato]cobalt(1+) chloride,279-741-9,81342-98-5,Carc. 2,Notified C&L,38,H351:38
27989,4-hydroxybutan-2-one,209-693-6,590-90-9,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,130,H317:86;H315:92;H318:86;H226:40;H335:5;H319:6;H351:1;H302:1;H330:1
27996,"Piperidin-4-one, N-BOC protected",616-664-5,79099-07-3,Not Classified,Notified C&L,9,Not classified:3;H335:3;H315:5;H319:6;H302:2
28002,(hydrazinocarbonylmethyl)trimethylammonium chloride,204-629-3,123-46-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
28005,"Ethyl 2,6,6-trimethylcyclohexa-1,3-ene-1-carboxylate",252-335-9,35044-59-8,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1542,H412:1338;H317:1338;Not classified:204
28009,Selenium tetrafluoride,236-703-6,13465-66-2,,Notified C&L,1,H301:1;H331:1;H373:1;H410:1;H400:1
28010,Dibismuth carbonate dioxide,227-567-9,5892-10-4,Not Classified,REACH registration C&L,93,Not classified:8;H413:83;H335:1;H317:1;H334:1
28011,Styryl acetate,234-065-3,10521-96-7,Not Classified,Notified C&L,88,Not classified:88
28016,"Proteins, soy, enzyme-modified",274-308-0,70084-94-5,Not Classified,Notified C&L,25,Not classified:25
28021,"Ethoxybis(pentane-2,4-dionato-O,O')(propan-2-olato)titanium",271-603-6,68586-02-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,72,H315:60;H319:5;H226:11;H318:70;H335:27
28026,3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,257-943-8,52475-89-5,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,454,H317:402;H411:441;H315:13;H410:13;H318:13;H400:13
28029,Tetradonium bromide,214-291-9,1119-97-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,641,H335:95;H373:69;H302:120;H315:96;H410:28;H318:569;H400:102;H314:75;H317:19;H334:19;H332:25;H411:4;Not classified:3;H312:1;H319:2
28033,"2-Butenedioic acid (2Z)-, ester with 1,2,3-propanetriol",609-377-1,37265-42-2,Not Classified,Notified C&L,1,Not classified:1
28042,"Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",269-631-9,68308-11-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H220:0;H350:0;Not classified:0
28045,"Thiosulfuric acid, S,S'-[2-(dimethylamino)trimethylene]ester, monosodium salt",608-375-8,29547-00-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H302:38;H315:38;H319:38
28046,"Cyclohexene, 1-methyl-4-(1-methylethenyl)-, sulfurized",272-933-3,68921-26-6,Not Classified,REACH registration C&L,98,Not classified:96;H411:1;H317:1;H335:1;H319:1;H226:1
28048,"Butene, homopolymer, hydrogenated",614-821-2,68937-10-0,Not Classified,Notified C&L,51,Not classified:36;H332:14;H304:1;H226:1
28057,2-naphthoic acid,202-217-8,93-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,138,H335:137;H315:138;H319:138;H320:1
28058,Flugestone 17-acetate,219-776-9,2529-45-5,Carc. 2;Repr. 1B,Notified C&L,17,H351:16;H360:16;H361:1
28060,1-benzyl-4-(p-toluidino)piperidine-4-carbonitrile,213-544-0,972-19-0,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38
28061,"Gas oils (petroleum), heavy atmospheric;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",272-184-2,68783-08-4,Carc. 1B,Harmonised C&L,0,H350:0
28063,Isodecane,252-052-0,34464-38-5,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,1,H304:1;H225:1
28066,"1,2-Benzenedicarboxylic acid, di-C6-10-alkyl esters",271-094-0,68515-51-5,Not Classified,Notified C&L,3,Not classified:3
28068,"Acetic acid, magnesium salt, hydrate (2:1:4)",605-451-2,16674-78-5,Not Classified,Notified C&L,89,Not classified:89
28072,"Alkenes, C7-9-branched, C8-rich",307-300-3,97593-00-5,Flam. Liq. 2;Asp. Tox. 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H304:2;H225:2;H400:2
28077,2-methylbutane-1-thiol,217-515-3,1878-18-8,Acute Tox. 4,Notified C&L,1444,H302:1286;H225:158;H335:54;H315:55;H319:55
28081,Pseudohypericin,611-335-2,55954-61-5,Acute Tox. 4,Notified C&L,41,H302:41
28083,2-naphthohydrazide,254-547-7,39627-84-4,,Notified C&L,7,H335:7;H315:7;H319:7;H302:1
28086,2-[(2-nitrophenyl)amino]ethanol,225-555-8,4926-55-0,Acute Tox. 4;Eye Irrit. 2A;Aquatic Chronic 3,REACH registration C&L,82,H412:14;H302:80;H319:40;H315:23;H332:3;H312:3;H335:1;Not classified:1
28087,Etacrynic acid,200-384-1,58-54-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:39;H335:39;H332:39;H302:40;H315:40;H312:39;H318:1
28090,"[nitrilotris(methylene)]trisphosphonic acid, sodium salt",243-900-0,20592-85-2,Not Classified,REACH registration C&L,195,Not classified:185;H319:8;H302:1;H315:1;H314:1;H290:1
28091,Sulfaclozine,203-044-0,102-65-8,Not Classified,Notified C&L,1,Not classified:1
28097,Ammonium lignosulfonate,617-126-2,8061-53-8,,Notified C&L,34,Not classified:33;H412:1
28098,Dimethyloxosilane,256-344-9,47956-45-6,Not Classified,Notified C&L,16,Not classified:16
28102,2-Chloro-3-Pyridinecarbonyl chloride,610-464-1,49609-84-9,Skin Corr. 1B,Notified C&L,46,H314:46;H318:2;H290:1
28105,4-Aminocyclohexane-1-carboxylic acid,605-807-7,1776-53-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
28113,Trimethyl(vinyl)ammonium bromide,234-227-3,10603-92-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H332:38;H302:38;H315:38;H312:38
28114,Ruthenium trichloride,233-167-5,10049-08-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,169,H314:159;H302:113;H411:83;H318:107;H412:25;H413:10;H290:14;H301:1;H410:1;H400:1
28117,"(1α,2β,5α)-2-methyl-5-(1-methylvinyl)cyclohexyl acetate",244-029-9,20777-49-5,Not Classified,Notified C&L,1404,Not classified:1404
28119,"Castor oil, ester with glycerol",270-616-4,68459-67-6,Not Classified,REACH registration C&L,18,Not classified:18
28124,"Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;Coal Tar Extract;[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",308-298-7,97926-78-8,Carc. 1B,Harmonised C&L,0,H350:0
28126,"2,2'-[(3,3'-dichloro-4,4'-biphenylylene)bis(azo)]bis[2',5'-dimethoxyacetoacetanilide]",239-160-3,15110-84-6,Not Classified,Notified C&L,5,Not classified:5
28128,carbon monoxide,211-128-3,630-08-0,Press. Gas;Flam. Gas 1;Acute Tox. 3;STOT RE 1;Repr. 1A,Harmonised C&L,0,H372:0;H331:0;H360:0;H220:0;Not classified:0
28134,Butyl 2-(4-butoxyphenyl)acetate,918-209-9,,,Notified C&L,1,H302:1
28136,"Pentasodium hydrogen C,C',C''-nitrilotris(methylphosphonate)",218-791-8,2235-43-0,Eye Irrit. 2,Notified C&L,122,H319:56;Not classified:66
28139,SP Polymer,432-700-0,,Not Classified,Notified C&L,1,Not classified:1
28142,Diterbium trioxalate,213-632-9,996-33-8,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1,Notified C&L,5,H318:4;H302:5;H312:5
28146,1-amino-5-chloroanthraquinone,204-174-0,117-11-3,Eye Irrit. 2,Notified C&L,42,H319:42;H335:4;H315:4
28148,Chloroisobutyldimethylsilane,248-493-3,27490-70-6,,Notified C&L,4,H314:4;H225:4
28150,"reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate",400-570-4,,Eye Irrit. 2,Harmonised C&L,0,H319:0
28151,Bis[N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide] fumarate,277-319-9,73210-73-8,Repr. 2,Notified C&L,1,H361:1
28156,3-bromo-4-hydroxybenzoic acid,238-299-7,14348-41-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H302:39;H318:39;H315:1;H319:1
28160,"Alkyl iodides, C6-18, perfluoro",292-474-2,90622-71-2,Not Classified,REACH registration C&L,39,Not classified:39
28161,2-Benzylacrylic Acid,611-412-0,5669-19-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H335:4;H315:5;H319:6
28166,"4,4'-Methylenebis(N-butoxycarbonylcyclohexanamine)",619-422-7,99305-42-7,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H317:1;H334:1
28171,"Cyclohexaneacetaldehyde, 4-pentyl-",606-674-8,209417-14-1,Not Classified,Notified C&L,1,Not classified:1
28175,"4-({6-AMINO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE",458-850-7,,Not Classified,REACH registration C&L,1,Not classified:1
28178,1-(o-tolyl)piperazine,254-481-9,39512-51-1,,Notified C&L,8,H314:7;H335:1;H315:1;H319:1;H318:2
28184,"Gas oils (petroleum), chemically neutralized;Gasoil - unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-129-9,64742-29-6,Carc. 1B,Harmonised C&L,0,H350:0
28185,"4'-undecyl[1,1'-biphenyl]-4-carbonitrile",265-953-9,65860-74-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H315:2;H319:2;H332:1;H302:1;H312:1
28186,"potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate",402-110-8,110081-40-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
28187,Beryllium fluoride,232-118-5,7787-49-7,,Notified C&L,4,H301:4;H372:4;H350:4;H314:4;H411:4;H330:4;H311:4
28188,Cyclobutanone,214-745-6,1191-95-3,Flam. Liq. 3,Notified C&L,50,H226:40;H225:10
28189,"2,4-dimethoxy-6-pyren-1-yl-1,3,5-triazine",221-896-1,3271-22-5,Not Classified,Notified C&L,37,Not classified:37
28190,"morphothion (ISO);O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate",205-628-0,144-41-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H410:0;H311:0;H400:0
28191,"1,2,3,6,7,11b-HEXAHYDRO-PYRAZINO[2,1-a]ISOQUINOLIN-4-ONE",917-666-1,,Not Classified,REACH registration C&L,2,Not classified:2
28196,N-potassium phthalimide,214-046-6,1074-82-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,69,H315:69;H319:69;H335:63
28199,m-nitroaniline,202-729-1,99-09-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H301:0;H331:0;H373:0;H412:0;H311:0
28200,"Residues (petroleum), topping plant, low-sulfur;Heavy Fuel oil;[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]",271-763-7,68607-30-7,Carc. 1B,Harmonised C&L,0,H350:0
28202,"2-hydroxypropane-1,3-diyl didocosanoate",303-650-6,94201-62-4,Not Classified,Notified C&L,2,Not classified:2
28211,"N-(2,4-diaminophenyl)acetamide",228-912-6,6373-15-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
28212,2-methylpent-2-en-1-oic acid,221-552-0,3142-72-1,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1296,H314:1296;H318:1027;H319:1;H290:1
28213,"Cumenesulphonic acid, compound with 2-aminoethanol (1:1)",299-830-6,93904-95-1,Not Classified,Notified C&L,1,Not classified:1
28216,"1,6-hexanediylbis[trichlorosilane]",235-994-7,13083-94-8,Skin Corr. 1B,Notified C&L,40,H314:40;H290:1;H318:1
28218,Ethyl 2-formamidothiazol-4-acetate,265-300-8,64987-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
28220,"1,3-dibenzylurea",215-984-9,1466-67-7,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:39;H302:39;H319:39;H400:38
28226,"1,3:2,4-bis-O-(3,4-dimethyl bezylidene)-D-sorbitol",413-110-2,135861-56-2,Not Classified,REACH registration C&L,18,Not classified:18
28227,"10,11-dihydro-5H-dibenz[b,f]azepine-5-carbonyl chloride",251-756-5,33948-19-5,Skin Corr. 1B,Notified C&L,39,H314:39;H290:1;H318:1
28228,4'-ethoxylactanilide,208-708-3,539-08-2,Eye Irrit. 2,Notified C&L,38,H319:38
28229,Potassium cyanide,205-792-3,151-50-8,Met. Corr. 1;Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,472,H372:234;H400:471;H290:177;H410:471;H300:472;H330:472;H310:472;H319:6;H315:61;H314:2;H370:101;H318:57;Not classified:1;H373:1
28230,3-icosyl-4-henicosylidene-2-oxetanone,401-210-9,83708-14-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
28236,"Furan-2,5-dicarboxylic acid",221-800-8,3238-40-2,Eye Irrit. 2,REACH registration C&L,167,H319:167;H335:45;H315:46
28240,Ethyl bis(ethylthio)acetate,243-836-3,20461-95-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38;H226:38
28241,"2,3-dibromo-2-butene-1,4-diol",221-779-5,3234-02-4,Acute Tox. 3;Eye Irrit. 2,REACH registration C&L,41,H301:1;H319:1;H317:40
28243,2-Fluor-4-[trans-4-(trans-4-pentylcyclohexyl)-cyclohexyl]-1- trifluormethoxybenzen,604-128-3,139395-98-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
28245,Linseed oil,232-278-6,8001-26-1,Not Classified,Notified C&L,567,Not classified:453;H317:93;H319:113;H335:38;H332:38;H302:38;H315:58;H312:38;H250:1;H225:1
28248,4-Chloro-2-iodophenol,615-320-1,71643-66-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H335:1;H332:1;H302:1;H315:2;H312:1
28251,Yttrium(3+) perchlorate,237-842-5,14017-56-2,Ox. Sol. 2;Skin Corr. 1B,Notified C&L,42,H314:38;H272:42;H335:4;H315:4;H319:4
28254,(2-bromoethyl)cyclohexane,216-712-1,1647-26-3,,Notified C&L,6,H315:6;H319:6;H335:2
28256,"5,7-dichloroquinolin-8-ol",212-258-3,773-76-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H335:45;H302:42;H315:46;H318:41;H319:5
28257,"Benzenamine, 2,4-dinitro-, sulfurized, leuco derivs.",606-787-2,215058-04-1,Not Classified,Notified C&L,31,Not classified:31
28258,"Octadecanoic acid, 12-hydroxy-, homopolymer, reaction products with N1,N1-dimethyl-1,3-propanediamine, di-Me sulfate-quaternized",615-188-5,70879-66-2,Not Classified,Notified C&L,1,Not classified:1
28259,Framycetin,204-292-2,119-04-0,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H317:38;H302:38;H334:38
28260,"4-(2,6,6-trimethyl-1-cyclohexen-1-yl)butan-2-one",241-318-1,17283-81-7,Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1717,H401:8;H411:1679;H315:38;H317:1
28263,"4-amino-2,5-dimethoxybenzenesulphonamide",259-016-3,54179-10-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
28264,Ditin pyrophosphate,239-635-5,15578-26-4,Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT RE 1;STOT RE 2,REACH registration C&L,52,H372:4;H319:51;H332:4;H317:4;H373:4;H335:48;H315:48;H411:1;H318:1
28268,"2,3-dimethyl-1H-indole",202-076-2,91-55-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H302:2;H312:2;H319:1;H335:1;H315:1
28273,Sucrose hexastearate,303-034-7,94139-18-1,Not Classified,Notified C&L,1,Not classified:1
28283,"(6'R)-β,ε-carotene-3(R),3'(R)-diol dipalmitate",208-916-4,547-17-1,Not Classified,Notified C&L,2,Not classified:2
28284,"3,3'-[1,2-ethanediylbis(oxy)]bisphenol",262-630-4,61166-00-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
28287,2-thienylacetic acid,217-639-8,1918-77-0,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,70,H315:4;H318:7;H314:66;H290:5;H335:5;H319:1
28289,2-fluoro-1-methylpyridinium toluene-p-sulphonate,261-108-3,58086-67-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
28294,"2,2'-thiophene-2,5-diylbis(benzoxazole)",220-685-1,2866-43-5,Not Classified,Notified C&L,40,Not classified:40
28295,Bismuth vanadium tetraoxide,237-898-0,14059-33-7,Not Classified,REACH registration C&L,2641,Not classified:195;H373:2362;H372:79;H332:22;H335:5;H302:4;H315:5;H319:5
28299,"Diisooctyl 2,2'-[(dioctylstannylene)bis(thio)]diacetate",247-666-0,26401-97-8,Acute Tox. 4;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,622,H412:18;H372:29;H302:539;H317:521;H319:441;Not classified:83;H413:55;H373:69;H370:55;H361:39;H410:25;H400:25
28304,"2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d]-1,3-dioxin",248-561-2,27606-09-3,Acute Tox. 4,Notified C&L,1602,H302:1602
28307,"3,5-bis{1-[4-(propan-2-yl)phenyl]propan-2-yl}heteropolycycle",,,Aquatic Chronic 4,REACH registration C&L,2,H413:2
28310,Enzymatic Hydrolysate of Meat (Peptic Digest),921-826-6,,Not Classified,Notified C&L,2,Not classified:2
28315,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-8-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sufonyl]phenyl]diazenyl]-, potassium sodium salt, coupled with diazotized 2-[(4-amino-5-methoxy-2-methylphenyl)sulfonyl]ethyl hydrogen sulfate",445-040-3,,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,22,H317:22;H318:22
28316,"Soaps, stocks, soya, acidulated",270-342-5,68425-24-1,Not Classified,Notified C&L,2,Not classified:2
28317,Hexanenitrile,211-052-0,628-73-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:38;H226:43;H302:40;H315:39
28323,trans-hept-2-ene,238-727-2,14686-13-6,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H304:43;H315:43;H225:43
28326,"(2-allyloxy-1,1-dimethyl-2-oxo-ethyl) 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidin-1-yl]benzoate",603-837-5,134605-64-4,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,195,H410:157;H373:157;H400:195
28331,"9-hydroxyandrost-4-ene-3,17-dione",611-349-9,560-62-3,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.,REACH registration C&L,4,H362:3;H302:3;H351:3;H360:4
28333,"1,1,1,3,3,3-hexafluoro-2-methylpropan-2-ol",216-155-4,1515-14-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:47;H335:46;H332:42;H302:42;H315:47;H312:42
28336,"Hydrocarbons, C9-C10, n-alkanes, isoalkanes, cyclics, aromatics (2-25%)",927-344-2,,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,1,H336:1;H372:1;H304:1;H226:1;H411:1
28339,"3-methylpentane-2,4-dione",212-420-3,815-57-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H226:44
28349,6-(4-Acryloxybutyloxycarbonyloxy)-2-naphtoesäure,926-056-4,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,84,H317:84;H319:84
28353,Antimony nickel titanium oxide yellow,232-353-3,8007-18-9,Not Classified,REACH registration C&L,990,Not classified:674;H332:220;H302:256;H411:256;H317:40;H334:39;H350:40;H372:39;H315:20;H319:20;H373:1
28354,2'-hydroxypropiophenone,210-244-1,610-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44,H335:43;H315:44;H319:44
28355,"4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone",429-150-9,67887-47-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
28357,"3,4-dichloroaniline",202-448-4,95-76-1,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H331:0;H400:0;H317:0;H410:0;H318:0;H311:0
28361,"D-gluconic acid, compound with (8α,9R)-6'-methoxycinchonan-9-ol (1:1)",224-358-4,4325-25-1,,Notified C&L,1,H317:1;H302:1
28368,Hexadecan-1-ol,253-149-0,36653-82-4,Not Classified,REACH registration C&L,3136,Not classified:2253;H411:244;H319:666;H400:246;H412:216;H410:123;H336:61;H335:90;H302:62;H225:61;H312:61;H318:61;H413:267;H315:297
28369,Indium,231-180-0,7440-74-6,STOT RE 1,REACH registration C&L,226,H372:40;Not classified:114;H319:49;H335:53;H332:55;H302:56;H315:57;H312:47;H228:25;H331:8;H400:8;H311:8;H411:1
28371,5methoxy-2-nitroaniline,240-293-4,16133-49-6,Skin Sens. 1,Notified C&L,39,H317:38;H302:1;H315:1;H319:1
28374,Lithium isopropoxide,424-140-0,2388-10-5,Flam. Sol. 2;Skin Corr. 1A,Notified C&L,1,H314:1;H228:1
28376,"4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers",403-000-2,91853-67-7,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0
28378,Discandium trisulphate,236-702-0,13465-61-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:39;H319:39;Not classified:1
28379,Milrinone,278-903-6,78415-72-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,43,H331:40;H301:43;H311:41;H319:2;H350:1;H335:1;H315:1
28381,"1,3,4,6,7,8a-hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-8(5H)-one",245-890-3,23787-90-8,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1603,H401:5;H317:1307;H315:1307;H411:1307;Not classified:296
28383,"ethyl 6,8-dichlorooctanoate",435-080-1,1070-64-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
28384,Ethyl 4-nitro-3-phenyl-L-alaninate monohydrochloride,261-455-0,58816-66-3,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
28388,(S)-α-(trifluoromethyl)benzylamine,263-450-9,62197-94-8,Eye Irrit. 2,Notified C&L,38,H319:38
28390,"Oils, Arnica montana",617-119-4,8057-65-6,Not Classified,Notified C&L,76,Not classified:76
28392,Sodium naphthyl hydrogen phosphate,220-171-7,2650-44-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H335:2;H315:2;H319:2
28397,"Piperazine-1,4-dipropiononitrile",223-992-9,4159-11-9,,Notified C&L,4,H319:4;H335:4;H332:4;H302:4;H315:4;H311:4
28400,"Ambergris, ext.",284-280-1,84836-94-2,Flam. Liq. 2,Notified C&L,2,H225:1;Not classified:1
28403,"(2S)-2-amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid;hydrochloride",611-205-5,5486-79-3,Eye Irrit. 2,REACH registration C&L,4,H319:4
28406,Aluminium ammonium bis(sulphate),232-055-3,7784-25-0,Not Classified,REACH registration C&L,77,Not classified:76;H335:1;H315:1;H319:1
28412,potassium pentachlorophenolate,231-911-3,7778-73-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H301:0;H351:0;H319:0;H335:0;H400:0;H315:0;H410:0;H330:0;H311:0
28414,2-aminoethyl oleate,221-924-2,3282-75-5,Not Classified,Notified C&L,2,Not classified:2
28416,"s-triazolo[4,3-a]quinoline",205-943-3,235-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
28419,"4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride",407-020-2,132885-85-9,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H302:0
28421,"2-ethyl-2-(methoxymethyl)propane-1,3-diol",231-621-7,7658-03-9,Not Classified,Notified C&L,474,Not classified:474
28422,"Fatty acids, C12-16, esters with neopentyl glycol",286-081-5,85186-95-4,Not Classified,Notified C&L,1,Not classified:1
28423,"4,5-dihydro-2,4,4-trimethyloxazole",217-201-6,1772-43-6,Flam. Liq. 2,Notified C&L,44,H225:44
28426,Polymeric N-methylimidazolinium salt,922-958-7,,Not Classified,Notified C&L,37,Not classified:37
28427,"2,4-dimethylcyclohex-3-ene-1-methyl acetate",266-831-8,67634-26-8,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,225,H412:2;H315:2;Not classified:223
28428,"Sodium [4-[[4,5-dihydro-3-methyl-5-oxo-1-(3-sulphophenyl)-1H-pyrazol-4-yl]azo]-3-hydroxynaphthalene-1-sulphonato(4-)]chromate(1-)",258-095-1,52677-44-8,,Notified C&L,55,Not classified:54;H413:1
28429,"Alcohols, C9-11, ethers with polyethylene glycol mono-Me ether",609-266-8,366009-01-0,Eye Irrit. 2,Notified C&L,464,H319:463;Not classified:1
28431,Tricobalt bis[tetracosa-μ-oxododecaoxo[μ12-[phosphato(3-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]dodecamolybdate(3-)],235-530-3,12263-08-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 2,Notified C&L,2,H317:2;H315:2;H371:2;H319:2;H370:1
28432,N-phenylacrylamide,606-936-1,2210-24-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,44,H302:3;H315:44;H319:44;H335:40
28436,"[4-[(4,6-diamino-m-tolyl)imino]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride",202-569-2,97-26-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
28437,"(1S,6bR,9aS,11R,11bR) 11-(Acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-3H-furo[4,3,2-de]indeno[4,5,-h]-2-h]-2-benzopyran-3,6,9-trione",606-337-5,19545-26-7,Acute Tox. 1;Acute Tox. 2;Acute Tox. 1,Notified C&L,43,H300:43;H330:43;H310:43
28438,sodium fluoroacetate,200-548-2,62-74-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H300:0;H400:0;H330:0;H310:0
28442,Dibenzylamine hydrochloride,243-834-2,20455-68-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H302:38;H318:38;H335:1;H315:1;H319:1
28444,"Dodecylbenzenesulphonic acid, compound with butylamine (1:1)",235-091-8,12068-09-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H302:1;H315:1;H318:1
28448,Vinyl laurate,218-414-7,2146-71-6,Not Classified,Notified C&L,3,Not classified:3
28449,Isobutylbenzene,208-706-2,538-93-2,Flam. Liq. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,161,H410:85;H226:161;H400:85;H335:64;H315:65;H319:65;H336:9;H304:8
28451,Phosphatase,232-744-9,9013-05-2,Resp. Sens. 1,Notified C&L,7,H334:7
28460,"1,2,3,4-Butanetetracarboxylic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and 3-hydroxy-2,2-dimethylpropanal, 1,2,2,6,6-pentamethyl-4-piperidinyl ester",600-196-3,101357-36-2,Not Classified,Notified C&L,1,Not classified:1
28463,"2-[7-(1,3-dihydro-1,1,3-trimethyl-2H-benz[e]indol-2-ylidene)hepta-1,3,5-trienyl]-1,1,3-trimethyl-1H-benz[e]indolium perchlorate",245-474-1,23178-67-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H315:38;H319:38
28464,"(2-oxo-1,3-dioxolan-4-yl)methyl chloroformate",245-628-8,23385-72-0,Skin Corr. 1B,Notified C&L,38,H314:38
28472,Oxadixyl,616-492-0,77732-09-3,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,201,H412:156;H302:201
28475,Fluorphlogopite (Mg3K[AlF2O(SiO3)3]),234-426-5,12003-38-2,Not Classified,REACH registration C&L,322,Not classified:322
28476,"4-isopropyl-2,5-dioxoimidazolidine-1,3-di(propionohydrazide)",289-384-0,88122-32-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1
28481,Cyclopent-2-enylacetic acid,237-146-1,13668-61-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
28487,"Sodium (9Z,12Z)-octadeca-9,12-dienoate",212-491-0,822-17-3,Skin Irrit. 2,Notified C&L,39,H315:39
28488,C.I. Disperse Blue 55,601-909-0,12217-78-6,Not Classified,Notified C&L,1,Not classified:1
28495,"tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate",432-550-6,243858-01-7,Eye Dam. 1,Harmonised C&L,0,H318:0
28498,"Proteins, thaumatins",258-822-2,53850-34-3,Not Classified,Notified C&L,148,Not classified:77;H334:70;H335:17;H317:1;H302:1;H315:1;H319:1
28499,(±)-2-amino-3-methylbutan-1-ol,240-425-0,16369-05-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H301:1
28500,"Aluminum, benzoate C16-18-fatty acids hydroxy complexes",617-419-5,82980-54-9,Not Classified,Notified C&L,1,Not classified:1
28502,Cadmium zinc sulphide,235-672-6,12442-27-2,Not Classified,Notified C&L,5,Not classified:5
28505,"Diisooctyl 2,2'-[(dibutylstannylene)bis(thio)]diacetate",246-703-8,25168-24-5,Not Classified,Notified C&L,58,Not classified:57;H373:1;H302:1;H315:1;H319:1
28508,Sodium methyl sulphate,208-142-7,512-42-5,Eye Irrit. 2,REACH registration C&L,178,H319:101;Not classified:39;H332:38;H302:39;H315:40;H335:39;H350:1
28511,"2-Pyrrolidinone, 1-ethenyl-, polymer with 1-eicosene",920-086-1,28211-18-9,Not Classified,Notified C&L,2,Not classified:2
28512,"Methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulphonyl)benzoate",600-172-2,101200-48-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,230,H410:229;H317:229;H400:229;H319:31;Not classified:1
28514,Cinchonine hydrochloride,246-139-2,24302-67-8,,Notified C&L,3,H317:2;H302:3
28515,"Bis(salicylato-O1,O2)bis[[2,2'-oxybis[ethanolato]](1-)-O1]titanium",271-604-1,68586-03-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H335:1;H315:1;H319:1
28518,5-phenyl-2-(prop-2-ynylamino)-4-oxazolone,251-312-0,32962-46-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H301:38;H315:38;H319:38
28522,Vinyl hexanoate,221-265-0,3050-69-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H226:1
28524,N-(4-chlorophenyl)-3-hydroxy-4-[(2-methyl-5-nitrophenyl)azo]naphthalene-2-carboxamide,229-100-4,6410-30-6,Not Classified,REACH registration C&L,9,Not classified:9
28526,2-({4-[(2-hexyldecyl)oxy]phenyl}sulfonyl)butanoyl chloride,700-365-2,,Not Classified,Notified C&L,1,Not classified:1
28528,"N,N,N-trimethylanilinium bromide",240-202-8,16056-11-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43;H301:4;H311:4
28532,Sodium benzenesulphonate,208-198-2,515-42-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:41;H315:45;H319:45;H302:2;H318:2
28537,2-ethylbutyric acid,201-796-4,88-09-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2,REACH registration C&L,1650,H373:14;H315:46;H319:1643;H311:1606;H335:40;H312:43;H314:4;Not classified:2;H318:2;H361:3;H411:1
28539,Manganese distearate,222-119-9,3353-05-7,Not Classified,Notified C&L,6,Not classified:5;H315:1
28541,"Parsnip, ext.",290-129-0,90082-39-6,Asp. Tox. 1,Notified C&L,1396,H304:1386;Not classified:10
28542,"(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine",682-717-4,61869-08-7,Acute Tox. 4;Repr. 1A;Aquatic Chronic 1,Notified C&L,6,H410:3;H302:4;H360:3;Not classified:1;H361:1;H400:1
28543,"Fats, animal, mixed with vegetable oil Me esters, sulfurized",273-649-2,68991-70-8,Not Classified,Notified C&L,25,Not classified:25
28548,Bromoethane-[2H5],222-944-4,3675-63-6,Flam. Liq. 2;Acute Tox. 4;Carc. 2,Notified C&L,38,H302:38;H351:38;H225:38
28551,C.I. Sulphur Brown 4,603-649-3,1326-90-5,Not Classified,Notified C&L,1,Not classified:1
28558,Sodium tridecyl sulphate,221-188-2,3026-63-9,,Notified C&L,4,H335:4;H315:4;H319:4
28561,Litmus,215-739-6,1393-92-6,Not Classified,Notified C&L,3,Not classified:3
28564,((4-phenylbutyl)hydroxyphosphoryl)acetic acid,412-170-7,83623-61-4,Eye Dam. 1;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H373:0;H318:0
28566,"2,2,4-trimethylpentan-1-ol",204-628-8,123-44-4,Acute Tox. 4,Notified C&L,38,H302:38
28568,(2E)-3-(pyridin-3-yl)prop-2-enoic acid,606-291-6,19337-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H335:56;H315:56;H319:56
28569,"Borate(1-), bis[ethanedioato(2-)-.kappa.O1,.kappa.O2]-, lithium (1:1), (T-4)-",607-383-9,244761-29-3,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,124,H301:84;H312:83;H317:84;H318:84;H335:38;H315:39;H319:39;Not classified:1
28570,"Phosphoric acid, ammonium magnesium salt (1:1:1), hexahydrate",603-871-0,13478-16-5,,Notified C&L,4,H335:4;H315:4;H319:4
28573,Barium cyclohexanebutyrate (1:2),263-685-7,62669-65-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H332:42;H302:42
28578,methyl 2-(3-oxo-2-pentylcyclopent-1-en-1-yl)acetate,607-449-7,24863-70-5,Not Classified,REACH registration C&L,2,Not classified:2
28579,"Ethanol, 2-amino-, oligomer with .alpha.-hydro-.omega.-[(1-oxo-2-propenyl)oxy]poly(oxy-1,2-ethanediyl) ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)",606-127-3,188012-57-9,Aquatic Chronic 2,Notified C&L,106,H411:83;H335:22;H315:23;H319:23;H317:1
28581,"Fatty acids, hydrogenated tallow, distn. residues",274-307-5,70084-85-4,Not Classified,REACH registration C&L,13,Not classified:13
28584,"Molybdate (Mo7O246-), ammonium, hydrate (1:6:4)",601-720-3,12054-85-2,Not Classified,Notified C&L,209,Not classified:177;H335:29;H302:26;H315:29;H319:29;H413:2;H332:1;H412:1
28585,"4-[(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridyl)azo]-N-(2-ethylhexyl)benzenesulphonamide",259-571-1,55290-62-5,Not Classified,REACH registration C&L,101,Not classified:101
28587,5-amino-N-ethyl-2-methyl-N-phenylbenzenesulphonamide,256-998-5,51123-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
28588,"Fatty acids, olive-oil, mixed esters with glycerol and isodecanol, reaction products with lard oil and C14-18 and C16-18-unsatd. glycerides, oxidized",307-164-5,97553-09-8,Not Classified,Notified C&L,1,Not classified:1
28589,"Benzene, di-C10-14-alkyl derivs., sulfonated",285-583-1,85117-34-6,Skin Corr. 1B,Notified C&L,1,H314:1
28591,"Naphtha (petroleum), light thermal cracked, sweetened;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20°C to 100°C (68°F to 212°F).]",295-447-3,92045-65-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
28592,"Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",269-632-4,68308-12-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H220:0;H350:0;Not classified:0
28595,Dodecyltrimethylammonium bromide,214-290-3,1119-94-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,88,H301:19;H319:83;H315:83;H410:59;H400:61;H335:52;H302:44;H317:21;Not classified:4;H314:1;H332:1
28596,"1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; hydrochloride",920-341-7,61675-64-7,Acute Tox. 4;Skin Sens. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H317:2;H302:2;H361:2;H410:2;H400:2
28597,11-methyldodecyl laurate,302-853-7,94134-83-5,Not Classified,REACH registration C&L,24,Not classified:24
28598,Disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),274-489-6,70236-57-6,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,9,H411:7;H319:8;H315:2;Not classified:1
28599,"1,2,3-propanetriol glycidyl ether; 1,2,3-propanetriol, polymer with (chloromethyl)oxirane",607-502-4,25038-04-4,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,101,H335:88;H315:89;H334:88;H319:100;H302:1
28601,"Distillates (petroleum), naphtha unifiner stripper;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C",272-932-8,68921-09-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
28602,"Formaldehyde, reaction products with propylene glycol",286-695-3,85338-22-3,Not Classified,Notified C&L,1,Not classified:1
28605,5-oxohexanonitrile,233-884-3,10412-98-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H302:39;H312:39;H319:1;H315:1
28607,"6,7,9,10,12,13,20,21,23,24,26,27-dodecahydrodibenz[b,n][1,4,7,10,13,16,19,22]octaoxacyclotetracosin",238-027-7,14174-09-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
28611,4-{[diethoxy(methyl)silyl]methyl}morpholine,605-937-4,18162-75-9,Skin Irrit. 2;Eye Irrit. 2A;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,4,H402:4;H412:4;H315:4;H319:4
28614,"Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;Low boiling point naphtha;[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C",272-931-2,68921-08-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
28617,(3R)-3-(acetyloxy)-4-(trimethylammonio)butanoate hydrochloride,610-570-8,5080-50-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H335:53;H315:54;H319:55;Not classified:2
28618,p-nitrophenyl α-D-galactopyranoside,231-343-6,7493-95-0,Not Classified,Notified C&L,3,Not classified:2;H335:1;H315:1;H319:1
28620,"p-dodecylbenzenesulphonic acid, compound with 2-aminoethanol (1:1)",261-109-9,58089-99-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
28622,Ammonium 3-nitrobenzoate,242-965-2,19328-56-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,3,H302:1;H315:3;H319:3;H335:2;H228:2
28623,"1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear",271-093-5,68515-50-4,Repr. 1B,Harmonised C&L,0,H360:0
28626,"Fatty acids, C8-16(even numbered), 2-ethylhexyl esters",603-931-6,135800-37-2,Not Classified,REACH registration C&L,105,Not classified:105
28627,1-benzyl-4-(m-toluidino)piperidine-4-carbonitrile,213-543-5,972-18-9,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38
28628,Ethyl cyclohex-3-ene-1-carboxylate,239-161-9,15111-56-5,Not Classified,Notified C&L,88,Not classified:88
28629,2'-acetonaphthone,202-216-2,93-08-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1842,H411:404;H315:115;H319:73;Not classified:1333;H302:215;H335:43
28630,"Decanoic acid, monoester with glycerol",247-667-6,26402-22-2,Not Classified,REACH registration C&L,6,Not classified:6
28637,"Gases (petroleum), refinery blend;Petroleum gas;[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",272-183-7,68783-07-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H340:0;H220:0;H350:0;Not classified:0
28640,"2-Butenedioic acid (E)-, di-C8-18-alkyl esters",271-880-3,68610-90-2,Not Classified,REACH registration C&L,147,Not classified:147
28642,"N,N-diethyl-3-oxobutyramide",218-792-3,2235-46-3,Not Classified,REACH registration C&L,171,Not classified:139;H335:32;H315:32;H319:32
28644,(ethylenedioxy)dimethanol,222-720-6,3586-55-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1122,H302:1051;H315:1081;H318:877;H332:462;H335:293;H319:204;Not classified:41;H317:22;H312:16;H412:1
28648,(Trimethylsilyl)methylmagnesium chloride,603-500-2,13170-43-9,Skin Corr. 1B,Notified C&L,65,H314:65;H225:26;H260:2;H318:1
28652,"1,3,6,8-tetrachloropyrene",201-340-4,81-29-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
28654,"1,3-benzodioxol-5-ylmethyl isobutyrate",226-745-3,5461-08-5,Acute Tox. 4,Notified C&L,1398,H302:1388;H412:102;H317:102;Not classified:10
28656,(E)-hept-3-ene,238-728-8,14686-14-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:42;H304:43;H315:42;H225:43
28659,KC defense,616-511-2,7782-75-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,35,H314:32;H318:32;Not classified:3
28660,Nalbuphine,243-901-6,20594-83-6,Acute Tox. 4,Notified C&L,5,H302:5;H332:2;H336:1
28664,Sulphoacetic acid,204-627-2,123-43-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,40,H315:2;H319:2;H314:38;H312:38;H335:38
28668,"Adipic acid, compound with 2,2'-iminodiethanol",249-901-2,29867-71-8,Not Classified,Notified C&L,2,Not classified:2
28671,"Lactalbumins, hydrolyzates",270-615-9,68458-87-7,Not Classified,Notified C&L,3,Not classified:3
28672,Isovaleraldehyde,209-691-5,590-86-3,Flam. Liq. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1882,H319:1882;H335:1617;H317:1605;H225:1882;H411:1581;Not classified:54;H315:14;H226:1;H332:1
28675,"4,4'-(1-Phenylethylidene)bisphenol",605-085-3,1571-75-1,Eye Irrit. 2,Notified C&L,39,H319:38;H410:1;H400:1
28676,Selenourea,211-129-9,630-10-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H301:43;H331:44;H373:44;H410:44;H400:44;H311:1;H300:1
28677,"Barium 2-[(2-hydroxynaphthyl)azo]naphthalene-1,5-disulphonate",267-580-7,67892-47-1,Not Classified,Notified C&L,8,Not classified:8
28678,"Tetrahydro-2,4-dimethylthiophene 1,1-dioxide",213-716-5,1003-78-7,Acute Tox. 3,Notified C&L,38,H301:38
28680,"Trioctyl benzene-1,2,4-tricarboxylate",201-877-4,89-04-3,Not Classified,REACH registration C&L,16,Not classified:16
28683,Methyl 6-chloro-6-oxohexanoate,252-569-1,35444-44-1,Skin Corr. 1B,Notified C&L,45,H314:45
28686,"Poly(oxy-1,2-ethanediyl), α-(12-hydroxydodecyl)-ω-[(12-hydroxydodecyl)oxy]-",616-616-3,78336-31-9,Not Classified,Notified C&L,36,Not classified:36
28691,"Ammonium 5-(2,4,6-trioxoperhydropyrimidin-5-ylideneamino)barbiturate",221-266-6,3051-09-0,Not Classified,Notified C&L,6,Not classified:6
28693,"[1,4'-bipiperidine]-4'-carboxamide",254-548-2,39633-82-4,Acute Tox. 4;Skin Corr. 1B,Notified C&L,4,H314:4;H302:4;H319:1;H335:1;H332:1;H312:1
28694,2-chlorophenyl cyclopentyl ketone,229-802-0,6740-85-8,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,3,H317:2;H302:2;H411:3
28697,"2H-1-Benzopyran-2-methanol, 6-fluoro-3,4-dihydro-.alpha.-[[(phenylmethyl)amino]methyl]-, (.alpha.S,2S)-",603-317-8,129050-29-9,Not Classified,REACH registration C&L,1,Not classified:1
28703,Theophylline,200-385-7,58-55-9,Acute Tox. 3,REACH registration C&L,341,H301:303;H302:37;H331:8;H400:8;H332:8;H315:9;Not classified:9;H311:8;H335:1;H319:1
28707,Dantron,204-173-5,117-10-2,Carc. 2,Notified C&L,49,H351:47;H373:2;H302:2;H319:1
28708,"Aniba rosaeodora, ext., acetylated",292-475-8,90622-72-3,Not Classified,Notified C&L,52,Not classified:52
28714,Diytterbium trioxalate,213-633-4,996-34-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H312:1
28716,"Lubricating oils (petroleum), solvent-refined distd. used",295-516-8,92062-03-8,Not Classified,Notified C&L,1,Not classified:1
28717,Solvent Red 127,612-927-3,61969-48-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,4,H302:3;H411:3;Not classified:1
28718,Benzamidinium chloride,216-795-4,1670-14-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53,H335:52;H315:53;H319:53
28727,"9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene",430-830-2,26912-64-1,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
28732,2-(propylamino)ethanol,240-426-6,16369-21-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H314:38;H302:38;H332:38;H312:38
28734,"chrysoidine compound with dibutylnaphthalene sulfonic acid;dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1)",304-236-8,94247-67-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2,Harmonised C&L,0,H302:0;H315:0;H341:0;H318:0
28737,1-(2-chlorophenyl)piperazine,254-480-3,39512-50-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1;H332:1;H302:1;H312:1
28744,Linalyl propionate,205-627-5,144-39-8,Aquatic Chronic 2,REACH registration C&L,1697,H411:1299;Not classified:307;H319:91;H335:38;H315:39
28750,N-[2-(diethylamino)ethyl]acrylamide monohydrochloride,277-875-2,74443-99-5,Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
28751,3-phenylbutyraldehyde,240-362-9,16251-77-7,Not Classified,REACH registration C&L,1517,Not classified:1377;H317:139;H302:1;H312:1;H331:1;H335:1;H315:1;H319:1
28752,"Anthra[2,1,9-mna]naphth[2,3-h]acridine-5,10,15(16H)-trione",221-897-7,3271-76-9,Not Classified,REACH registration C&L,23,Not classified:22;H412:1
28753,4-Iodobenzonitrile,608-503-2,3058-39-7,,Notified C&L,11,H301:6;H319:11;H335:10;H332:7;H315:11;H312:7;H302:2
28756,4'-chloroacetanilide,208-707-8,539-03-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:45;H319:45;H332:1;H302:1;H312:1
28766,"Carbonic acid disodium salt, decahydrate",612-116-4,6132-02-1,Eye Irrit. 2,Notified C&L,43,H319:43
28767,Methanesulphonamide,221-553-6,3144-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:51;H315:51;H319:52
28769,C.I. Acid Red 226,602-823-6,12269-99-7,Not Classified,Notified C&L,1,Not classified:1
28774,"2-Propenoic acid, 3-[(4S,7R,7aR)-2,4,5,6,7,7a-hexahydro-3,7-dimethyl-1H-inden-4-yl]-2-methyl-, (2E)-",609-163-8,3569-10-6,Not Classified,Notified C&L,2,Not classified:2
28777,Methyl 4-amino-o-anisate,248-494-9,27492-84-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H302:39;H315:40;H319:40
28781,"Bis(octadeca-9(Z),12(Z)-dienoyloxy)dioctylstannane",288-888-8,85938-53-0,STOT RE 2;Aquatic Chronic 4,Notified C&L,55,H373:55;H413:55
28782,4-(2-cyanoethyl)-4-nitroheptanedinitrile,215-983-3,1466-48-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H335:38;H332:38;H302:38;H315:38;H312:38
28783,Inositol phosphates,700-206-7,,Skin Corr. 1B,Notified C&L,36,H314:36
28795,"1,5-dichloropentane",211-053-6,628-76-2,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H301:38;H319:43;H335:42;H226:43;H315:43
28797,dimethylnitrosoamine;N-nitrosodimethylamine,200-549-8,62-75-9,Acute Tox. 3;Acute Tox. 2;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H301:0;H372:0;H350:0;H411:0;H330:0
28798,Hirudin,232-279-1,8001-27-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,25,H317:25;H334:25
28800,Ammonium hydroxybenzenesulphonate,263-293-6,61886-53-1,,Notified C&L,38,Not classified:38
28804,2-Benzylacrylic acid,438-550-2,,Eye Irrit. 2,REACH registration C&L,2,H319:2
28805,3-(imidazol-4-yl)propionic acid,214-045-0,1074-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,195,H335:195;H315:195;H319:195
28806,"(2,2,2-trifluoroethyl)sulphonyl chloride",216-713-7,1648-99-3,Skin Corr. 1B,Notified C&L,42,H314:42
28807,Tritin bis(orthophosphate),239-636-0,15578-32-2,Not Classified,Notified C&L,2,Not classified:2
28808,"Benzenesulfonic acid, C10-16-alkyl derivs., potassium salts",271-534-1,68584-27-0,Eye Irrit. 2,Notified C&L,108,H319:62;H315:49;H318:46;H412:20;H302:22
28810,"Flue dust, lead-refining",273-809-1,69029-67-0,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Muta. 1B;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,32,H301:32;H372:32;H350:32;H340:32;H318:32;H360:32;H317:32;H315:32;H410:32;H330:32;H400:32
28811,"Fatty acids, C3-24",273-598-6,68990-37-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,182,H302:181;H319:86;H332:68;H315:78;H312:68;H412:35;H335:1;H413:1
28812,[2-[(allylamino)carbonyl]phenoxy]acetic acid,204-326-6,119-45-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38
